0001410578-22-000664.txt : 20220331 0001410578-22-000664.hdr.sgml : 20220331 20220330192011 ACCESSION NUMBER: 0001410578-22-000664 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 81 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220331 DATE AS OF CHANGE: 20220330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kubient, Inc. CENTRAL INDEX KEY: 0001729750 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 821808844 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39441 FILM NUMBER: 22788530 BUSINESS ADDRESS: STREET 1: 500 7TH AVE., SUITE 14A131 CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: (800) 409-9456 MAIL ADDRESS: STREET 1: 500 7TH AVE., SUITE 14A131 CITY: NEW YORK STATE: NY ZIP: 10018 10-K 1 kbnt-20211231x10k.htm 10-K
136957005185204000001729750--12-312021FYNASDAQNASDAQ14253948117561090.751.85P5YP3YP4Y6Mfalse0001729750srt:MinimumMemberus-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:WarrantMember2020-12-310001729750srt:MinimumMemberus-gaap:MeasurementInputOptionVolatilityMemberus-gaap:WarrantMember2020-12-310001729750srt:MinimumMemberus-gaap:MeasurementInputExpectedTermMemberus-gaap:WarrantMember2020-12-310001729750srt:MaximumMemberus-gaap:MeasurementInputRiskFreeInterestRateMemberus-gaap:WarrantMember2020-12-310001729750srt:MaximumMemberus-gaap:MeasurementInputOptionVolatilityMemberus-gaap:WarrantMember2020-12-310001729750srt:MaximumMemberus-gaap:MeasurementInputExpectedTermMemberus-gaap:WarrantMember2020-12-310001729750us-gaap:MeasurementInputExpectedDividendRateMemberus-gaap:WarrantMember2020-12-310001729750kbnt:EmployeesMemberkbnt:Plan2017Memberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2021-04-012021-06-300001729750kbnt:TwoThousandSeventeenEquityIncentivePlanMember2020-01-012020-12-310001729750srt:BoardOfDirectorsChairmanMember2021-10-012021-12-310001729750kbnt:ServiceProvidersMemberkbnt:Plan2017Member2021-01-012021-03-310001729750kbnt:Plan2017Member2021-01-012021-03-310001729750kbnt:ServiceProvidersMemberkbnt:Plan2017Member2020-01-012020-12-310001729750us-gaap:RetainedEarningsMember2021-12-310001729750us-gaap:AdditionalPaidInCapitalMember2021-12-310001729750us-gaap:RetainedEarningsMember2020-12-310001729750us-gaap:AdditionalPaidInCapitalMember2020-12-310001729750us-gaap:RetainedEarningsMember2019-12-310001729750us-gaap:AdditionalPaidInCapitalMember2019-12-310001729750us-gaap:CommonStockMember2021-12-310001729750us-gaap:CommonStockMember2020-12-310001729750us-gaap:CommonStockMember2019-12-310001729750kbnt:TwoThousandSeventeenEquityIncentivePlanMember2021-11-090001729750us-gaap:OverAllotmentOptionMember2020-12-280001729750us-gaap:EmployeeStockOptionMemberkbnt:ExercisePriceRangeTwoMember2021-12-310001729750us-gaap:EmployeeStockOptionMemberkbnt:ExercisePriceRangeThreeMember2021-12-310001729750us-gaap:EmployeeStockOptionMemberkbnt:ExercisePriceRangeOneMember2021-12-310001729750us-gaap:EmployeeStockOptionMemberkbnt:ExercisePriceRangeFourMember2021-12-310001729750us-gaap:EmployeeStockOptionMemberkbnt:ExercisePriceRangeTwoMember2021-01-012021-12-310001729750us-gaap:EmployeeStockOptionMemberkbnt:ExercisePriceRangeThreeMember2021-01-012021-12-310001729750us-gaap:EmployeeStockOptionMemberkbnt:ExercisePriceRangeOneMember2021-01-012021-12-310001729750us-gaap:EmployeeStockOptionMemberkbnt:ExercisePriceRangeFourMember2021-01-012021-12-310001729750us-gaap:EmployeeStockOptionMember2020-12-310001729750us-gaap:EmployeeStockOptionMember2021-01-012021-12-310001729750us-gaap:EmployeeStockOptionMember2021-12-310001729750us-gaap:EmployeeStockOptionMember2020-01-012020-12-310001729750us-gaap:PerformanceSharesMemberkbnt:Plan2021Memberus-gaap:SubsequentEventMember2022-01-012022-01-010001729750kbnt:ChiefProductOfficerMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2021-04-092021-04-090001729750kbnt:ChiefProductOfficerMemberkbnt:ShareBasedPaymentArrangementTrancheFourMember2021-04-092021-04-090001729750us-gaap:RestrictedStockUnitsRSUMemberkbnt:Plan2021Memberus-gaap:SubsequentEventMember2022-01-012022-01-010001729750kbnt:EmployeesMemberkbnt:Plan2017Memberus-gaap:ShareBasedCompensationAwardTrancheOneMember2021-04-012021-06-300001729750kbnt:GrantUnderEconomicInjuryDisasterLoanCaresActMember2021-12-3100017297502022-01-012021-12-310001729750us-gaap:ConvertibleNotesPayableMember2021-01-012021-12-310001729750us-gaap:ConvertibleNotesPayableMember2020-01-012020-12-310001729750kbnt:NotesPayableRelatedPartiesMember2020-01-012020-12-310001729750kbnt:PaycheckProtectionProgramLoanCaresActMember2020-04-062020-04-060001729750us-gaap:OverAllotmentOptionMember2020-08-142020-08-140001729750kbnt:MediacrossingIncMember2021-11-012021-11-300001729750srt:ChiefFinancialOfficerMemberkbnt:Plan2021Memberus-gaap:SubsequentEventMember2022-01-012022-01-010001729750kbnt:MediacrossingIncMember2021-12-012021-12-310001729750us-gaap:RetainedEarningsMember2021-01-012021-12-310001729750us-gaap:RetainedEarningsMember2020-01-012020-12-310001729750kbnt:EngageBdrLlcMember2018-11-142018-11-140001729750kbnt:EngageBdrLlcMemberkbnt:SettlementAgreementsMember2021-02-192021-02-190001729750kbnt:AdvisioSolutionsLlcMemberus-gaap:CustomerListsMember2021-06-040001729750kbnt:AureusHoldingsLlcDBLo70sMemberus-gaap:SettledLitigationMember2021-01-012021-12-310001729750kbnt:MediacrossingIncMemberkbnt:RestrictiveCovenantAgreementsMember2021-11-302021-11-300001729750kbnt:MediacrossingIncMemberkbnt:CustomerContractsAndRelatedCustomerRelationshipsMember2021-11-302021-11-300001729750kbnt:AdvisioSolutionsLlcMemberus-gaap:CustomerListsMember2021-06-042021-06-040001729750us-gaap:ComputerSoftwareIntangibleAssetMember2021-01-012021-12-310001729750kbnt:CapitalizedSoftwareMember2021-01-012021-12-310001729750us-gaap:CustomerListsMember2019-12-310001729750kbnt:RestrictiveCovenantAgreementsMember2019-12-310001729750kbnt:AcquiredDataMember2019-12-310001729750us-gaap:CustomerListsMember2021-12-310001729750kbnt:RestrictiveCovenantAgreementsMember2021-12-310001729750kbnt:AcquiredSoftwareMember2021-12-310001729750kbnt:AcquiredDataMember2021-12-310001729750kbnt:AccumulatedAmortizationMember2021-12-310001729750kbnt:AcquiredSoftwareMember2020-12-310001729750kbnt:AcquiredDataMember2020-12-310001729750kbnt:AccumulatedAmortizationMember2020-12-310001729750kbnt:AcquiredSoftwareMember2019-12-310001729750kbnt:AccumulatedAmortizationMember2019-12-310001729750kbnt:NotesPayableRelatedPartiesMember2021-01-012021-12-310001729750kbnt:EconomicInjuryDisasterLoanCaresActMember2020-06-232020-06-230001729750srt:MinimumMemberkbnt:NotesPayableRelatedPartiesMember2021-12-310001729750srt:MaximumMemberkbnt:NotesPayableRelatedPartiesMember2021-12-310001729750srt:ChiefExecutiveOfficerMember2020-07-280001729750kbnt:PaycheckProtectionProgramLoanCaresActMember2020-04-060001729750kbnt:EconomicInjuryDisasterLoanCaresActMember2020-06-230001729750us-gaap:WarrantMember2020-08-142020-08-140001729750us-gaap:ConvertibleNotesPayableMember2020-08-142020-08-140001729750kbnt:HoldersOfNotesPayableMember2020-08-142020-08-140001729750us-gaap:ConvertibleNotesPayableMember2020-08-122020-08-120001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:TopFourSuppliersMember2021-01-012021-12-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierEMember2021-01-012021-12-310001729750kbnt:TopThreeCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001729750kbnt:TopFiveCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001729750kbnt:CustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001729750kbnt:CustomerEMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001729750kbnt:CustomerDMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001729750kbnt:CustomerBMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2021-01-012021-12-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:TopFourSuppliersMember2020-01-012020-12-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierDMember2020-01-012020-12-310001729750us-gaap:CostOfGoodsProductLineMemberus-gaap:SupplierConcentrationRiskMemberkbnt:SupplierBMember2020-01-012020-12-310001729750kbnt:TopThreeCustomersMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001729750kbnt:TopFiveCustomersMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001729750kbnt:CustomerMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001729750kbnt:CustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001729750kbnt:CustomerGMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001729750kbnt:CustomerFMemberus-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMember2020-01-012020-12-310001729750us-gaap:IPOMember2020-12-280001729750kbnt:Plan2021Member2021-12-310001729750kbnt:Plan2017Member2021-12-310001729750kbnt:TwoThousandSeventeenStockOptionPlanMember2021-12-310001729750kbnt:UnderwritersMember2020-12-280001729750kbnt:TwoThousandSeventeenEquityIncentivePlanMember2020-11-090001729750us-gaap:WarrantMember2020-08-1400017297502019-12-310001729750kbnt:MediacrossingIncMemberkbnt:RestrictiveCovenantAgreementsMember2021-11-300001729750kbnt:MediacrossingIncMemberkbnt:CustomerContractsAndRelatedCustomerRelationshipsMember2021-11-300001729750kbnt:MediacrossingIncMember2021-11-302021-11-300001729750kbnt:MediacrossingIncMember2020-01-012020-12-310001729750kbnt:MediacrossingIncMember2021-01-012021-12-310001729750us-gaap:WarrantMember2021-01-012021-12-310001729750us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-12-310001729750us-gaap:RestrictedStockMember2021-01-012021-12-310001729750us-gaap:EmployeeStockMember2021-01-012021-12-310001729750us-gaap:WarrantMember2020-01-012020-12-310001729750us-gaap:EmployeeStockMember2020-01-012020-12-310001729750us-gaap:CustomerListsMember2021-01-012021-12-310001729750kbnt:RestrictiveCovenantAgreementsMember2021-01-012021-12-310001729750kbnt:AcquiredSoftwareMember2021-01-012021-12-310001729750kbnt:AcquiredDataMember2021-01-012021-12-310001729750kbnt:AccumulatedAmortizationMember2021-01-012021-12-310001729750kbnt:AcquiredSoftwareMember2020-01-012020-12-310001729750kbnt:AcquiredDataMember2020-01-012020-12-310001729750kbnt:AccumulatedAmortizationMember2020-01-012020-12-310001729750us-gaap:TechnologyServiceMember2021-01-012021-12-310001729750us-gaap:SellingAndMarketingExpenseMember2021-01-012021-12-310001729750us-gaap:GeneralAndAdministrativeExpenseMember2021-01-012021-12-310001729750us-gaap:TechnologyServiceMember2020-01-012020-12-310001729750us-gaap:SellingAndMarketingExpenseMember2020-01-012020-12-310001729750us-gaap:GeneralAndAdministrativeExpenseMember2020-01-012020-12-310001729750us-gaap:AdditionalPaidInCapitalMember2021-01-012021-12-310001729750us-gaap:ShareBasedPaymentArrangementNonemployeeMemberkbnt:Plan2021Memberus-gaap:SubsequentEventMember2022-01-012022-01-010001729750kbnt:TwoThousandSeventeenEquityIncentivePlanMember2021-11-092021-11-090001729750srt:ChiefExecutiveOfficerMember2020-07-282020-07-280001729750srt:ExecutiveOfficerMember2020-01-012020-12-310001729750kbnt:SecondYearBonusOn24MonthAnniversaryMembersrt:VicePresidentMemberus-gaap:PerformanceSharesMemberkbnt:EmploymentAgreementsMember2021-06-042021-06-040001729750kbnt:FirstYearBonusOn12MonthAnniversaryMembersrt:VicePresidentMemberus-gaap:PerformanceSharesMemberkbnt:EmploymentAgreementsMember2021-06-042021-06-040001729750srt:MinimumMemberus-gaap:PerformanceSharesMemberkbnt:Plan2021Memberus-gaap:SubsequentEventMember2022-01-012022-01-010001729750srt:MaximumMemberus-gaap:PerformanceSharesMemberkbnt:Plan2021Memberus-gaap:SubsequentEventMember2022-01-012022-01-010001729750kbnt:PaycheckProtectionProgramLoanCaresActMember2021-12-310001729750kbnt:PaycheckProtectionProgramLoanCaresActMember2020-12-310001729750kbnt:TwoThousandSeventeenStockOptionPlanMember2021-01-012021-12-310001729750kbnt:UnderwritersMember2020-12-282020-12-280001729750srt:BoardOfDirectorsChairmanMemberkbnt:Plan2017Member2021-01-012021-03-310001729750kbnt:EmployeesMemberkbnt:Plan2017Member2021-04-012021-06-300001729750kbnt:NonEmployeesMemberkbnt:Plan2017Member2020-01-012020-12-310001729750kbnt:EmployeesMemberkbnt:Plan2017Member2020-01-012020-12-310001729750kbnt:NotesPayableRelatedPartiesMember2021-12-310001729750us-gaap:CommonStockMember2020-01-012020-12-310001729750srt:MinimumMember2021-01-012021-12-310001729750srt:MaximumMember2021-01-012021-12-310001729750us-gaap:IPOMember2020-12-282020-12-280001729750us-gaap:IPOMember2020-08-142020-08-1400017297502020-08-142020-08-140001729750us-gaap:ConvertibleNotesPayableMember2020-08-140001729750kbnt:HoldersOfNotesPayableMember2020-08-1400017297502020-08-140001729750us-gaap:ConvertibleNotesPayableMember2020-08-120001729750kbnt:WarrantsExercisePriceTwoMember2021-01-012021-12-310001729750kbnt:WarrantsExercisePriceThreeMember2021-01-012021-12-310001729750kbnt:WarrantsExercisePriceOneMember2021-01-012021-12-310001729750kbnt:WarrantsExercisePriceFourMember2021-01-012021-12-310001729750kbnt:WarrantsExercisePriceFiveMember2021-01-012021-12-310001729750kbnt:WarrantsExercisePriceTwoMember2021-12-310001729750kbnt:WarrantsExercisePriceThreeMember2021-12-310001729750kbnt:WarrantsExercisePriceOneMember2021-12-310001729750kbnt:WarrantsExercisePriceFourMember2021-12-310001729750kbnt:WarrantsExercisePriceFiveMember2021-12-310001729750us-gaap:OverAllotmentOptionMember2020-08-140001729750us-gaap:IPOMember2020-08-140001729750kbnt:AureusHoldingsLlcDBLo70sMemberus-gaap:SettledLitigationMemberus-gaap:SubsequentEventMember2022-03-142022-03-140001729750kbnt:MediacrossingIncMember2021-11-300001729750kbnt:AdvisioSolutionsLlcMember2021-06-042021-06-040001729750kbnt:ChiefTechnologyOfficerMember2021-11-292021-11-290001729750kbnt:ChiefProductOfficerMember2021-04-092021-04-090001729750srt:VicePresidentMemberus-gaap:PerformanceSharesMemberkbnt:EmploymentAgreementsMember2021-06-042021-06-040001729750kbnt:AureusHoldingsLlcDBLo70sMemberus-gaap:SettledLitigationMember2021-12-310001729750us-gaap:AdditionalPaidInCapitalMember2020-01-012020-12-310001729750us-gaap:OverAllotmentOptionMember2020-12-282020-12-2800017297502020-01-012020-12-3100017297502021-12-3100017297502020-12-310001729750us-gaap:WarrantMember2021-01-012021-12-310001729750us-gaap:CommonStockMember2021-01-012021-12-3100017297502021-06-3000017297502022-03-2500017297502021-01-012021-12-31xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:purekbnt:itemkbnt:installment

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2021

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                     to                    

Commission file number 001-39441

KUBIENT, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

    

82-1808844

State or Other Jurisdiction of
Incorporation or Organization

I.R.S. Employer
Identification No.

500 7th Avenue, 8th Floor

New York, NY

    

10018

Address of Principal Executive Offices

Zip Code

800-409-9456

Registrant’s telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Common Stock

KBNT

Nasdaq

Common Stock Purchase Warrants

KBNTW

Nasdaq

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes    No 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  Yes    No 

Note – Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes      No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes     No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

Accelerated filer 

Non-accelerated filer  

Smaller reporting company 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes   No 

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, based upon the closing price of common stock on June 30, 2021 of $5.71 per share, was approximately $64,423,000. Shares of voting stock held by each executive officer, director and 10% stockholders have been excluded from this calculation. This determination of affiliate status is not necessarily a conclusive determination for other purposes.

As of March 25, 2022, there were 14,303,743 shares of the registrant’s common stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

None.

TABLE OF CONTENTS

Page

PART I

1

Item 1.

Business

1

Item 1A.

Risk Factors

14

Item 1B.

Unresolved Staff Comments

14

Item 2.

Properties

14

Item 3.

Legal Proceedings

14

Item 4.

Mine Safety Disclosures

14

 

 

PART II

15

Item 5.

Market for Registrant’s Common Equity, Related Shareholder Matters, and Issuer Purchases of Equity Securities

15

Item 6.

[Reserved]

16

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

Item 7A.

Quantitative and Qualitative Disclosures about Market Risk

22

Item 8.

Financial Statements and Supplementary Data

23

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

24

Item 9A.

Controls and Procedures

24

Item 9B.

Other Information

25

Item 9C.

 Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

25

PART III

26

Item 10.

Directors, Executive Officers and Corporate Governance

26

Item 11.

Executive Compensation

36

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

44

Item 13.

Certain Relationships and Related Transactions, and Director Independence

46

Item 14.

Principal Accounting Fees and Services

48

PART IV

49

Item 15.

Exhibits and Financial Statement Schedules

49

Item 16.

Form 10-K Summary

50

SIGNATURES

51

USE OF MARKET AND INDUSTRY DATA

This Annual Report on Form 10-K includes market and industry data that we have obtained from third-party sources, including industry publications, as well as industry data prepared by our management on the basis of its knowledge of and experience in the industries in which we operate (including our management’s estimates and assumptions relating to such industries based on that knowledge). Management has developed its knowledge of such industries through its experience and participation in these industries. While our management believes the third-party sources referred to in this Annual Report on Form 10-K are reliable, neither we nor our management have independently verified any of the data from such sources referred to in this Annual Report on Form 10-K or ascertained the underlying economic assumptions relied upon by such sources. Furthermore, internally prepared and third-party market prospective information, in particular, are estimates only and there will usually be differences between the prospective and actual results, because events and circumstances frequently do not occur as expected, and those differences may be material. Also, references in this Annual Report on Form 10-K to any publications, reports, surveys or articles prepared by third parties should not be construed as depicting the complete findings of the entire publication, report, survey or article. The information in any such publication, report, survey or article is not incorporated by reference in this Annual Report on Form 10-K.

TRADEMARKS, TRADE NAMES AND SERVICE MARKS

“Kubient” and other trademarks or service marks of Kubient, Inc. appearing in this registration statement are the property of Kubient, Inc. The other trademarks, trade names and service marks appearing in this Annual Report on Form 10-K are the property of their respective owners. Solely for convenience, the trademarks and trade names in this Annual Report on Form 10-K are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto.

OTHER PERTINENT INFORMATION

Unless the context otherwise indicates, when used in this Annual Report on Form 10-K, the terms “Kubient” “we,” “us,” “our,” the “Company” and similar terms refer to Kubient, Inc., a Delaware corporation and its wholly-owned subsidiary, Fidelity Media, LLC.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This report contains forward-looking statements within the meaning of the federal securities laws, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. All statements of historical fact included in this report regarding our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, plans and objectives of management are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “may,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. These forward-looking statements are based on management’s current beliefs, based on currently available information, as to the outcome and timing of future events. Forward-looking statements contained in this report include, but are not limited to, statements about:

·

our future financial performance, including our expectations regarding our revenue, annual recurring revenue, gross profit or gross margin, operating expenses, ability to generate cash flow, revenue mix and ability to achieve and maintain future profitability;

·

our beliefs regarding the possible effects of the widespread domestic and global impact of the COVID-19 pandemic, including on general economic conditions, public health, and consumer demand and financial markets, as well as our results of operations, liquidity, capital resources, and general performance in the future;

·

anticipated trends and growth rates in our business and in the markets in which we operate;

·

our ability to maintain and expand our customer base;

·

our ability to sell our platform, inclusive of KAI and expand internationally;

i

·

our ability to anticipate market needs and successfully develop new and enhanced solutions to meet those needs;

·

our ability to hire and retain necessary qualified employees to grow our business and expand our operations;

·

the evolution of technology affecting our platform; and

·

our ability to adequately protect our intellectual property.

We caution you that the foregoing list may not contain all of the forward-looking statements made in this report.

You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this report primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described elsewhere in this report. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this report. We cannot assure you that the results, events and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

GLOSSARY

“Ad network” means an intermediary network or company that acts as a broker between advertisers who want to purchase ad placements and content publishers who want to host the advertiser’s ads. Examples of advertisers are consumer good companies, multimedia companies and automobile manufacturers. Publishers in the context are website operators or app developers.

“Audience Marketplace” means the modular, highly scalable, transparent, cloud-based software platform created by the Company for real-time trading of digital, Programmatic Advertising.

“Bot” or “internet bot” means an autonomous program (or robot) running on a network (usually, the internet) that can interact with computer systems or users. Typically, Bots perform tasks that are both simple and structurally repetitive, at a much higher rate than would be possible for a human alone. According to Imperva, more than half of all web traffic is fraudulent, as it is made up of Bots rather than actual human beings.

“Brand” means a particular name used to identify a type of product or products manufactured by a particular company.

“Demand Side Platform” or “DSP” means a system that allows buyers of digital advertising space (ie, advertisers) to manage multiple ad exchange and data exchange accounts through one interface.

“Full stack” means computer engineering that encompasses databases, servers, systems engineering, and clients, across mobile applications, web-based applications and native applications.

“Latency” means the lag time between a customer click on an internet link and the conversion of that customer to a sale. The term can also refer to the lag time between ad inventory’s purchase and its display on publisher’s media.

“Omni-channel marketing” means marketing that is intended to reach target consumers across all advertising channels — mobile, video, desktop, and more — within the context of how the specific customer has interacted with a brand (for example, those first seeing an ad about a brand they have never experienced will receive a different message from those who have engaged with that brand a number of times).

“Programmatic advertising” means the purchase of advertising space meant to target audiences using software and tools that help agencies and brands target, deliver, and analyze their digital advertising efforts., rather than the traditional method of purchasing time slots in mass media, such as television programming.

“Pre-bid” means the bid placed by an advertiser for placement of its ad, verified prior to such ad being run or displayed.

ii

“Post-bid” means the verification of the running or display of an ad, after such running or display has occurred.

“Publisher” means a source of ad inventory, such as website owners, website operators or app developers. Publishers are generally either managed or owned and operated. An owned and operated publisher receives 100% of the profit for impressions sold. This is opposed to a managed publisher: a publisher that does not own its inventory but has a financial relationship with those who do.

“Supply Side Platform” or “SSP” means a platform that enables Publishers to access advertiser demand from a variety of networks, exchanges, and platforms via one interface.

“300-millisecond window” means the window of time adopted by the digital advertising industry in which a website or app has to load the content on their website and auction off the advertising space on their web property.

“Volume” means the concept buying large scale amounts of media in hopes of reaching a specific, smaller audience that lives within that larger pool.

iii

PART I

ITEM 1. BUSINESS

Overview

Kubient, Inc. (“Kubient,” “we,” “our,” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection & prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. Most importantly, it’s self-learning, getting smarter and more accurate over time. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources.  By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

Recent Updates

Paul Roberts Promoted to Chief Executive Officer

On December 16, 2021, the Company’s board of directors (with Paul Roberts abstaining from the vote) determined to remove the designation of “interim” from Mr. Roberts’ title, effective immediately, such that Mr. Roberts is now the Company’s Chief Executive Officer, Chief Strategy Officer, President and Chairman. This action represents a change in title only and Mr. Robert’s authority and power and duties and responsibilities remain the same.

MediaCrossing, Inc. Acqui-hire

On November 30, 2021, the Company entered into and consummated an Asset Purchase Agreement between the Company and MediaCrossing Inc., a Delaware corporation (“MediaCrossing”) pursuant to which the Company acquired certain assets of MediaCrossing for (i) $500,000 in cash, and (ii) if the acquired business achieves certain milestones in 2022, up to 822,369 shares of the Company’s common stock.  In connection with the transaction, the Company offered employment to ten employees of MediaCrossing, including the hiring of Michael Kalman, Founder and Former CEO of MediaCrossing, for the newly-created role of President – Agency & Brand Partnerships. Mr. Kalman brings his experience from working with leading brands to help direct the Company’s new Managed Services division, which is described in further detail later in this Annual Report on Form 10-K.

Upon the closing of the transaction, MediaCrossing was rebranded as Kubient Managed Services (“KMS”). KMS will continue to operate as a digital-first media buying agency focused on driving growth for both brands and agencies. KMS’s mission is to provide the advertising tools, technology and expertise necessary for brand leaders to focus on what matters most - growing their business. KMS leverages technology and multi-tactic initiatives to drive performance and exceed client requested KPIs through continuous innovation and client service. KMS intends to act as a true extension of our clients’ advertising teams; handling all media strategy development,

1

planning, buying and analytics, in conjunction with offering a multitude of tactics for our clients including programmatic advertising, paid social, paid search, search engine optimization, direct to publisher, and traditional media advertising.

Mitchell Berg Appointment

Effective November 29, 2021, Mitchell Berg was appointed to serve as its Chief Technology Officer of the Company.  Mr. Berg was appointed after the Company’s board of directors accepted Pavel Medvedev’s resignation effective as of November 30, 2021. Mr. Medvedev’s resignation was not in connection with any known disagreement with the Company on any matter relating to the Company’s operations, policies, or practices.

Mitchell Berg, 60, brings close to 20 years’ experience as a senior information technology executive, including several stints as Chief Technology Officer at a number of leading digital marketplaces.  Most recently, Mr. Berg worked as the Chief Technology Officer of Koddi Inc., an ad-tech marketplace, from March 2020 to October 2021.  From June 2018 to March, 2020 he served as the Chief Technology Officer of Vroom Inc. (NASDAQ:VRM), an-online car buying marketplace. From August 2016 to March 2018, Mr. Berg served as the Senior Vice President of dailymotion, a publisher-side video advertising platform that is a subsidiary of the international media conglomerate Vivendi SE (Euronext:VIV).  From July 2014 to August 2016, he was the Vice President of Display Advertising at IgnitionOne, Inc., a digital display advertising platform that was acquired by the multinational advertising company, Publicis Groupe (Euronext:PUB).  From March 2014 to July 2014, he served as the Principal Architect at Cablevision Systems Corporation (NYSE:CVC), a cable television company which was acquired by Altice Europe N.V. (Euronext:ATC).  From November 2012 to February 2014 he worked as the Vice President of Engineering at Kikin, Inc., an internet search engine.  Mr. Berg has also held senior information technology positions at SEMplest LLC, BenefitPlan Manager Corp. and The Boeing Company (NYSE: BA).  Mr. Berg holds a Bachelor of Science in Industrial Engineering and Computer Science from the University at Buffalo, a Master of Engineering in Systems Engineering from the University of Virginia, a Master of Business Administration in Technology Management from the University of Washington, and a Doctor of Philosophy in Industrial Engineering from the University of Pittsburgh.

There are no arrangements or understandings between Mr. Berg and any other persons pursuant to which he was appointed Chief Technology Officer. There are no family relationships between Mr. Berg and any director or executive officer of the Company, and Mr. Berg does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

Russian Sanctions

The current invasion of Ukraine by Russia has escalated tensions among the United States, the North Atlantic Treaty Organization (“NATO”) and Russia. The United States and other NATO member states, as well as non-member states, have announced new sanctions against Russia and certain Russian banks, enterprises and individuals. Violation of such sanctions could result in civil and criminal, monetary and non-monetary penalties, disruptions to our business, limitations on our ability to import and export products and services, and damage to our reputation. As a result, the Company had terminated 10 contractors performing software engineering services as of March 25, 2022. As a result, the Company does not currently employ or contract with any engineers located in Russia. The current political climate has reduced the available number of engineers for hire in such regions.  Furthermore, on-going conflict in Ukraine and the spread of political tensions in surrounding areas could increase the threat of cyberwarfare as well as wide-spread internet service interruptions, which would likely disrupt or delay the operations of many digitally-focused companies such as our own.

COVID-19

The novel coronavirus (“COVID-19”) pandemic continues to impact global economic conditions, as well as the Company's operations. COVID-19 had a meaningful negative impact on our financial condition, cash flows and results of operations during 2020, as revenues declined and we reduced spending in light of COVID-19 uncertainty. Although we continued to experience disruption and volatility during 2021, which could continue to have an adverse effect on our revenues and earnings in 2022, the ultimate economic impact of the pandemic remains fluid, as there continue to be periods of COVID-19 resurgence in various parts of the world. The extent of the impact of the COVID-19 pandemic in 2022 on our operational and financial performance will depend on a variety of factors, some of which are outside our control, including the duration and spread of COVID-19 and its variants, and its impact on our clients, partners, industry, and employees, all of which are uncertain at this time and cannot be accurately predicted.

2

Similarly, the economic uncertainty caused by the COVID-19 pandemic has made and may continue to make it difficult for us to forecast revenue and operating results and to make decisions regarding operational cost structures and investments. We have committed, and we plan to continue to commit, resources to grow our business, employee base, and technology development, and such investments may not yield anticipated returns, particularly if worldwide business activity continues to be impacted by the COVID-19 pandemic. The duration and extent of the impact from the COVID-19 pandemic depend on future developments that cannot be accurately predicted at this time, and if we are not able to respond to and manage the impact of such events effectively, our business may be harmed.

There can be no assurance that precautionary measures, whether adopted by us or imposed by others, will be effective, and such measures could negatively affect our sales, marketing, and client service efforts, delay and lengthen our sales cycles, decrease our employees’, clients’, or partners’ productivity, or create operational or other challenges, any of which could harm our business and results of operations.

What We Do: Audience-Based Marketing on Our Full Stack Platform

Our Audience Marketplace’s platform enables advertisers and publishers to transact directly between each other on an open, end to end real-time bidding platform for programmatic digital advertising. The advertising inventory on our platform is available in any channel: desktop, mobile, digital out-of-home, and connected devices; and in any format: video, display, audio, and native. Indeed, we believe our single, fully integrated audience platform provides a comprehensive, fraud-minimized, transparent, independent advertising marketplace that facilitates intelligent decision-making, and automated transaction execution for the programmatic advertising industry. We optimize the liquidity and effectiveness of the advertising supply chain, increasing revenue for publishers and improving return on investment for advertisers.

Our platform offers a machine learning-powered fraud prevention solution, extremely low latency times and an audience management platform which provides omni-channel access into all advertising channels, inventory and ad formats. Thanks to our management and development teams’ deep experience with artificial intelligence applications, our platform is constantly self-optimizing, using our software’s ability to analyze and learn from vast volumes of data. We are confident that the additional data we obtain from the volume of transactions on our platform helps to make our machine-learning algorithms more intelligent over time.

Advertising is sometimes defined as the transfer of a message from one party to another for the purpose of education, motivation or suggestion. Advertisers who pay to send a message, should be confident that it arrives to the individual it was intended for and delivers its expected outcome. Our solution consistently ensures this is the case, by verifying each and every message and intended audience. As a result, we believe that we process, analyze and connect billions of audience participants and devices faster and more efficiently than the industry standard.

Graphic

3

Digital Advertising Fraud Solution: Machine Learning Combined with Artificial Intelligence

Thanks to advances in technology, the advertising inventory that is bought and sold in these real time auctions during the bid stream is customized to each individual viewer. This viewer customization is often called programmatic advertising, a new form of advertising where advertisers are able to specifically target their preferred audiences and demographics (rather than placing ads in generic public forums such as billboards or during live events, in hopes that the coveted audience or demographic sees the ad). According to eMarketer, digital advertising is one of the fastest growing sectors in the advertising industry, which is expected to reach $717.44 billion by 2024; rising from $380.75 billion in 2020. Worldwide digital ad spending surged by 29% in the trailing year of 2021 to a total of $491.70 billion. Digital programmatic advertising’s reach includes channels such as online, mobile browsing, in-app, text messages, “out of home” video advertising (in locations such as gas stations and airports) and digital or internet television services. The explosive growth of programmatic digital advertising has created unique challenges for advertisers and publishers that want to connect and engage their audiences. One of the primary challenges facing the digital advertising industry is that, like the meteoric growth of digital advertising itself, fraud is also growing rapidly. Despite attempts by advertisers and publishers to prevent fraud and conduct quality assurance checks, both Forrester Research and Juniper Research estimates that the losses experienced by advertisers will more than double to $100 billion in 2023, with advertisers losing an estimated 25% of every dollar spent due to fraud. Additionally, programmatic advertising was seen by the majority of industry professionals as the overwhelming medium at highest risk of compromise to fraud. In a market of spent advertising dollars projected to increase almost 50% from 2020-2025, the total addressable market for properly servicing ad fraud is ripe for the picking.

Digital advertising fraud occurs when an ad is displayed to a fake website or Bot in an effort to falsely inflate web traffic numbers, rather than being displayed to a legitimate web site to be viewed by a human being. An advertiser that pays for an ad that is displayed to a Bot has wasted the budget spent for the placement of that ad, as it is human beings that might spend money on the product or service being advertised, as opposed to a Bot. Thus, brands and advertisers that cannot prevent their ads being shown to Bots become victims to the billions of dollars lost to ad fraud annually, as calculated by Juniper Research and Forrester Consulting.

We believe that digital advertising fraud is further exacerbated by the fact that our industry is increasingly fragmented. The most popular solutions that have emerged in the marketplace for selling digital advertising are not connected to the solutions used by industry participants for purchases of digital advertising. In other words, advertisers use DSPs to purchase digital advertising, whereas publishers use completely different platforms called SSPs to sell advertising space to those advertisers. Therefore, advertisers may not know who is selling them advertising inventory, and publishers may not know who is purchasing such inventory. With the two sides of any auction not connected, and likely not communicating with each other across different platforms, it is difficult to assign responsibility to tracking down fraud after an ad sale has already occurred. We have created a marketplace where advertisers and publishers can interact directly. This layer of direct transparency allows advertisers to more efficiently identify ad fraud, and to ensure that they are only buying advertising space that delivers the expected value of a particular campaign. Furthermore, fraud prevention is also fragmented as a result of advertisers and publishers using different platforms to conduct digital advertising auctions. Indeed, many DSPs and SSPs do not even have built-in fraud prevention solutions, instead relying on third parties to identify ad fraud after an ad is displayed. Our internally-developed fraud prevention solution is native to our platform and detects fraud before the digital advertising auction is concluded.

As a result of the fragmented, complex and inefficient infrastructure currently in use for programmatic advertising, fraud is rampant in the digital advertising marketplace. Bad actors’ use of fake websites and Bots to sell advertising space costs advertisers billions of dollars a year. A large part of the reason that widespread fraud runs rampant in the digital advertising industry is that current machine learning and fraud prevention solutions in our industry can only identify such fraud after an ad purchase has already occurred. We believe it is much harder to stop fraud when trying to catch perpetrators after the fraud has already occurred because the fraudsters have the ability to completely change the fingerprint of the Bot, which allows it to reenter the ecosystem and commit fraud again.

4

We believe it is more effective to stop fraud before it occurs than trying to catch perpetrators after the fraud has already occurred. Thus, we have developed what we believe to be the first machine learning technology that can detect fraud within the 300-millisecond window known as the “bid stream” prior to ad purchases. Our platform’s fraud detection solution, called Kubient Artificial Intelligence (“KAI”) is our patent-pending proprietary technology that uses artificial intelligence to analyze live advertising bid stream data to detect potential ad fraud, a major issue within the digital advertising ecosystem. KAI’s proprietary technology allows all advertisers to make better-informed, real-time decisions within this brief window of time by identifying potentially fraudulent activity in real-time. KAI is trained using different statistical and machine learning algorithms and is capable of detecting various types of fraud, including user fraud, device fraud, content fraud and heuristic fraud. KAI analyzes 100% of real-time programmatic data and industry-specific information to determine patterns and data points consistent with fraudulent activity, helping advertisers maximize return on ad spend and protecting publishers. KAI is fully integrated into Kubient’s Audience Marketplace, or alternatively, can be deployed as a standalone application or enterprise solution on third party real time bidding platforms.

Latency Solution: Machine Learning

We believe that our platform allows us to process digital advertising auctions faster than the competition. Faster auctions ensure that ad campaigns create more impressions that are seen by consumers, as consumers are less likely to become frustrated by slowly loading websites or apps (which normally results in consumers leaving such websites or apps before the ad is displayed).

To substantially reduce and minimize latency issues across our fully integrated open marketplace, we use a highly-specialized programming language originally designed to be used in extremely fast (but highly dependable) digital telephone communications switches, as well as quant-based speed trading of securities on Wall Street. In addition, our platform’s proprietary machine-learning algorithms, sophisticated data processing, high volume storage, detailed analytics capabilities, and a distributed infrastructure that supercharges our bidding process and helps our customers place, and win, more bids for advertising space. We believe we are transforming the digital advertising industry by analyzing billions of data points in record real time speed to enable our solution to make complex decisions in milliseconds, and to execute over 1 million queries per second, billions of transactions per week and trillions of bid requests per month.

Additional Platform Functionalities

Not only do we believe our platform works faster, more efficiently and more safely in terms of fraud than our competition, we also believe that it provides added functionality over our competitors, such as real time reporting of ad sales, and an open audience marketplace which enables publishers, including websites, mobile applications, video and other digital media properties, to connect their advertising inventory more efficiently and effectively to buyers across the entire advertising ecosystem, including brands, DSPs, ad networks and advertising agencies.

In addition, our platform’s functionality allows us to quickly adapt to emerging media channels that might have been previously overlooked by the digital marketing ecosystem. For example, outdoor advertising, often referred to as out of home media, such as billboards, bus-stop shelters, public elevators, airport monitors and gas station pump placards, has not traditionally been connected to digital advertising sources. However, these traditional forms of out of home media are increasingly being converted to digital signage. Unlike their traditional out of home counterparts, these updated digital signs, often referred to as digital out of home (“DOOH”) media, can display programmatic advertising, such that all of the advantages of our Audience Marketplace can be applied to this rapidly proliferating media channel. By allowing brands, DSPs, ad networks, advertising agencies and brands to bid on DOOH publishers’ inventory in real-time, just as if DOOH screens were video screens on a desktop computer or mobile device, our Audience Marketplace will allow advertisers to scale campaigns across new and thriving media channels, thereby maximizing inventory fill rates and increasing the audiences that advertisers may target by digital means.

Kubient Managed Services (KMS)

The Company has embraced platforms, tools and a culture that’s designed to help clients achieve their required outcomes. We remain focused on differentiating by helping advertisers achieve tangible, quantifiable outcomes such as heightened brand awareness and increased sales. As such, the Company believes that its Kubient Managed Services division will be able to benefit advertisers by providing: (i) better audience and performance insight, campaign control, transparency, and execution (ii) expert staff with varied, relevant backgrounds to assist advertisers, and (iii) access to quality tools and platforms for advertisement placement with an emphasis on return on media investment.

5

Furthermore, KMS will provide advertising agencies and advertisers with several significant competitive advantages relative to existing media buying vendors, such as:

Managed services at scale. KMS provides strategy, planning, execution and reporting to advertising agencies and advertisers that do not have the capital and expertise to deliver impactful programmatic digital media campaigns at scale.
Audience Marketplace and KAI Integration. The company intends to utilize Kubient’s transparent and fraud-free publisher supply from its Audience Marketplace powered by KAI whenever appropriate for (KMS) Managed Service campaigns.
Leveraging data. Digital media advertising is a data-driven industry, and we believe all key players in the space require insightful analytics.  Due to the sheer volume of data available on online users, however, we believe advertisers and agencies have struggled to gain valuable insights in a timely, actionable fashion, especially price action and audience data.
Operating in real-time with transparent reporting. The massive volume and real-time creation of data generally precludes effective human review, analysis, optimization and implementation of advertising campaigns. This, in turn, makes it difficult and timely for existing providers of digital solutions to deliver transparency with in-market campaigns which we’ve solved by providing clients with accurate, reliable dashboard reporting.
Achieving measurable and repeatable results. In aiming to improve methods of measuring campaign success, advertisers are seeking tangible, quantifiable outcomes such as heightened brand awareness and increased sales. Similarly, publishers are demanding higher fill rates and maximum spend from advertisers.

Additional Platform Functionalities

Not only do we believe our platform works faster, more efficiently and more safely in terms of fraud than our competition, we also believe that it provides added functionality over our competitors, such as real time reporting of ad sales, and an open audience marketplace which enables publishers, including websites, mobile applications, video and other digital media properties, to connect their advertising inventory more efficiently and effectively to buyers across the entire advertising ecosystem, including brands, DSPs, ad networks and advertising agencies.

In addition, the acquisition of MediaCrossing and its re-branding to KMS, has also brought Kubient the systems and processes required to execute complex campaigns at scale. With a laser focus on maintaining the agility to adapt to evolving client needs, KMS is designed to execute campaigns with precision regardless of volume, using software and automation that can scale with increased client engagement. This agility also allows the team to adapt to an ever-changing advertising landscape and add new solutions in short order.

Intellectual Property

We have filed two provisional patents, one relating to our inventory and decision management system that allows DOOH media buying agencies to purchase ads on our programmatic and real-time-bidding marketplace, and one relating to our KAI real time, digital advertising fraud prevention solution. In addition, we have filed six registered trademarks, and we have filed an additional trademark application relating to our brand name, corporate logos and KAI product.

Customers and Revenue

We provide our customers with a platform to connect advertisers and publishers. Generally, our revenue generation process begins with publishers. When a publisher aims to fill the available advertising space on its website or app, we typically enter into a twelve-month master service agreement allowing the publisher to sell advertising inventory through our platform. Once the publisher executes our master service agreement and is accepted onto our platform, the publisher is allowed to electronically communicate with our platform through its ad server, in order to provide us information about the publisher’s advertising inventory, user base, minimum sale prices and other data signals, as applicable. We also enter into master service agreements to allow third-party exchanges that aggregate publishers’ available advertising inventory to sell such inventory on our platform. We earn a mark-up, which is the spread between what we collect from advertisers and what we remit to publishers. We only pay for inventory when an advertiser is connected to a publisher and an impression is successfully delivered. We sometimes refer to the amount we pay publishers for inventory upon the delivery of an

6

impression as “cost pay.” As described further below, cost pay is generally lower than what advertisers ultimately spend to have their ad impression delivered on a publisher’s website or app.

We also typically enter into twelve-month master service agreements with advertisers that wish to purchase advertising inventory, either on our platform or through their DSP. Our proprietary algorithms use the industry information available (from advertisers, publishers, third parties and our own internal database) to automatically target and bid on publishers’ inventory to meet an advertiser’s campaign objective. We generate revenue from advertisers by charging them fees on a sliding scale based on a percentage of their spend on advertising purchased through our platform, the total of which we sometimes refer to as “gross spend.”

Thanks to the speed of our platform, the matching of publisher and advertiser occurs in fractions of a second, within the short time frame of the bidstream. We recognize revenue upon the completion of each matching transaction, at the moment when an impression has been delivered to the consumer viewing a website or application. We generally bill and collect the full purchase price of impressions from advertisers, unless the advertiser pays through its DSP, in which case the DSP is the entity that pays our fees. In either case, our gross revenue from each impression is equal to gross spend minus cost pay.

We consider our customers to be those that generate revenue during the period and is a mix of direct publishers, third-party exchanges that aggregate both publishers’ available advertising inventory and advertising budgets, along with direct advertisers and advertising agencies. Further, the Company’s definition of “customer” encompasses advertisers that purchased even a single impression on the Company’s platform during the period, not just advertisers that signed a twelve-month master service agreement.

We believe that growth of the programmatic advertising market is important for our ability to continually grow our business. Adoption of programmatic advertising by advertisers allows us to acquire new customers and grow revenue from existing customers. We also believe that current industry trends will lead more advertisers to seek out a better fraud prevention solution to protect their advertising budgets, such as the one offered on our platform.

Similarly, we believe that the adoption of programmatic advertising by unique advertising inventory owners, such as digital out of home content providers for which we have developed a unique solution, will allow us to expand the volume and type of advertising inventory that we present to advertisers using our platform.

KAI

In addition, during the first quarter of 2020, we allowed two clients to beta test KAI, our fraud prevention technology powered by machine learning. Our Supply Side Platform also provides KAI with hundreds of millions of rows of data in real-time which improves accuracy, and provides our clients the ability to prevent the purchase of non-human or fraudulent advertising traffic.

Based on the success of the beta test of KAI, beginning in the fourth quarter of 2020, we began providing potential KAI customers with a free KAI audit, which provides our prospective customer with the intricate details of types and quantity of ad-fraud occurring on their platforms as a means of demonstrating KAI’s product differentiation and its ability to prevent ad fraud. After conducting client satisfaction surveys after a series of free KAI audits, the Company discovered that the bulk of its new customers were far more interested in contracting for access to the Audience Marketplace as a whole, rather than contracting for the use of KAI as a standalone product. Accordingly, the Company decided to terminate such free KAI audits, and instead, the Company intends to sell KAI as part of the overall package of solutions available through the Company’s Audience Marketplace.

KMS

With our acquisition of MediaCrossing and re-brand to KMS in November 2021, we are now able to provide middle-market (and sometimes underserved) advertisers and agencies with access to advertising services. KMS is a managed service solution that provides our clients with access to the platforms, people, and processes to plan and activate advertising campaigns across media types and platforms at scale.

The KMS team is staffed by subject matter experts with the expertise required to plan and execute campaigns across programmatic, search, social, and traditional media channels to reach a client’s expected outcome. The services provided to our clients are specific to media planning, buying, and reporting with a focus on digital media formats.

7

Prior to the acquisition, MediaCrossing was platform agnostic and remains so. This gives the KMS team a broad suite of solutions they can deploy to meet client needs. With the addition of Kubient’s offerings, the solution set has and will continue to grow.

The KMS team has also brought Kubient the systems and processes required to execute complex campaigns at scale. With a laser focus on maintaining the agility to adapt to evolving client needs, KMS is designed to execute campaigns with precision regardless of volume using software and automation that can scale with increased client engagement. This agility also allows the team to adapt to an ever-changing advertising landscape and add new solutions in short order.

KMS primarily operates as an agency of record for brands, but also provides agencies and brands with the skillsets and tools that they lack via more narrow engagements. Whether planning and executing a brand’s annual advertising efforts or pitching in on a project with an agency, the KMS team devotes the same energy and effort to provide a positive outcome for our client.

Growth Strategy

Organic Growth

The key elements of our long-term growth strategy are as follows:

·

Enhancing our existing auction technology to improve adoption among publishers and advertisers, which we expect will increase our revenue.

·

Further developing our fraud prevention system, which is powered by our proprietary KAI machine learning technology.

·

Growing our customer base by increasing our salesforce to engage brands, agencies, website owners, app owners and other connected device owners, to facilitate marketplace participation. This will allow us to reach more audiences and garner larger budgets, growing our revenue and building long lasting customer relationships.

Providing a proficient and cost-effective solution for advertisers and agencies with Kubient Managed Services (KMS) where we deliver strategy, planning, execution and reporting to those constituents that do not have the capital and/or the expertise to deliver impactful digital media campaigns at scale.

·

Launching and scaling our reach with advertisers by introducing real-time auctions into a previously static corners of the marketplace, such as digital out of home channels, allowing for video advertising at gas stations, hotels and airports.

·

Further developing our Audience Marketplace platform to improve omni-channel relevance, and personalization at scale.

·

Further diversifying both our products and revenue streams to include stand-alone applications that address advertisers’ business needs, such as first party data hosting, and audience targeting solutions.

·

Increasing our global footprint across the globe, especially in Latin America, Asia-Pacific, Europe, the Middle East and Africa.

M &A Growth

In addition to the long-term, organic growth discussed above, we intend to opportunistically acquire companies that expand our core technologies and introduce the Company to potential new client bases that are potentially accretive to the Company’s future earnings. At present, Kubient is looking for companies that will grow its existing ecosystem of services by adding additional direct publishers, direct advertising partnerships, as well as ones that provide additional engineering, operational, business development, and human capital resources.

8

Industry Overview

Most consumers are unaware that when they browse a webpage, watch a video on the internet, use a mobile app or watch an internet-connected TV, there is often a behind-the-scenes auction for the purchase and sale of digital advertising space as the consumer’s desired content loads. In such auctions, advertisers (i.e., ad space buyers, such as sporting goods or consumer products manufacturers) purchase advertising space from publishers (i.e., ad space sellers, such as mobile app developers or website operators). Advertisers bid on each impression and if the bid is won, the ad is displayed on the publisher’s website or app being viewed by the consumer.

As the technology behind these auctions began to develop, traditional methods of digital advertising were used, where manual negotiations conducted by human brokers played a vital role in deciding the prices of digital advertising inventory to be bought and sold. Similarly, human brokers sought to place ad inventory in the digital equivalents of traditional public forums such as billboard-like banner ads or during digitally-broadcast sporting events, in hopes that the largest audience possible might see an ad.

However, in recent years, the technology behind these auctions has changed dramatically. Now, “real time bidding” has become an automated process that enables the buying and selling of individual impressions for each digital ad in milliseconds. In the blink of an eye, real time digital auctions determine what ad will display, where the ad will be displayed and what price the advertiser has to pay to the publisher for displaying the ad. The real time auction process is currently in the process of completely replacing the role of a human broker, by automating the buying and selling of ad space in a 300 millisecond window called the “bid stream.”

Another significant challenge facing participants in the digital marketing industry is the problem of latency, or loading wait times. Existing participants in the digital advertising marketplace have invested billions of dollars in large and cumbersome system infrastructures that are costly and slow by today’s standards. Their outdated infrastructure has caused hundreds of companies to provide a patchwork of solutions to address the slow and costly nature of the current digital advertising infrastructure that we believe are ineffective when compared with our solution. As a result of this patchwork of solutions, we believe the digital advertising marketplace has become complex and inefficient, with relatively long delays before an ad is displayed becoming commonplace. These delays often result in a user leaving a website or smartphone app before the advertiser’s content loads. If the user does not view the ad which the advertiser paid to place on the publisher’s website or app, then the advertiser has wasted the budget spent for the placement of that ad.

The problem of ineffective digital advertising has created large-scale lost revenue in our industry. In their 2020 “Not Another State of Marketing Report”, Hubspot states that only 61% of marketers believe their marketing strategy is effective. Furthermore, 40% of marketers say proving their ROI of their marketing activities is their top marketing challenge, with over 10% indicating that they are unable to measure the ROI of their digital advertising campaigns. Given that ROI is generally the main driver of digital advertising decision making, the inability to calculate it correctly, or at all, will continue to perpetuate the ineffective digital advertising environment.

To combat the large-scale loss in advertising dollars spent, the landscape of marketing from the perspective of metric-based analysis has evolved. In their 2021 “The State of Marketing” report, Salesforce states that marketers are embracing more sophisticated metrics to cater to various KPI standards, with 78% of marketers reprioritizing their metrics due to the previous pandemic conditions. The following metrics are the most tracked by marketing organizations: revenue, marketing/sales funnel performance, customer satisfaction analytics, content engagement, customer acquisition cost, customer retention rates, web/mobile analytics, customer referral rates/volume, and customer lifetime value. While all of these marketing KPIs saw an increase across the board, customer referral rates, customer acquisition costs, and content engagement saw the biggest year-over-year jumps in adoption. Additionally, a related study published by Salesforce estimated that 60% of customer interactions would take place online; a rapid acceleration from the reported 49% in 2019. The increasing need for effective advertising spend has seemingly illuminated the increasing need by both publishers and advertisers to cut fraudulent advertising engagement significantly.

9

Competition

We derive our revenue from the digital advertising market, which is rapidly evolving, highly competitive, complex and fragmented. We currently compete for advertising spend with large, well-established companies as well as smaller, privately-held companies. Some of our larger competitors with more resources may be better positioned to execute on advertising campaigns conducted over multiple channels such as social media, mobile and video, yet we provide unique channels not found in the digital advertising market typically, such as the true programmatic DOOH auctions we perform. We believe that this, coupled with our other capabilities, will allow us to keep step with the larger competitors in the short term and surpass them in the long term.

While the majority of the market is dominated by two companies, Facebook and Google, we do not consider them to be our competitors. Our growth is focused in the rest of the available market and there are many companies who compete with us for that share. The Trade Desk is one of our fastest growing competitors for brand and advertiser budgets with a solid foundation and strong cash flow and client base. Their product known as a Demand Side Platform competes with our own Demand Side Platform however, we believe our platform has key advantages, such as built-in proprietary fraud prevention, direct publisher connections, a Supply Side Platform and a centralized auction hub. These advantages, in our opinion, provide us with more leverage when approaching advertisers and requesting budget. There are other platforms and exchanges that can be considered a competitor to one or more of our products as well.

A majority of our competitors are significantly larger than we are and have more capital to invest in their businesses however they operate on technology we consider to be outdated and inferior to our newer more agile technology. Competitors could also seek to gain market share by reducing the prices they charge to advertisers, introducing products and solutions that are similar to ours or introducing new technology tools for advertisers and digital media properties, yet the failure of these competitors to offer transparency on pricing as we do is likely to reduce or negate such impact. Moreover, increased competition for video advertising inventory from digital media properties could result in an increase in the portion of advertiser revenue that we must pay to digital media property owners to acquire that advertising inventory which is beneficial to us as our technology offers a more efficient auction thus allowing us to reduce cost for advertisers and increase revenue for publishers.

Some large advertising agencies that represent advertising customers have their own relationships with digital media properties and can directly connect advertisers with digital media properties. Our business will suffer to the extent that our advertisers and digital media properties purchase and sell advertising inventory directly from one another or through other companies that act as intermediaries between advertisers and digital media properties. Other companies that offer analytics, mediation, ad exchange or other third-party solutions have or may become intermediaries between advertisers and digital media properties and thereby compete with us. Any of these developments would make it more difficult for us to sell our solutions and could result in increased pricing pressure, reduced profit margins, increased sales and marketing expenses or the loss of market share.

Other companies that offer analytics, mediation, ad exchange or other third-party solutions have or may become intermediaries between advertisers and digital media properties and thereby compete with us. Despite this, we believe that they do not offer a full software suite like us, as such, the long-term effect of any interruption caused by such companies will be limited.

Our fraud prevention solution competes with the small landscape of other fraud prevention companies such as Human, Double Verify and Integral Ad Science. However, we believe that our product is the only product in this space that has patent pending technology allowing it to perform instream prevention as opposed to the landscapes standard.

10

Sales and Marketing

Given our self-serve business model, we focus on supporting, advising and training our customers to use our platform independently as soon as they are ready to transact. There is an element of education about our platform that requires us to invest in sales and marketing programs and personnel to grow our business. We focus our efforts to build this awareness through trade shows and sponsored events.

The addition of KMS has augmented our sales and marketing capabilities by adding assigned account managers, real time dashboard monitoring, performance analysis, as well as quarterly client reviews, ensuring that our advertising clients using the Audience Marketplace have all logistics running smoothly and that any assistance they need would be there in an instant.

As of March 25, 2022, our sales and marketing team consisted of 14 employees. The team employs a consultative approach to both new and existing customers. Once a new customer has access to our platform, they work closely with our customer service teams as they onboard the new customer and provide continuous support throughout the early campaigns. Typically, once a customer has gained some initial experience, it will move to a fully self-serve model and request support as needed.

Seasonality

Our cash flows from operations vary from quarter to quarter due to the seasonal nature of advertiser spending. For example, many advertisers devote a disproportionate amount of their advertising budgets to the fourth quarter of the calendar year to coincide with increased holiday purchasing. Indeed, in digital advertising, seasonal downswings typically occur at the start in January (the beginning of the calendar year) and October (the beginning of the fiscal year for many companies). Upswings occur in December (the end of the calendar year) and September (the end of the fiscal year for many companies). This is due to the timing of when budgets are negotiated and distributed. Other swings occur around holidays, and other large consumer focused events such as Black Friday and Cyber Monday.

Platform Development

Part of our dedication to innovation means that we are constantly improving our platform, with new features and products being routinely released. We empower our development teams by encouraging them to release updated features and increase functionality fast and often. As a company, we are always exploring new and better ways to continuously improve the performance of our technology. Our development teams are intentionally lean and nimble in nature, providing for transparency and accountability.

Privacy and Data Protection Regulation

Privacy and data protection legislation and regulation play a significant role in our business. We and our customers use data about Internet users collected through our platform to manage and execute digital advertising campaigns in a variety of ways, including delivering advertisements to Internet users based on their particular geographic locations, the type of device they are using, or their interests as inferred from their web browsing or app usage activities. We do not use this data to identify specific individuals, and we do not seek to associate this data with information that can be used to identify specific individuals. We take steps not to collect or store personally identifiable information, or personal data. The definitions of personally identifiable information and personal data, however, vary by jurisdiction and are evolving. As a result, our platform and business practices must be assessed regularly in each jurisdiction where we do business to avoid violating applicable legislation and regulation.

In the United States, a complex patchwork quilt of both state and federal legislation governs activities such as the collection and use of data by companies like us. Digital advertising in the United States has, up until very recently, primarily been subject to regulation by the Federal Trade Commission, or the FTC, which has primarily relied upon Section 5 of the Federal Trade Commission Act, which prohibits companies from engaging in “unfair” or “deceptive” trade practices, including alleged violations of representations concerning privacy protections and acts that allegedly violate individuals’ privacy interests. The FTC has commenced the examination of privacy issues that arise when marketers track consumers across multiple devices, otherwise known as cross-device tracking.

The United States legal landscape concerning data and privacy continues to evolve at a rapid, and sometimes unpredictable pace. Domestic laws in this area are also complex and developing rapidly. Many state legislatures have adopted legislation that regulates how online business handle data. California recently enacted the California Consumer Privacy Act (“CCPA”), which took effect on January 1, 2020. The CCPA gives California residents expanded rights to access and delete their personal information, opt out of certain personal information sharing, and receive detailed information about how their personal information is used. The CCPA provides for civil

11

penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. The CCPA may increase our compliance costs and potential liability. Some observers have noted that the CCPA could mark the beginning of a trend toward more stringent privacy legislation in the United States, which could increase our potential liability and adversely affect our business. Similar privacy legislation has been proposed in a number of states. Indeed, Virginia and Colorado have also enacted similar statutes; the Virginia Consumer Data Protection Act (“VCDPA”), and the Colorado Privacy Act (“CPA”). In addition, a dozen other states have data privacy bills either introduced or in committee, with the expectation that they will be enacted in coming years, further complicating the compliance landscape.

Because our platform reaches users throughout the world, including Europe, Australia and Asia, some of our activities may also be subject to foreign legislation. Internationally, virtually every jurisdiction in which we operate has established its own data security and privacy legal framework with which we or our customers must comply, including but not limited to the European Union. The European Union has adopted what is known as one of the most robust and comprehensive data protection regulations in the world - the General Data Protection Regulation (“GDPR”). The GDPR and contains numerous requirements and obligations on data processors and comprehensive documentation requirements for data protection, processing, and compliance programs. In addition, the GDPR promulgates data subject rights for EU citizens, which provides increased control for Eu citizens. Specifically, EU citizens posses rights of access, corrections, deletion, and portability. These rights translate into increased operational costs to companies who have to take steps to operationalize these rights in order to comply and meet any request. Non-compliance risks substantial fines. Under the GDPR, fines of up to 20 million euros or up to 4% of the annual global revenue of the noncompliant company, whichever is greater, could be imposed for violations of certain of the GDPR’s requirements. In additional the GDPR, the European Union is currently in the process of replacing the current ePrivacy directive with the ePrivacy Regulation, which contains enhanced protections and regulations concerning the use of electronic communications services, including in connection with online tracking technologies.

Accordingly, once the ePrivacy Regulation is enacted, the compliance landscape will only become more challenging. Certainly, an increase in operational costs and risk will arise to the extent we continue to do business in the European market. In particular, risks associated with non-compliance proceedings from governmental agencies, as well as limitations on our ability to attract and retain European customers.  

The interpretation and application of many privacy and data protection laws along with contractually imposed industry standards are simply not predictable in light of the nascent nature of the data privacy legal landscape. These laws may be interpreted and applied in a manner that is inconsistent with our existing data handling practices or how our products and platform capabilities operate. The possibility of fines, lawsuits, and other claims and penalties may necessitate a change in our business activities and practices or modify our products and platform capabilities, which could have an adverse effect on our business.

In prior years, some government regulators and privacy advocates advocated vigorously for a Do Not Track standard that would allow Internet users to express a preference, independent of cookie settings in their browsers, not to have their online browsing activities tracked. In 2010, the FTC issued a staff report emphasizing the need for simplified notice, choice and transparency to the consumer regarding the collection, use and sharing of data, and suggested implementing a Do Not Track browser setting that would allow consumers to choose whether or not to allow tracking of their online browsing activities. All major Internet browsers have implemented some version of a Do Not Track setting. However, there is no commonly accepted definition of “tracking,” no consensus regarding what message is conveyed by a Do Not Track setting and no industry standards regarding how to respond to a Do Not Track preference.

Our Employees and Culture

As of March 25, 2022, we had 38 full time employees, and 3 consultants. None of our employees are represented by a union or parties to a collective bargaining agreement. We believe our employee relations to be good.

Corporate Information

Our mailing address is 500 7th Avenue, 8th Floor, New York, New York 10018. Our telephone number is (800) 409-9456.

12

Available Information

Our website, www.Kubient.com, provides access, without charge, to our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, current reports on Form 8-K, and all amendments to those reports as soon as reasonably practicable after such material is electronically filed with the Securities and Exchange Commission (“SEC”). The information provided on our website is not part of this Annual Report and is therefore not incorporated by reference unless such information is otherwise specifically referenced elsewhere in this Annual Report. The SEC also maintains a website at www.sec.gov that contains reports, proxy and information statements, and other information regarding our company that we file electronically with the SEC.

Implications of Being an Emerging Growth Company

We are an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). For as long as we are an emerging growth company, unlike public companies that are not emerging growth companies under the JOBS Act, we will not be required to:

·

provide an auditor’s attestation report on management’s assessment of the effectiveness of our system of internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002 (the “Sarbanes Oxley Act”);

·

provide more than two years of audited financial statements and related management’s discussion and analysis of financial condition and results of operations;

·

comply with any new requirements adopted by the Public Company Accounting Oversight Board (the “PCAOB”) requiring mandatory audit firm rotation or a supplement to the auditor’s report in which the auditor would be required to provide additional information about the audit and the financial statements of the issuer;

·

provide certain disclosure regarding executive compensation required of larger public companies or hold stockholder advisory votes on the executive compensation required by the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”); or

·

obtain stockholder approval of any golden parachute payments not previously approved.

We will cease to be an emerging growth company upon the earliest of the:

·

last day of the fiscal year in which we have $1.07 billion or more in total annual gross revenues;

·

date on which we become a “large accelerated filer” (the fiscal year-end on which the total market value of our common equity securities held by non-affiliates is $700 million or more as of June 30);

·

date on which we issue more than $1.0 billion of non-convertible debt over a three-year period; or

·

last day of the fiscal year following the fifth anniversary of our initial public offering.

We have elected to take advantage of certain of the reduced disclosure obligations in this report and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that we provide to our stockholders may be different than you might receive from other public reporting companies in which you hold equity interests.

In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended, for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.

13

ITEM 1A. RISK FACTORS

Not applicable to smaller reporting companies.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

On July 14, 2021, as amended on February 1, 2022, we entered into a lease agreement for the use of our current office space located at 500 7th Avenue, 8th Floor, New York, New York 10018 of approximately 917 square feet for $15,630 per month. Previously, our offices were located at 330 Seventh Avenue, 10th Floor, New York, NY 10001 and consisted of approximately 1,800 square feet of leased office space. The lease for 330 Seventh Avenue, 10th Floor, New York, NY 10001 was supposed to expire on June 1, 2021. The rent under such lease was $9,000 per month based on the use of 15 desks in the office space per month. On June 18, 2020, we entered into that certain Sublease Termination Agreement and terminated the lease for 330 Seventh Avenue, 10th Floor, New York, NY 10001. We believe that our facilities are adequate for our current needs and that suitable additional or substitute space would be available if needed.

ITEM 3. LEGAL PROCEEDINGS

From time to time, we may be subject to various other legal proceedings and claims that are routine and incidental to our business. Although some of the legal proceedings set forth herein may result in adverse decisions or settlements, Management believes that the final disposition of such matters will not have a material adverse effect on our business, financial position, results of operations or cash flows.

In addition, the following material legal proceedings were recently settled:

On October 6, 2017, the Company entered into a Master Service Agreement for Buyers and Sellers, and an “Engage Buyer Addendum”, with Engage BDR, LLC whereby the Company could gain access to the Engage BDR, LLC proprietary trading technology platform in order to both offer and purchase inventory for the placement of ads. On August 31, 2018, Engage BDR, LLC filed suit against the Company (Engage BDR, LLC v. Kubient, Inc., Los Angeles County Superior Court Case No. SC129764) setting forth claims of breach of contract, unjust enrichment, quantum meruit, accounts stated, and breach of implied covenant of good faith and fair dealing. On November 14, 2018, Engage BDR, LLC obtained a summary default judgment against the Company for $35,936. On February 17, 2021, the Company paid a total of $33,461 in full satisfaction of the matter.

On March 11, 2022, the Company, Aureus Holdings, LLC d/b/a Lo70s (“Lo70s”) and JPAR, LLC entered into a Settlement Agreement and Mutual Release (the “Lo70s Settlement Agreement”).  Pursuant to the Lo70s Settlement Agreement, the parties agreed to dismiss the litigation (Aureus Holdings, LLC d/b/a Lo70s v. Kubient, Inc., et al., Superior Court of Delaware, Case No. N20C-07-061) and resolve all claims among them, including potential or future claims arising from the letter of intent that the Company and Lo70s had entered into in March 2019, as well as a consulting agreement entered into between the Company and an employee of Lo70s in connection with such letter of intent. On March 14, 2022, the court in the matter entered an order approving the Lo70s Settlement Agreement, and the case was dismissed with prejudice.  In the Lo70s Settlement Agreement, the Company expressly denies any and all liability and the dismissal of the case with prejudice was entered by the court without a final judgment of liability entered against the Company. Under the terms of the Lo70s Settlement Agreement, the Company made a cash payment of $975,000 to Lo70s in full satisfaction of the matter, as well as the releases and covenants of Lo70s and JPAR, LLC set forth in the agreement, such that the Lo70s Settlement Agreement fully concludes this matter.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

14

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is listed on The Nasdaq Capital Market under the symbol “KBNT.” Our common stock purchase warrants are listed on The Nasdaq Capital Market under the symbol “KBNTW.”

Holders of Record

As of March 25, 2022, we had approximately 37 holders of record of our common stock.

Dividends

We have not historically declared dividends on our common stock, and we do not currently intend to pay dividends on our common stock. The declaration, amount and payment of any future dividends on shares of our common stock, if any, will be at the sole discretion of our board of directors, out of funds legally available for dividends. We anticipate that we will retain our earnings, if any, for the growth and development of our business.

Securities Authorized for Issuance Under Equity Compensation Plans

Number of securities

remaining available for

Number of securities

future issuance under

to be issued upon

Weighted-average

equity compensation

exercise of outstanding

exercise price of

plans (excluding

options, warrants and

outstanding options,

securities reflected in

    

rights

    

warrants and rights

    

column (a))

Plan category

(a)

(b)

(c)

Equity compensation plans approved by security holders

 

94,447

$

11.56

 

1,411,889

Equity compensation plans not approved by security holders

 

 

Total

 

94,447

$

11.56

 

1,411,889

The Kubient, Inc. 2017 Equity Incentive Plan was originally adopted by our board of directors and approved by our stockholders on September 12, 2017, and was subsequently amended and restated on June 5, 2019 (the “2017 Plan”). The purposes of the 2017 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our service providers and to promote the success of the Company’s business. We have reserved 333,334 shares of our common stock to issue awards under our 2017 Plan. As of December 31, 2021, there were options to purchase 94,447 shares of our common stock with a weighted average exercise price of $11.56 per share that were outstanding under the 2017 Plan. As of December 31, 2021, a total of 236,073 shares of common stock were issued under the 2017 Plan. Accordingly, as of December 31, 2021, 11,889 shares of common stock remained available for future issuance under the 2017 Plan.

The Kubient, Inc. 2021 Equity Incentive Plan was originally adopted by our board of directors and approved by our stockholders on June 30, 2021 (the “2021 Plan”). The purposes of the 2021 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our service providers and to promote the success of the Company’s business. We have reserved 1,500,000 shares of our common stock to issue awards under our 2021 Plan. As of December 31, 2021, a total of 100,000 shares of common stock were issued under the 2021 Plan. Accordingly, as of December 31, 2021, 1,400,000 shares of common stock remained available for future issuance under the 2021 Plan.

15

Recent Sales of Unregistered Securities

During the three months ended December 31, 2021, the Company issued 1,062 shares of common stock to a former director.

The foregoing securities were issued in reliance upon an exemption from registration pursuant to Rule 701 promulgated under the Securities Act.

Purchase of Equity Securities by Issuer and Affiliated Purchasers

None.

ITEM 6. [RESERVED]

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read together with our consolidated financial statements and related notes thereto included elsewhere in this Annual Report. This discussion and analysis contains forward-looking statements that are based upon current expectations and involve risks, assumptions and uncertainties.

Overview

Kubient, a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

Our experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. Our platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.

We also provide unique capabilities with our proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows us to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. Most importantly, it’s self-learning, getting smarter and more accurate over time. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

We believe that our Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources. By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, we believe that our Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

16

Results of Operations

Year Ended December 31, 2021 Compared With Year Ended December 31, 2020

    

For the Years Ended

December 31, 

2021

    

2020

Net Revenues

$

2,737,767

$

2,900,029

Costs and Expenses:

 

  

 

  

Sales and marketing

3,032,133

1,117,375

Technology

 

3,079,752

 

2,088,538

General and administrative

 

6,117,601

 

4,160,854

Loss on legal settlement

880,381

Total Costs and Expenses

 

13,109,867

 

7,366,767

Loss From Operations

 

(10,372,100)

 

(4,466,738)

Other (Expense) Income:

 

  

 

  

Interest expense

 

(8,383)

 

(1,135,675)

Interest expense - related parties

 

 

(403,372)

Interest income

 

88,537

 

25,178

Amortization of beneficial conversion feature

 

 

(1,984,322)

Gain on settlement of notes and other payables, net

 

 

124,999

Gain on forgiveness of accounts payable - supplier

 

 

236,248

Loss on extinguishment of convertible note payable

 

 

(297,272)

Other income

 

233

 

15,294

Total Other Income (Expense)

 

80,387

 

(3,418,922)

Net Loss

 

(10,291,713)

 

(7,885,660)

Deemed dividend related to warrant down round adjustment

 

 

(1,682,000)

Net Loss Attributable to Common Shareholders

$

(10,291,713)

$

(9,567,660)

17

Net Revenues

For the year ended December 31, 2021, net revenues decreased by $162,262, or 6%, to $2,737,767 from $2,900,029 for the year ended December 31, 2020. The decrease was primarily due to approximately $1,300,000 of revenue generated in connection with beta testing of KAI, our fraud detection service, which commenced during the 2020 period, as well as approximately $1,496,000 of net revenue generated from one new customer in the 2020 period, as compared to approximately $2,348,000 of revenue generated from the same customer in the 2021 period.

Sales and Marketing

For the year ended December 31, 2021, sales and marketing expenses increased by $1,914,758, or 171%, to $3,032,133 from $1,117,375 for the year ended December 31, 2020. The increase is primarily a result of the expansion of our sales and marketing department which resulted in increases in salary expense of approximately $1,194,000 arising from an increase in sales and marketing personnel headcount, as well as increased stock-based compensation of approximately $270,000, consulting fees of approximately $195,000 and selling expense of approximately $164,000.

Technology

For the year ended December 31, 2021, technology expenses increased by $991,214, or 47%, to $3,079,752 from $2,088,538 for the year ended December 31, 2020. The increase is primarily due to increases in salary expense of approximately $207,000 arising from an increase in technology personnel headcount, as well as increased stock-based compensation of approximately $18,000, consulting expenses of approximately $39,000, amortization of software of approximately $124,000 and cloud hosting costs of approximately $310,000.

General and Administrative

For the year ended December 31, 2021, general and administrative expenses increased by $1,956,747, or 47%, to $6,117,601 from $4,160,854 for the year ended December 31, 2020. The increase from 2020 to 2021 is primarily due to increases in legal fees of approximately $979,000, recruiting fees of approximately $275,000 arising from an increase in headcount, insurance expense of approximately $322,000, and state franchise taxes of approximately $160,000.

Loss on Legal Settlement

The Company recognized a loss on legal settlement of $880,381 for the year ended December 31, 2021 related to a settlement agreement reached in March 2022 wherein we made a cash payment of $975,000 to Lo70s in consideration of the dismissal of the ligation among the parties, as well as the releases and covenants of the parties.

Other Income (Expense)

For the year ended December 31, 2021, the Company had other income of $80,387 as compared to other expense of $(3,418,922) during the year ended December 31, 2020. The net decrease in other expense is primarily due to the absence of the amortization of beneficial conversion feature of approximately $1,984,000 and interest expense of approximately $1,539,000 that were recognized in the 2020 period, as these items no longer continued after the notes payable were converted at the closing of the initial public offering in August 2020 which resulted in net proceeds of approximately $10.6 million (“IPO”).

Non-GAAP Measures

Adjusted EBITDA

The Company defines EBITDA as net income (loss) before interest, taxes and depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA, further adjusted to eliminate the impact of certain non-recurring items and other items that we do not consider in our evaluation of our ongoing operating performance from period to period. These items will include stock-based compensation, restructuring and severance costs, transaction costs, acquisition costs, certain other non-recurring charges and gains that the Company does not believe reflects the underlying business performance.

18

For the years ended December 31, 2021 and 2020, EBITDA and Adjusted EBITDA consisted of the following:

    

For the Years Ended 

December 31, 

 

2021

    

2020

Net Loss Attributable to Common Shareholders

$

(10,291,713)

$

(9,567,660)

Interest expense

 

8,383

 

1,135,675

Interest expense - related parties

 

 

403,372

Interest income

 

(88,537)

 

(25,178)

Depreciation and amortization

 

452,136

 

315,202

Amortization of beneficial conversion feature

 

 

1,984,322

EBITDA

 

(9,919,731)

 

(5,754,267)

Adjustments:

 

  

 

  

Deemed dividend related to warrant down round adjustment

 

 

1,682,000

Stock-based compensation expense

 

724,042

 

468,216

Adjusted EBITDA

$

(9,195,689)

$

(3,604,051)

Adjusted Loss Per Share

$

(0.67)

$

(0.70)

Weighted Average Common Shares Outstanding -

 

  

 

  

Basic and Diluted

 

13,695,700

 

5,185,204

EBITDA and Adjusted EBITDA is a financial measure that is not calculated in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes that because Adjusted EBITDA excludes (a) certain non-cash expenses (such as depreciation, amortization and stock-based compensation) and (b) expenses that are not reflective of the Company’s core operating results over time (such as stock-based compensation expense), this measure provides investors with additional useful information to measure the Company’s financial performance, particularly with respect to changes in performance from period to period. The Company’s management uses EBITDA and Adjusted EBITDA (a) as a measure of operating performance, (b) for planning and forecasting in future periods, and (c) in communications with the Company’s board of directors concerning the Company’s financial performance. The Company’s presentation of EBITDA and Adjusted EBITDA are not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation and should not be used by investors as a substitute or alternative to net income or any measure of financial performance calculated and presented in accordance with U.S. GAAP. Instead, management believes EBITDA and Adjusted EBITDA should be used to supplement the Company’s financial measures derived in accordance with U.S. GAAP to provide a more complete understanding of the trends affecting the business.

Although Adjusted EBITDA is frequently used by investors and securities analysts in their evaluations of companies, Adjusted EBITDA has limitations as an analytical tool, and investors should not consider it in isolation or as a substitute for, or more meaningful than, amounts determined in accordance with U.S. GAAP. Some of the limitations to using non-GAAP measures as an analytical tool are (a) they do not reflect the Company’s interest income and expense, or the requirements necessary to service interest or principal payments on the Company’s debt, (b) they do not reflect future requirements for capital expenditures or contractual commitments, and (c) although depreciation and amortization charges are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and non-GAAP measures do not reflect any cash requirements for such replacements.

Liquidity and Capital Resources

We measure our liquidity in a number of ways, including the following:

    

December 31,

2021

    

2020

Cash and cash equivalents

$

24,907,963

$

24,782,128

Working capital

$

22,676,301

$

23,570,158

19

Availability of Additional Funds

As a result of its public offerings and the related note conversions, we believe our current cash on hand is sufficient to meet its operating and capital requirements for at least the next twelve months from the date these financial statements are issued. Our operating needs include the planned costs to operate our business, including amounts required to fund working capital and capital expenditures. Our future capital requirements and the adequacy of our available funds will depend on many factors, including our ability to successfully commercialize our products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement our product and service offerings.

Cash Flows

Year Ended December 31, 2021 Compared With Year Ended December 31, 2020

Our sources and uses of cash were as follows:

Cash Flows From Operating Activities

We experienced negative cash flows from operating activities for the years ended December 31, 2021 and 2020 in the amounts of $7,674,792 and $4,805,116, respectively. The net cash used in operating activities for the year ended December 31, 2021 was primarily a result of cash used to fund a net loss of $10,291,713, adjusted for net non-cash expenses of $1,198,876, partially offset by $1,418,045 of net cash provided by changes in the levels of operating assets and liabilities. The net cash used in operating activities for the year ended December 31, 2020 was primarily a result of cash used to fund a net loss of $7,885,660, adjusted for net non-cash expenses of $3,984,553, and $904,009 of net cash used in changes in the levels of operating assets and liabilities.

Cash Flows From Investing Activities

Net cash used in investing activities for the year ended December 31, 2021 was $1,672,486, which was attributable to aggregate purchases of intangible assets, property and equipment of $1,133,072 and $500,000 used in connection with the MediaCrossing purchase consideration. Net cash used in investing activities for the year ended December 31, 2020 was $1,316,336, which was attributable to aggregate purchases of intangible assets, property and equipment.

Cash Flows From Financing Activities

We experienced positive cash flows from financing activities for the years ended December 31, 2021 and 2020 in the amounts of $9,473,113 and $30,869,795, respectively. During the year ended December 31, 2021, $9,787,149 of proceeds were from exercises of options and warrants, partially offset by $145,050 of cash used to repay financed director and officer insurance premiums and $177,347 was used to partially repay our loan from JPMorgan Chase Bank, N.A., as lender, pursuant to the Paycheck Protection Program of the Coronavirus Aid, Relief and Economic Security Act, as amended. During the year ended December 31, 2020, $30,732,981 of proceeds were from the sale of common stock and warrants in our IPO and follow-on public offering, $1,241,190 of proceeds were received from debt financings, and $11,000 of proceeds were received from the exercise of warrant, partially offset by $841,376 used for payment of initial public offering costs and $274,000 that was used to repay debt.

Off-Balance Sheet Arrangements

We did not have, during the periods presented, and we do not currently have, any relationships with any organizations or financial partnerships, such as structured finance or special purpose entities, that would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Contractual Obligations

As a smaller reporting company, we are not required to provide the information required by paragraph (a)(5) of this Item.

20

Critical Accounting Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or U.S. GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, contingent assets and liabilities, each as of the date of the financial statements, and revenues and expenses during the periods presented. On an ongoing basis, management evaluates their estimates and assumptions, and the effects of any such revisions are reflected in the financial statements in the period in which they are determined to be necessary. Management bases their estimates on historical experience and on various other factors that they believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual outcomes could differ materially from those estimates in a manner that could have a material effect on our consolidated financial statements. While our significant accounting policies are more fully described in the notes to our consolidated financial statements appearing elsewhere in this prospectus, we believe that the following accounting policies and estimates are critical to the process of making significant judgments and estimates in the preparation of our financial statements and understanding and evaluating our reported financial results.

Revenue Recognition

The Company maintains a contract with each customer and supplier, which specify the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which it expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

21

Business Combinations

Business combinations are accounted for using the acquisition method and, accordingly, the assets acquired (including identified intangible assets), the liabilities assumed and any contingent consideration are recorded at their acquisition date fair values. The Company’s fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect the Company’s own assumptions in measuring fair value.

Intangible Assets

Intangible assets are comprised of costs to acquire and develop computer software, including the costs to acquire third-party data which is used to improve the Company’s artificial intelligence platform for client use, as well as costs to acquire customer lists, customer contracts and related customer relationship and restrictive covenant agreements. The intangible assets have estimated useful lives of two years for the computer software, five years for the capitalized data, seven years for the customer lists and three years for the restrictive covenant agreements. Once placed into service, the Company amortizes the cost of the intangible assets over their estimated useful lives on a straight-line basis.

Impairment of Long-lived Assets

The Company reviews for the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. An impairment would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount.

Stock-Based Compensation

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The Company accrues for any equity awards at fair value that have been contractually earned but not yet issued.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not required for smaller reporting companies.

22

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Stockholders and Board of Directors of

Kubient, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of Kubient, Inc. (the “Company”) as of December 31, 2021 and 2020, the related consolidated statements of operations, stockholders’ equity (deficiency) and cash flows for each of the two years in the period ended December 31, 2021, and the related notes (collectively referred to as the “financial statements”).  In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Marcum LLP

Marcum LLP

We have served as the Company’s auditor since 2019.

Los Angeles, CA

March 30, 2022

F-1

Kubient, Inc.

Consolidated Balance Sheets

December 31, 

    

2021

    

2020

Assets

 

  

 

  

Current Assets:

 

  

 

  

Cash and cash equivalents

$

24,907,963

$

24,782,128

Accounts receivable, net

 

2,291,533

 

1,373,754

Other receivables

526,070

Prepaid expenses and other current assets

 

495,178

 

107,651

Total Current Assets

 

28,220,744

 

26,263,533

Intangible assets, net

 

2,946,610

 

1,071,850

Goodwill

463,000

Property and equipment, net

 

44,756

 

17,166

Deferred offering costs

 

10,000

 

10,000

Total Assets

$

31,685,110

$

27,362,549

Liabilities and Stockholders’ Equity

 

  

 

  

Current Liabilities:

 

  

 

  

Accounts payable - suppliers

$

1,844,544

$

336,028

Accounts payable - trade

 

659,362

 

1,106,604

Accrued expenses and other current liabilities

 

2,493,287

 

1,017,282

Deferred revenue

395,914

15,000

Notes payable

 

151,336

 

218,461

Total Current Liabilities

 

5,544,443

 

2,693,375

Contingent consideration

613,000

Notes payable, non-current portion

 

77,407

 

187,629

Total Liabilities

 

6,234,850

 

2,881,004

Commitments and contingencies (Note 9)

 

  

 

  

Stockholders’ Equity:

 

  

 

  

Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of December 31, 2021 and 2020

 

 

Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,253,948 and 11,756,109 shares issued and outstanding as of December 31, 2021 and 2020 respectively

 

143

 

118

Additional paid-in capital

 

52,030,907

 

40,770,504

Accumulated deficit

 

(26,580,790)

 

(16,289,077)

Total Stockholders’ Equity

 

25,450,260

 

24,481,545

Total Liabilities and Stockholders’ Equity

$

31,685,110

$

27,362,549

The accompanying notes are an integral part of these consolidated financial statements.

F-2

Kubient, Inc.

Consolidated Statements of Operations

For the Years Ended

December 31, 

    

2021

    

2020

Net Revenues

$

2,737,767

$

2,900,029

Costs and Expenses:

 

 

  

Sales and marketing

3,032,133

1,117,375

Technology

 

3,079,752

 

2,088,538

General and administrative

 

6,117,601

 

4,160,854

Loss on legal settlement

880,381

Total Costs and Expenses

 

13,109,867

 

7,366,767

Loss From Operations

 

(10,372,100)

 

(4,466,738)

Other (Expense) Income:

 

  

 

  

Interest expense

 

(8,383)

 

(1,135,675)

Interest expense - related parties

 

 

(403,372)

Interest income

88,537

25,178

Amortization of beneficial conversion feature

 

 

(1,984,322)

Gain on settlement of notes and other payables, net

 

 

124,999

Gain on forgiveness of accounts payable - supplier

 

 

236,248

Loss on extinguishment of convertible note payable

 

 

(297,272)

Other income

 

233

 

15,294

Total Other Income (Expense)

 

80,387

 

(3,418,922)

Net Loss

 

(10,291,713)

 

(7,885,660)

Deemed dividend related to warrant down round adjustment

 

 

(1,682,000)

Net Loss Attributable to Common Shareholders

$

(10,291,713)

$

(9,567,660)

Net Loss Per Share - Basic and Diluted

$

(0.75)

$

(1.85)

Weighted Average Common Shares Outstanding - Basic and Diluted

 

13,695,700

 

5,185,204

The accompanying notes are an integral part of these consolidated financial statements.

F-3

Kubient, Inc.

Consolidated Statements of Changes in Stockholders’ Equity (Deficiency)

For the Years Ended December 31, 2021 and 2020

    

Additional

Common Stock

Paid-In

Accumulated

    

Shares

    

Amount

    

Capital

    

Deficit

    

Total

Balance - January 1, 2020

 

3,601,521

$

36

$

3,362,724

$

(8,403,417)

$

(5,040,657)

Issuance of common stock and warrants in initial public offering, net of issuance costs [1]

 

2,500,000

 

25

 

10,605,720

 

 

10,605,745

Conversion of notes payable and accrued interest into common stock and warrants

1,461,090

15

7,304,815

7,304,830

Conversion of notes payable and accrued interest into common stock

 

94,223

 

1

 

388,143

 

 

388,144

Issuance of common stock and warrants in follow-on public offering, net of issuance costs [2]

4,058,822

41

18,889,872

18,889,913

 

 

 

 

 

Stock-based compensation:

 

 

 

 

 

Common stock

 

38,433

 

 

154,922

 

 

154,922

Options

 

 

 

19,570

 

 

19,570

Forgiveness of accrued expenses by related party

 

 

 

33,738

 

 

33,738

Exercise of warrant

 

2,000

 

 

11,000

 

 

11,000

Effect of reverse stock-split

 

20

Net loss

(7,885,660)

(7,885,660)

Balance - December 31, 2020

11,756,109

118

40,770,504

(16,289,077)

24,481,545

Shares issued upon exercise of warrants, net of issuance costs [3]

2,156,322

21

9,703,609

9,703,630

Common stock issued upon exercise of options

2,815

8,361

8,361

Shares issued as partial consideration for intangible asset

100,000

1

531,999

532,000

Stock-based compensation:

Common stock

238,702

3

993,044

993,047

Options

23,390

23,390

Net loss

(10,291,713)

(10,291,713)

Balance - December 31, 2021

14,253,948

$

143

$

52,030,907

$

(26,580,790)

$

25,450,260

[1] Includes gross proceeds of $12,503,750, less issuance costs of $1,898,005.

[2] Includes gross proceeds of $20,699,992, less issuance costs of $1,810,080.

[3] Includes gross proceeds of $10,169,027, less issuance costs of $465,397.

The accompanying notes are an integral part of these consolidated financial statements.

F-4

Kubient, Inc.

Consolidated Statements of Cash Flows

    

For the Years Ended

December 31, 

    

2021

    

2020

Cash Flows From Operating Activities:

 

 

Net loss

$

(10,291,713)

$

(7,885,660)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

Depreciation and amortization

 

452,136

 

315,202

Bad debt expense

 

22,698

 

7,593

Gain on forgiveness of accounts payable - supplier

 

 

(236,248)

Stock-based compensation:

 

 

Common stock

 

700,652

 

448,646

Options

 

23,390

 

19,570

Amortization of debt discount and debt issuance costs

 

 

915,994

Amortization of debt discount and debt issuance costs - related parties

 

 

357,201

Amortization of beneficial conversion feature

 

 

1,984,322

Loss on extinguishment of convertible note payable

297,272

Loss on settlement of other payables

 

 

23,601

Gain on settlement of notes and other payables

 

 

(148,600)

Changes in operating assets and liabilities:

 

 

Accounts receivable

 

(940,477)

 

(1,342,643)

Other receivable

 

3,955

 

Prepaid expenses and other current assets

 

73,491

 

(79,579)

Accounts payable - suppliers

 

1,508,516

 

(191,125)

Accounts payable - trade

 

(447,242)

 

211,922

Accrued expenses and other current liabilities

 

1,467,306

 

497,416

Deferred revenue

 

(247,504)

 

Net Cash Used In Operating Activities

 

(7,674,792)

 

(4,805,116)

Cash Flows From Investing Activities:

 

 

Purchase of intangible assets

 

(1,133,072)

 

(1,300,336)

Purchase consideration of MediaCrossing

 

(500,000)

 

Purchase of property and equipment

 

(39,414)

 

(16,000)

Net Cash Used In Investing Activities

(1,672,486)

(1,316,336)

 

 

Cash Flows From Financing Activities:

Proceeds from exercise of warrants [1]

 

9,787,149

 

Repayment of PPP loan

 

(177,347)

 

Repayment of financed director and officer insurance premiums

 

(145,050)

 

Proceeds from exercise of options

8,361

Proceeds from sale of common stock and warrants in initial public offering, net [2]

 

 

11,503,488

Payment of initial public offering issuance costs

 

 

(841,376)

Proceeds from sale of common stock and warrants in follow-on public offering, net [3]

 

 

19,354,493

Payment of follow-on public offering issuance costs

 

 

(125,000)

Proceeds from exercise of warrant

 

 

11,000

Repayment of advance from related party

 

 

(29,000)

Proceeds from issuance of notes payable

 

 

406,190

Repayment of notes payable

 

 

(95,000)

Proceeds from issuance of notes payable - related parties

 

 

835,000

Repayment of note payable - related party

 

 

(150,000)

Net Cash Provided By Financing Activities

 

9,473,113

 

30,869,795

Net Increase In Cash and Cash Equivalents

 

125,835

 

24,748,343

Cash and Cash Equivalents - Beginning of the Year

 

24,782,128

 

33,785

Cash and Cash Equivalents - End of the Year

$

24,907,963

$

24,782,128

[1] Includes gross proceeds of $10,169,027, less issuance costs of $381,878.

[2] Includes gross proceeds of $12,503,750, less underwriting discounts and commissions of $1,000,262.

[3] Includes gross proceeds of $20,699,992, less underwriting discounts and commissions of $1,470,499.

The accompanying notes are an integral part of these consolidated financial statements.

F-5

Kubient, Inc.

Consolidated Statements of Cash Flows (Continued)

    

For the Years Ended

December 31, 

    

2021

    

2020

Supplemental Disclosures of Cash Flow Information:

 

  

 

  

Cash paid during the year for:

 

  

 

  

Interest

$

7,912

$

574

Income taxes

$

$

Non-cash investing and financing activities:

 

  

 

  

Accrual of warrant exercise issuance costs

$

83,519

$

Shares issued as partial consideration for intangible asset

$

532,000

$

Shares of common stock issued in satisfaction of accrued issuable equity

$

507,044

$

Contingent consideration

$

613,000

$

Financing of insurance premiums

$

362,625

$

Conversion of notes payable and accrued interest into common stock

$

$

5,411,381

Original issue discount in connection with convertible notes payable

$

$

285,000

Original issue discount in connection with convertible notes payable - related party

$

$

75,500

Accrual of follow-on offering deferred offering costs

$

$

(339,581)

Reduction of additional paid-in capital for initial public offering issuance costs that were previously paid

$

$

56,367

Reversal of previously accrued deferred offering costs

$

$

218,829

Forgiveness of related party liability

$

$

33,738

The accompanying notes are an integral part of these consolidated financial statements.

F-6

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES

Organization and Operations

Kubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources.  By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

Risks and Uncertainties

The novel coronavirus (“COVID-19”) pandemic continues to impact global economic conditions, as well as the Company’s operations. COVID-19 had a meaningful negative impact on our financial condition, cash flows and results of operations during 2020, as revenues declined and we reduced spending in light of COVID-19 uncertainty. Although we continued to experience disruption and volatility during 2021, which could continue to have an adverse effect on our revenues and earnings in 2022, the ultimate economic impact of the pandemic remains fluid, as there continue to be periods of COVID-19 resurgence in various parts of the world. The extent of the impact of the COVID-19 pandemic in 2022 on our operational and financial performance will depend on a variety of factors, some of which are outside our control, including the duration and spread of COVID-19 and its variants, and its impact on our clients, partners, industry, and employees, all of which are uncertain at this time and cannot be accurately predicted.

Similarly, the economic uncertainty caused by the COVID-19 pandemic has made and may continue to make it difficult for us to forecast revenue and operating results and to make decisions regarding operational cost structures and investments. We have committed, and we plan to continue to commit, resources to grow our business, employee base, and technology development, and such investments may not yield anticipated returns, particularly if worldwide business activity continues to be impacted by the COVID-19 pandemic. The duration and extent of the impact from the COVID-19 pandemic depend on future developments that cannot be accurately predicted at this time, and if we are not able to respond to and manage the impact of such events effectively, our business may be harmed.

There can be no assurance that precautionary measures, whether adopted by us or imposed by others, will be effective, and such measures could negatively affect our sales, marketing, and client service efforts, delay and lengthen our sales cycles, decrease our employees’, clients’, or partners’ productivity, or create operational or other challenges, any of which could harm our business and results of operations.

F-7

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying audited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements. Such consolidated financial statements and accompanying notes are the representations of Company’s management, who is responsible for their integrity and objectivity.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s significant estimates used in these financial statements include, but are not limited to, fair value calculations for equity securities, revenue recognition, stock-based compensation,the valuation of intangible assets and contingent consideration, useful lives of intangibles assets, the collectability of receivables and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and may cause actual results to differ from those estimates.

Principles of Consolidation

The consolidated financial statements of the Company include the accounts of Fidelity Media, LLC (“Fidelity”). All intercompany transactions have been eliminated in the consolidation.

Cash and Cash Equivalents

The Company maintains cash in bank accounts, which, at times, may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company has not experienced any losses in such accounts. The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2021 and 2020, the Company’s cash and cash equivalents were comprised of demand deposits held in bank accounts.  

Revenue Recognition

The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps:

Identification of a contract with a customer;
Identification of the performance obligations in the contract;
Determination of the transaction price;
Allocation of the transaction price to the performance obligations in the contract; and
Recognition of revenue when or as the performance obligations are satisfied.

F-8

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

The Company maintains a contract with each customer and supplier, which specify the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which it expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

As of December 31, 2021 and 2020, the Company did not have any contract assets from contracts with customers. As of December 31, 2021 and 2020, the Company had $395,914 and $15,000, respectively, of contract liabilities where performance obligations have not yet been satisfied. The Company expects to satisfy its remaining performance obligations and recognize the revenue within the next twelve months. During the years ended December 31, 2021 and 2020, there was no revenue was recognized from performance obligations satisfied (or partially satisfied) in previous periods.

Accounts Receivable and Accounts Payable

Accounts receivable are carried at their contractual amounts, less an estimate for uncollectible amounts. As of December 31, 2021 and 2020, there was an allowance for uncollectible amounts of $12,149 and $10,209, respectively. Management estimates the allowance for bad debts based on existing economic conditions, the financial conditions of the customers, and the amount and age of past due accounts.

Receivables are considered past due if full payment is not received by the contractual due date. Past due accounts are generally written off against the corresponding accounts payable in the event that the Company’s contract contains sequential liability terms, with the excess receivable being written off against the allowance for bad debts only after all collection attempts have been exhausted.

Accounts receivable are recorded at the amount the Company is responsible to collect from the customer. See Note 2 — Significant Accounting Policies — Revenue Recognition for additional details. In the event that the Company does not collect the Gross Billing amount from the customer, the Company generally is not contractually obligated to pay the associated Supplier Cost.

F-9

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

Convertible Instruments

The Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for in accordance with the Financial Accounting Standards Board (“FASB”) ASC Topic 815 “Derivatives and Hedging” (“ASC 815”). The accounting treatment of derivative financial instruments requires that the Company record embedded conversion options and any related freestanding instruments at their fair values as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded in earnings each period as non-operating, non-cash income or expense. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. Embedded conversion options and any related freestanding instruments are recorded as a discount to the host instrument. The Company allocates proceeds based on the relative fair values of the debt and equity components.

Prior to the adoption of ASU 2020-06, if the instrument is not determined to be a derivative liability, the Company then evaluates for the existence of a beneficial conversion feature by comparing the fair value of the Company’s common stock as of the commitment date to the effective conversion price of the instrument (the intrinsic value). The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital.

Deferred Offering Costs

Deferred offering costs, which consist of direct, incremental professional fees incurred in connection with the Company’s future offerings of equity and debt securities that have yet to close, are capitalized as non-current assets on the consolidated balance sheet. Upon the closing of the offering, the deferred offering costs are either (i) charged off against the offering proceeds in connection with an equity offering or (ii) reclassified such that they represent a reduction in the carrying amount of the face value of the debt security.

Property and Equipment

Property and equipment are stated at cost, net of accumulated depreciation which is recorded commencing at the in-service date using the straight-line method at rates sufficient to charge the cost of depreciable assets to operations over their estimated useful lives, which is three years. Leasehold improvements are amortized over the lesser of (a) the useful life of the asset; or (b) the remaining lease term. Maintenance and repairs are charged to operations as incurred. The Company capitalizes cost attributable to the betterment of property and equipment when such betterment extends the useful life of the assets.

Intangible Assets

Intangible assets are comprised of costs to acquire and develop computer software, including the costs to acquire third-party data which is used to improve the Company’s artificial intelligence platform for client use, as well as costs to acquire customer lists, customer contracts and related customer relationship and restrictive covenant agreements. The intangible assets have estimated useful lives of two years for the computer software, five years for the capitalized data, seven years for the customer lists and three years for the restrictive covenant agreements. Once placed into service, the Company amortizes the cost of the intangible assets over their estimated useful lives on a straight-line basis.

Impairment of Long-lived Assets

The Company reviews for the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. An impairment would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. The Company did not record any impairment losses during the years ended December 31, 2021 and 2020.

F-10

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

Fair Value of Financial Instruments

The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”).

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

Level 1 — quoted prices in active markets for identical assets or liabilities

Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 — inputs that are unobservable (for example, cash flow modeling inputs based on assumptions

The carrying amounts of the Company’s financial instruments, such as cash, accounts receivable, accounts payable, convertible notes and notes payable approximate fair value due to the short-term nature of these instruments. The carrying amounts of the Company’s short-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates, are comparable to rates of returns for instruments of similar credit risk.

Software Development Costs

The Company develops and utilizes software in connection with its ability to generate customer revenue (which is further explained in Note 2 – Significant Accounting Policies – Revenue Recognition). Costs incurred in this effort are accounted for under the provisions of ASC 985-20, Software – Cost of Software to be Sold, Leased or Marketed, whereby costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. The Company capitalizes subsequent additions, modifications, or upgrades to internally developed software only to the extent that such changes allow the software to perform a task it previously did not perform.

Income Taxes

The Company is subject to federal and state income taxes in the United States. The Company files income tax returns in the jurisdictions in which nexus threshold requirements are met.

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse.

The Company utilizes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.

The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as general and administrative expenses in the consolidated statements of operations.

F-11

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

Advertising Costs

Advertising costs are charged to operations in the year incurred and totaled approximately $270,000 and $101,000 for the years ended December 31, 2021 and 2020, respectively, and are reflected in general and administrative expenses in the consolidated statements of operations.

Stock-Based Compensation

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The Company accrues for any equity awards at fair value that have been contractually earned but not yet issued.

Fair Value of Stock Options and Warrants

The Company has computed the fair value of stock options and warrants granted using the Black-Scholes option pricing model. Option forfeitures are accounted for at the time of occurrence. The expected term used for options is the estimated period of time that options granted are expected to be outstanding. The expected term used for warrants is the contractual life. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” option grants. The Company does not currently have a sufficient trading history to support its historical volatility calculations. Accordingly, the Company is utilizing an expected volatility figure based on a review of the historical volatility of comparable entities over a period of time equivalent to the expected life of the instrument being valued. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive.

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Years Ended

December 31, 

    

2021

    

2020

Stock options

 

94,447

 

118,412

Restricted stock awards

166,489

Restricted stock units

100,000

Warrants [1]

 

5,122,074

 

7,403,722

 

5,483,010

 

7,522,134

[1] During 2021, includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share. During 2020, includes shares underlying warrants that are exercisable into an aggregate of (i) 1,235,977 shares of common stock and (ii) five-year warrants to purchase 1,235,977 shares of common stock at an exercise price of $5.50 per share.

F-12

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

Recently Issued Accounting Standards

In February 2016, the FASB issued ASU 2016-02“, “Leases (Topic 842)” (“ASU 2016-02”), as amended, with guidance regarding the accounting for and disclosure of leases. The update requires that a lessee recognize the assets and liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions. In May 2020, the FASB issued ASU 2020-05 that deferred these dates one year for all other entities, including emerging growth companies. This standard is effective for annual reporting periods beginning after December 15, 2021, and interim periods within annual periods beginning after December 15, 2022. Early adoption is permitted. The Company expects to adopt ASU 2016-02 during the fiscal year ending December 31, 2022 and is evaluating the impact on its statements of operations and cash flows. Based upon the leases currently in place, management believes that its current leases will qualify for the practical expedient for leases with terms less than one year, such that there will be no material impact of adopting the new standard on the Company’s consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). In April 2020, the FASB issued clarification to ASU 2016-13 within ASU 2020-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. This guidance is effective for public business entities that meet the definition of a Securities and Exchange Commission filer, excluding eligible smaller reporting companies, for fiscal years beginning after December 15, 2019. For all other entities, including emerging growth companies, it is effective for fiscal years beginning after December 15, 2020. The Company is currently evaluating ASU 2016-13 and its impact on its consolidated financial statements and disclosures.

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This update for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted, including adoption in any interim period for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The Company adopted ASU 2019-12 effective January 1, 2022 and its adoption did not have a material impact on the Company’s consolidated financial statements and disclosures.

In August 2020, the FASB issued ASU 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”) which simplifies the accounting for convertible instruments by eliminating certain accounting models when the conversion features are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in-capital. Under this ASU, certain debt instruments with embedded conversion features will be accounted for as a single liability measured at its amortized cost. Additionally, this ASU eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments. The new guidance is effective for annual periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company adopted ASU 2020-06 effective January 1, 2022 which eliminated the need to assess whether a beneficial conversion feature needed to be recognized upon either (a) the future issuance of new convertible notes; or (b) the resolution of any contingent beneficial conversion features.

F-13

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). This new standard provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Issuers should apply the new standard prospectively to modifications or exchanges occurring after the effective date of the new standard. Early adoption is permitted, including adoption in an interim period. If an issuer elects to early adopt the new standard in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The Company adopted ASU 2021-04 effective January 1, 2022 such adoption did not have a material impact on the Company’s consolidated financial statements or disclosures.

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805)” (“ASU 2021-08”). The ASU improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. The update is effective for annual and interim periods within the fiscal year beginning after December 15, 2022, and early adoption is permitted, including adoption in an interim period. The Company is evaluating this new standard and its impact on its consolidated financial statements and related disclosures.

NOTE 3 – BUSINESS COMBINATION

On November 30, 2021, Kubient entered into and consummated an Asset Purchase Agreement (the “Purchase Agreement”) between the Company and MediaCrossing Inc., a Delaware corporation (“MediaCrossing”), pursuant to which the Company acquired certain assets and liabilities that were critical to continue to operate the business of MediaCrossing for (i) $500,000 in cash and (ii) if the acquired business achieves certain milestones in 2022, up to 822,369 shares of the Company’s common stock, par value $0.00001 per share (the “Earnout Shares”) (the “Transaction”). In accordance with ASC 805, the Company determined that the Transaction should be accounted for as a business combination after determining that the acquired set of assets of MediaCrossing, the fair value of which was not concentrated in a single asset or group of similar assets and included (a) cash, (b) prepaid expenses and other current assets, (c) intangible assets as detailed further below and (d) an assembled workforce, met the definition of a business. As a result, Kubient has recorded the business combination in its consolidated financial statements and has applied the acquisition method to account for MediaCrossing’s assets acquired and liabilities assumed upon completion of the Transaction. The acquisition method requires recording the identifiable assets acquired and liabilities assumed at their fair values on the acquisition date and recording goodwill for the excess of the purchase price over the aggregate fair value of the identifiable assets acquired and liabilities assumed.

The Earnout Shares consist of up to 822,369 shares of the Company’s common stock, depending on the amount of revenue generated by the acquisition in 2022. Each share had a fair value of $2.55 as of the acquisition date. The Earnout Shares were measured using a Monte Carlo simulation. Key assumptions used in the fair value assessment consisted of revenue projections (which were used to estimate the number of Earnout Shares issuable), discount rate and standard deviation. The fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect Kubient’s own assumptions in measuring fair value.

MediaCrossing is engaged in the business of providing managed media services to agencies and direct brand advertisers, including media planning, strategy, contracting for media, developing, executing and managing campaigns, reporting and services ancillary to the foregoing.

In connection with the Acquisition and pursuant to the terms of the Purchase Agreement, the Company has offered employment to ten employees of MediaCrossing, including Michael Kalman as President – Agency & Brand Partnerships. In addition, the Purchase Agreement contains customary representations, warranties, post-closing covenants and indemnification provisions.

F-14

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

The aggregate preliminary purchase price was allocated to the assets acquired and liabilities assumed as follows:

Purchase Consideration:

    

  

Cash

 

$

500,000

Contingent consideration

 

 

613,000

Total Purchase Consideration

 

 

1,113,000

Less:

 

 

  

Customer contracts and related customer relationships (1)

 

 

580,000

Restrictive covenant agreements (1)

 

 

70,000

Debt-free net working capital

 

 

Fair Value of Identified Net Assets

 

 

650,000

Remaining Unidentified Goodwill Value

$

463,000

(1)As part of the preliminary valuation analysis, the Company identified (i) customer contracts and related customer relationships and (ii) restrictive covenant agreements as intangible assets. The fair value of the identifiable intangible assets is determined using the “income approach”. The customer contracts and related customer relationships have an estimated useful life of five (5) years and the restrictive covenant agreements have an estimated useful life of three (3) years.

The components of debt free net working capital deficit are as follows:

Current Assets:

    

  

Prepaid expenses and other current assets

$

109,083

Other receivables

 

526,070

Total Current Assets

 

635,153

Current Liabilities:

 

  

Deferred revenue

 

628,418

Accrued expenses and other current liabilities

 

6,735

Total Current Liabilities

 

635,153

Debt-Free Net Working Capital

$

Goodwill was recorded based on the amount by which the purchase price exceeded the fair value of the net assets acquired and the amount is attributable to the reputation of the business acquired, the workforce in place and the synergies to be achieved from this acquisition. Goodwill is deductible for tax purposes.

The consolidated financial statements of the Company include the results of operations of MediaCrossing from November 30, 2021 to December 31, 2021 and do not include results of operations for the year ended December 31, 2020. The results of operations of MediaCrossing from November 30, 2021 to December 31, 2021 included revenues of $154,954 and a net loss of $18,447.

F-15

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

The following table presents the unaudited pro forma consolidated results of operations for the year ended December 31, 2021 as if the Transaction had occurred on January 1, 2020. The pro forma information provided below is compiled from the pre-acquisition financial information of MediaCrossing and includes certain pro forma adjustments for the amortization of intangible assets and transaction costs. The pro forma results are not necessarily indicative of (i) the results of operations that would have occurred had the operations of this acquisition actually been acquired at the beginning of fiscal year 2020 or (ii) future results of operations:

    

For the Years Ended

December 31, 

2021

    

2020

Net Revenues

$

5,439,093

$

7,527,651

Net Loss

$

(12,510,391)

$

(9,032,939)

NOTE 4 - INTANGIBLE ASSETS

On June 15, 2021, pursuant to an asset purchase agreement dated June 4, 2021, the Company closed on the acquisition of a customer list (the “Customer List”) and other assets of Advisio Solutions, LLC (“Advisio”) for consideration consisting of: (i) $1,050,000 paid in cash and (ii) the issuance of an aggregate of 100,000 shares of the Company’s common stock with an aggregate issuance date fair value of $532,000. Under the screen test requirements under ASC 805, the Company concluded that the Customer List represented substantially all of the fair value of the gross assets acquired and, accordingly, determined the set was not considered a business, such that the Company applied asset acquisition accounting and recorded the acquisition of the Customer List as an intangible asset in the amount of $1,582,000 that will be amortized on a straight-line basis over its useful life of seven years.

Intangible assets consist of the following:

    

December 31, 

    

2021

    

2020

Acquired data

$

1,300,336

$

1,300,336

Acquired software

 

183,072

 

100,000

Acquired customer lists

 

2,162,000

 

Restrictive covenant agreements

70,000

3,715,408

1,400,336

Less: accumulated amortization

 

(768,798)

 

(328,486)

Intangible assets, net

$

2,946,610

$

1,071,850

F-16

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

Amortization of intangible assets consists of the following:

    

    

    

Acquired 

    

Restrictive 

    

    

Acquired 

Acquired 

Customer 

Covenant 

Accumulated 

Data

Software

Lists

Agreements

Amortization

Total

Balance as of January 1, 2020

$

$

100,000

$

$

$

(16,667)

$

83,333

Additions

 

1,300,336

 

 

 

 

 

1,300,336

Amortization expense

 

 

 

 

 

(311,819)

 

(311,819)

Balance as of December 31, 2020

 

1,300,336

 

100,000

 

 

 

(328,486)

 

1,071,850

Additions

 

 

83,072

 

2,162,000

 

70,000

 

 

2,315,072

Amortization expense

 

 

 

 

 

(440,312)

 

(440,312)

Balance as of December 31, 2021

$

1,300,336

$

183,072

$

2,162,000

$

70,000

$

(768,798)

$

2,946,610

Weighted average remaining amortization period at December 31, 2021 (in years)

 

3.0

 

1.0

 

5.5

 

4.9

 

4.4

 

  

    

    

    

Acquired 

    

Restrictive

    

Acquired 

Acquired 

Customer

 Covenant 

Accumulated 

Data

Software

 Lists

Agreements

Amortization

Balance as of January 1, 2020

$

$

16,667

$

$

$

16,667

Amortization expense

 

261,819

 

50,000

 

 

 

311,819

Balance as of December 31, 2020

 

261,819

 

66,667

 

 

 

328,486

Amortization expense

 

252,081

 

48,538

 

138,528

 

1,165

 

440,312

Balance as of December 31, 2021

$

513,900

$

115,205

$

138,528

$

1,165

$

768,798

The estimated future amortization expense is as follows:

For the Years Ending December 31,

    

Total

2022

$

718,601

2023

 

706,206

2024

 

683,192

2025

 

270,194

2026 and beyond

 

568,417

$

2,946,610

F-17

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

NOTE 5 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:

    

December 31, 

    

2021

    

2020

Accrued bonuses

$

554,997

$

541,834

Accrued payroll

13,750

Accrued payroll taxes

 

 

5,947

Financed director and officer insurance premiums

217,575

Accrued supplier expenses

 

1,042,971

 

50,972

Accrued legal and professional fees

 

20,323

 

80,653

Accrued commissions

 

36,109

 

2,768

Accrued media commissions

138,028

Credit card payable

328,075

901

Accrued programming expenses

 

1,750

 

16,750

Accrued issuable equity

 

1,258

 

293,724

Accrued interest

 

9,017

 

3,975

Accrued warrant exercise costs

83,519

Other

 

45,915

 

19,758

Total accrued expenses and other current liabilities

$

2,493,287

$

1,017,282

NOTE 6 — INCOME TAXES

The provision for income taxes consists of the following provisions/(benefits):

    

For the Years Ended

December 31,

    

2021

    

2020

Deferred tax benefit:

  

 

  

Federal

$

(2,183,635)

$

(132,480)

State and local

 

(978,739)

 

(641,793)

 

(3,162,374)

 

(774,273)

Change in valuation allowance

 

3,162,374

 

774,273

Provision for income taxes

$

$

The provision for income taxes differs from the statutory federal income tax rates as follows:

    

For the Years Ended

 

 December 31,

    

2021

    

2020

 

Tax expense at the federal statutory rate

21.0

%  

21.0

%

State taxes, net of federal benefit

8.7

%  

3.5

%

Permanent differences

(0.2)

%  

(10.3)

%

True-up

1.2

%  

(4.4)

%

Change in valuation allowance

(30.7)

%  

(9.8)

%

Effective income tax rate

0.0

%  

0.0

%

F-18

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

The components of deferred tax assets as of December 31, 2021 and 2020 relate to temporary differences and carryforwards as follows:

    

December 31,

    

2021

    

2020

Net operating loss carryforwards

$

5,383,659

$

2,702,003

Stock-based compensation expense

 

169,427

 

102,409

Deferred Revenue

7,972

Accrued Legal Settlement

290,948

Other reserve

 

59,682

 

55,699

Intangibles

 

211,651

 

68,733

Tax credits

 

90,952

 

90,952

Deferred tax assets

 

6,214,291

 

3,019,796

Fixed assets

 

(36,902)

 

(4,781)

Deferred tax liabilities

 

(36,902)

 

(4,781)

Valuation allowance

 

(6,177,389)

 

(3,015,015)

Deferred tax assets, net

$

$

As of December 31, 2021, the Company had approximately $18,263,000 of federal net operating loss (“NOL”) carryforwards that may be available to offset future taxable income. As of that date, approximately $533,000 of federal net operating losses will expire in 2037 and approximately $17,730,000 have no expiration. In addition, the Company has approximately $91,000 of federal research and development credit carryforwards that begin to expire in 2037. The Company also had approximately $29,016,000 of state and local NOLs that begin to expire in 2037. The utilization of NOL carryforwards and research and development credits to offset future taxable income may be subject to limitations under Section 382 of the Internal Revenue Code and similar state statutes as a result of ownership changes that could occur in the future. If necessary, the deferred tax assets will be reduced by any carryforward that expires prior to utilization as a result of such limitations, with a corresponding reduction of the valuation allowance.

The Company has assessed the likelihood that deferred tax assets will be realized in accordance with the provisions of ASC 740, Income Taxes (“ASC 740”). ASC 740 requires that such a review considers all available positive and negative evidence, including the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. ASC 740 requires that a valuation allowance be established when it is “more likely than not” that all, or a portion of, deferred tax assets will not be realized. After the performance of such reviews as of December 31, 2021 and 2020, management believes that uncertainty exists with respect to future realization of its deferred tax assets and has, therefore, established a full valuation allowance as of those dates. Thus, the Company increased the valuation allowance by $3,162,374 and $774,273 during the years ended December 31, 2021 and 2020, respectively.

Management has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s consolidated financial statements as of December 31, 2021 and 2020. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date.

The Company is subject to income taxes in the United States and in various state taxing jurisdictions including New York, New York City and California. No tax audits were commenced or were in process during the years ended December 31, 2021 and 2020. No tax related interest or penalties were incurred during the years ended December 31, 2021 and 2020. The Company’s Federal, New York State and City, and State of California income tax returns filed since inception remain subject to examination.

F-19

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

NOTE 7 – NOTES PAYABLE

During the years ended December 31, 2021 and 2020, the Company recorded cash interest expense of $8,383 and $207,092, respectively, and non-cash amortization of debt discount and debt issuance costs of $0 and $915,994, respectively, which is included in interest expense on the consolidated statements of operations. As of December 31, 2021 and 2020, the Company had $9,017 and $4,599, respectively, of accrued interest related to notes payable.

During the years ended December 31, 2021 and 2020, the Company recorded cash interest expense – related parties of $0 and $46,171, respectively, and non-cash amortization of debt discount and debt issuance costs – related parties of $0 and $357,201, respectively.

During the years ended December 31, 2021 and 2020, the Company made aggregate principal repayments of notes payable of $177,347 and $95,000, respectively, and $0 and $150,000, respectively, of repayments of notes payable – related party.

Notes Payable

PPP Loan

On April 6, 2020, the Company received a loan in the amount of approximately $327,000 (the “PPP Loan”) from JPMorgan Chase Bank, N.A., as lender, pursuant to the Paycheck Protection Program (“PPP”) of the Coronavirus Aid, Relief and Economic Security Act, as amended (the “CARES Act”). The PPP Loan matures on April 16, 2022 and bears interest at a rate of 0.98% per annum. Commencing May 16, 2021, the Company is required to pay the lender equal monthly payments of principal and interest as required to fully amortize by April 16, 2022 the principal amount outstanding on the PPP Loan as of the date prescribed by guidance issued by the U.S. Small Business Administration (“SBA”). The PPP Loan is evidenced by a promissory note dated April 6, 2020, which contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. The PPP Loan may be prepaid by the Company at any time prior to maturity with no prepayment penalties. As of December 31, 2021 and 2020, the amount outstanding under the PPP Loan was $149,843 and $327,290, respectively.

EIDL Loan

On June 23, 2020, the Company received a loan in the amount of approximately $79,000 (the “EIDL Loan”) from the SBA, as lender, under the SBA’s Economic Injury Disaster Loan (“EIDL”) assistance program. The EIDL Loan bears interest at 3.75% per annum. Monthly installment payments in the amount of $385 per month, including principal and interest, will begin June 20, 2021. The EIDL Loan matures on June 20, 2050, and is evidenced by a promissory note, loan authorization agreement, and security agreement, all dated June 20, 2020, and all of which contain customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. The EIDL Loan is collateralized by the assets of the Company. Such EIDL Loan amount will reduce the Company’s PPP loan forgiveness amount described above. The EIDL Loan may be prepaid by the Company at any time prior to maturity with no prepayment penalties. As of December 31, 2021 and 2020, the amount outstanding under the EIDL Loan was $78,900.

Separately, during the year ended December 31, 2020, the Company also received a grant of $10,000 from the SBA under the EIDL assistance program. The grant was recognized as other income during the year ended December 31, 2020.

F-20

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

Notes Payable – Related Parties

During the year ended December 31, 2020, the Company received aggregate proceeds of $685,000 in connection with three-year notes payable issued to three of its executive officers. The notes bear interest ranging from 0.91% and 1.60% per annum, payable annually. The outstanding principal and accrued and unpaid interest became immediately due and payable upon the Company’s initial public offering. Effective July 13, 2020, the holders agreed to amend the terms of the notes to provide for automatic conversion of principal and interest thereunder into shares of common stock and warrants to purchase shares of common stock at the public offering price per unit. The Company determined that the amended terms were debt modifications. Upon closing of the initial public offering which resulted in net proceeds of approximately $10.6 million (“IPO”) on August 14, 2020, such notes payable, along with accrued interest of $6,048, automatically converted into an aggregate of 138,209 shares of common stock and five-year warrants to purchase 138,209 shares of common stock at an exercise price of $5.50 per share.

In addition to these related party notes, on July 28, 2020, the Company received proceeds of $150,000 in connection with a note payable that was issued to an entity controlled by the Company’s then-Chief Executive Officer. The note bears interest at 0.17% per annum, payable annually. The note matures and is repayable in cash by the Company on October 28, 2020, subject to acceleration following the occurrence of an IPO, qualified financing or sale of the Company (as such terms are defined in the note). On September 24, 2020, the Company fully repaid the note.

Convertible Notes Payable

Upon the closing of the initial public offering, the Senior Notes and Junior Notes automatically converted into common stock and warrants at a conversion price of $3.50. Based on the foregoing, the Senior Notes and Junior Notes converted into an aggregate of 1,322,881 shares of common stock and five-year warrants to purchase an aggregate of 1,322,881 shares of common stock at an exercise price of $5.50 per share (based on aggregate principal balance of $4,326,000 and aggregate accrued interest of $304,090 as of August 14, 2020). The Company recognized expense of approximately $2.4 million associated with the recognition of a beneficial conversion feature of $1,984,322 and interest expense in connection with the amortization of unamortized debt discount of $393,959.

Upon the closing of the IPO, a down round feature was triggered in warrants held by holders of Senior Notes and Junior Notes, such that the warrants, which have an exercise price of $4.20 per unit, are exercisable into an aggregate of 1,235,997 shares of common stock and five-year warrants to purchase an aggregate of 1,235,997 shares of common stock at an exercise price of $5.50 per share. In connection with the down round being triggered, the Company recognized a deemed dividend of $1,682,000 during the year ended December 31, 2020 on the consolidated statements of operations, which represents the incremental fair value, estimated using a binomial model, provided to the holders in connection with the down round.

On August 12, 2020, a noteholder exercised its option to convert a convertible note payable in the principal amount of $20,000 and accrued interest in the amount of $3,370 at a conversion price of $0.29 per share that was not subject to the Reverse Stock Split, which resulted in the issuance of 80,586 shares of common stock. In connection with the conversion, the Company recognized a loss on extinguishment of convertible note payable of $297,272, which represented the fair value of the additional shares issued to the noteholder as a result of not applying the Reverse Stock Split.

On August 14, 2020, a noteholder exercised its option to convert a convertible note payable in the principal amount of $45,000 and accrued interest in the amount of $22,502 at a conversion price of $4.95 per share, which resulted in the issuance of 13,637 shares of common stock.

Due to Related Party

The Company repaid $29,000 during the year ended December 31, 2020 related to a non-interest-bearing advance from a company controlled by an executive officer.

F-21

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

NOTE 8 — STOCKHOLDERS’ EQUITY

Authorized Capital

The authorized capital of Kubient consists of 95,000,000 shares of common stock, par value $0.00001 per share, and 5,000,000 shares of preferred stock, par value $0.00001 per share. The holders of the Company’s common stock are entitled to one vote per share.

Reverse Stock Split

A 1:9 reverse stock split of the Company’s common stock was affected on August 6, 2020 (the “Reverse Stock Split”). All share and per share information has been retroactively adjusted to give effect to the Reverse Stock Split for all periods presented, unless otherwise indicated.

Public Offerings

On August 14, 2020, the Company consummated its initial public offering of 2,500,000 units (the “Units”) at a price of $5.00 per Unit, which resulted in aggregate gross and net proceeds of approximately $12.5 million and $10.6 million, respectively. Each Unit consisted of one share of common stock, par value $0.00001 per share and one warrant to purchase one share of common stock (the “Warrants”). The Warrants are exercisable immediately upon issuance and at any time up to the date that is five years from the date of issuance and will have an exercise price of $5.50 per share.

On August 14, 2020, the Company consummated the closing of a partial exercise of the over-allotment option granted to the underwriters in connection with its IPO to purchase 375,000 additional common stock purchase warrants at a price of $0.01 per warrant for aggregate proceeds of $3,750.

On August 14, 2020, in connection with its IPO, the Company issued to the underwriters warrants to purchase 125,000 shares of common stock at $6.25 per share. The warrants are exercisable at any time for cash or on a cashless basis during the four- and one-half year period commencing 180 days from the effective date of the Company’s registration statement. The warrants had an issuance date fair value of $225,850 that was recorded as a debit and credit to additional paid-in capital.

On December 28, 2020, the Company consummated a Follow-On Offering of 4,058,822 shares of common stock at a price of $5.10 per share for aggregate gross and net proceeds of approximately $20.7 million and $18.9 million, respectively, which such amounts include the full exercise by the underwriters of the over-allotment option to purchase an additional 529,411 shares of common stock at $5.10 per share. The Company issued to the representatives of the underwriters warrants to purchase 176,470 shares of common stock at an exercise price of $6.38 per share. The warrants are exercisable at any time for cash or on a cashless basis during the four- and one-half year period commencing 180 days from the effective date of the Company’s registration statement. The warrants had an issuance date fair value of $447,987 that was recorded as a debit and credit to additional paid-in capital.

See Note 6 – Notes Payable for additional details.

F-22

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

Equity Incentive Plans

The 2017 Equity Incentive Plan (the “2017 Plan”) was originally adopted by the Company’s board of directors and approved by its stockholders on September 12, 2017 and was subsequently amended and restated on June 5, 2019. The purposes of the 2017 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our service providers and to promote the success of the Company’s business. The Company has reserved 333,334 shares of common stock to issue awards under the 2017 Plan. as of December 31, 2021, 11,889 shares of common stock remained available for future issuance under the 2017 Plan.

The 2021 Equity Incentive Plan was originally adopted by the Company’s board of directors and approved by its stockholders on June 30, 2021 (the “2021 Plan”). The purposes of the 2021 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our service providers and to promote the success of the Company’s business. The Company has reserved 1,500,000 shares of common stock to issue awards under the 2021 Plan. As of December 31, 2021, 1,400,000 shares of common stock remained available for future issuance under the 2021 Plan.

Founder Employee Incentive Program

On July 2, 2020, the Company’s board of directors adopted the Founder Employee Incentive Program (the “Founder Program”) under the 2017 Plan. The purposes of the Founder Program are to offer near-term and long-term incentives to founder employees of the Company that are intended to keep such employees in the employ of the Company, and that are based on individual performance, the achievement of financial goals of the Company and the total return to the Company’s stockholders. Through December 31, 2021, no awards have been issued by the Company under the Founder Program.

Stock-Based Compensation

For the years ended December 31, 2021 and 2020, the Company recognized stock-based compensation expense related to stock options and common stock as follows:

    

For the Years Ended

December 31, 

    

2021

    

2020

Sales and marketing

$

270,460

$

54,723

Technology

 

31,631

 

13,891

General and administrative

 

421,951

 

399,602

Total

$

724,042

$

468,216

As of December 31, 2021, there was approximately $875,000 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 2.3 years.

Common Stock

During the year ended December 31, 2020, the Company issued an aggregate of 38,433 shares of immediately vested common stock under the 2017 Plan to three employees and two non-employee service providers. The shares had an issuance date fair value of an aggregate of $107,503, which was recognized immediately.

During the three months ended March 31, 2021, the Company issued an aggregate of 20,040 shares of common stock under the 2017 Plan to the four members of the Company’s Board of Directors. The shares had a grant date fair value of $60,120, which was recognized ratably from the grant date of November 5, 2020 through January 15, 2021, the date the shares were issued.

F-23

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

During the three months ended March 31, 2021, the Company issued an aggregate of 50,000 shares of immediately vested common stock (10,000 shares were issued under the Company’s 2017 Plan) to an employee and a consultant for services provided. The common stock had an aggregate issuance date fair value of $500,400 which was recognized immediately.

During the three months ended June 30, 2021, the Company issued an aggregate of 167,600 restricted shares of its common stock under the 2017 Plan to six employees. The restricted stock had an aggregate issuance date fair value of $963,701, of which, awards with an aggregate fair value of $957,313 vest over a period of one year and an award with an aggregate fair value of $6,388 vests immediately. The fair value of the awards is being recognized over the vesting term.

During the three months ended December 31, 2021, the Company issued 1,062 shares of immediately vested common stock to a former member of the Company’s Board of Directors that had an issuance date fair value of $3,282 that was recognized immediately.

See Note 4 – Intangible Assets for details regarding the issuance of common stock as partial consideration for the acquisition of intangible assets. See Note 7 – Notes Payable for additional details related to common stock issuances. See Note 9 – Commitments and Contingencies – Employment Agreements for details regarding the grant of a bonus that is payable in common stock of the Company.

Stock Options

On November 9, 2020, the Company granted a ten-year option to purchase 20,000 shares of common stock at an exercise price of $2.81 per share to an employee under the 2017 Equity Incentive Plan. The shares vest over a four-year period, with 5,000 shares vesting on November 9, 2021 and the remaining 15,000 shares vesting ratably on a monthly basis over the remaining three-year period. The options had an aggregate grant date fair value of $32,981, or $1.31 per share, which will be recognized over the vesting period.

During the year ended December 31, 2021, the holder of an option under the 2017 Plan to purchase 2,815 shares of the Company’s common stock at an exercise price of $2.97 per share exercised such option resulting in cash proceeds of $8,361 to the Company.

In applying the Black-Scholes option pricing model to stock options granted, the Company used the following approximate assumptions:

    

For the Years Ended

 

December 31, 

 

 

2021

    

2020

Expected term (years)

 

N/A

6.08

Expected volatility

 

N/A

55.8%-56.3%

Risk free interest rate

 

N/A

0.57%-1.65%

Expected dividends

 

N/A

0.00%

A summary of the Company’s stock option activity during the year ended December 31, 2021 is as follows:

    

    

    

Weighted Average

    

Number

Weighted Average

Remaining Term 

Intrinsic

    

of Options

    

Exercise Price

    

(Years)

    

Value

Outstanding at January 1,2021

 

118,412

$

15.22

 

  

 

  

Granted

 

 

 

  

 

  

Forfeited

 

(21,150)

 

33.16

 

  

 

  

Exercised

 

(2,815)

 

2.97

 

  

 

  

Outstanding at December 31, 2021

 

94,447

$

11.56

 

4.4

$

6,339

Exercisable at December 31, 2021

 

66,240

$

9.49

 

2.9

$

3,276

F-24

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

The following table presents information related to stock options as of December 31, 2021:

Options Outstanding

    

Options Exercisable

Weighted

Outstanding

Average

Exercisable

Number of

Remaining Life

Number of

Exercise Price

    

Options

    

In Years

    

Options

$

2.81

 

20,000

 

8.9

 

5,416

$

2.97

 

42,779

 

0.7

 

42,779

$

4.95

 

5,556

 

0.9

 

4,255

$

33.75

 

26,112

 

7.8

 

13,790

 

94,447

 

2.9

 

66,240

Stock Warrants

See Note 6 – Notes Payable – Convertible Notes Payable and Note 7 – Stockholder’s Equity – Public Offerings for details regarding the issuance of warrants during the year ended December 31, 2020.

The Company used the following approximate assumptions in connection with its estimation of fair value of warrants:

    

For the Years Ended

 

December 31, 

 

2021

    

2020

 

Expected term (years)

 

N/A

3.86-4.75

Expected volatility

 

N/A

58.0%-61.2%

Risk free interest rate

 

N/A

0.24%-0.39%

Expected dividends

 

N/A

0.00%

A summary of the warrant activity during the year ended December 31, 2021 is presented below:

    

    

    

    

Weighted

    

    

Weighted

Average

Average

Remaining

Number of

Exercise

Life

Intrinsic

    

Warrants

    

Price

    

In Years

    

Value

Outstanding, January 1, 2021

 

6,167,745

$

5.26

 

  

 

  

Issued

 

867,286

 

5.50

 

  

 

  

Exercised

 

(2,281,668)

 

5.04

 

  

 

  

Expired

 

 

 

  

 

  

Outstanding, December 31, 2021[1]

 

4,753,363

$

5.42

 

3.5

$

Exercisable, December 31, 2021

 

4,753,363

$

5.35

 

3.5

$

[1] Excludes five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share that are issuable upon exercise of certain warrants.

F-25

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

The following table presents information related to stock warrants as of December 31, 2021:

Warrants Outstanding

    

Warrants Exercisable

Weighted

Outstanding

Average

Exercisable

Number of

Remaining Life

Number of

Exercise Price

Warrants

In Years

    

Warrants

$

4.20

 

368,711

 

2.7

 

368,711

$

4.95

 

177,223

 

1.3

 

177,223

$

5.50

 

3,998,459

 

3.7

 

3,998,459

$

6.25

 

32,500

 

3.6

 

32,500

$

6.38

 

176,470

 

4.0

 

176,470

 

4,753,363

 

3.5

 

4,753,363

NOTE 9 – COMMITMENTS AND CONTINGENCIES

From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

Settlements

On October 6, 2017, the Company entered into a Master Service Agreement for Buyers and Sellers, and an “Engage Buyer Addendum”, with Engage BDR, LLC whereby the Company could gain access to the Engage BDR, LLC proprietary trading technology platform in order to both offer and purchase inventory for the placement of ads. On August 31, 2018, Engage BDR, LLC filed suit against the Company (Engage BDR, LLC v. Kubient, Inc., Los Angeles County Superior Court Case No. SC129764) setting forth claims of breach of contract, unjust enrichment, quantum meruit, accounts stated, and breach of implied covenant of good faith and fair dealing. On November 14, 2018, Engage BDR, LLC obtained a summary default judgment against the Company for $35,936. On February 17, 2021, the Company and Engage BDR, LLC entered into a settlement agreement in the amount of $33,461 and the Company paid such amount on February 19, 2021, which had been accrued for as of December 31, 2020.

See Note 11 – Subsequent Events for details of the settlement of previously outstanding litigation.

Obligations Arising from Employment Agreements

On April 9, 2021, the Company entered into an at-will employment agreement with its new Chief Product Officer, Mr. Leon Zemel, that provides for an annual base salary of $390,000, plus annual performance bonuses with a target achievement of up to 20% of Mr. Zemel’s base salary. Subject to the approval of the board or its compensation committee, the Company agreed to take appropriate action within ninety (90) days following April 9, 2021 to make an award of 100,000 shares of common stock to Mr. Zemel, which will vest at the rate of 1/4th of the total number of shares on the first anniversary of the Effective Date and 1/36th of the total number of remaining unvested shares each month thereafter. As of September 30, 2021, the award had not been granted. Upon termination of Mr. Zemel’s employment for any reason, Mr. Zemel is entitled to (i) any portion of his base salary earned through the date of his termination date, (ii) any expenses owed to him, (iii) subject to Company policy and the law, any accrued, but unused vacation pay owed to him, pursuant to Company policy, if any, to the extent not inconsistent with applicable laws, and (iv) any amount arising from Mr. Zemel’s participation in, or benefits under, the Company’s employee benefit plans. In the event Mr. Zemel is terminated without cause or that Mr. Zemel resigns for Good Reason (as defined in his employment agreement), Mr. Zemel is entitled to receive: to six month’s salary paid in one lump sum, six months continued healthcare coverage, any pro-rated bonus amounts outstanding at the time of termination, and immediate vesting of any equity awards that would have become vested and exercisable during the three months after his termination. Mr. Zemel’s employment agreement contains an accelerated vesting provision which provides that 25% of his share award under the agreement shall vest if he is terminated before the one-year anniversary date of the agreement for good cause, or if he chooses to terminate his

F-26

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

employment with the Company for Good Reason (as defined in the agreement), then 100% of his share award under the agreement shall vest immediately. All outstanding awards due to Mr. Zemel automatically vest upon a change in control of the Company.

On June 4, 2021 (the “Effective Date”), the Company entered into two-year employment agreements with its two new Vice Presidents of Performance Media. The agreements provide for a bonus paid to each Vice President of Performance Media of (i) the issuance of up to 67,738 shares of the Company’s common stock (the “First Year Bonus”) on the 12-month anniversary of the Effective Date if as of such date the net revenue, as defined within the agreement, generated from the Customer List through the respective Vice President of Performance Media’s performance marketing is between $175,000 and an amount in excess of $350,000, which First Year Bonus shall vest in two equal equity installments, the first of which occurring on the second anniversary of the issuance thereof and the second of which occurring on the fourth anniversary of the issuance thereof (the “Year 1 Equity Grant”), and (ii) the issuance of up to 67,738 shares of the Company’s common stock (the “Second Year Bonus”) on the 24-month anniversary of the Effective Date if as of such date the net revenue, as defined within the agreement, generated from the Customer List through the respective Vice President of Performance Media’s performance marketing is between $262,000 and an amount in excess of $525,000, which Second Year Bonus shall vest in two equal equity installments, the first of which occurring on the second anniversary of the issuance thereof and the second of which occurring on the fourth anniversary of the issuance thereof (the “Year 2 Equity Grant”).  If either Vice President of Performance Media ends the Term of Employment for good reason, as defined within the agreement, or the Company terminates either Vice President of Performance Media without cause, such Vice President of Performance Media shall (i) receive $150,000 prorated for two months following such termination and for an additional year for every year the Vice President of Performance Media was employed by Company, and (ii) payment of any earned, but unpaid, performance-based performances due as of the date of such termination (“Severance”). The Company determined that the First Year Bonus and Second Year Bonus to each Vice President of Performance Media represents an accounting grant with a performance-based vesting condition pursuant to Accounting Standards Codification 718. The aggregate grant date fair value of the awards of $1,400,822 will be recognized over the respective vesting term for awards that are deemed to be probable to vest.

On November 29, 2021, Mitchell Berg was appointed to serve as its Chief Technology Officer of the Company. Upon joining the Company as Chief Technology Officer, Mr. Berg will receive an annual base salary of $300,000, a restricted stock unit (“RSU”) award of 80,000 shares of common stock of the Company, and a performance stock unit (“PSU”) award of 50,000 shares of common stock of the Company. Mr. Berg will also be eligible to participate in the Company’s Short Term Incentive Plan (“STIP”) and his target bonus pursuant to the STIP will be $100,000. Provided, however that any payout pursuant to the STIP will be determined by the Company and its board of directors or compensation committee, in its discretion, after considering Mr. Berg’s individual performance and the overall performance of the Company’s business. Upon a termination for any reason, Mr. Berg is entitled to any unpaid but accrued portion of his base salary earned through the date of his termination, payment for any accrued but unused vacation pay, any expenses owed to him pursuant to his employment agreement, and any amounts owed under the Company’s benefit plans. In the event Mr. Berg experiences a Covered Termination (as defined in his employment agreement), Mr. Berg shall be entitled to six month’s salary paid in one lump sum, six months continued healthcare coverage, payment of any Annual Bonus (as defined in his employment agreement) earned but that has not been paid and a pro-rata portion of any Annual Bonus earned in the fiscal year in which the Covered Termination takes place, and immediate vesting of any equity awards that would have become vested and exercisable during the three months after his termination. All outstanding RSU awards due to Mr. Berg automatically vest upon a change in control of the Company. The RSU was determined to be granted for accounting purposes on November 29, 2021 under the 2021 Plan and had a grant date fair value $216,800 that will be recognized vesting term. Given that the PSU contains performance conditions that had not been determined as of December 31, 2021, the Company determined that the PSU had not been considered granted for accounting purposes as of December 31, 2021. The PSU was deemed to be granted on January 12, 2022 and both PSU and RSU awards were issued on February 15, 2022.

F-27

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

NOTE 10 — CONCENTRATIONS

Customer Concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:

    

For the Years Ended

 

December 31, 

 

Customer

    

2021

    

2020

 

Customer A

 

85.77

%  

51.40

%

Customer B

 

N/A

26.43

%

Customer C

 

N/A

18.24

%

Customer D

 

11.56

%

N/A

Customer H

N/A

N/A

Customer I

 

N/A

 

*

Total

 

97.33

%  

96.07

%

*

Less than 10%.

From time to time, certain customers generate negative net revenues that resulted from Supplier Costs that exceeded the Gross Billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:

December 31, 

 

Customer

    

2021

    

2020

 

Customer A

 

N/A

 

89.02

%

Customer B

 

22.08

%

N/A

Customer E

 

52.18

%  

N/A

Total

 

74.26

%  

89.02

%

A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.

F-28

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

Supplier Concentrations

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:

    

For the Years Ended

 

December 31, 

 

Supplier

    

2021

    

2019

 

Supplier B

 

N/A

15.51

%

Supplier C

 

N/A

 

N/A

Supplier D

 

N/A

16.32

%

Supplier E

 

42.36

%

N/A

Total

 

42.36

%  

31.83

%

*

Less than 10%.

NOTE 11 – SUBSEQUENT EVENTS

The Company has evaluated events that have occurred after the balance sheet and through the date the financial statements were issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements, except as disclosed below.

Stock-Based Compensation

Subsequent to December 31, 2021, the Company granted 53,192 shares of immediately vested common stock to non-employee directors under the 2021 Plan with an aggregate grant date fair value of $100,000.

Subsequent to December 31, 2021, the Company issued an aggregate of 489,990 RSUs and a target number of 184,376 PSUs, all issued under the 2021 Plan. The RSUs vest ratably over four years and the PSUs are earned based upon based upon actual net revenue generated by the Company during 2022 as compared to the targeted revenue specified in each award. Depending on actual net revenues generated as compared to the targeted amounts, the grantees may earn between 0% and 150% of their target award. The awards had an aggregate issuance date fair value of approximately $1,500,000.

Subsequent to December 31, 2021, the Company’s chief financial officer surrendered to the Company 3,397 shares of common stock in order to satisfy a tax withholding obligation of approximately $18,000 in connection with a previous grant.

F-29

Table of Contents

Kubient, Inc.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

Settlement Agreement

On March 11, 2022, the Company, Aureus Holdings, LLC d/b/a Lo70s (“Lo70s”) and JPAR, LLC entered into a Settlement Agreement and Mutual Release (the “Lo70s Settlement Agreement”).  Pursuant to the Lo70s Settlement Agreement, the parties agreed to dismiss the litigation (Aureus Holdings, LLC d/b/a Lo70s v. Kubient, Inc., et al., Superior Court of Delaware, Case No. N20C-07-061) and resolve all claims among them, including potential or future claims arising from the letter of intent that the Company and Lo70s had entered into in March 2019, as well as a consulting agreement entered into between the Company and an employee of Lo70s in connection with such letter of intent. On March 14, 2022, the court in the matter entered an order approving the Lo70s Settlement Agreement, and the case was dismissed with prejudice. In the Lo70s Settlement Agreement, the Company expressly denies any and all liability and the dismissal of the case with prejudice was entered by the court without a final judgment of liability entered against the Company Under the terms of the Lo70s Settlement Agreement, the Company made a cash payment of $975,000 to Lo70s in full satisfaction of the matter, as well as the releases and covenants of Lo70s and JPAR, LLC set forth in the Lo70s Settlement Agreement, such that the Lo70s Settlement Agreement fully concludes this matter. During the year ended December 31, 2021, the Company recognized a loss on settlement of approximately $875,000 such that, as of December 31, 2021, it had accrued for the $975,000 cash payment.

F-30

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this Annual Report on Form 10-K. Our disclosure controls and procedures are designed to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on such evaluation, and as a result of the material weakness described below, our CEO and CFO have concluded that as of December 31, 2021, our disclosure controls and procedures were not effective at the reasonable assurance level.

Management’s Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external purposes in accordance with generally accepted accounting principles.

Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2021 using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control—Integrated Framework (2013). Based on its assessment, our management, including our CEO and CFO, has concluded that our internal control over financial reporting was not effective as of December 31, 2021 and that a material weakness in internal control over financial reporting existed as described as follows:

The Company had inadequate segregation of duties in its finance and accounting function because of its limited personnel.

A material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight Board (“PCAOB”) Auditing Standard AS 2201, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company's annual or interim financial statements will not be prevented or detected on a timely basis.  These deficiencies listed above, combined with inadequate compensating controls, created a reasonable possibility that a material misstatement to the consolidated financial statements might not be prevented or detected on a timely basis.

Management expects to remediate these control deficiencies during 2022, including by expanding the number of personnel in its finance and accounting department.

Attestation Report of the Registered Public Accounting Firm

This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s assessment was not subject to attestation by our independent registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit us to provide only management’s assessment in this Annual Report on Form 10-K.

Changes in Internal Control over Financial Reporting

During 2021, management continued to implement improvements to the Company’s internal control system. Throughout the year, from executive management on down, a strong commitment was made to the importance of internal control and to create and maintain an

24

infrastructure to support the Company’s compliance program. The Audit Committee was actively engaged and exercised continuous oversight throughout the process. Further, management and the Audit Committee fostered open and regular dialogue with the Company’s external auditors. Internal controls were strengthened and, when possible, automated and centralized. The Company’s process included:

The Company continued its engagement with outside advisory and consulting firms with expertise in evaluating and remediating material weaknesses in internal control over financial reporting, including controls related to our information technology environment.
All financially significant business processes and entity-level assessments were documented, evaluated and tested for their adequacy of design.
The Company’s information technology security and general controls were documented, evaluated and tested for their adequacy of design.
The Company successfully tested for operational effectiveness in its business processes and entity level internal controls and information technology general and security controls.

Except as described above, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Management recognizes that a control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud or error, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

ITEM 9B. OTHER INFORMATION

None.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.

Not applicable.

25

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Directors and Executive Officers

The following table sets forth information about our directors and executive officers as of March 29, 2022.

Name

 

Age

 

Position(s)

Executive Officers

 

 

 

 

 

 

 

 

 

Paul Roberts

 

45

 

Chief Executive Officer, Chief Strategy Officer, President and Chairman

Joshua Weiss

 

38

 

Chief Financial Officer

Mitchell Berg

 

60

 

Chief Technology Officer

Leon Zemel

 

52

 

Chief Product Officer

 Non-Employee Directors

 

 

 

 

 

 

 

 

 Jonathan Bond(2)(4)

 

64

 

Director

Peter A. Bordes

 

58

 

Director

Grainne Coen(1)(3)(4)

 

49

 

Director

Elisabeth H. DeMarse(1)(2)(3)(4)

 

68

 

Director

Lawrence Harris(2)(4)

 

59

 

Director

Jeannie Mun(1)(3)(4)

 

45

 

Director

(1)

Member of the Audit Committee

(2)

Member of the Business Development and Marketing Committee

(3)

Member of the Compensation Committee

(4)

Member of the Nominating and Corporate Governance Committee

Executive Officers

Paul Roberts, has served as Chief Strategy Officer, President and Chairman since May 15, 2019, prior to which he acted as our Chief Executive Officer and Chairman since May 2017, overseeing the development and commercialization of our Company. Mr. Roberts served as our Interim Chief Executive Officer from October 31, 2020 until December 16, 2021, when the designation of “interim” was removed from Mr. Roberts’ title. From August 2012 to February 2018, Mr. Roberts was the Chief Executive Officer of CenterPoint Media LLC, an online marketing company that helped brands engage with their customers over lifestyle blogs. Mr. Roberts has over 15 years’ experience in digital media, with particular focus on the art of building companies from inception and shepherding those companies growth all the way to their initial public offering of securities. Accordingly, his background and experience also encompasses sales, marketing strategy, brand development and customer engagement, as such disciplines uniquely exist in the technology and advertising industries. From August 2012 to February 2018, Mr. Roberts was the Chief Executive Officer of CenterPoint Media LLC, an online marketing company that helped brands engage with their customers over lifestyle blogs. Mr. Roberts has also held positions at Logical SEO, Inc. d/b/a Logical Media Group from July 2011 to July 2012, TanzAct Media Inc. from November 2006 to November 2008, Yahoo! Inc. (NASDAQ:YHOO) from April 2005 to November 2006, Hotjobs.com, Ltd. (NASDAQ:HOTJ) from April 2005 to November 2006, and Attain Media, Inc. from October 2001 to February 2005. Mr. Roberts attended Long Island University.

Joshua Weiss has served as our Chief Financial Officer since December 23, 2019. From October 2016 to June 2019, Mr. Weiss was employed as a Vice President, Finance at Cambridge Information Group, a family office specializing in education and education technology. From October 2011 to October 2016, Mr. Weiss held various positions at an international accounting firm, including Senior Audit Manager, specializing in the firm’s SEC and Transaction Advisory groups. From August 2005 to October 2011, Mr. Weiss held various positions at a different international accounting firm, including Audit Manager, specializing in Real Estate and Hospitality. Mr. Weiss holds a Bachelor of Science degree in Accounting from Yeshiva University and is a licensed Certified Public Accountant in the State of New York.

26

Mitchell Berg has served as our Chief Technology Officer since November 29, 2021 and has close to 20 years’ experience as a senior information technology executive, including several stints as Chief Technology Officer at a number of leading digital marketplaces. Most recently, Mr. Berg worked as the Chief Technology Officer of Koddi Inc., an ad-tech marketplace, from March 2020 to October 2021. From June 2018 to March, 2020 he served as the Chief Technology Officer of Vroom Inc. (NASDAQ:VRM), an-online car buying marketplace. From August 2016 to March 2018, Mr. Berg served as the Senior Vice President of dailymotion, a publisher-side video advertising platform that is a subsidiary of the international media conglomerate Vivendi SE (Euronext:VIV). From July 2014 to August 2016, he was the Vice President of Display Advertising at IgnitionOne, Inc., a digital display advertising platform that was acquired by the multinational advertising company, Publicis Groupe (Euronext:PUB). From March 2014 to July 2014, he served as the Principal Architect at Cablevision Systems Corporation (NYSE:CVC), a cable television company which was acquired by Altice Europe N.V. (Euronext:ATC). From November 2012 to February 2014 he worked as the Vice President of Engineering at Kikin, Inc., an internet search engine. Mr. Berg has also held senior information technology positions at SEMplest LLC, BenefitPlan Manager Corp. and The Boeing Company (NYSE: BA). Mr. Berg holds a Bachelor of Science in Industrial Engineering and Computer Science from the University at Buffalo, a Master of Engineering in Systems Engineering from the University of Virginia, a Master of Business Administration in Technology Management from the University of Washington, and a Doctor of Philosophy in Industrial Engineering from the University of Pittsburgh.

Leon Zemel has served as our Chief Product Officer since April 12, 2021, and has worked in the area of data analytics, programmatic advertising, and digital strategy for over 20 years. From March 2020 to March 2021, he was the Senior Vice President of Programmatic and Platform Product at DoubleVerify, Inc. (NYSE:DV), a digital advertising marketplace. From July 2017 to March 2020, he was a General Manager of Intelligence Products at MediaMath, an advertising technology company focused on brands and agencies. From August 2016 to June 2018, Mr. Zemel was a member of the adjunct faculty of Columbia University, lecturing on Applied Analytics for the school’s Master of Science program. From June 2015 to June 2017, he was the Senior Vice President of Data and Audience at Sharecare, Inc. (NASDAQ:SHCR), a digital health company. From November 2004 to May 2015, Mr. Zemel served in various roles at x+1, which was acquired by Rocket Fuel, Inc. (NASDAQ:FUEL), a programmatic media-buying platform, eventually becoming the company’s Chief Analytics Officer in April of 2009. Mr. Zemel holds a Bachelor of Arts from Yeshiva University and a Master of Business Administration from Columbia University.

Non-Employee Directors

Jonathan Bond has been a member of our board of directors since June 30, 2021. Mr. Bond is one of the advertising and marketing industry’s most recognized leaders and an entrepreneur with over 35 years of experience. He previously was the Co-Founder and Chief Executive Officer of Kirshenbaum Bond Senecal & Partners, LLC, an integrated advertising and media agency. Prior to his tenure at Kirshenbaum Bond Senecal & Partners, LLC, Mr. Bond served as the Chief Executive Officer of Big Fuel Communications, LLC (now part of Publicis Groupe S.A. (OTCMKTS: PUBGY)), one of the world’s largest social media agencies. He helped establish iballs LLC, one of the first online media agencies, which was sold to Avenue A Inc. (and later acquired as Avenue A / Razorfish by Microsoft Corporation) in July 2006. He also co-founded The Media Kitchen and Varick Media Management LLC under the Kirshenbaum Bond Senecal & Partners, LLC umbrella. From August 2012 to December 2016, Mr. Bond was the founder of Maestro Management, LLC d/b/a Tomorro, an innovation consultancy. From January 2017 to June 2018, Mr. Bond was the Co-Chairman at The Shipyard, LLC, a full-service advertising agency focused on data science, which acquired Maestro Management, LLC d/b/a Tomorro. From June 2017 to July 2020, Mr. Bond was the Chairman and director of SITO Mobile, Ltd. (OTCMKTS:SITOQ), a digital brand insights platform. He has served as fractional Chief Marketing Officer of UCG, Inc. d/b/a Union Cannabis Group since August 2019. Additionally, since April 2013 he has served as a member of the board of advisors of Sonobi, Inc., an advertising technology developer. Since February 2021, he has been employed as the Chief Executive Officer and has served as a member of the board of directors of Signal Hill Acquisition Corp. (NASDAQ:SGHL), a special purpose acquisition company (“SPAC”), since February 2021 he has served as a member of the board of directors of Trajectory Alpha Acquisition Corp. (NYSE:TCOA), a SPAC, and since August 2020, as a member of the board of directors of PAWS, LLC d/b/a Halo Collar, a pet products company. Mr. Bond holds a Bachelor of Arts from Washington University (St. Louis).

Peter Anthony Bordes, Jr. has been a member of our board of directors since May 15, 2019 and served as the Company’s Chief Executive Officer from May 15, 2019 until October 31, 2020. From February 2021 to the present, Mr. Bordes has been employed as the Executive Chairman and Chief Executive Officer of Trajectory Alpha Acquisition Corp. (NYSE:TCOA.U), a SPAC, or blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or companies. Mr. Bordes also serves on the Board of Directors of Alfi, Inc. (NASDAQ: ALF) since March 2021 and is acting as Interim Chief Executive Officer since October 2021. Prior to joining the Company, from January 2011 to June 2019, Mr. Bordes acted as the Founder and Chief Executive Officer of OneQube, Inc., a digital Audience

27

Management Platform, which enables its customers to develop, manage and market to custom digital audiences. Mr. Bordes continues to serve as Chairman of the Board of OneQube, Inc. From June 2004 to August 2011, Mr. Bordes was a Co-Founder and Chief Executive Officer of MediaTrust, a real-time performance marketing advertising exchange for direct response marketing. From November 2018 to June 2019, Mr. Bordes acted as the Chairman and Co-Founder of MainBloq, a cloud-based modular Full Stack Execution Management platform for trading digital currencies and investing in digital assets. From January 2017 to June 2019, Mr. Bordes worked as the Co-Founder and Director of TruVest a sustainable affordable housing, real estate investment, development and technology company. Mr. Bordes’ current board service includes seats on the board of directors of Beasley Broadcast Group (NASDAQ: BBGI), Brooklyn School of Music, New England College, Fraud.net, Hoo.be, Ocearch and RevTrax. Mr. Bordes holds a Bachelor of Arts from New England College.

Grainne Coen has been a member of our board of directors since October 2, 2019. Ms. Coen has over 20 years’ experience in financial and investment management. She is responsible for managing the financial and administrative aspects of the Company including finance and accounting, acquisitions, divestitures, financing transactions, financial structuring, insurance, taxes and human resources. Since February 2021, Ms. Coen has been employed as the Chief Financial Officer, President, Treasurer and Secretary of Signal Hill Acquisition Corp. (NASDAQ:SGHL), a SPAC. In November 2021, Ms. Coen became Co-Chairperson of Genesis Unicorn Capital Corp. (NASDAQ:GENQ), a SPAC. In June 2021, Ms. Coen joined the board of Commonwealth Credit Partners BDC I, Inc., a business development company. In May 2018, she founded and has remained a partner of Elevation Investment Partners, LLC, a diversified investment group operating in multiple industries both as strategic consultants and early stage investors. From August 2001 to December 2015, she was a principal and portfolio manager at Columbia Partners, LLC Investment Management, where she co-managed over $1 billion in assets held in the fund’s U.S. Small Cap Equity Fund. From September 1998 to March 2001, she was a General Partner at Kensington Partners, LLC, and from May 1996 to August 1998, she was employed at G&O Partners, LP. Since January 2015, Ms. Coen has also served as Co-Founder and Chairperson of AREA4, LLC, an experiential marketing agency. From March 2019 to December 2020, Ms. Coen served as Chair of the board of directors of ERIE ARMADA, Inc., a non-profit focused on the development of underserved communities in conjunction with New York City’s Parks and Trails Department. Ms. Coen holds a Bachelor of Science from London Guildhall University.

Elisabeth H. DeMarse has been a member of our board of directors since January 7, 2020. From February 2021 to the present, Ms. DeMarse has been employed as the Executive Chairman and Chief Executive Officer of Trajectory Alpha Acquisition Corp. (NYSE:TCOA.U), a Special Purpose Acquisition Company, or blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or companies. From 2012 to March 2016, Ms. DeMarse served as the President and Chief Executive Officer and chair of the board of directors of TheStreet, Inc. Ms. DeMarse diversified The Street, Inc. from a B2C ad supported retail stock picking business to B2B global M&A, data and news businesses. Ms. DeMarse spent 10 years as the Chief Marketing Officer for Bloomberg LP working directly for the founder, Michael Bloomberg. She is currently a member of the board of directors and a chair of the audit committee of Clever Leaves Holdings Inc. (NASDAQ: CLVR). Ms. DeMarse previously served as a member of the boards of directors of AppNexus, CreditCards.com, ZipRealty (ZIPR), InsWeb Corp (INSW), Internet Patents Corporation (INTP), Edgar-Online (EDGR), Heska Corporation (HSKA), Incredimail (MAIL), Stockgroup (SWB), LiveDeal (LIVE), YP.com (YP), Nedsense (NEDSE), All Star Directories and ProNoun. She is also a member of The Committee of 200.Ms. DeMarse holds a Bachelor of Arts from Wellesley College, and a Master of Business Administration from Harvard University.

Lawrence Harris has been a member of our board of directors since June 30, 2021. As the Founder and Chief Executive Officer of Alpha Precision Media, an adtech company that leverages Amazon’s data and technology to build brand value and turbocharge sales that was founded in August 2020, Mr. Harris is seeking to cement his place as a global leader in the advertising technology industry. From September 2019 to the present, Mr. Harris has also acted as the Managing Partner of Glarris Consulting LLC, which provides strategic advisory services to companies, organizations and startups. From October 2016 to December 2019, Mr. Harris served as the Chief Executive Officer of Sightly, a performance video advertising firm. Prior to that time, from July 2007 to June 2010, Mr. Harris was the co-founder and Chief Executive Officer of Ansible Mobile, an Interpublic Group mobile marketing company. From March 2015 to June 2016, he was the Chief Strategy Officer at Kiosked, a publisher of digital advertising, and from February 2012 to November 2014, he was the Chief Marketing Officer of PubMatic, Inc. (NASDAQ:PUBM), an advertising technology company. He has also served as an advisor to a number of companies in the advertising technology industry, including SafeGuard Privacy, Qntfy, Reset Digital, and Thunder11. Mr. Harris holds a Bachelor of Arts from Harvard University.

28

Jeannie Mun has been a member of our board of directors since January 7, 2020. From October 2020 to the present, Ms. Mun has served as the Chief Financial Officer of OwnBackup, Ltd., a cloud software data protection platform. In addition, from January 2016 to the present, Ms. Mun has been employed as a consultant for JMM Capital, LLC, a CFO advisory firm. From March 2015 to September 2015, she was the Chief Financial Officer of Oyster Books, a predecessor to the Google Books service. From February 2009 to February 2015, Ms. Mun was the Chief Financial Officer of MediaMath, Inc., a programmatic marketing technology provider. From May 2007 to January 2009, she was employed as a Vice President of Finance and Strategy at SintecMedia Ltd. d/b/a Operative, a media technology company. Ms. Mun holds a Bachelor of Arts from the University of California Los Angeles, and a Master of Business Administration from Harvard University.

Involvement in Certain Legal Proceedings

To our knowledge, none of our current directors or executive officers has, during the past ten years:

been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;
been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;
been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;
been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or
been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

Except as set forth in our discussion below in “Certain Relationships and Related Party Transactions,” none of our directors or executive officers has been involved in any transactions with us or any of our directors, executive officers, affiliates or associates which are required to be disclosed pursuant to the rules and regulations of the SEC.

We are not currently a party to any legal proceedings, the adverse outcome of which, individually or in the aggregate, we believe will have a material adverse effect on our business, financial condition or operating results.

Family Relationships

There are no family relationships among any of our executive officers or directors.

29

Corporate Governance Overview

We are committed to having sound corporate governance principles, which are essential to running our business efficiently and maintaining our integrity in the marketplace. We understand that corporate governance practices change and evolve over time, and we seek to adopt and use practices that we believe will be of value to our stockholders and will positively aid in the governance of the Company. To that end, we regularly review our corporate governance policies and practices and compare them to the practices of other peer institutions and public companies. We will continue to monitor emerging developments in corporate governance and enhance our policies and procedures when required or when our board determines that it would benefit our Company and our stockholders.

In this section, we describe the roles and responsibilities of our board of directors and its committees and describe our corporate governance policies, procedures and related-documents. The charters of the audit, nominating and corporate governance, and compensation committees of our board of directors, our Corporate Governance Guidelines and Code of Business Conduct and Ethics can be accessed electronically under the “Governance” link on the Investor Relations page of our website at https://www.Kubient.com. We will also provide a copy of the audit and compensation committee charters, our Corporate Governance Guidelines and our Code of Business Conduct and Ethics without charge upon written request sent to our Investor Relations department at Attn: Investor Relations, Kubient, Inc., c/o Joshua Weiss, 500 7th Avenue, 8th Floor, New York, New York 10018. The inclusion of our website address in this section does not include or incorporate by reference the information on our website into this report.

Board Composition and Leadership Structure

Paul Roberts serves as our Chief Executive Officer, Chief Strategy Officer, President and Chairman. Although the roles of Chief Executive Officer, Chief Strategy Officer, President and Chairman of our board of directors are currently performed by the same person, we do not have a policy regarding the separation of these roles, as our board of directors believes that it is in the best interests of the Company and our stockholders to make that determination from time to time based upon the position and direction of the Company and the membership of our board of directors.

Our board of directors has determined that our leadership structure is appropriate for the Company and our stockholders as it helps to ensure that the board of directors and management act with a common purpose and provides a single, clear chain of command to execute our strategic initiatives and business plans. In addition, our board of directors believes that a combined role of Chief Strategy Officer, President and Chairman is better positioned to act as a bridge between management and our board of directors, facilitating the regular flow of information. Our board of directors also believes that it is advantageous to have a Chairman with an extensive history with and knowledge of our technology and industry (as is the case with our Chief Executive Officer, Chief Strategy Officer and President, Paul Roberts).

Director Independence

Nasdaq rules require that, subject to specified exceptions, each member of a listed company’s audit, compensation and nominating and corporate governance committees be independent, and that audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the Exchange Act. The Nasdaq independence definition includes a series of objective tests, such as that the director is not, and has not been for at least three (3) years, one of our employees, that neither the director nor any of his family members has engaged in various types of business dealings with us and that the director is not associated with the holders of more than five percent (5%) of our common stock. In addition, under applicable Nasdaq rules, a director will only qualify as an “independent director” if, in the opinion of the listed company’s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.

Our board of directors has undertaken a review of the independence of each director. Based on information provided by each director concerning their background, employment and affiliations, our board of directors has determined that four of our six directors, do not have relationships that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors is “independent” as that term is defined under the listing standards of Nasdaq. In making such determination, our board of directors considered the relationships that each such non-employee director has with us and all other facts and circumstances that our board of directors deemed relevant in determining his independence, including the beneficial ownership of our capital stock by each non-employee director.

30

Board’s Role in Risk Oversight and Management

Our board of directors, as a whole and through its committees, is responsible for the oversight of risk management, while our management is responsible for the day-to-day management of risks faced by us. The board of directors receives regular reports from members of senior management on areas of material risk to the Company, including operational, financial, legal, regulatory, strategic and reputational risks. In its risk oversight role, our board of directors has the responsibility to satisfy itself that the risk management processes designed and implemented by management are adequate and functioning as designed.

Committees of Our Board of Directors

Our board of directors has established an audit committee, a business development and marketing committee, a compensation committee, and a nominating and corporate governance committee. The composition and responsibilities of each committee of our board of directors are described below. Members serve on these committees until their resignation or until otherwise determined by our board of directors. Our board of directors may establish other committees as it deems necessary or appropriate from time to time.

Although each committee is directly responsible for evaluating certain enumerated risks and overseeing the management of such risks, the entire board of directors is generally responsible for and is regularly informed through committee reports about such risks and any corresponding remediation efforts designed to mitigate such risks. In addition, appropriate committees of the board of directors receive reports from senior management within the organization in order to enable the board of directors to understand risk identification, risk management and risk mitigation strategies. When a committee receives such a report, the chairman of the relevant committee reports on the discussion to the full board of directors during the committee reports portion of the next board of directors meeting. This enables the board of directors and its committees to coordinate the risk oversight role.

Audit Committee

The members of our audit committee are Grainne Coen, Elisabeth H. DeMarse, and Jeannie Mun. Ms. Coen chairs the audit committee. After reviewing the qualifications of the current members of the audit committee, and any relationships they may have with us that might affect their independence, the board of directors has determined that all current audit committee members are “independent” as that concept is defined in Section 10A of the Exchange Act, all current audit committee members are “independent” as that concept is defined in the applicable rules of The Nasdaq Stock Market, LLC, all current audit committee members are financially literate, and both Ms. Coen and Ms. Mun qualify as an “audit committee financial expert” under the applicable rules promulgated pursuant to the Exchange Act.

The audit committee’s main function is to oversee our accounting and certain financial reporting processes, internal systems of control, independent registered public accounting firm relationships and the audits of our financial statements. The committee’s responsibilities include, among other things:

appointing, approving the compensation of and assessing the independence of our registered public accounting firm;
overseeing the work of our independent registered public accounting firm, including through the receipt and consideration of reports from such firm;
reviewing and discussing with management and the independent registered public accounting firm our annual and quarterly financial statements and related disclosures;
monitoring our internal control over financial reporting, disclosure controls and procedures and code of business conduct and ethics;
overseeing our internal audit function;
overseeing our risk assessment and risk management policies;

31

establishing policies regarding hiring employees from the independent registered public accounting firm and procedures for the receipt and retention of accounting related complaints and concerns;
meeting independently with our internal auditing staff, independent registered public accounting firm and management;
reviewing and approving or ratifying any related person transactions; and
preparing the audit committee report required by SEC rules.

All audit and non-audit services, other than de minimis non-audit services, to be provided to us by our independent registered public accounting firm must be approved in advance by our audit committee.

Business Development and Marketing Committee

The members of our business development and marketing committee are Jonathan Bond, Elisabeth DeMarse, and Lawrence Harris. Ms. DeMarse chairs the business development and marketing committee. This committee’s responsibilities include, among other things:

identifying and creating plans to fulfill relevant short and long-term goals from the Kubient strategic plan;
maintaining the integrity and increasing the awareness of the Kubient brand;
recommending an annual marketing budget;
developing and implementing a comprehensive marketing and communications strategy;
working with the executive team on short and long-term marketing needs;
setting priorities for marketing efforts;
assisting with the continued development of the website and ensuring relevant and current content;
determining and engaging audience through various media channels; and
identifying collaborative opportunities with businesses and organizations on new and existing events.

Compensation Committee

The members of our compensation committee are Grainne Coen,Elisabeth DeMarse, and Jeannie Mun. Ms. Mun chairs the compensation committee. Each member of our compensation committee is a non-employee director, as defined in Rule 16b-3 promulgated under the Exchange Act and an outside director, as defined pursuant to Section 162(m) of the Internal Revenue Code of 1986, as amended. The primary purpose of our compensation committee is to discharge the responsibilities of our board of directors in overseeing our compensation policies, plans and programs and to review and determine the compensation to be paid to our executive officers, directors and other senior management, as appropriate. Specific responsibilities of our compensation committee include, among other things:

reviewing and recommending corporate goals and objectives relevant to the compensation of our chief executive officer and other executive officers;
making recommendations to our board of directors with respect to, the compensation level of our executive officers;
reviewing and recommending to our board of directors employment agreements and significant arrangements or transactions with executive officers;

32

reviewing and recommending to our board of directors with respect to director compensation; and
overseeing and administering our equity-based incentive plan or plans.

With respect to director compensation, our compensation committee is responsible for reviewing the compensation paid to members of the board and recommending modifications to board compensation that the compensation committee determines are appropriate and advisable to the board for its approval from time to time. In this regard, the compensation committee may request that management report to the compensation committee periodically on the status of the board’s compensation in relation to other similarly situated companies.

In determining compensation for our executive officers, the compensation committee typically considers, but is not required to accept, the recommendations of our Chief Executive Officer regarding the performance and proposed base salary and bonus and equity awards for the other executive officers, as well as himself. The compensation committee may also request the assistance of our Chief Financial Officer in evaluating the financial, accounting and tax implications of various compensation awards paid to the executive officers. However, our Chief Financial Officer does not determine the amounts or types of compensation paid to the executive officers. Our Chief Executive Officer and certain of our other executive officers may attend compensation committee meetings, as requested by the compensation committee. None of our executive officers, including our Chief Executive Officer, will attend any portion of the compensation committee meetings during which the executive officer’s compensation is established and approved.

Nominating and Corporate Governance Committee

The members of our nominating and corporate governance committee are Jonathan Bond, Grainne Coen, Elisabeth DeMarse, Lawrence Harris, and Jeannie Mun. Ms. DeMarse chairs the nominating and corporate governance committee. This committee’s responsibilities include, among other things:

identifying and evaluating candidates, including the nomination of incumbent directors for reelection and nominees recommended by stockholders, to serve on our board of directors;
considering and making recommendations to our board of directors regarding the composition and chairmanship of the committees of our board of directors;
developing and recommending to our board of director’s corporate governance principles, codes of conduct and compliance mechanisms; and
overseeing periodic evaluations of the board of directors’ performance, including committees of the board of directors.

When evaluating director candidates, the nominating and corporate governance committee may consider several factors, including relevant experience, independence, commitment, compatibility with the Chief Executive Officer and the board of directors’ culture, prominence and understanding of the Company’s business, as well as any other factors the corporate governance and nominating committee deems relevant at the time. The corporate governance and nominating committee makes a recommendation to the full board of directors as to any person it believes should be nominated by our board of directors, and our board of directors determines the nominees after considering the recommendation and report of the corporate governance and nominating committee.

33

Any director or executive officer of the Company may recommend a candidate to the nominating and corporate governance committee for its consideration. The nominating and corporate governance committee will also consider nominees to our board of directors recommended by stockholders if stockholders comply with the advance notice requirements in our bylaws. Our bylaws provide that a stockholder who wishes to nominate a person for election as a director at a meeting of stockholders must deliver timely written notice to our Corporate Secretary at the following address:

Paul Roberts

Chief Executive Officer

Kubient, Inc.

500 7th Avenue

8th Floor

New York, New York 10018

This notice must contain, as to each nominee, all of the information relating to such person as would be required to be disclosed in a proxy statement meeting the requirements of Regulation 14A under the Exchange Act and certain other information, including: the name and address of the stockholder delivering the notice as it appears on our books; the class and number of shares owned beneficially and of record by such stockholder; information about derivative instruments beneficially owned by such stockholder and any opportunity to profit or share in any profit derived from any increase or decrease in the value of the shares of our stock; any proxy, contract, arrangement, understanding or relationship pursuant to which such stockholder has a right to vote any shares of our stock; any short interest in any of our securities held by such stockholder; any rights to dividends on shares of our stock owned beneficially or of record by such stockholder that are separated or separable from the underlying shares of stock; any proportionate interest in shares of our stock or derivative instruments held by a general or limited partnership in which such stockholder is, or owns a beneficial interest in, the general partner; any performance-related fees to which such stockholder is entitled based on the value of our securities; any arrangement or understanding between such stockholder and the proposed nominee; and whether such stockholder intends to deliver a solicitation notice, as more fully described in our bylaws. The foregoing summary does not include all requirements a stockholder must satisfy in order to nominate a candidate to our board of directors. Stockholders who wish to recommend a nominee to our board of directors should carefully read our bylaws, which are available at https://Kubient.com. The inclusion of our website address in this report does not include or incorporate by reference the information on our website into this report.

Board Diversity

Our nominating and corporate governance committee is responsible for reviewing with board of directors, on an annual basis, the appropriate characteristics, skills and experience required for the board of directors as a whole and its individual members. In evaluating the suitability of individual candidates (both new candidates and current members), the nominating and corporate governance committee, in recommending candidates for election, and the board of directors, in approving (and, in the case of vacancies, appointing) such candidates, will take into account many factors, including the following:

personal and professional integrity, ethics and values;
experience in corporate management, such as serving as an officer or former officer of a publicly-held company;
development or commercialization experience in large consumer products companies;
experience as a board member or executive officer of another publicly-held company;
strong finance experience;
diversity of expertise and experience in substantive matters pertaining to our business relative to other board members;
diversity of background and perspective, including with respect to age, gender, race, place of residence and specialized experience;
conflicts of interest; and

34

practical and mature business judgment.

Currently, our board of directors evaluates each individual in the context of the board of directors as a whole, with the objective of assembling a group that can best maximize the success of the business and represent stockholder interests through the exercise of sound judgment using its diversity of experience in these various areas.

Director Nomination Process

Our board of directors believes that its directors should have the highest professional and personal ethics and values, consistent with the Company’s longstanding values and standards. They should have broad experience at the policy-making level in business, government or civic organizations. They should be committed to enhancing stockholder value and should have sufficient time to carry out their duties and to provide insight and practical wisdom based on their own unique experience. Each director must represent the interests of all stockholders. When considering potential director candidates, our board of directors also considers the candidate’s independence, character, judgment, diversity, age, skills, including financial literacy, and experience in the context of our needs and those of our board of directors. Our board of directors believe that diversity is an important attribute of the members who comprise our board of directors and that the members should represent an array of backgrounds and experiences and should be capable of articulating a variety of viewpoints. Our board of directors priority in selecting board members is the identification of persons who will further the interests of our stockholders through his or her record of professional and personal experiences and expertise relevant to our business.

Stockholder Nominations to the Board of Directors

Our bylaws provides that our board of directors will accept for consideration submissions from stockholders of recommendations for the nomination of directors. Acceptance of a recommendation for consideration does not imply that the board of directors will nominate the recommended candidate. Director nominations by a stockholder or group of stockholders for consideration by our stockholders at our annual meeting of stockholders, or at a special meeting of our stockholders that includes on its agenda the election of one or more directors, may only be made pursuant to our bylaws or as otherwise provided by law. Nominations pursuant to our bylaws are made by delivering to our Corporate Secretary, within the time frame described in our bylaws, all of the materials and information that our bylaws require for director nominations by stockholders.

No person shall be eligible to serve as a director of the Company unless nominated in accordance with the procedures set forth in our bylaws and any nominee proposed by a stockholder not nominated in accordance with our bylaws shall not be considered or acted upon for execution at such meeting. Stockholders’ notice for any proposals requested to be included in our proxy statement pursuant to Rule 14a-8 under the Exchange Act (including director nominations), must be made in accordance with that rule.

There were no material changes to the procedures by which stockholders may recommend nominees to the Company’s board of directors during the year ended December 31, 2021.

Role of Board in Risk Oversight Process

Our board of directors has responsibility for the oversight of the Company’s risk management processes and, either as a whole or through its committees, regularly discusses with management our major risk exposures, their potential impact on our business and the steps we take to manage them. The risk oversight process includes receiving regular reports from board committees and members of senior management to enable our board to understand the company’s risk identification, risk management and risk mitigation strategies with respect to areas of potential material risk, including operations, finance, legal, regulatory, strategic and reputational risk.

The audit committee reviews information regarding liquidity and operations, and oversees our management of financial risks. Periodically, the audit committee reviews our policies with respect to risk assessment, risk management, loss prevention and regulatory compliance. Oversight by the audit committee includes direct communication with our external auditors, and discussions with management regarding significant risk exposures and the actions management has taken to limit, monitor or control such exposures. The compensation committee is responsible for assessing whether any of our compensation policies or programs has the potential to encourage excessive risk-taking. The nominating and corporate governance committee manages risks associated with the independence of the board, corporate disclosure practices, and potential conflicts of interest. While each committee is responsible for evaluating certain risks and overseeing the management of such risks, the entire board is regularly informed through committee reports about such risks. Matters of significant strategic risk are considered by our board of directors as a whole.

35

Compliance with Section 16(a) of the Exchange Act

Section 16(a) of the Exchange Act requires our officers, directors, and persons who own more than ten percent of a registered class of our equity securities to file reports of securities ownership and changes in such ownership with the SEC. Officers, directors, and greater-than-ten-percent stockholders are required by SEC regulations to furnish us with copies of all Section 16(a) forms that they file.

Based solely upon a review of Forms 3, Forms 4, and Forms 5 furnished to us pursuant to Rule 16a-3 under the Exchange Act, we believe that all such forms required to be filed pursuant to Section 16(a) of the Exchange Act during the year ended December 31, 2021 were timely filed, as necessary, by the officers, directors, and security holders required to file such forms, except for the following:

Messrs. Bond and Harris did not timely file their respective Forms 3 following their election to our Board of Directors.
Mr. Leon Zemel did not timely file a Form 3 following his classification as an officer subject to Section 16(a) of the Exchange Act.
Mr. Jonathan Bond did not timely file a Form 4 with respect to one transaction.
Ms. Grainne Coen did not timely file a Form 4 with respect to one transaction.
Ms. Elisabeth DeMarse did not timely file a Form 4 with respect to one transaction.
Mr. Chris Francia did not timely file a Form 4 with respect to one transaction.
Ms. Jeannie Mun did not timely file a Form 4 with respect to one transaction.
Mr. Christopher Smith did not timely file a Form 4 with respect to one transaction.
Mr. Leon Zemel did not timely file a Form 4 with respect to one transaction.

Code of Business Conduct and Ethics

We have adopted a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. A current copy of the code is posted on the Corporate Governance section of our website, www.Kubient.com. In addition, we post on our website all disclosures that are required by law or the listing standards of The Nasdaq Capital Market concerning any amendments to, or waivers from, any provision of the code. The reference to our website address does not constitute incorporation by reference of the information contained at or available through our website, and you should not consider it to be a part of this report.

ITEM 11. EXECUTIVE COMPENSATION

As an emerging growth company under the JOBS Act, we have opted to comply with the executive compensation disclosure rules applicable to “smaller reporting companies” as such term is defined in the rules promulgated under the Securities Act, which permit us to limit reporting of executive compensation to our principal executive officer and our two (2) other most highly compensated named executive officers.

36

Summary Compensation Table

The following table provides information regarding the compensation awarded to or earned during 2021 and 2020, as applicable, by our named executive officers.

Option and

All other

Name and Principal Position

    

Year

    

Salary

    

Bonus

    

Stock awards (1)

    

warrant awards (1)

    

compensation (2)  

    

Total

Paul Roberts

 

2021

$

325,000

$

159,250

$

628,970

(3)

$

$

19,554

$

1,132,744

Chief Executive Officer (4)

 

2020

$

171,458

$

590,000

(5)

$

35,569

(6)

$

$

33

$

797,060

Joshua Weiss

 

2021

$

302,500

$

120,000

$

143,750

(7)

$

$

26,965

$

593,215

Chief Financial Officer (8)

 

2020

$

263,282

$

82,500

$

79,584

(9)

$

$

22,775

$

448,141

Pavel Medvedev

 

2021

$

289,167

$

35,000

$

68,368

(10)

$

$

53,730

(11)

$

446,264

Chief Technology Officer (11)

 

2020

$

219,583

$

90,000

$

$

$

36

$

309,619

(1)The amounts reported in these columns represent the grant date fair value of the stock, option and warrant awards granted during the years ended December 31, 2021 and 2020, calculated in accordance with FASB ASC Topic 718. These amounts do not represent cash compensation paid to the named individual. These non-cash amounts represent the aggregate grant date fair value of the restricted stock awards as computed in accordance with the SEC’s Staff Accounting Bulletin 107. For a discussion of the assumptions made in the valuation of the awards, see the discussion under Note 2 and Note 8 to the consolidated financial statements included in this Annual Report on Form 10-K.

(2)Includes health benefits paid for by the Company in the form of health insurance.

(3)On June 29, 2021, Mr. Roberts was issued 109,386 shares of the Company’s common stock for services rendered.

(4)Mr. Roberts served as our Interim Chief Executive Officer from October 31, 2020 to December 16, 2021, when the designation of “interim” was removed from Mr. Roberts’ title.

(5)Consists of (i) a $250,000 cash bonus related to Mr. Robert’s efforts in connection with the Company’s IPO, (ii) a $250,000 cash bonus in related to Mr. Robert’s efforts in connection with the Company’s follow-on offering, and (iii) a $90,000 contractual annual performance bonus.

(6)On November 20, 2020, Mr. Roberts was issued 12,658 shares of the Company’s common stock for services rendered.

(7)On June 29, 2021, Mr. Weiss was issued 25,000 shares of the Company’s common stock for services rendered.

(8)Mr. Weiss began his employment with the Company on December 23, 2019.

(9)Consists of (i) 10,000 shares of the Company’s common stock earned by Mr. Weiss during the year ended December 31, 2020 for services in connection with the Company’s public offering which closed on December 28, 2020 (3,397 of which were ultimately withheld by the Company to satisfy Mr. Weiss’ tax obligations in connection with such award), (ii) 2,222 shares of the Company’s common stock earned by Mr. Weiss on March 22, 2020 pursuant to the terms of his employment agreement, and (iii) 6,329 shares of the Company’s common stock issued to Mr. Weiss on November 20, 2020 for services rendered.

(10)On June 29, 2021, Mr. Medvedev was issued 11,890 shares of the Company’s common stock for services rendered, which Mr. Medvedev forfeited on December 31, 2021 in connection with his resignation from employment with the Company.

(11)Mr. Medvedev served as the Company’s Chief Technology Officer from April 16, 2018 to December 31, 2021, when he resigned from employment with the Company. In connection with his resignation from the Company, he was paid cash severance of $51,666.67.

37

Narrative to Summary Compensation Table

Executive Compensation Considerations

The Company’s compensation committee reviews financial information and other performance metrics relative to the historical compensation of executive management and comparative information prepared internally. The compensation committee also reviews management’s recommendations for compensation levels of all of the Company’s named executive officers and considered these recommendations with reference to relative compensation levels of like-size institutions. The totality of the information reviewed by the compensation committee is considered when establishing current executive salary levels, and similar analysis is expected to be considered when reviewing and establishing future salaries and long-term incentives. The Company’s compensation policies and practices are designed to ensure that they do not foster risk taking above the level of risk associated with the Company’s business model. For this purpose, the compensation committee generally considers the Company’s financial performance, comparing that performance to the performance metrics included in the Company’s strategic plan. The compensation committee also generally evaluates management’s compensation in light of other specific risk parameters. The Company’s compensation programs are aimed at enabling it to attract and retain the best possible executive talent and rewarding those executives commensurate with their ability and performance. The Company’s compensation programs consist primarily of base salary and bonus.

Independent Advice on Pay-Setting Process

In 2021, the compensation committee retained an outside compensation consultant, Mercer LLC (“Mercer”), to benchmark pay levels for the executive leadership team and outside directors, including base salary and short- and long-term incentives. Mercer also assisted with the design of the short- and long-term incentive programs to ensure such programs support the Company’s business strategy and are consistent with market practice. To benchmark pay, Mercer considered data from three sources to reflect the Company’s intersecting talent markets:

Option Impact Database: This database is made up of private technology companies based in the United States that have completed at least a Post Series B funding round.
Mercer Comptryx Database: This database is made up of both private and public technology companies based in the United States with revenues less than $500 million.
Public Company Peer Group: Mercer reviewed the public filings and financial statements of 17 publicly traded companies with revenues approximately 0.5x-2.5x that of the Company, and with which the Company competes for talent and that are in industries similar to the Company, including advertising, application/systems software, interactive media and services, and internet and direct marketing retail.

Mercer also referenced peer practices in assisting with the design of the short- and long-term incentive plans, including metrics and weightings, and payout leverage and performance periods, and equity vehicle prevalence for the long-term plan. Mercer considered the public company peer group practices as well as the practices of larger companies in recommending incentive plan design decisions.

Employment Agreements; Potential Payments Upon Termination or Change-in-Control

We have entered into employment agreements with Mitchell Berg, Paul Roberts, Joshua Weiss, and Leon Zemel.

38

The terms of Mr. Berg’s employment agreement, which was entered into on November 18, 2021 with an Effective Date of November 29, 2021, state he will receive an annual base salary of $300,000, a restricted stock unit (“RSU”) award of 80,000 shares of common stock of the Company, and a performance stock unit (“PSU”) award of 50,000 shares of common stock of the Company. Mr. Berg will also be eligible to participate in the Company’s Short Term Incentive Plan (“STIP”) and his target bonus pursuant to the STIP will be $100,000. Provided, however that any payout pursuant to the STIP will be determined by the Company and its board of directors or compensation committee, in its discretion, after considering Mr. Berg’s individual performance and the overall performance of the Company’s business. Upon a termination for any reason, Mr. Berg is entitled to any unpaid but accrued portion of his base salary earned through the date of his termination, payment for any accrued but unused vacation pay, any expenses owed to him pursuant to his employment agreement, and any amounts owed under the Company’s benefit plans. In the event Mr. Berg experiences a Covered Termination (as defined in his employment agreement), Mr. Berg shall be entitled to six month’s salary paid in one lump sum, six months continued healthcare coverage, payment of any Annual Bonus (as defined in his employment agreement) earned but that has not been paid and a pro-rata portion of any Annual Bonus earned in the fiscal year in which the Covered Termination takes place, and immediate vesting of any equity awards that would have become vested and exercisable during the three months after his termination. All outstanding RSU awards due to Mr. Berg automatically vest upon a change in control of the Company.

The terms of Mr. Roberts’ employment agreement, which was entered into on May 26, 2017 and amended October 2, 2019 solely to reflect his change in position at the Company to Chief Strategy Officer and President, provide for an annual base salary of $120,000, plus an annual bonus of up to 30% of his base salary based upon the achievement of certain performance goals to be established by the board of directors or a committee of the board of directors. Upon a termination for any reason, Mr. Roberts is entitled to any unpaid but accrued portion of his base salary earned through the date of his termination, payment for any accrued but unused vacation time, any expenses owed to him pursuant to his employment agreement, and any amounts owed under the Company’s benefit plans. In the event Mr. Roberts is terminated without cause or that Mr. Roberts resigns for Good Reason (as defined in his employment agreement), Mr. Roberts shall be entitled to six month’s salary plus one additional month of salary for each full year of his service to the Company, continued healthcare coverage for the earlier of (i) six months plus one additional month of additional coverage for each full year of his service to the Company, or (ii) until such time as Mr. Roberts becomes eligible for health coverage under another employer’s plan, and immediate vesting of any equity awards that would have become vested and exercisable during the six months after his termination, plus one additional month of salary for each full year of his service to the Company. Mr. Roberts was also granted options to purchase 33,334 shares of the Company’s common stock at $2.97 per share for a five-year period, pursuant to the terms, conditions and vesting schedule set forth in the corresponding Non-Qualified Option Agreement. Upon a change in control, all outstanding awards due to Mr. Roberts automatically vest upon a change in control of the Company. On October 1, 2020, the board of directors increased the Reporting Person’s salary under his employment agreement, to $300,00 per annum to reflect his appointment as Interim Chief Executive Officer of the Company.

The terms of Mr. Weiss’ employment agreement, which was entered into on December 23, 2019, provide for an annual base salary of $150,000, until March 22, 2020, when Mr. Weiss’ base salary was increased to $275,000. Upon execution of his employment agreement, Mr. Weiss was granted options to purchase 16,667 shares of the Company’s common stock at $33.75 per share for a five-year period, pursuant to the terms, conditions and vesting schedule set forth in the corresponding Non-Qualified Option Agreement. Pursuant to the terms of his employment agreement, Mr. Weiss was awarded 2,223 shares of the Company’s common stock on March 22, 2020. Mr. Weiss is also entitled to an annual bonus of up to 30% of his base salary based upon the achievement of certain performance goals to be established by the board of directors or a committee of the board of directors. Upon a termination for any reason, Mr. Weiss is entitled to any unpaid but accrued portion of his base salary earned through the date of his termination, payment for any accrued but unused vacation pay, any expenses owed to him pursuant to his employment agreement, and any amounts owed under the Company’s benefit plans. In the event Mr. Weiss is terminated without cause or that Mr. Weiss resigns for Good Reason (as defined in his employment agreement), Mr. Weiss shall be entitled to six month’s salary paid in one lump sum, six months continued healthcare coverage plus one additional month of salary for each full year of his service to the Company, and immediate vesting of any equity awards that would have become vested and exercisable during the three months after his termination. Upon a change in control, all outstanding awards due to Mr. Weiss automatically vest upon a change in control of the Company.

39

The terms of Mr. Zemel’s employment agreement, which was entered into on April 12, 2021, provide for an annual base salary of $390,000. Mr. Zemel is entitled to an annual bonus of up to 20% of his base salary based upon the achievement of certain performance goals to be established by the board of directors or its compensation committee. Subject to the approval of the board of directors or its compensation committee, the Company will take appropriate action within 90 days following April 12, 2021 to make an award of 100,000 shares of the Company’s common stock to Mr. Zemel. The award will vest at the rate ¼1/4th of the total number of shares on April 12, 2022 and 1/36th of the total number of remaining unvested shares each month thereafter. Vesting will depend and be contingent upon Mr. Zemel’s continued employment with the Company through the completion of any vesting date, and any unvested shares will be forfeited upon Mr. Zemel’s termination of employment from the Company for whatever reason. Upon a termination for any reason, Mr. Zemel is entitled to any unpaid but accrued portion of his base salary earned through the date of his termination, payment for any accrued but unused vacation pay, any expenses owed to him pursuant to his employment agreement, and any amounts owed under the Company’s benefit plans. In the event Mr. Zemel is terminated without cause or that Mr. Zemel resigns for Good Reason (as defined in his employment agreement), Mr. Zemel shall be entitled to six month’s salary paid in one lump sum, six months continued healthcare coverage plus one additional month of salary for each full year of his service to the Company, and immediate vesting of any equity awards that would have become vested and exercisable during the three months after his termination. Upon a change in control, all outstanding awards due to Mr. Zemel automatically vest upon a change in control of the Company.

Base Salary

In consultation with Mercer, the compensation committee establishes salary guidelines by comparing the responsibilities of the individual’s position in relation to similar positions at our peer group companies. Base salaries for named executive officers are determined in the same manner as those for other salaried employees.

Under their respective compensatory contracts, the base salaries of our named executive officers as of December 31, 2021 were as follows:

Named Executive Officer

    

Title

    

Base Salary(1)

Paul Roberts

 

Chief Executive Officer, Chief Strategy Officer, President, and Chairman

 

$ 350,000

Joshua Weiss

 

Chief Financial Officer

 

$ 330,000

Pavel Medvedev

 

Chief Technology Officer

 

$ 310,000 (2)

(1)Each named executive officer’s salary is subject to adjustment at the discretion of the compensation committee, subject to certain limitations.
(2)Represents the base salary of Mr. Medvedev on the date of his resignation from employment with the Company on December 31, 2021.

Bonuses

In setting target bonus levels and designing the 2021 bonus plan, after consultation with Mercer, the compensation committee referenced bonuses paid by the Company in previous years, as well as plan designs at 17 of our peer group companies.

Under the terms of his employment agreement, Mr. Roberts is eligible to receive an annual bonus of up to 30% of his base salary based upon the achievement of certain performance goals established by the board of directors or a committee of the board of directors.  On February 1, 2022, Mr. Roberts was paid a bonus of $159,250.

Under the terms of his employment agreement, Mr. Weiss is eligible to receive an annual bonus of up to 30% of his base salary based upon the achievement of certain performance goals established by the board of directors or a committee of the board of directors.  On February 15, 2022, Mr. Weiss was paid a bonus of $120,000.

Under the terms of his employment agreement, Mr. Medvedev was eligible to receive an annual bonus of eight percent of all net revenue generated by introductions made by Mr. Medvedev to us. On December 15, 2021, Mr. Medvedev was paid a bonus of $35,000.

40

Restricted Stock Awards

On June 29, 2021, Mr. Roberts was awarded 109,386 shares of the Company’s common stock for services rendered.  The Company’s board of directors determined that such shares had a fair market value of $5.75 per share at the time of transfer, based on the closing price of the Company’s common stock as of June 28, 2021, and shall vest after a period of one year, as described in the award agreement entered into between the Company and Mr. Roberts in connection with such award, and shall be subject to such further terms and conditions included in such award agreement, and the 2017 Plan.

On January 12, 2022, the Company awarded Mr. Roberts with 93,360 performance stock units (“PSUs”) and 233,974 restricted stock units (“RSUs”) in recognition of Mr. Robert’s commitment to the Company and his exceptional performance in the role of Chief Executive Officer of the Company during 2021. The PSUs awarded to Mr. Roberts vest over a period of three years, and the RSUs awarded to Mr. Roberts vest over a period of four years.

On March 22, 2020, Mr. Weiss was issued 2,222 shares of the Company’s common stock pursuant to the terms of his employment agreement of the Company.  

On November 20, 2020, Mr. Weiss was issued 6,329 shares of the Company’s common stock for services rendered.

On March 2, 2021, Mr. Weiss was issued 10,000 shares of the Company’s common stock for services rendered in connection with the Company’s public offering that closed on December 28, 2020.  On February 25, 2022, Mr. Weiss surrendered to the Company 3,397 shares of the Company’s common stock in order to satisfy a tax withholding obligation of roughly $18,000 in connection with the March 2, 2021 issuance discussed in the preceding sentence.

On June 29, 2021, Mr. Weiss was awarded 25,000 shares of the Company’s common stock for services rendered.  The Company’s board of directors determined that such shares had a fair market value of $5.75 per share at the time of transfer, based on the closing price of the Company’s common stock as of June 28, 2021, and shall vest after a period of one year, as described in the award agreement entered into between the Company and Mr. Weiss in connection with such award, and shall be subject to such further terms and conditions included in such award agreement, and the 2017 Plan.

On January 12, 2022, the Company awarded Mr. Weiss with 20,000 performance stock units (“PSUs”) and 80,000 restricted stock units (“RSUs”) in recognition of Mr. Weiss’ commitment to the Company and his exceptional performance in the role of Chief Financial Officer of the Company during 2021.  The PSUs awarded to Mr. Weiss vest over a period of three years, and the RSUs awarded to Mr. Weiss vest over a period of four years.

On June 29, 2021, Mr. Medvedev was awarded 11,890 shares of the Company’s common stock for services rendered.  The Company’s board of directors determined that such shares had a fair market value of $5.75 per share at the time of transfer, based on the closing price of the Company’s common stock as of June 28, 2021, and shall vest after a period of one year, as described in the award agreement entered into between the Company and Mr. Medvedev in connection with such award, and shall be subject to such further terms and conditions included in such award agreement, and the 2017 Plan.  Mr. Medvedev forfeited all 11,890 shares on December 31, 2021 in connection with his resignation from employment with the Company.

All Other Compensation

Each named executive officer was entitled to participate in any benefit plan from time to time in effect for our executives and/or employees generally, subject to the eligibility provisions of that plan.

Section 162(m) of the Code

Section 162(m) of the Code generally limits the corporate tax deduction for compensation in excess of $1 million that is paid to “covered employees”. Section 162(m) of the Code was amended by the Tax Cuts and Jobs Act of 2018 so that the exceptions for payment of “performance-based compensation” or commissions have been eliminated. However, none of our named executive officers received annual compensation in excess of $1 million as of December 31, 2021.

41

Resignation, Retirement, or Termination Agreements

On November 30, 2021, the Company entered into a separation agreement and general release with Mr. Medvedev in connection with his resignation from employment with the Company.  Under the terms of the separation agreement, the Company paid Mr. Medvedev a total sum of $51,666.67 in severance pay, less applicable taxes and withholding and other legal deductions, on December 15, 2021.  Mr. Medvedev’s receipt of the aforementioned payments was conditioned upon the fulfillment of his obligations under the separation agreement, as well as Mr. Medvedev’s compliance with the other standard covenants set forth in such agreement.

Outstanding Equity Awards at 2021 Fiscal Year End

The following table provides information with respect to holdings of unvested options and stock awards held by our named executive officers, at December 31, 2021.

Option Awards

    

Number of

    

Number of

    

    

securities

securities

underlying

underlying

unexercised

unexercised

option

option

Option

Option

exercisable

unexercisable

exercise price

expiration

Name

(#)

(#)

($)

date

Paul Roberts

 

33,334

 

$

2.97

 

15/09/2022

Joshua Weiss

 

8,328

 

8,339

$

33.75

 

23/12/2029

Warrant Awards

    

Number of

    

Number of

    

    

securities

securities

underlying

underlying

unexercised

unexercised

warrant

warrant

Warrant

Warrant

exercisable

unexercisable

exercise price

expiration

Name

(#)

(#)

($)

date

Paul Roberts

 

55,541

 

$

5.50

 

14/08/2025

Pavel Medvedev

 

27,778

 

$

4.95

 

16/04/2023

Option and Warrant Exercises

None of our named executive officers exercised stock options or warrants in 2021.

Securities Authorized for Issuance Under Equity Compensation Plans

The table below provides information on our equity compensation plans as of December 31, 2021:

Number of securities

remaining available for

Number of securities

future issuance under

to be issued upon

Weighted-average

equity compensation

exercise of outstanding

exercise price of

plans (excluding

options, warrants and

outstanding options,

securities reflected in

    

rights

    

warrants and rights

    

column (a))

Plan category

(a)

(b)

(c)

Equity compensation plans approved by security holders(1)(2)

 

94,447

$

11.56

 

1,411,889

Equity compensation plans not approved by security holders

 

 

Total

 

94,447

$

11.56

 

1,411,889

(1)As of December 31, 2021, there were options to purchase 94,447 shares of our common stock with a weighted average exercise price of $11.56 per share that were outstanding under the 2017 Plan. As of December 31, 2021, a total of 236,073 shares of common

42

stock were issued under the 2017 Plan. Accordingly, as of December 31, 2021, 11,889 shares of common stock remained available for future issuance under the 2017 Plan.

(2)As of December 31, 2021, a total of 100,000 shares of common stock were issued under the 2021 Plan. Accordingly, as of December 31, 2021, 1,400,000 shares of common stock remained available for future issuance under the 2021 Plan.

Benefit Plans

Kubient, Inc. 2017 Equity Incentive Plan

The 2017 Plan was originally adopted by our board of directors and approved by our stockholders on September 12, 2017, and was subsequently amended and restated on June 5, 2019. The purposes of the 2017 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our service providers and to promote the success of the Company’s business. We have reserved 333,334 shares of our common stock to issue awards under our 2017 Plan.

Kubient, Inc. 2021 Equity Incentive Plan

The 2021 Plan was originally adopted by our board of directors and approved by our stockholders on June 30, 2021. The purposes of the 2021 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our service providers and to promote the success of the Company's business. We have reserved 1,500,000 shares of our common stock to issue awards under our 2021 Plan.

Founder Employee Incentive Program

On July 2, 2020, the Company’s board of directors adopted the Founder Employee Incentive Program (the “Founder Program”) under the 2017 Plan. The purposes of the Founder Program are to offer near-term and long-term incentives to founder employees of the Company that are intended to keep such employees in the employ of the Company, and that are based on individual performance, the achievement of financial goals of the Company and the total return to the Company’s stockholders.

Except for the Founder Program, we currently have no long-term incentive plans. As of March 25, 2022, no awards have been made under the Founder Program.

401(k) Plan

We offer a 401(k) plan pursuant to Section 401(k) of the Code. All full-time United States employees are eligible to participate in the plan. The plan permits pretax contributions by participants not to exceed annual amounts allowable under the Code. Participants are fully vested in their contributions.

Hedging Policy

The Company’s Insider Trading Policy prohibits trading in call or put options involving the Company’s securities and other derivative securities; engaging in short sales of the Company’s securities (i.e., the sale of a security that the seller does not own); engaging in hedging or monetization transactions with respect to the Company’s securities, such as prepaid variable forwards, equity swaps, collars and exchange funds; and holding the Company’s securities in a margin account.

Director Compensation

On March 4, 2021, the board of directors of the Company approved a $50,000 cash retainer to Ms. Coen as the audit committee chair for her service during 2021.

On November 8, 2021, the compensation committee and the board of directors of the Company adopted the Kubient, Inc. Non-Employee Director Compensation Policy (the “2022 Non-Employee Director Policy”), which covers all compensation to be paid by the Company to non-employee directors beginning with fiscal year 2022, including, without limitation, amounts paid or awards granted under the 2021 Plan.

43

Under the 2022 Non-Employee Director Policy, on the close of business on the date of each annual shareholders meeting of the Company, each Non-Employee Director then in office shall receive an award of restricted stock that has an aggregate fair value on the date of such annual meeting of $55,000 (as determined based on the average trading price of the shares of common stock for the ten consecutive trading days immediately preceding the date of grant and with the number of shares of common stock of the Company underlying such award subject to adjustment as provided in the Plan). In addition, each Non-Employee Director shall receive an annual cash retainer of $50,000 for their service on the board of directors.  Furthermore, the chairpersons of certain board committees shall receive an additional annual cash retainer as follows:

Audit Committee: $50,000
Compensation Committee: $10,500
Nominating and Corporate Governance Committee: $8,000

On March 9, 2022, the compensation committee and the board of directors of the Company approved annual compensation for the services of its non-employee directors during 2021 in the form of an award of restricted common stock of the Company with a fair market value of $25,000 per non-employee director, which such shares vest immediately upon issuance.

The table below shows the equity and other compensation granted to our non-employee directors during fiscal 2021:

    

Fees Earned

    

Stock

    

Option

    

All Other

    

  

or Paid

Awards (3)

Awards (3)

Compensation

Total

Jonathan Bond

$

21,000

(1)  

$

$

$

$

21,000

Grainne Coen

$

92,000

(1)(2)

$

$

$

$

92,000

Elisabeth DeMarse

$

42,000

(1)  

$

$

$

$

42,000

Lawrence Harris

$

21,000

(1)  

$

$

$

$

21,000

Jeannie Mun

$

42,000

(1)  

$

$

$

$

42,000

(1)The amounts reported represent $10,500 cash retainer for each quarter of service.
(2)Includes $50,000 cash retainer related to service during 2021 as audit committee chair.
(3)The amounts reported in these columns represent the grant date fair value of the stock awards granted during the year ended December 31, 2021, calculated in accordance with FASB ASC Topic 718.

Compensation Committee Interlocks and Insider Participation

Not applicable to smaller reporting companies.

Compensation Committee Report

Not applicable to smaller reporting companies.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth the beneficial ownership of our common stock as of March 25, 2022 by:

each stockholder known by us to beneficially own more than 5% of our outstanding common stock;
each of our directors;
each of our named executive officers; and
all of our directors and executive officers as a group.

44

We have determined beneficial ownership in accordance with the rules of the SEC. These rules generally provide that a person is the beneficial owner of securities if such person has or shares the power to vote or direct the voting of securities, or to dispose or direct the disposition of securities. A security holder is also deemed to be, as of any date, the beneficial owner of all securities that such security holder has the right to acquire within 60 days after such date through (i) the exercise of any option or warrant, (ii) the conversion of a security, (iii) the power to revoke a trust, discretionary account or similar arrangement or (iv) the automatic termination of a trust, discretionary account or similar arrangement. Except as disclosed in the footnotes to this table and subject to applicable community property laws, we believe that each person identified in the table has sole voting and investment power over all of the shares shown opposite such person’s name.

The percentage of beneficial ownership is based on 14,303,743 shares of our common stock outstanding as of March 25, 2022.

    

Number of

    

 

Name of Beneficial Owner

Shares

Percentage

Executive Officers and Directors

 

  

 

  

Paul Roberts(1)

 

2,212,606

15.37

%

Joshua Weiss(2)

 

27,120

*

Leon Zemel (3)

 

7,053

*

Mitchell Berg(4)

 

*

Peter Anthony Bordes, Jr. (5)

 

767,160

5.18

%

Grainne Coen

 

44,308

*

Jeannie Mun

 

18,308

*

Elisabeth DeMarse

 

18,308

*

Jonathan Bond

 

13,899

*

Lawrence Harris

 

6,649

*

All directors and executive officers as a group(6)

 

3,115,411

20.89

%

5% Shareholders

 

Mithaq Capital SPC

c/o Synergy, Anas IBN Malik Road

Al Malq, Riyadh T0 13521

1,737,917

12.15

%

*

Less than 1%

(1)Includes (i) 666,667 shares of common stock held by the Paul Roberts 2019 Annuity Trust, of which Mr. Roberts is a partial beneficiary, (ii) 33,334 shares of common stock underlying stock options that are exercisable or will become exercisable within 60 days, and (iii) 55,541 shares of common stock underlying stock warrants that are exercisable or will become exercisable within 60 days. Does not include 436,720 shares of common stock underlying unvested restricted stock awards.
(2)Includes 10,066 shares of common stock underlying stock options that are exercisable or will become exercisable within 60 days. Does not include 6,601 shares of common stock underlying unvested stock options or 181,016 shares of common stock underlying unvested restricted stock awards.
(3)Does not include 156,016 shares of common stock underlying unvested restricted stock awards.
(4)Does not include 130,000 shares of common stock underlying unvested restricted stock awards.
(5)Includes (i) 62,470 shares of common stock held by Trajectory Capital, LLC, over which Mr. Bordes has voting and dispositive power, and (ii) 513,638 shares of common stock underlying stock warrants that are exercisable or will become exercisable within 60 days.
(6)Includes 612,579 shares of common stock underlying options or warrants that are exercisable or will become exercisable within 60 days.

45

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Policies and Procedures for Related Person Transactions

Our board of directors has adopted written policies and procedures for the review of any transaction, arrangement or relationship in which we are a participant, the amount involved exceeds $120,000 and one of our executive officers, directors, director nominees or 5% stockholders, or their immediate family members, each of whom we refer to as a “related person,” has a direct or indirect material interest.

If a related person proposes to enter into such a transaction, arrangement or relationship, which we refer to as a “related person transaction,” the related person must report the proposed related person transaction to our Chief Financial Officer. The policy calls for the proposed related person transaction to be reviewed and, if deemed appropriate, approved by our audit committee. Whenever practicable, the reporting, review and approval will occur prior to entry into the transaction. If advance review and approval is not practicable, the committee will review, and, in its discretion, may ratify the related person transaction. The policy also permits the chairman of the committee to review and, if deemed appropriate, approve proposed related person transactions that arise between committee meetings, subject to ratification by the committee at its next meeting. Any related person transactions that are ongoing in nature will be reviewed annually.

A related person transaction reviewed under the policy will be considered approved or ratified if it is authorized by the committee after full disclosure of the related person’s interest in the transaction. As appropriate for the circumstances, the committee will review and consider:

the related person’s interest in the related person transaction;
the approximate dollar value of the amount involved in the related person transaction;
the approximate dollar value of the amount of the related person’s interest in the transaction without regard to the amount of any profit or loss;
whether the transaction was undertaken in the ordinary course of our business;
whether the terms of the transaction are no less favorable to us than terms that could have been reached with an unrelated third party; and
the purpose of, and the potential benefits to us of, the transaction.

The audit committee may approve or ratify the transaction only if the committee determines that, under all of the circumstances, the transaction is in our best interests. The committee may impose any conditions on the related person transaction that it deems appropriate.

In addition to the transactions that are excluded by the instructions to the SEC’s related person transaction disclosure rule, our board of directors has determined that the following transactions do not create a material direct or indirect interest on behalf of related persons and, therefore, are not related person transactions for purposes of this policy:

interests arising solely from the related person’s position as an executive officer of another entity (whether or not the person is also a director of such entity) that is a participant in the transaction, where (i) the related person and all other related persons own in the aggregate less than a 10% equity interest in such entity, (ii) the related person and his or her immediate family members are not involved in the negotiation of the terms of the transaction and do not receive any special benefits as a result of the transaction, and (iii) the amount involved in the transaction is less than the greater of   $200,000 or 5% of the annual gross revenues of the company receiving payment under the transaction; and
a transaction that is specifically contemplated by provisions of our certificate of incorporation, as amended and restated, or bylaws.

46

The policy provides that transactions involving compensation of executive officers shall be reviewed and approved by the compensation committee in the manner specified in its charter. We have a written policy regarding the review and approval of related person transactions. With respect to such transactions, it is our policy for our board of directors to consider the nature of and business reason for such transactions, how the terms of such transactions compared to those which might be obtained from unaffiliated third parties and whether such transactions were otherwise fair to and in the best interests of, or not contrary to, our best interests. In addition, all related person transactions required prior approval, or later ratification, by our board of directors.

Related Party Transactions

There were no related party transactions during the year ended December 31, 2021.

47

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The following is a summary of the fees billed to the Company by Marcum LLP for professional accounting services rendered for the fiscal years ended December 31, 2021 and 2020:

    

Fiscal Year 2021

    

Fiscal Year 2020

Audit fees (1)

$

276,695

$

266,032

Audit related fees

 

 

Tax fees (2)

 

 

All other fees (3)

 

 

$

276,695

$

266,032

1)Audit fees consist of fees billed for services rendered for the audit of our financial statements and review of our financial statements included in our Quarterly Reports on Form 10–Q.
2)Tax fees consist of fees billed for professional services related to the preparation of our U.S. federal and state income tax returns.
3)All other fees consist of fees billed for professional services related to non-recurring fees related to the Registration Statement on Form S-1 and amendments thereto filed with the SEC in those years.

48

PART IV

ITEM 15. EXHIBITS

(a)

Exhibits.

Exhibit 

Number

 Exhibit Descriptions

    

Incorporated by
References

    

 Filed

    

 Number

 

    

 

 

 

 

3.1

Amended and Restated Certificate of Incorporation of Kubient, Inc.

S-1A

8/6/2020

3.1

 

 

 

 

 

3.2

Certificate of Correction to the Amended and Restated Certificate of Incorporation of Kubient, Inc.

S-1A

8/7/2020

3.2

 

 

 

 

 

3.3

Amended and Restated Bylaws of Kubient, Inc.

S-1A

7/30/2020

3.3

 

 

 

 

 

4.1

Description of Securities

 10-K

 3/30/2021

 4.1

 

 

 

 

 

10.1

Amended and Restated Kubient, Inc. Incentive Stock Plan dated October 2, 2019+

DRS

11/26/2019

 10.1

 

 

 

 

 

10.2

License Agreement with OneQube, Inc. dated June 1, 2018

DRS

11/26/2019

10.2

 

 

 

 

 

10.3

Sublease Termination Agreement with OneQube, Inc. dated June 18, 2020

S-1

7/2/2020

10.3

 

 

 

 

 

10.4

Employment Agreement with Paul Roberts dated May 26, 2017+

DRS

11/26/2019

10. 7

 

 

 

 

 

10.5

Employment Agreement with Joshua Weiss dated December 23, 2019+

S-1

7/2/2020

10.9

 

 

 

 

 

10.6

Amendment to Employment Agreement with Paul Roberts dated October 2, 2019+

DRS

11/26/2019

10.8

 

 

 

 

 

10.7

Separation and Consulting Agreement with Peter A. Bordes, Jr. dated October 31, 2020+

8-K

11/6/2020

10.1

 

 

 

 

 

10.8

Separation Agreement and General Release with Christopher Andrews dated January 28, 2020*+

10-K

03/30/2021

10.13

 

 

 

 

 

10.9

Employment Agreement with Leon Zemel, dated April 9 2021+

10-Q

08/19/2021

10.2

 

 

 

 

 

10.10

Employment Agreement with Mitchell Berg dated November 24, 2021+

8-K

11/29/2021

10.1

 

 

 

 

 

10.11

Form of Warrant Agency Agreement including Form of Unit Warrant

S-1A

7/30/2020

10.15

 

 

 

 

 

10.12

Kubient, Inc. 2021 Equity Incentive Plan

8-K

07/02/2021

10.1

 

 

 

 

 

49

10.13

    

Asset Purchase Agreement, dated November 30, 2021, by and between MediaCrossing Inc. and the Company

8-K

 12/23/2021

 10.1

 

 

 

 

 

21.1

Subsidiary of the Registrant

DRS

11/26/2019

21.1

 

 

 

 

 

23.1

Consent of Marcum LLP

31.1

Chief Executive Officer Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

 

 

 

 

 

 

 

 

31.2

Chief Financial Officer Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*

 

 

 

 

 

 

 

 

32.1

Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

 

 

 

101.INS*

    

XBRL Instance Document

101.SCH*

XBRL Taxonomy Extension Schema Document

101.CAL*

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

XBRL Taxonomy Extension Label Linkbase Document

101.PRE*

XBRL Taxonomy Extension Presentation Linkbase Document

*Filed herewith.

**Furnished herewith.

+Denotes a management compensatory plan, contract or arrangement

ITEM 16. FORM 10-K SUMMARY

None.

50

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on the 30th day of March, 2022.

 

KUBIENT, INC.

 

By:

/s/ Paul Roberts

 

Name:

Paul Roberts

 

Title:

Chief Executive Officer, Chief Strategy Officer, President and Chairman

 

 

(principal executive officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature

    

Title

    

Date

/s/ Paul Roberts

Chief Executive Officer, Chief Strategy Officer, President and Chairman

March 30, 2022

Paul Roberts

(principal executive officer)

/s/ Joshua Weiss

Chief Financial Officer

March 30, 2022

Joshua Weiss

(principal financial and accounting officer)

/s/ Jonathan Bond

Director

March 30, 2022

Jonathan Bond

/s/ Peter A. Bordes, Jr.

Director

March 30, 2022

Peter A. Bordes, Jr.

/s/ Grainne Coen

Director

March 30, 2022

Grainne Coen

/s/ Elisabeth DeMarse

Director

March 30, 2022

Elisabeth DeMarse

/s/ Lawrence Harris

Director

March 30, 2022

Lawrence Harris

/s/ Jeannie Mun

Director

March 30, 2022

Jeannie Mun

51

EX-23.1 2 kbnt-20211231xex23d1.htm EX-23.1

Exhibit 23.1

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

We consent to the incorporation by reference in the Registration Statements of Kubient, Inc. on Form S-8 (File No. 333-257088 and File No. 333-257778) of our report dated March 30, 2022, with respect to our audits of the consolidated financial statements of Kubient, Inc. as of December 31, 2021 and 2020 and each of the two years in the period ended December 31, 2021, which report is included in this Annual Report on Form 10-K of Kubient, Inc. for the year ended December 31, 2021.

/s/ Marcum LLP

Marcum LLP

Los Angeles, CA

March 30, 2022


EX-31.1 3 kbnt-20211231xex31d1.htm EX-31.1

Exhibit 31.1

Certification of Principal Executive Officer

pursuant to

Exchange Act Rules 13a-14(a) and 15d-14(a),

as adopted pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Paul Roberts, certify that:

1.

I have reviewed this annual report on Form 10-K of Kubient, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:        March 30, 2022

/s/ Paul Roberts

Paul Roberts

Chief Executive Officer

(principal executive officer)


EX-31.2 4 kbnt-20211231xex31d2.htm EX-31.2

Exhibit 31.2

Certification of Principal Financial Officer

pursuant to

Exchange Act Rules 13a-14(a) and 15d-14(a),

as adopted pursuant to

Section 302 of the Sarbanes-Oxley Act of 2002

I, Joshua Weiss, certify that:

1.

I have reviewed this annual report on Form 10-K of Kubient, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:        March 30, 2022

/s/ Joshua Weiss

Joshua Weiss

Chief Financial Officer

(principal financial and accounting officer)


EX-32.1 5 kbnt-20211231xex32d1.htm EX-32.1

Exhibit 32.1

Certifications of Principal Executive Officer and Principal Financial Officer

pursuant to

18 U.S.C. Section 1350,

as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Paul Roberts, Interim Chief Executive Officer (principal executive officer) of Kubient, Inc. (the “Company”), and Joshua Weiss, Chief Financial Officer (principal financial and accounting officer) of the Company, each hereby certifies that, to the best of his knowledge:

1)

The Company’s Annual Report on Form 10-K for the year ended December 31, 2021, to which this certification is attached as Exhibit 32.1 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 30, 2022

/s/ Paul Roberts

Paul Roberts

Chief Executive Officer

(principal executive officer)

/s/ Joshua Weiss

Joshua Weiss

Chief Financial Officer

(principal financial and accounting officer) 

The foregoing certifications are being furnished pursuant to 18 U.S.C. Section 1350. They are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not to be incorporated by reference into any filing of the Company, regardless of any general incorporation language in such filing.


GRAPHIC 6 kbnt-20211231x10k001.jpg GRAPHIC begin 644 kbnt-20211231x10k001.jpg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end EX-101.SCH 7 kbnt-20211231.xsd EX-101.SCH 99900 - Disclosure - Standard And Custom Axis Domain Defaults link:presentationLink link:calculationLink link:definitionLink 00100 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00400 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - INCOME TAXES - Provision for income taxes (Details) link:presentationLink link:calculationLink link:definitionLink 40602 - Disclosure - INCOME TAXES - Statutory federal income tax rates (Details) link:presentationLink link:calculationLink link:definitionLink 40603 - Disclosure - INCOME TAXES - Deferred tax assets relate to temporary differences and carryforwards (Details) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency) link:presentationLink link:calculationLink link:definitionLink 00305 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - BUSINESS COMBINATION (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details) link:presentationLink link:calculationLink link:definitionLink 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation Default (Details) link:presentationLink link:calculationLink link:definitionLink 40205 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 40207 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - BUSINESS COMBINATION - Purchase consideration (Details) link:presentationLink link:calculationLink link:definitionLink 40302 - Disclosure - BUSINESS COMBINATION - Debt-free net working capital (Details) link:presentationLink link:calculationLink link:definitionLink 40303 - Disclosure - BUSINESS COMBINATION - Pro Forma Information (Details) link:presentationLink link:calculationLink link:definitionLink 40304 - Disclosure - BUSINESS COMBINATION - Additional information (Details) link:presentationLink link:calculationLink link:definitionLink 40402 - Disclosure - INTANGIBLE ASSETS - Intangible assets consist (Details) link:presentationLink link:calculationLink link:definitionLink 40403 - Disclosure - INTANGIBLE ASSETS - Amortization of intangible assets consists (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - NOTES PAYABLE - (Details) link:presentationLink link:calculationLink link:definitionLink 40703 - Disclosure - NOTES PAYABLE - Note Payable to Related Parties (Details) link:presentationLink link:calculationLink link:definitionLink 40704 - Disclosure - NOTES PAYABLE - Convertible Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 40803 - Disclosure - STOCKHOLDERS' EQUITY - Black-Scholes Option Pricing Model to Stock Options Granted (Details) link:presentationLink link:calculationLink link:definitionLink 40804 - Disclosure - STOCKHOLDERS' EQUITY - Company's stock option activity (Details) link:presentationLink link:calculationLink link:definitionLink 40805 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Information Related to Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 40806 - Disclosure - STOCKHOLDERS' EQUITY - Estimation of fair value of warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40808 - Disclosure - STOCKHOLDERS' EQUITY - Stock Warrants (Details) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - COMMITMENTS AND CONTINGENCIES - Outstanding Litigation (Details) link:presentationLink link:calculationLink link:definitionLink 40902 - Disclosure - COMMITMENTS AND CONTINGENCIES - Settlements (Details) link:presentationLink link:calculationLink link:definitionLink 40903 - Disclosure - COMMITMENTS AND CONTINGENCIES - Employment Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 41001 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 41002 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details) link:presentationLink link:calculationLink link:definitionLink 41101 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00105 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00405 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - BUSINESS COMBINATION link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - STOCKHOLDERS' EQUITY link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 11001 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 11101 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 30803 - Disclosure - STOCKHOLDERS' EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 31003 - Disclosure - CONCENTRATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable and Accounts Payable (Details) link:presentationLink link:calculationLink link:definitionLink 40204 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 40206 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Advertising Costs (Details) link:presentationLink link:calculationLink link:definitionLink 40404 - Disclosure - INTANGIBLE ASSETS - Future amortization expense (Details) link:presentationLink link:calculationLink link:definitionLink 40604 - Disclosure - INCOME TAXES - (Details) link:presentationLink link:calculationLink link:definitionLink 40807 - Disclosure - STOCKHOLDERS' EQUITY - Warrant Activity (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 kbnt-20211231_cal.xml EX-101.CAL EX-101.DEF 9 kbnt-20211231_def.xml EX-101.DEF EX-101.LAB 10 kbnt-20211231_lab.xml EX-101.LAB EX-101.PRE 11 kbnt-20211231_pre.xml EX-101.PRE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2021
Mar. 25, 2022
Jun. 30, 2021
Document Information [Line Items]      
Document Type 10-K    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2021    
Entity File Number 001-39441    
Entity Registrant Name KUBIENT, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 82-1808844    
Entity Address, Address Line One 500 7th Avenue    
Entity Address, Adress Line Two 8th Floor    
Entity Address, City or Town New York    
Entity Address State Or Province NY    
Entity Address, Postal Zip Code 10018    
City Area Code 800    
Local Phone Number 409-9456    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
ICFR Auditor Attestation Flag false    
Entity Shell Company false    
Entity Public Float     $ 64,423,000
Entity Common Stock, Shares Outstanding   14,303,743  
Entity Central Index Key 0001729750    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2021    
Document Fiscal Period Focus FY    
Amendment Flag false    
Auditor Name Marcum LLP    
Auditor Location Los Angeles, CA    
Auditor Firm ID 688    
Common Stock      
Document Information [Line Items]      
Title of 12(b) Security Common Stock    
Trading Symbol KBNT    
Security Exchange Name NASDAQ    
Warrants      
Document Information [Line Items]      
Title of 12(b) Security Common Stock Purchase Warrants    
Trading Symbol KBNTW    
Security Exchange Name NASDAQ    

XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 24,907,963 $ 24,782,128
Accounts receivable, net 2,291,533 1,373,754
Other receivables 526,070  
Prepaid expenses and other current assets 495,178 107,651
Total Current Assets 28,220,744 26,263,533
Intangible assets, net 2,946,610 1,071,850
Goodwill 463,000  
Property and equipment, net 44,756 17,166
Deferred offering costs 10,000 10,000
Total Assets 31,685,110 27,362,549
Current Liabilities:    
Accounts payable - suppliers 1,844,544 336,028
Accounts payable - trade 659,362 1,106,604
Accrued expenses and other current liabilities 2,493,287 1,017,282
Deferred revenue 395,914 15,000
Notes payable 151,336 218,461
Total Current Liabilities 5,544,443 2,693,375
Contingent consideration 613,000  
Notes payable, non-current portion 77,407 187,629
Total Liabilities 6,234,850 2,881,004
Commitments and contingencies (Note 9)
Stockholders' Equity :    
Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of December 31, 2021 and 2020
Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,253,948 and 11,756,109 shares issued and outstanding as of December 31, 2021 and 2020 respectively 143 118
Additional paid-in capital 52,030,907 40,770,504
Accumulated deficit (26,580,790) (16,289,077)
Total Stockholders' Equity 25,450,260 24,481,545
Total Liabilities and Stockholders' Equity $ 31,685,110 $ 27,362,549
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2021
Dec. 31, 2020
Consolidated Balance Sheets    
Preferred stock, par value $ 0.00001 $ 0.00001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.00001 $ 0.00001
Common stock, shares authorized 95,000,000 95,000,000
Common stock, shares issued 14,253,948 11,756,109
Common stock, shares outstanding 14,253,948 11,756,109
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Consolidated Statements of Operations    
Net Revenues $ 2,737,767 $ 2,900,029
Costs and Expenses:    
Sales and marketing 3,032,133 1,117,375
Technology 3,079,752 2,088,538
General and administrative 6,117,601 4,160,854
Loss on legal settlement 880,381  
Total Costs and Expenses 13,109,867 7,366,767
Loss From Operations (10,372,100) (4,466,738)
Other (Expense) Income:    
Interest expense (8,383) (1,135,675)
Interest expense - related parties   (403,372)
Interest income 88,537 25,178
Amortization of beneficial conversion feature   (1,984,322)
Gain on settlement of notes and other payables, net   124,999
Gain on forgiveness of accounts payable - supplier   236,248
Loss on extinguishment of convertible note payable   (297,272)
Other income 233 15,294
Total Other Income (Expense) 80,387 (3,418,922)
Net Loss (10,291,713) (7,885,660)
Deemed dividend related to warrant down round adjustment   (1,682,000)
Net Loss Attributable to Common Shareholders $ (10,291,713) $ (9,567,660)
Net Loss Per Share - Basic $ (0.75) $ (1.85)
Net Loss Per Share - Diluted $ (0.75) $ (1.85)
Weighted Average Common Shares Outstanding - Basic 13,695,700 5,185,204
Weighted Average Common Shares Outstanding - Diluted 13,695,700 5,185,204
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Stockholders' Equity (Deficiency) - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2019 $ 36 $ 3,362,724 $ (8,403,417) $ (5,040,657)
Balance at the beginning (in shares) at Dec. 31, 2019 3,601,521      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock and warrants in initial public offering, net of issuance costs [1] $ 25 10,605,720   10,605,745
Issuance of common stock and warrants in initial public offering, net of issuance costs (in shares) [1] 2,500,000      
Conversion of notes payable and accrued interest into common stock and warrants $ 15 7,304,815   7,304,830
Conversion of notes payable and accrued interest into common stock and warrants (in shares) 1,461,090      
Conversion of notes payable and accrued interest into common stock $ 1 388,143   388,144
Conversion of notes payable and accrued interest into common stock (in shares) 94,223      
Issuance of common stock and warrants in follow-on public offering, net of issuance costs $ 41 18,889,872   18,889,913
Issuance of common stock and warrants in follow-on public offering, net of issuance costs (in shares) 4,058,822      
Stock-based compensation: Common stock   154,922   154,922
Stock-based compensation: Common stock (in shares) 38,433      
Stock-based compensation: Options   19,570   19,570
Forgiveness of accrued expenses by related party   33,738   33,738
Exercise of warrant   11,000   11,000
Exercise of warrant (in shares) 2,000      
Effect of reverse stock-split (in shares) 20      
Net loss     (7,885,660) (7,885,660)
Balance at the end at Dec. 31, 2020 $ 118 40,770,504 (16,289,077) 24,481,545
Balance at the end (in shares) at Dec. 31, 2020 11,756,109      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation: Common stock $ 3 993,044   993,047
Stock-based compensation: Common stock (in shares) 238,702      
Stock-based compensation: Options   23,390   23,390
Net loss     (10,291,713) (10,291,713)
Shares issued upon exercise of warrants, net of issuance costs $ 21 9,703,609   9,703,630
Shares issued upon exercise of warrants, net of issuance costs (in shares) 2,156,322      
Common stock issued upon exercise of options   8,361   8,361
Common stock issued upon exercise of options (in shares) 2,815      
Shares issued as partial consideration for intangible asset $ 1 531,999   532,000
Shares issued as partial consideration for intangible asset (in shares) 100,000      
Balance at the end at Dec. 31, 2021 $ 143 $ 52,030,907 $ (26,580,790) $ 25,450,260
Balance at the end (in shares) at Dec. 31, 2021 14,253,948      
[1] Includes gross proceeds of $12,503,750, less issuance costs of $1,898,005.
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Consolidated Statements of Changes in Stockholders' Equity (Deficiency)    
Gross proceeds from initial public offering $ 10,169,027 $ 12,503,750
Issuance costs on initial public offering 381,878 1,898,005
Gross proceeds from Issuance of common stock and warrants in follow-on public offering   20,699,992
Issuance costs on follow-on public offering   $ 1,810,080
Gross proceeds upon exercise of warrants 10,169,027  
Issuance costs upon exercise of warrants $ 465,397  
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash Flows From Operating Activities:    
Net loss $ (10,291,713) $ (7,885,660)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 452,136 315,202
Bad debt expense 22,698 7,593
Gain on forgiveness of accounts payable - supplier   (236,248)
Stock-based compensation: Common stock 700,652 448,646
Stock-based compensation: Stock options 23,390 19,570
Amortization of debt discount and debt issuance costs   915,994
Amortization of debt discount and debt issuance costs - related parties   357,201
Amortization of beneficial conversion feature   1,984,322
Loss on extinguishment of convertible note payable   297,272
Loss on settlement of other payables   23,601
Gain on settlement of notes and other payables   (148,600)
Changes in operating assets and liabilities:    
Accounts receivable (940,477) (1,342,643)
Other receivable 3,955  
Prepaid expenses and other current assets 73,491 (79,579)
Accounts payable - suppliers 1,508,516 (191,125)
Accounts payable - trade (447,242) 211,922
Accrued expenses and other current liabilities 1,467,306 497,416
Deferred revenue (247,504)  
Net Cash Used In Operating Activities (7,674,792) (4,805,116)
Cash Flows From Investing Activities:    
Purchase of intangible assets (1,133,072) (1,300,336)
Purchase consideration of MediaCrossing (500,000)  
Purchase of property and equipment (39,414) (16,000)
Net Cash Used In Investing Activities (1,672,486) (1,316,336)
Cash Flows From Financing Activities:    
Proceeds from exercise of warrants [1] 9,787,149 [1] 11,000
Repayment of PPP loan [2] (177,347)  
Repayment of financed director and officer insurance premiums (145,050)  
Proceeds from exercise of options 8,361  
Proceeds from sale of common stock and warrants in initial public offering, net [2] [2]   11,503,488
Payment of initial public offering issuance costs   (841,376)
Proceeds from sale of common stock and warrants in follow-on public offering, net [3] [3]   19,354,493
Payment of follow-on public offering issuance costs   (125,000)
Repayment of advance from related party   (29,000)
Proceeds from issuance of notes payable   406,190
Repayment of notes payable   (95,000)
Proceeds from issuance of notes payable - related parties   835,000
Repayment of note payable - related party   (150,000)
Net Cash Provided By Financing Activities 9,473,113 30,869,795
Net Increase In Cash and Cash Equivalents 125,835 24,748,343
Cash and Cash Equivalents - Beginning of the Year 24,782,128 33,785
Cash and Cash Equivalents - End of the Year 24,907,963 24,782,128
Cash paid during the year for:    
Interest 7,912 574
Non-cash investing and financing activities:    
Accrual of warrant exercise issuance costs 83,519  
Shares issued as partial consideration for intangible asset 532,000  
Shares of common stock issued in satisfaction of accrued issuable equity 507,044  
Contingent consideration 613,000  
Financing of insurance premiums $ 362,625  
Conversion of notes payable and accrued interest into common stock   5,411,381
Original issue discount in connection with convertible notes payable   285,000
Original issue discount in connection with convertible notes payable - related party   75,500
Accrual of follow-on offering deferred offering costs   (339,581)
Reduction of additional paid-in capital for initial public offering issuance costs that were previously paid   56,367
Reversal of previously accrued deferred offering costs   218,829
Forgiveness of related party liability   $ 33,738
[1] Includes gross proceeds of $10,169,027, less issuance costs of $381,878.
[2] Includes gross proceeds of $12,503,750, less underwriting discounts and commissions of $1,000,262.
[3] Includes gross proceeds of $20,699,992, less underwriting discounts and commissions of $1,470,499.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Parenthetical)
12 Months Ended
Dec. 31, 2021
USD ($)
Condensed Consolidated Statements of Cash Flows  
Gross proceeds from initial public offering $ 12,503,750
Payments of offering costs for initial public offering 1,000,262
Gross proceeds from sale of common stock and warrants in follow-on public offering, net 20,699,992
Payments of offering costs for sale of common stock and warrants in follow-on public offering, net 1,470,499
Gross proceeds from initial public offering 10,169,027
Issuance costs on initial public offering $ 381,878
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES
12 Months Ended
Dec. 31, 2021
BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES  
BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES

NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES

Organization and Operations

Kubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.

The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.

The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.

The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources.  By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.

Risks and Uncertainties

The novel coronavirus (“COVID-19”) pandemic continues to impact global economic conditions, as well as the Company’s operations. COVID-19 had a meaningful negative impact on our financial condition, cash flows and results of operations during 2020, as revenues declined and we reduced spending in light of COVID-19 uncertainty. Although we continued to experience disruption and volatility during 2021, which could continue to have an adverse effect on our revenues and earnings in 2022, the ultimate economic impact of the pandemic remains fluid, as there continue to be periods of COVID-19 resurgence in various parts of the world. The extent of the impact of the COVID-19 pandemic in 2022 on our operational and financial performance will depend on a variety of factors, some of which are outside our control, including the duration and spread of COVID-19 and its variants, and its impact on our clients, partners, industry, and employees, all of which are uncertain at this time and cannot be accurately predicted.

Similarly, the economic uncertainty caused by the COVID-19 pandemic has made and may continue to make it difficult for us to forecast revenue and operating results and to make decisions regarding operational cost structures and investments. We have committed, and we plan to continue to commit, resources to grow our business, employee base, and technology development, and such investments may not yield anticipated returns, particularly if worldwide business activity continues to be impacted by the COVID-19 pandemic. The duration and extent of the impact from the COVID-19 pandemic depend on future developments that cannot be accurately predicted at this time, and if we are not able to respond to and manage the impact of such events effectively, our business may be harmed.

There can be no assurance that precautionary measures, whether adopted by us or imposed by others, will be effective, and such measures could negatively affect our sales, marketing, and client service efforts, delay and lengthen our sales cycles, decrease our employees’, clients’, or partners’ productivity, or create operational or other challenges, any of which could harm our business and results of operations.

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.1
SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2021
SIGNIFICANT ACCOUNTING POLICIES  
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying audited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements. Such consolidated financial statements and accompanying notes are the representations of Company’s management, who is responsible for their integrity and objectivity.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s significant estimates used in these financial statements include, but are not limited to, fair value calculations for equity securities, revenue recognition, stock-based compensation,the valuation of intangible assets and contingent consideration, useful lives of intangibles assets, the collectability of receivables and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and may cause actual results to differ from those estimates.

Principles of Consolidation

The consolidated financial statements of the Company include the accounts of Fidelity Media, LLC (“Fidelity”). All intercompany transactions have been eliminated in the consolidation.

Cash and Cash Equivalents

The Company maintains cash in bank accounts, which, at times, may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company has not experienced any losses in such accounts. The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2021 and 2020, the Company’s cash and cash equivalents were comprised of demand deposits held in bank accounts.  

Revenue Recognition

The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps:

Identification of a contract with a customer;
Identification of the performance obligations in the contract;
Determination of the transaction price;
Allocation of the transaction price to the performance obligations in the contract; and
Recognition of revenue when or as the performance obligations are satisfied.

The Company maintains a contract with each customer and supplier, which specify the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which it expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

As of December 31, 2021 and 2020, the Company did not have any contract assets from contracts with customers. As of December 31, 2021 and 2020, the Company had $395,914 and $15,000, respectively, of contract liabilities where performance obligations have not yet been satisfied. The Company expects to satisfy its remaining performance obligations and recognize the revenue within the next twelve months. During the years ended December 31, 2021 and 2020, there was no revenue was recognized from performance obligations satisfied (or partially satisfied) in previous periods.

Accounts Receivable and Accounts Payable

Accounts receivable are carried at their contractual amounts, less an estimate for uncollectible amounts. As of December 31, 2021 and 2020, there was an allowance for uncollectible amounts of $12,149 and $10,209, respectively. Management estimates the allowance for bad debts based on existing economic conditions, the financial conditions of the customers, and the amount and age of past due accounts.

Receivables are considered past due if full payment is not received by the contractual due date. Past due accounts are generally written off against the corresponding accounts payable in the event that the Company’s contract contains sequential liability terms, with the excess receivable being written off against the allowance for bad debts only after all collection attempts have been exhausted.

Accounts receivable are recorded at the amount the Company is responsible to collect from the customer. See Note 2 — Significant Accounting Policies — Revenue Recognition for additional details. In the event that the Company does not collect the Gross Billing amount from the customer, the Company generally is not contractually obligated to pay the associated Supplier Cost.

Convertible Instruments

The Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for in accordance with the Financial Accounting Standards Board (“FASB”) ASC Topic 815 “Derivatives and Hedging” (“ASC 815”). The accounting treatment of derivative financial instruments requires that the Company record embedded conversion options and any related freestanding instruments at their fair values as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded in earnings each period as non-operating, non-cash income or expense. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. Embedded conversion options and any related freestanding instruments are recorded as a discount to the host instrument. The Company allocates proceeds based on the relative fair values of the debt and equity components.

Prior to the adoption of ASU 2020-06, if the instrument is not determined to be a derivative liability, the Company then evaluates for the existence of a beneficial conversion feature by comparing the fair value of the Company’s common stock as of the commitment date to the effective conversion price of the instrument (the intrinsic value). The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital.

Deferred Offering Costs

Deferred offering costs, which consist of direct, incremental professional fees incurred in connection with the Company’s future offerings of equity and debt securities that have yet to close, are capitalized as non-current assets on the consolidated balance sheet. Upon the closing of the offering, the deferred offering costs are either (i) charged off against the offering proceeds in connection with an equity offering or (ii) reclassified such that they represent a reduction in the carrying amount of the face value of the debt security.

Property and Equipment

Property and equipment are stated at cost, net of accumulated depreciation which is recorded commencing at the in-service date using the straight-line method at rates sufficient to charge the cost of depreciable assets to operations over their estimated useful lives, which is three years. Leasehold improvements are amortized over the lesser of (a) the useful life of the asset; or (b) the remaining lease term. Maintenance and repairs are charged to operations as incurred. The Company capitalizes cost attributable to the betterment of property and equipment when such betterment extends the useful life of the assets.

Intangible Assets

Intangible assets are comprised of costs to acquire and develop computer software, including the costs to acquire third-party data which is used to improve the Company’s artificial intelligence platform for client use, as well as costs to acquire customer lists, customer contracts and related customer relationship and restrictive covenant agreements. The intangible assets have estimated useful lives of two years for the computer software, five years for the capitalized data, seven years for the customer lists and three years for the restrictive covenant agreements. Once placed into service, the Company amortizes the cost of the intangible assets over their estimated useful lives on a straight-line basis.

Impairment of Long-lived Assets

The Company reviews for the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. An impairment would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. The Company did not record any impairment losses during the years ended December 31, 2021 and 2020.

Fair Value of Financial Instruments

The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”).

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

Level 1 — quoted prices in active markets for identical assets or liabilities

Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 — inputs that are unobservable (for example, cash flow modeling inputs based on assumptions

The carrying amounts of the Company’s financial instruments, such as cash, accounts receivable, accounts payable, convertible notes and notes payable approximate fair value due to the short-term nature of these instruments. The carrying amounts of the Company’s short-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates, are comparable to rates of returns for instruments of similar credit risk.

Software Development Costs

The Company develops and utilizes software in connection with its ability to generate customer revenue (which is further explained in Note 2 – Significant Accounting Policies – Revenue Recognition). Costs incurred in this effort are accounted for under the provisions of ASC 985-20, Software – Cost of Software to be Sold, Leased or Marketed, whereby costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. The Company capitalizes subsequent additions, modifications, or upgrades to internally developed software only to the extent that such changes allow the software to perform a task it previously did not perform.

Income Taxes

The Company is subject to federal and state income taxes in the United States. The Company files income tax returns in the jurisdictions in which nexus threshold requirements are met.

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse.

The Company utilizes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.

The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as general and administrative expenses in the consolidated statements of operations.

Advertising Costs

Advertising costs are charged to operations in the year incurred and totaled approximately $270,000 and $101,000 for the years ended December 31, 2021 and 2020, respectively, and are reflected in general and administrative expenses in the consolidated statements of operations.

Stock-Based Compensation

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The Company accrues for any equity awards at fair value that have been contractually earned but not yet issued.

Fair Value of Stock Options and Warrants

The Company has computed the fair value of stock options and warrants granted using the Black-Scholes option pricing model. Option forfeitures are accounted for at the time of occurrence. The expected term used for options is the estimated period of time that options granted are expected to be outstanding. The expected term used for warrants is the contractual life. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” option grants. The Company does not currently have a sufficient trading history to support its historical volatility calculations. Accordingly, the Company is utilizing an expected volatility figure based on a review of the historical volatility of comparable entities over a period of time equivalent to the expected life of the instrument being valued. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive.

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Years Ended

December 31, 

    

2021

    

2020

Stock options

 

94,447

 

118,412

Restricted stock awards

166,489

Restricted stock units

100,000

Warrants [1]

 

5,122,074

 

7,403,722

 

5,483,010

 

7,522,134

[1] During 2021, includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share. During 2020, includes shares underlying warrants that are exercisable into an aggregate of (i) 1,235,977 shares of common stock and (ii) five-year warrants to purchase 1,235,977 shares of common stock at an exercise price of $5.50 per share.

Recently Issued Accounting Standards

In February 2016, the FASB issued ASU 2016-02“, “Leases (Topic 842)” (“ASU 2016-02”), as amended, with guidance regarding the accounting for and disclosure of leases. The update requires that a lessee recognize the assets and liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions. In May 2020, the FASB issued ASU 2020-05 that deferred these dates one year for all other entities, including emerging growth companies. This standard is effective for annual reporting periods beginning after December 15, 2021, and interim periods within annual periods beginning after December 15, 2022. Early adoption is permitted. The Company expects to adopt ASU 2016-02 during the fiscal year ending December 31, 2022 and is evaluating the impact on its statements of operations and cash flows. Based upon the leases currently in place, management believes that its current leases will qualify for the practical expedient for leases with terms less than one year, such that there will be no material impact of adopting the new standard on the Company’s consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). In April 2020, the FASB issued clarification to ASU 2016-13 within ASU 2020-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. This guidance is effective for public business entities that meet the definition of a Securities and Exchange Commission filer, excluding eligible smaller reporting companies, for fiscal years beginning after December 15, 2019. For all other entities, including emerging growth companies, it is effective for fiscal years beginning after December 15, 2020. The Company is currently evaluating ASU 2016-13 and its impact on its consolidated financial statements and disclosures.

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This update for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted, including adoption in any interim period for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The Company adopted ASU 2019-12 effective January 1, 2022 and its adoption did not have a material impact on the Company’s consolidated financial statements and disclosures.

In August 2020, the FASB issued ASU 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”) which simplifies the accounting for convertible instruments by eliminating certain accounting models when the conversion features are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in-capital. Under this ASU, certain debt instruments with embedded conversion features will be accounted for as a single liability measured at its amortized cost. Additionally, this ASU eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments. The new guidance is effective for annual periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company adopted ASU 2020-06 effective January 1, 2022 which eliminated the need to assess whether a beneficial conversion feature needed to be recognized upon either (a) the future issuance of new convertible notes; or (b) the resolution of any contingent beneficial conversion features.

In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). This new standard provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Issuers should apply the new standard prospectively to modifications or exchanges occurring after the effective date of the new standard. Early adoption is permitted, including adoption in an interim period. If an issuer elects to early adopt the new standard in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The Company adopted ASU 2021-04 effective January 1, 2022 such adoption did not have a material impact on the Company’s consolidated financial statements or disclosures.

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805)” (“ASU 2021-08”). The ASU improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. The update is effective for annual and interim periods within the fiscal year beginning after December 15, 2022, and early adoption is permitted, including adoption in an interim period. The Company is evaluating this new standard and its impact on its consolidated financial statements and related disclosures.

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS COMBINATION
12 Months Ended
Dec. 31, 2021
BUSINESS COMBINATION  
BUSINESS COMBINATION

NOTE 3 – BUSINESS COMBINATION

On November 30, 2021, Kubient entered into and consummated an Asset Purchase Agreement (the “Purchase Agreement”) between the Company and MediaCrossing Inc., a Delaware corporation (“MediaCrossing”), pursuant to which the Company acquired certain assets and liabilities that were critical to continue to operate the business of MediaCrossing for (i) $500,000 in cash and (ii) if the acquired business achieves certain milestones in 2022, up to 822,369 shares of the Company’s common stock, par value $0.00001 per share (the “Earnout Shares”) (the “Transaction”). In accordance with ASC 805, the Company determined that the Transaction should be accounted for as a business combination after determining that the acquired set of assets of MediaCrossing, the fair value of which was not concentrated in a single asset or group of similar assets and included (a) cash, (b) prepaid expenses and other current assets, (c) intangible assets as detailed further below and (d) an assembled workforce, met the definition of a business. As a result, Kubient has recorded the business combination in its consolidated financial statements and has applied the acquisition method to account for MediaCrossing’s assets acquired and liabilities assumed upon completion of the Transaction. The acquisition method requires recording the identifiable assets acquired and liabilities assumed at their fair values on the acquisition date and recording goodwill for the excess of the purchase price over the aggregate fair value of the identifiable assets acquired and liabilities assumed.

The Earnout Shares consist of up to 822,369 shares of the Company’s common stock, depending on the amount of revenue generated by the acquisition in 2022. Each share had a fair value of $2.55 as of the acquisition date. The Earnout Shares were measured using a Monte Carlo simulation. Key assumptions used in the fair value assessment consisted of revenue projections (which were used to estimate the number of Earnout Shares issuable), discount rate and standard deviation. The fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect Kubient’s own assumptions in measuring fair value.

MediaCrossing is engaged in the business of providing managed media services to agencies and direct brand advertisers, including media planning, strategy, contracting for media, developing, executing and managing campaigns, reporting and services ancillary to the foregoing.

In connection with the Acquisition and pursuant to the terms of the Purchase Agreement, the Company has offered employment to ten employees of MediaCrossing, including Michael Kalman as President – Agency & Brand Partnerships. In addition, the Purchase Agreement contains customary representations, warranties, post-closing covenants and indemnification provisions.

The aggregate preliminary purchase price was allocated to the assets acquired and liabilities assumed as follows:

Purchase Consideration:

    

  

Cash

 

$

500,000

Contingent consideration

 

 

613,000

Total Purchase Consideration

 

 

1,113,000

Less:

 

 

  

Customer contracts and related customer relationships (1)

 

 

580,000

Restrictive covenant agreements (1)

 

 

70,000

Debt-free net working capital

 

 

Fair Value of Identified Net Assets

 

 

650,000

Remaining Unidentified Goodwill Value

$

463,000

(1)As part of the preliminary valuation analysis, the Company identified (i) customer contracts and related customer relationships and (ii) restrictive covenant agreements as intangible assets. The fair value of the identifiable intangible assets is determined using the “income approach”. The customer contracts and related customer relationships have an estimated useful life of five (5) years and the restrictive covenant agreements have an estimated useful life of three (3) years.

The components of debt free net working capital deficit are as follows:

Current Assets:

    

  

Prepaid expenses and other current assets

$

109,083

Other receivables

 

526,070

Total Current Assets

 

635,153

Current Liabilities:

 

  

Deferred revenue

 

628,418

Accrued expenses and other current liabilities

 

6,735

Total Current Liabilities

 

635,153

Debt-Free Net Working Capital

$

Goodwill was recorded based on the amount by which the purchase price exceeded the fair value of the net assets acquired and the amount is attributable to the reputation of the business acquired, the workforce in place and the synergies to be achieved from this acquisition. Goodwill is deductible for tax purposes.

The consolidated financial statements of the Company include the results of operations of MediaCrossing from November 30, 2021 to December 31, 2021 and do not include results of operations for the year ended December 31, 2020. The results of operations of MediaCrossing from November 30, 2021 to December 31, 2021 included revenues of $154,954 and a net loss of $18,447.

The following table presents the unaudited pro forma consolidated results of operations for the year ended December 31, 2021 as if the Transaction had occurred on January 1, 2020. The pro forma information provided below is compiled from the pre-acquisition financial information of MediaCrossing and includes certain pro forma adjustments for the amortization of intangible assets and transaction costs. The pro forma results are not necessarily indicative of (i) the results of operations that would have occurred had the operations of this acquisition actually been acquired at the beginning of fiscal year 2020 or (ii) future results of operations:

    

For the Years Ended

December 31, 

2021

    

2020

Net Revenues

$

5,439,093

$

7,527,651

Net Loss

$

(12,510,391)

$

(9,032,939)

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS
12 Months Ended
Dec. 31, 2021
INTANGIBLE ASSETS  
INTANGIBLE ASSETS

NOTE 4 - INTANGIBLE ASSETS

On June 15, 2021, pursuant to an asset purchase agreement dated June 4, 2021, the Company closed on the acquisition of a customer list (the “Customer List”) and other assets of Advisio Solutions, LLC (“Advisio”) for consideration consisting of: (i) $1,050,000 paid in cash and (ii) the issuance of an aggregate of 100,000 shares of the Company’s common stock with an aggregate issuance date fair value of $532,000. Under the screen test requirements under ASC 805, the Company concluded that the Customer List represented substantially all of the fair value of the gross assets acquired and, accordingly, determined the set was not considered a business, such that the Company applied asset acquisition accounting and recorded the acquisition of the Customer List as an intangible asset in the amount of $1,582,000 that will be amortized on a straight-line basis over its useful life of seven years.

Intangible assets consist of the following:

    

December 31, 

    

2021

    

2020

Acquired data

$

1,300,336

$

1,300,336

Acquired software

 

183,072

 

100,000

Acquired customer lists

 

2,162,000

 

Restrictive covenant agreements

70,000

3,715,408

1,400,336

Less: accumulated amortization

 

(768,798)

 

(328,486)

Intangible assets, net

$

2,946,610

$

1,071,850

Amortization of intangible assets consists of the following:

    

    

    

Acquired 

    

Restrictive 

    

    

Acquired 

Acquired 

Customer 

Covenant 

Accumulated 

Data

Software

Lists

Agreements

Amortization

Total

Balance as of January 1, 2020

$

$

100,000

$

$

$

(16,667)

$

83,333

Additions

 

1,300,336

 

 

 

 

 

1,300,336

Amortization expense

 

 

 

 

 

(311,819)

 

(311,819)

Balance as of December 31, 2020

 

1,300,336

 

100,000

 

 

 

(328,486)

 

1,071,850

Additions

 

 

83,072

 

2,162,000

 

70,000

 

 

2,315,072

Amortization expense

 

 

 

 

 

(440,312)

 

(440,312)

Balance as of December 31, 2021

$

1,300,336

$

183,072

$

2,162,000

$

70,000

$

(768,798)

$

2,946,610

Weighted average remaining amortization period at December 31, 2021 (in years)

 

3.0

 

1.0

 

5.5

 

4.9

 

4.4

 

  

    

    

    

Acquired 

    

Restrictive

    

Acquired 

Acquired 

Customer

 Covenant 

Accumulated 

Data

Software

 Lists

Agreements

Amortization

Balance as of January 1, 2020

$

$

16,667

$

$

$

16,667

Amortization expense

 

261,819

 

50,000

 

 

 

311,819

Balance as of December 31, 2020

 

261,819

 

66,667

 

 

 

328,486

Amortization expense

 

252,081

 

48,538

 

138,528

 

1,165

 

440,312

Balance as of December 31, 2021

$

513,900

$

115,205

$

138,528

$

1,165

$

768,798

The estimated future amortization expense is as follows:

For the Years Ending December 31,

    

Total

2022

$

718,601

2023

 

706,206

2024

 

683,192

2025

 

270,194

2026 and beyond

 

568,417

$

2,946,610

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.1
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
12 Months Ended
Dec. 31, 2021
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES  
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

NOTE 5 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:

    

December 31, 

    

2021

    

2020

Accrued bonuses

$

554,997

$

541,834

Accrued payroll

13,750

Accrued payroll taxes

 

 

5,947

Financed director and officer insurance premiums

217,575

Accrued supplier expenses

 

1,042,971

 

50,972

Accrued legal and professional fees

 

20,323

 

80,653

Accrued commissions

 

36,109

 

2,768

Accrued media commissions

138,028

Credit card payable

328,075

901

Accrued programming expenses

 

1,750

 

16,750

Accrued issuable equity

 

1,258

 

293,724

Accrued interest

 

9,017

 

3,975

Accrued warrant exercise costs

83,519

Other

 

45,915

 

19,758

Total accrued expenses and other current liabilities

$

2,493,287

$

1,017,282

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES
12 Months Ended
Dec. 31, 2021
INCOME TAXES  
INCOME TAXES

NOTE 6 — INCOME TAXES

The provision for income taxes consists of the following provisions/(benefits):

    

For the Years Ended

December 31,

    

2021

    

2020

Deferred tax benefit:

  

 

  

Federal

$

(2,183,635)

$

(132,480)

State and local

 

(978,739)

 

(641,793)

 

(3,162,374)

 

(774,273)

Change in valuation allowance

 

3,162,374

 

774,273

Provision for income taxes

$

$

The provision for income taxes differs from the statutory federal income tax rates as follows:

    

For the Years Ended

 

 December 31,

    

2021

    

2020

 

Tax expense at the federal statutory rate

21.0

%  

21.0

%

State taxes, net of federal benefit

8.7

%  

3.5

%

Permanent differences

(0.2)

%  

(10.3)

%

True-up

1.2

%  

(4.4)

%

Change in valuation allowance

(30.7)

%  

(9.8)

%

Effective income tax rate

0.0

%  

0.0

%

The components of deferred tax assets as of December 31, 2021 and 2020 relate to temporary differences and carryforwards as follows:

    

December 31,

    

2021

    

2020

Net operating loss carryforwards

$

5,383,659

$

2,702,003

Stock-based compensation expense

 

169,427

 

102,409

Deferred Revenue

7,972

Accrued Legal Settlement

290,948

Other reserve

 

59,682

 

55,699

Intangibles

 

211,651

 

68,733

Tax credits

 

90,952

 

90,952

Deferred tax assets

 

6,214,291

 

3,019,796

Fixed assets

 

(36,902)

 

(4,781)

Deferred tax liabilities

 

(36,902)

 

(4,781)

Valuation allowance

 

(6,177,389)

 

(3,015,015)

Deferred tax assets, net

$

$

As of December 31, 2021, the Company had approximately $18,263,000 of federal net operating loss (“NOL”) carryforwards that may be available to offset future taxable income. As of that date, approximately $533,000 of federal net operating losses will expire in 2037 and approximately $17,730,000 have no expiration. In addition, the Company has approximately $91,000 of federal research and development credit carryforwards that begin to expire in 2037. The Company also had approximately $29,016,000 of state and local NOLs that begin to expire in 2037. The utilization of NOL carryforwards and research and development credits to offset future taxable income may be subject to limitations under Section 382 of the Internal Revenue Code and similar state statutes as a result of ownership changes that could occur in the future. If necessary, the deferred tax assets will be reduced by any carryforward that expires prior to utilization as a result of such limitations, with a corresponding reduction of the valuation allowance.

The Company has assessed the likelihood that deferred tax assets will be realized in accordance with the provisions of ASC 740, Income Taxes (“ASC 740”). ASC 740 requires that such a review considers all available positive and negative evidence, including the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. ASC 740 requires that a valuation allowance be established when it is “more likely than not” that all, or a portion of, deferred tax assets will not be realized. After the performance of such reviews as of December 31, 2021 and 2020, management believes that uncertainty exists with respect to future realization of its deferred tax assets and has, therefore, established a full valuation allowance as of those dates. Thus, the Company increased the valuation allowance by $3,162,374 and $774,273 during the years ended December 31, 2021 and 2020, respectively.

Management has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s consolidated financial statements as of December 31, 2021 and 2020. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date.

The Company is subject to income taxes in the United States and in various state taxing jurisdictions including New York, New York City and California. No tax audits were commenced or were in process during the years ended December 31, 2021 and 2020. No tax related interest or penalties were incurred during the years ended December 31, 2021 and 2020. The Company’s Federal, New York State and City, and State of California income tax returns filed since inception remain subject to examination.

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.1
NOTES PAYABLE
12 Months Ended
Dec. 31, 2021
NOTES PAYABLE  
NOTES PAYABLE

NOTE 7 – NOTES PAYABLE

During the years ended December 31, 2021 and 2020, the Company recorded cash interest expense of $8,383 and $207,092, respectively, and non-cash amortization of debt discount and debt issuance costs of $0 and $915,994, respectively, which is included in interest expense on the consolidated statements of operations. As of December 31, 2021 and 2020, the Company had $9,017 and $4,599, respectively, of accrued interest related to notes payable.

During the years ended December 31, 2021 and 2020, the Company recorded cash interest expense – related parties of $0 and $46,171, respectively, and non-cash amortization of debt discount and debt issuance costs – related parties of $0 and $357,201, respectively.

During the years ended December 31, 2021 and 2020, the Company made aggregate principal repayments of notes payable of $177,347 and $95,000, respectively, and $0 and $150,000, respectively, of repayments of notes payable – related party.

Notes Payable

PPP Loan

On April 6, 2020, the Company received a loan in the amount of approximately $327,000 (the “PPP Loan”) from JPMorgan Chase Bank, N.A., as lender, pursuant to the Paycheck Protection Program (“PPP”) of the Coronavirus Aid, Relief and Economic Security Act, as amended (the “CARES Act”). The PPP Loan matures on April 16, 2022 and bears interest at a rate of 0.98% per annum. Commencing May 16, 2021, the Company is required to pay the lender equal monthly payments of principal and interest as required to fully amortize by April 16, 2022 the principal amount outstanding on the PPP Loan as of the date prescribed by guidance issued by the U.S. Small Business Administration (“SBA”). The PPP Loan is evidenced by a promissory note dated April 6, 2020, which contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. The PPP Loan may be prepaid by the Company at any time prior to maturity with no prepayment penalties. As of December 31, 2021 and 2020, the amount outstanding under the PPP Loan was $149,843 and $327,290, respectively.

EIDL Loan

On June 23, 2020, the Company received a loan in the amount of approximately $79,000 (the “EIDL Loan”) from the SBA, as lender, under the SBA’s Economic Injury Disaster Loan (“EIDL”) assistance program. The EIDL Loan bears interest at 3.75% per annum. Monthly installment payments in the amount of $385 per month, including principal and interest, will begin June 20, 2021. The EIDL Loan matures on June 20, 2050, and is evidenced by a promissory note, loan authorization agreement, and security agreement, all dated June 20, 2020, and all of which contain customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. The EIDL Loan is collateralized by the assets of the Company. Such EIDL Loan amount will reduce the Company’s PPP loan forgiveness amount described above. The EIDL Loan may be prepaid by the Company at any time prior to maturity with no prepayment penalties. As of December 31, 2021 and 2020, the amount outstanding under the EIDL Loan was $78,900.

Separately, during the year ended December 31, 2020, the Company also received a grant of $10,000 from the SBA under the EIDL assistance program. The grant was recognized as other income during the year ended December 31, 2020.

Notes Payable – Related Parties

During the year ended December 31, 2020, the Company received aggregate proceeds of $685,000 in connection with three-year notes payable issued to three of its executive officers. The notes bear interest ranging from 0.91% and 1.60% per annum, payable annually. The outstanding principal and accrued and unpaid interest became immediately due and payable upon the Company’s initial public offering. Effective July 13, 2020, the holders agreed to amend the terms of the notes to provide for automatic conversion of principal and interest thereunder into shares of common stock and warrants to purchase shares of common stock at the public offering price per unit. The Company determined that the amended terms were debt modifications. Upon closing of the initial public offering which resulted in net proceeds of approximately $10.6 million (“IPO”) on August 14, 2020, such notes payable, along with accrued interest of $6,048, automatically converted into an aggregate of 138,209 shares of common stock and five-year warrants to purchase 138,209 shares of common stock at an exercise price of $5.50 per share.

In addition to these related party notes, on July 28, 2020, the Company received proceeds of $150,000 in connection with a note payable that was issued to an entity controlled by the Company’s then-Chief Executive Officer. The note bears interest at 0.17% per annum, payable annually. The note matures and is repayable in cash by the Company on October 28, 2020, subject to acceleration following the occurrence of an IPO, qualified financing or sale of the Company (as such terms are defined in the note). On September 24, 2020, the Company fully repaid the note.

Convertible Notes Payable

Upon the closing of the initial public offering, the Senior Notes and Junior Notes automatically converted into common stock and warrants at a conversion price of $3.50. Based on the foregoing, the Senior Notes and Junior Notes converted into an aggregate of 1,322,881 shares of common stock and five-year warrants to purchase an aggregate of 1,322,881 shares of common stock at an exercise price of $5.50 per share (based on aggregate principal balance of $4,326,000 and aggregate accrued interest of $304,090 as of August 14, 2020). The Company recognized expense of approximately $2.4 million associated with the recognition of a beneficial conversion feature of $1,984,322 and interest expense in connection with the amortization of unamortized debt discount of $393,959.

Upon the closing of the IPO, a down round feature was triggered in warrants held by holders of Senior Notes and Junior Notes, such that the warrants, which have an exercise price of $4.20 per unit, are exercisable into an aggregate of 1,235,997 shares of common stock and five-year warrants to purchase an aggregate of 1,235,997 shares of common stock at an exercise price of $5.50 per share. In connection with the down round being triggered, the Company recognized a deemed dividend of $1,682,000 during the year ended December 31, 2020 on the consolidated statements of operations, which represents the incremental fair value, estimated using a binomial model, provided to the holders in connection with the down round.

On August 12, 2020, a noteholder exercised its option to convert a convertible note payable in the principal amount of $20,000 and accrued interest in the amount of $3,370 at a conversion price of $0.29 per share that was not subject to the Reverse Stock Split, which resulted in the issuance of 80,586 shares of common stock. In connection with the conversion, the Company recognized a loss on extinguishment of convertible note payable of $297,272, which represented the fair value of the additional shares issued to the noteholder as a result of not applying the Reverse Stock Split.

On August 14, 2020, a noteholder exercised its option to convert a convertible note payable in the principal amount of $45,000 and accrued interest in the amount of $22,502 at a conversion price of $4.95 per share, which resulted in the issuance of 13,637 shares of common stock.

Due to Related Party

The Company repaid $29,000 during the year ended December 31, 2020 related to a non-interest-bearing advance from a company controlled by an executive officer.

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2021
STOCKHOLDERS' EQUITY  
STOCKHOLDERS' EQUITY

NOTE 8 — STOCKHOLDERS’ EQUITY

Authorized Capital

The authorized capital of Kubient consists of 95,000,000 shares of common stock, par value $0.00001 per share, and 5,000,000 shares of preferred stock, par value $0.00001 per share. The holders of the Company’s common stock are entitled to one vote per share.

Reverse Stock Split

A 1:9 reverse stock split of the Company’s common stock was affected on August 6, 2020 (the “Reverse Stock Split”). All share and per share information has been retroactively adjusted to give effect to the Reverse Stock Split for all periods presented, unless otherwise indicated.

Public Offerings

On August 14, 2020, the Company consummated its initial public offering of 2,500,000 units (the “Units”) at a price of $5.00 per Unit, which resulted in aggregate gross and net proceeds of approximately $12.5 million and $10.6 million, respectively. Each Unit consisted of one share of common stock, par value $0.00001 per share and one warrant to purchase one share of common stock (the “Warrants”). The Warrants are exercisable immediately upon issuance and at any time up to the date that is five years from the date of issuance and will have an exercise price of $5.50 per share.

On August 14, 2020, the Company consummated the closing of a partial exercise of the over-allotment option granted to the underwriters in connection with its IPO to purchase 375,000 additional common stock purchase warrants at a price of $0.01 per warrant for aggregate proceeds of $3,750.

On August 14, 2020, in connection with its IPO, the Company issued to the underwriters warrants to purchase 125,000 shares of common stock at $6.25 per share. The warrants are exercisable at any time for cash or on a cashless basis during the four- and one-half year period commencing 180 days from the effective date of the Company’s registration statement. The warrants had an issuance date fair value of $225,850 that was recorded as a debit and credit to additional paid-in capital.

On December 28, 2020, the Company consummated a Follow-On Offering of 4,058,822 shares of common stock at a price of $5.10 per share for aggregate gross and net proceeds of approximately $20.7 million and $18.9 million, respectively, which such amounts include the full exercise by the underwriters of the over-allotment option to purchase an additional 529,411 shares of common stock at $5.10 per share. The Company issued to the representatives of the underwriters warrants to purchase 176,470 shares of common stock at an exercise price of $6.38 per share. The warrants are exercisable at any time for cash or on a cashless basis during the four- and one-half year period commencing 180 days from the effective date of the Company’s registration statement. The warrants had an issuance date fair value of $447,987 that was recorded as a debit and credit to additional paid-in capital.

See Note 6 – Notes Payable for additional details.

Equity Incentive Plans

The 2017 Equity Incentive Plan (the “2017 Plan”) was originally adopted by the Company’s board of directors and approved by its stockholders on September 12, 2017 and was subsequently amended and restated on June 5, 2019. The purposes of the 2017 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our service providers and to promote the success of the Company’s business. The Company has reserved 333,334 shares of common stock to issue awards under the 2017 Plan. as of December 31, 2021, 11,889 shares of common stock remained available for future issuance under the 2017 Plan.

The 2021 Equity Incentive Plan was originally adopted by the Company’s board of directors and approved by its stockholders on June 30, 2021 (the “2021 Plan”). The purposes of the 2021 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our service providers and to promote the success of the Company’s business. The Company has reserved 1,500,000 shares of common stock to issue awards under the 2021 Plan. As of December 31, 2021, 1,400,000 shares of common stock remained available for future issuance under the 2021 Plan.

Founder Employee Incentive Program

On July 2, 2020, the Company’s board of directors adopted the Founder Employee Incentive Program (the “Founder Program”) under the 2017 Plan. The purposes of the Founder Program are to offer near-term and long-term incentives to founder employees of the Company that are intended to keep such employees in the employ of the Company, and that are based on individual performance, the achievement of financial goals of the Company and the total return to the Company’s stockholders. Through December 31, 2021, no awards have been issued by the Company under the Founder Program.

Stock-Based Compensation

For the years ended December 31, 2021 and 2020, the Company recognized stock-based compensation expense related to stock options and common stock as follows:

    

For the Years Ended

December 31, 

    

2021

    

2020

Sales and marketing

$

270,460

$

54,723

Technology

 

31,631

 

13,891

General and administrative

 

421,951

 

399,602

Total

$

724,042

$

468,216

As of December 31, 2021, there was approximately $875,000 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 2.3 years.

Common Stock

During the year ended December 31, 2020, the Company issued an aggregate of 38,433 shares of immediately vested common stock under the 2017 Plan to three employees and two non-employee service providers. The shares had an issuance date fair value of an aggregate of $107,503, which was recognized immediately.

During the three months ended March 31, 2021, the Company issued an aggregate of 20,040 shares of common stock under the 2017 Plan to the four members of the Company’s Board of Directors. The shares had a grant date fair value of $60,120, which was recognized ratably from the grant date of November 5, 2020 through January 15, 2021, the date the shares were issued.

During the three months ended March 31, 2021, the Company issued an aggregate of 50,000 shares of immediately vested common stock (10,000 shares were issued under the Company’s 2017 Plan) to an employee and a consultant for services provided. The common stock had an aggregate issuance date fair value of $500,400 which was recognized immediately.

During the three months ended June 30, 2021, the Company issued an aggregate of 167,600 restricted shares of its common stock under the 2017 Plan to six employees. The restricted stock had an aggregate issuance date fair value of $963,701, of which, awards with an aggregate fair value of $957,313 vest over a period of one year and an award with an aggregate fair value of $6,388 vests immediately. The fair value of the awards is being recognized over the vesting term.

During the three months ended December 31, 2021, the Company issued 1,062 shares of immediately vested common stock to a former member of the Company’s Board of Directors that had an issuance date fair value of $3,282 that was recognized immediately.

See Note 4 – Intangible Assets for details regarding the issuance of common stock as partial consideration for the acquisition of intangible assets. See Note 7 – Notes Payable for additional details related to common stock issuances. See Note 9 – Commitments and Contingencies – Employment Agreements for details regarding the grant of a bonus that is payable in common stock of the Company.

Stock Options

On November 9, 2020, the Company granted a ten-year option to purchase 20,000 shares of common stock at an exercise price of $2.81 per share to an employee under the 2017 Equity Incentive Plan. The shares vest over a four-year period, with 5,000 shares vesting on November 9, 2021 and the remaining 15,000 shares vesting ratably on a monthly basis over the remaining three-year period. The options had an aggregate grant date fair value of $32,981, or $1.31 per share, which will be recognized over the vesting period.

During the year ended December 31, 2021, the holder of an option under the 2017 Plan to purchase 2,815 shares of the Company’s common stock at an exercise price of $2.97 per share exercised such option resulting in cash proceeds of $8,361 to the Company.

In applying the Black-Scholes option pricing model to stock options granted, the Company used the following approximate assumptions:

    

For the Years Ended

 

December 31, 

 

 

2021

    

2020

Expected term (years)

 

N/A

6.08

Expected volatility

 

N/A

55.8%-56.3%

Risk free interest rate

 

N/A

0.57%-1.65%

Expected dividends

 

N/A

0.00%

A summary of the Company’s stock option activity during the year ended December 31, 2021 is as follows:

    

    

    

Weighted Average

    

Number

Weighted Average

Remaining Term 

Intrinsic

    

of Options

    

Exercise Price

    

(Years)

    

Value

Outstanding at January 1,2021

 

118,412

$

15.22

 

  

 

  

Granted

 

 

 

  

 

  

Forfeited

 

(21,150)

 

33.16

 

  

 

  

Exercised

 

(2,815)

 

2.97

 

  

 

  

Outstanding at December 31, 2021

 

94,447

$

11.56

 

4.4

$

6,339

Exercisable at December 31, 2021

 

66,240

$

9.49

 

2.9

$

3,276

The following table presents information related to stock options as of December 31, 2021:

Options Outstanding

    

Options Exercisable

Weighted

Outstanding

Average

Exercisable

Number of

Remaining Life

Number of

Exercise Price

    

Options

    

In Years

    

Options

$

2.81

 

20,000

 

8.9

 

5,416

$

2.97

 

42,779

 

0.7

 

42,779

$

4.95

 

5,556

 

0.9

 

4,255

$

33.75

 

26,112

 

7.8

 

13,790

 

94,447

 

2.9

 

66,240

Stock Warrants

See Note 6 – Notes Payable – Convertible Notes Payable and Note 7 – Stockholder’s Equity – Public Offerings for details regarding the issuance of warrants during the year ended December 31, 2020.

The Company used the following approximate assumptions in connection with its estimation of fair value of warrants:

    

For the Years Ended

 

December 31, 

 

2021

    

2020

 

Expected term (years)

 

N/A

3.86-4.75

Expected volatility

 

N/A

58.0%-61.2%

Risk free interest rate

 

N/A

0.24%-0.39%

Expected dividends

 

N/A

0.00%

A summary of the warrant activity during the year ended December 31, 2021 is presented below:

    

    

    

    

Weighted

    

    

Weighted

Average

Average

Remaining

Number of

Exercise

Life

Intrinsic

    

Warrants

    

Price

    

In Years

    

Value

Outstanding, January 1, 2021

 

6,167,745

$

5.26

 

  

 

  

Issued

 

867,286

 

5.50

 

  

 

  

Exercised

 

(2,281,668)

 

5.04

 

  

 

  

Expired

 

 

 

  

 

  

Outstanding, December 31, 2021[1]

 

4,753,363

$

5.42

 

3.5

$

Exercisable, December 31, 2021

 

4,753,363

$

5.35

 

3.5

$

[1] Excludes five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share that are issuable upon exercise of certain warrants.

The following table presents information related to stock warrants as of December 31, 2021:

Warrants Outstanding

    

Warrants Exercisable

Weighted

Outstanding

Average

Exercisable

Number of

Remaining Life

Number of

Exercise Price

Warrants

In Years

    

Warrants

$

4.20

 

368,711

 

2.7

 

368,711

$

4.95

 

177,223

 

1.3

 

177,223

$

5.50

 

3,998,459

 

3.7

 

3,998,459

$

6.25

 

32,500

 

3.6

 

32,500

$

6.38

 

176,470

 

4.0

 

176,470

 

4,753,363

 

3.5

 

4,753,363

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2021
COMMITMENTS AND CONTINGENCIES  
COMMITMENTS AND CONTINGENCIES

NOTE 9 – COMMITMENTS AND CONTINGENCIES

From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.

Settlements

On October 6, 2017, the Company entered into a Master Service Agreement for Buyers and Sellers, and an “Engage Buyer Addendum”, with Engage BDR, LLC whereby the Company could gain access to the Engage BDR, LLC proprietary trading technology platform in order to both offer and purchase inventory for the placement of ads. On August 31, 2018, Engage BDR, LLC filed suit against the Company (Engage BDR, LLC v. Kubient, Inc., Los Angeles County Superior Court Case No. SC129764) setting forth claims of breach of contract, unjust enrichment, quantum meruit, accounts stated, and breach of implied covenant of good faith and fair dealing. On November 14, 2018, Engage BDR, LLC obtained a summary default judgment against the Company for $35,936. On February 17, 2021, the Company and Engage BDR, LLC entered into a settlement agreement in the amount of $33,461 and the Company paid such amount on February 19, 2021, which had been accrued for as of December 31, 2020.

See Note 11 – Subsequent Events for details of the settlement of previously outstanding litigation.

Obligations Arising from Employment Agreements

On April 9, 2021, the Company entered into an at-will employment agreement with its new Chief Product Officer, Mr. Leon Zemel, that provides for an annual base salary of $390,000, plus annual performance bonuses with a target achievement of up to 20% of Mr. Zemel’s base salary. Subject to the approval of the board or its compensation committee, the Company agreed to take appropriate action within ninety (90) days following April 9, 2021 to make an award of 100,000 shares of common stock to Mr. Zemel, which will vest at the rate of 1/4th of the total number of shares on the first anniversary of the Effective Date and 1/36th of the total number of remaining unvested shares each month thereafter. As of September 30, 2021, the award had not been granted. Upon termination of Mr. Zemel’s employment for any reason, Mr. Zemel is entitled to (i) any portion of his base salary earned through the date of his termination date, (ii) any expenses owed to him, (iii) subject to Company policy and the law, any accrued, but unused vacation pay owed to him, pursuant to Company policy, if any, to the extent not inconsistent with applicable laws, and (iv) any amount arising from Mr. Zemel’s participation in, or benefits under, the Company’s employee benefit plans. In the event Mr. Zemel is terminated without cause or that Mr. Zemel resigns for Good Reason (as defined in his employment agreement), Mr. Zemel is entitled to receive: to six month’s salary paid in one lump sum, six months continued healthcare coverage, any pro-rated bonus amounts outstanding at the time of termination, and immediate vesting of any equity awards that would have become vested and exercisable during the three months after his termination. Mr. Zemel’s employment agreement contains an accelerated vesting provision which provides that 25% of his share award under the agreement shall vest if he is terminated before the one-year anniversary date of the agreement for good cause, or if he chooses to terminate his

employment with the Company for Good Reason (as defined in the agreement), then 100% of his share award under the agreement shall vest immediately. All outstanding awards due to Mr. Zemel automatically vest upon a change in control of the Company.

On June 4, 2021 (the “Effective Date”), the Company entered into two-year employment agreements with its two new Vice Presidents of Performance Media. The agreements provide for a bonus paid to each Vice President of Performance Media of (i) the issuance of up to 67,738 shares of the Company’s common stock (the “First Year Bonus”) on the 12-month anniversary of the Effective Date if as of such date the net revenue, as defined within the agreement, generated from the Customer List through the respective Vice President of Performance Media’s performance marketing is between $175,000 and an amount in excess of $350,000, which First Year Bonus shall vest in two equal equity installments, the first of which occurring on the second anniversary of the issuance thereof and the second of which occurring on the fourth anniversary of the issuance thereof (the “Year 1 Equity Grant”), and (ii) the issuance of up to 67,738 shares of the Company’s common stock (the “Second Year Bonus”) on the 24-month anniversary of the Effective Date if as of such date the net revenue, as defined within the agreement, generated from the Customer List through the respective Vice President of Performance Media’s performance marketing is between $262,000 and an amount in excess of $525,000, which Second Year Bonus shall vest in two equal equity installments, the first of which occurring on the second anniversary of the issuance thereof and the second of which occurring on the fourth anniversary of the issuance thereof (the “Year 2 Equity Grant”).  If either Vice President of Performance Media ends the Term of Employment for good reason, as defined within the agreement, or the Company terminates either Vice President of Performance Media without cause, such Vice President of Performance Media shall (i) receive $150,000 prorated for two months following such termination and for an additional year for every year the Vice President of Performance Media was employed by Company, and (ii) payment of any earned, but unpaid, performance-based performances due as of the date of such termination (“Severance”). The Company determined that the First Year Bonus and Second Year Bonus to each Vice President of Performance Media represents an accounting grant with a performance-based vesting condition pursuant to Accounting Standards Codification 718. The aggregate grant date fair value of the awards of $1,400,822 will be recognized over the respective vesting term for awards that are deemed to be probable to vest.

On November 29, 2021, Mitchell Berg was appointed to serve as its Chief Technology Officer of the Company. Upon joining the Company as Chief Technology Officer, Mr. Berg will receive an annual base salary of $300,000, a restricted stock unit (“RSU”) award of 80,000 shares of common stock of the Company, and a performance stock unit (“PSU”) award of 50,000 shares of common stock of the Company. Mr. Berg will also be eligible to participate in the Company’s Short Term Incentive Plan (“STIP”) and his target bonus pursuant to the STIP will be $100,000. Provided, however that any payout pursuant to the STIP will be determined by the Company and its board of directors or compensation committee, in its discretion, after considering Mr. Berg’s individual performance and the overall performance of the Company’s business. Upon a termination for any reason, Mr. Berg is entitled to any unpaid but accrued portion of his base salary earned through the date of his termination, payment for any accrued but unused vacation pay, any expenses owed to him pursuant to his employment agreement, and any amounts owed under the Company’s benefit plans. In the event Mr. Berg experiences a Covered Termination (as defined in his employment agreement), Mr. Berg shall be entitled to six month’s salary paid in one lump sum, six months continued healthcare coverage, payment of any Annual Bonus (as defined in his employment agreement) earned but that has not been paid and a pro-rata portion of any Annual Bonus earned in the fiscal year in which the Covered Termination takes place, and immediate vesting of any equity awards that would have become vested and exercisable during the three months after his termination. All outstanding RSU awards due to Mr. Berg automatically vest upon a change in control of the Company. The RSU was determined to be granted for accounting purposes on November 29, 2021 under the 2021 Plan and had a grant date fair value $216,800 that will be recognized vesting term. Given that the PSU contains performance conditions that had not been determined as of December 31, 2021, the Company determined that the PSU had not been considered granted for accounting purposes as of December 31, 2021. The PSU was deemed to be granted on January 12, 2022 and both PSU and RSU awards were issued on February 15, 2022.

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.1
CONCENTRATIONS
12 Months Ended
Dec. 31, 2021
CONCENTRATIONS  
CONCENTRATIONS

NOTE 10 — CONCENTRATIONS

Customer Concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:

    

For the Years Ended

 

December 31, 

 

Customer

    

2021

    

2020

 

Customer A

 

85.77

%  

51.40

%

Customer B

 

N/A

26.43

%

Customer C

 

N/A

18.24

%

Customer D

 

11.56

%

N/A

Customer H

N/A

N/A

Customer I

 

N/A

 

*

Total

 

97.33

%  

96.07

%

*

Less than 10%.

From time to time, certain customers generate negative net revenues that resulted from Supplier Costs that exceeded the Gross Billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:

December 31, 

 

Customer

    

2021

    

2020

 

Customer A

 

N/A

 

89.02

%

Customer B

 

22.08

%

N/A

Customer E

 

52.18

%  

N/A

Total

 

74.26

%  

89.02

%

A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.

Supplier Concentrations

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:

    

For the Years Ended

 

December 31, 

 

Supplier

    

2021

    

2019

 

Supplier B

 

N/A

15.51

%

Supplier C

 

N/A

 

N/A

Supplier D

 

N/A

16.32

%

Supplier E

 

42.36

%

N/A

Total

 

42.36

%  

31.83

%

*

Less than 10%.

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2021
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

NOTE 11 – SUBSEQUENT EVENTS

The Company has evaluated events that have occurred after the balance sheet and through the date the financial statements were issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements, except as disclosed below.

Stock-Based Compensation

Subsequent to December 31, 2021, the Company granted 53,192 shares of immediately vested common stock to non-employee directors under the 2021 Plan with an aggregate grant date fair value of $100,000.

Subsequent to December 31, 2021, the Company issued an aggregate of 489,990 RSUs and a target number of 184,376 PSUs, all issued under the 2021 Plan. The RSUs vest ratably over four years and the PSUs are earned based upon based upon actual net revenue generated by the Company during 2022 as compared to the targeted revenue specified in each award. Depending on actual net revenues generated as compared to the targeted amounts, the grantees may earn between 0% and 150% of their target award. The awards had an aggregate issuance date fair value of approximately $1,500,000.

Subsequent to December 31, 2021, the Company’s chief financial officer surrendered to the Company 3,397 shares of common stock in order to satisfy a tax withholding obligation of approximately $18,000 in connection with a previous grant.

Settlement Agreement

On March 11, 2022, the Company, Aureus Holdings, LLC d/b/a Lo70s (“Lo70s”) and JPAR, LLC entered into a Settlement Agreement and Mutual Release (the “Lo70s Settlement Agreement”).  Pursuant to the Lo70s Settlement Agreement, the parties agreed to dismiss the litigation (Aureus Holdings, LLC d/b/a Lo70s v. Kubient, Inc., et al., Superior Court of Delaware, Case No. N20C-07-061) and resolve all claims among them, including potential or future claims arising from the letter of intent that the Company and Lo70s had entered into in March 2019, as well as a consulting agreement entered into between the Company and an employee of Lo70s in connection with such letter of intent. On March 14, 2022, the court in the matter entered an order approving the Lo70s Settlement Agreement, and the case was dismissed with prejudice. In the Lo70s Settlement Agreement, the Company expressly denies any and all liability and the dismissal of the case with prejudice was entered by the court without a final judgment of liability entered against the Company Under the terms of the Lo70s Settlement Agreement, the Company made a cash payment of $975,000 to Lo70s in full satisfaction of the matter, as well as the releases and covenants of Lo70s and JPAR, LLC set forth in the Lo70s Settlement Agreement, such that the Lo70s Settlement Agreement fully concludes this matter. During the year ended December 31, 2021, the Company recognized a loss on settlement of approximately $875,000 such that, as of December 31, 2021, it had accrued for the $975,000 cash payment.

XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.1
SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2021
SIGNIFICANT ACCOUNTING POLICIES  
Basis of Presentation

Basis of Presentation

The accompanying audited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements. Such consolidated financial statements and accompanying notes are the representations of Company’s management, who is responsible for their integrity and objectivity.

Use of Estimates

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s significant estimates used in these financial statements include, but are not limited to, fair value calculations for equity securities, revenue recognition, stock-based compensation,the valuation of intangible assets and contingent consideration, useful lives of intangibles assets, the collectability of receivables and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and may cause actual results to differ from those estimates.

Principles of Consolidation

Principles of Consolidation

The consolidated financial statements of the Company include the accounts of Fidelity Media, LLC (“Fidelity”). All intercompany transactions have been eliminated in the consolidation.

Cash and Cash Equivalents

Cash and Cash Equivalents

The Company maintains cash in bank accounts, which, at times, may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company has not experienced any losses in such accounts. The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2021 and 2020, the Company’s cash and cash equivalents were comprised of demand deposits held in bank accounts.  

Revenue Recognition

Revenue Recognition

The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps:

Identification of a contract with a customer;
Identification of the performance obligations in the contract;
Determination of the transaction price;
Allocation of the transaction price to the performance obligations in the contract; and
Recognition of revenue when or as the performance obligations are satisfied.

The Company maintains a contract with each customer and supplier, which specify the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.

The transaction price is determined based on the consideration to which it expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost.

The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.

As of December 31, 2021 and 2020, the Company did not have any contract assets from contracts with customers. As of December 31, 2021 and 2020, the Company had $395,914 and $15,000, respectively, of contract liabilities where performance obligations have not yet been satisfied. The Company expects to satisfy its remaining performance obligations and recognize the revenue within the next twelve months. During the years ended December 31, 2021 and 2020, there was no revenue was recognized from performance obligations satisfied (or partially satisfied) in previous periods.

Accounts Receivable and Accounts Payable

Accounts Receivable and Accounts Payable

Accounts receivable are carried at their contractual amounts, less an estimate for uncollectible amounts. As of December 31, 2021 and 2020, there was an allowance for uncollectible amounts of $12,149 and $10,209, respectively. Management estimates the allowance for bad debts based on existing economic conditions, the financial conditions of the customers, and the amount and age of past due accounts.

Receivables are considered past due if full payment is not received by the contractual due date. Past due accounts are generally written off against the corresponding accounts payable in the event that the Company’s contract contains sequential liability terms, with the excess receivable being written off against the allowance for bad debts only after all collection attempts have been exhausted.

Accounts receivable are recorded at the amount the Company is responsible to collect from the customer. See Note 2 — Significant Accounting Policies — Revenue Recognition for additional details. In the event that the Company does not collect the Gross Billing amount from the customer, the Company generally is not contractually obligated to pay the associated Supplier Cost.

Convertible Instruments

Convertible Instruments

The Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for in accordance with the Financial Accounting Standards Board (“FASB”) ASC Topic 815 “Derivatives and Hedging” (“ASC 815”). The accounting treatment of derivative financial instruments requires that the Company record embedded conversion options and any related freestanding instruments at their fair values as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded in earnings each period as non-operating, non-cash income or expense. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. Embedded conversion options and any related freestanding instruments are recorded as a discount to the host instrument. The Company allocates proceeds based on the relative fair values of the debt and equity components.

Prior to the adoption of ASU 2020-06, if the instrument is not determined to be a derivative liability, the Company then evaluates for the existence of a beneficial conversion feature by comparing the fair value of the Company’s common stock as of the commitment date to the effective conversion price of the instrument (the intrinsic value). The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital.

Deferred Offering Costs

Deferred Offering Costs

Deferred offering costs, which consist of direct, incremental professional fees incurred in connection with the Company’s future offerings of equity and debt securities that have yet to close, are capitalized as non-current assets on the consolidated balance sheet. Upon the closing of the offering, the deferred offering costs are either (i) charged off against the offering proceeds in connection with an equity offering or (ii) reclassified such that they represent a reduction in the carrying amount of the face value of the debt security.

Property and Equipment

Property and Equipment

Property and equipment are stated at cost, net of accumulated depreciation which is recorded commencing at the in-service date using the straight-line method at rates sufficient to charge the cost of depreciable assets to operations over their estimated useful lives, which is three years. Leasehold improvements are amortized over the lesser of (a) the useful life of the asset; or (b) the remaining lease term. Maintenance and repairs are charged to operations as incurred. The Company capitalizes cost attributable to the betterment of property and equipment when such betterment extends the useful life of the assets.

Intangible Assets

Intangible Assets

Intangible assets are comprised of costs to acquire and develop computer software, including the costs to acquire third-party data which is used to improve the Company’s artificial intelligence platform for client use, as well as costs to acquire customer lists, customer contracts and related customer relationship and restrictive covenant agreements. The intangible assets have estimated useful lives of two years for the computer software, five years for the capitalized data, seven years for the customer lists and three years for the restrictive covenant agreements. Once placed into service, the Company amortizes the cost of the intangible assets over their estimated useful lives on a straight-line basis.

Impairment of Long-lived Assets

Impairment of Long-lived Assets

The Company reviews for the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. An impairment would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. The Company did not record any impairment losses during the years ended December 31, 2021 and 2020.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”).

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:

Level 1 — quoted prices in active markets for identical assets or liabilities

Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable

Level 3 — inputs that are unobservable (for example, cash flow modeling inputs based on assumptions

The carrying amounts of the Company’s financial instruments, such as cash, accounts receivable, accounts payable, convertible notes and notes payable approximate fair value due to the short-term nature of these instruments. The carrying amounts of the Company’s short-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates, are comparable to rates of returns for instruments of similar credit risk.

Software Development Costs

Software Development Costs

The Company develops and utilizes software in connection with its ability to generate customer revenue (which is further explained in Note 2 – Significant Accounting Policies – Revenue Recognition). Costs incurred in this effort are accounted for under the provisions of ASC 985-20, Software – Cost of Software to be Sold, Leased or Marketed, whereby costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. The Company capitalizes subsequent additions, modifications, or upgrades to internally developed software only to the extent that such changes allow the software to perform a task it previously did not perform.

Income Taxes

Income Taxes

The Company is subject to federal and state income taxes in the United States. The Company files income tax returns in the jurisdictions in which nexus threshold requirements are met.

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse.

The Company utilizes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.

The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as general and administrative expenses in the consolidated statements of operations.

Advertising Costs

Advertising Costs

Advertising costs are charged to operations in the year incurred and totaled approximately $270,000 and $101,000 for the years ended December 31, 2021 and 2020, respectively, and are reflected in general and administrative expenses in the consolidated statements of operations.

Stock-Based Compensation

Stock-Based Compensation

The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The Company accrues for any equity awards at fair value that have been contractually earned but not yet issued.

Fair Value of Stock Options and Warrants

Fair Value of Stock Options and Warrants

The Company has computed the fair value of stock options and warrants granted using the Black-Scholes option pricing model. Option forfeitures are accounted for at the time of occurrence. The expected term used for options is the estimated period of time that options granted are expected to be outstanding. The expected term used for warrants is the contractual life. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” option grants. The Company does not currently have a sufficient trading history to support its historical volatility calculations. Accordingly, the Company is utilizing an expected volatility figure based on a review of the historical volatility of comparable entities over a period of time equivalent to the expected life of the instrument being valued. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.

Net Loss Per Common Share

Net Loss Per Common Share

Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive.

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Years Ended

December 31, 

    

2021

    

2020

Stock options

 

94,447

 

118,412

Restricted stock awards

166,489

Restricted stock units

100,000

Warrants [1]

 

5,122,074

 

7,403,722

 

5,483,010

 

7,522,134

[1] During 2021, includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share. During 2020, includes shares underlying warrants that are exercisable into an aggregate of (i) 1,235,977 shares of common stock and (ii) five-year warrants to purchase 1,235,977 shares of common stock at an exercise price of $5.50 per share.

Recently Issued Accounting Standards

Recently Issued Accounting Standards

In February 2016, the FASB issued ASU 2016-02“, “Leases (Topic 842)” (“ASU 2016-02”), as amended, with guidance regarding the accounting for and disclosure of leases. The update requires that a lessee recognize the assets and liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions. In May 2020, the FASB issued ASU 2020-05 that deferred these dates one year for all other entities, including emerging growth companies. This standard is effective for annual reporting periods beginning after December 15, 2021, and interim periods within annual periods beginning after December 15, 2022. Early adoption is permitted. The Company expects to adopt ASU 2016-02 during the fiscal year ending December 31, 2022 and is evaluating the impact on its statements of operations and cash flows. Based upon the leases currently in place, management believes that its current leases will qualify for the practical expedient for leases with terms less than one year, such that there will be no material impact of adopting the new standard on the Company’s consolidated financial statements.

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). In April 2020, the FASB issued clarification to ASU 2016-13 within ASU 2020-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. This guidance is effective for public business entities that meet the definition of a Securities and Exchange Commission filer, excluding eligible smaller reporting companies, for fiscal years beginning after December 15, 2019. For all other entities, including emerging growth companies, it is effective for fiscal years beginning after December 15, 2020. The Company is currently evaluating ASU 2016-13 and its impact on its consolidated financial statements and disclosures.

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This update for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted, including adoption in any interim period for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The Company adopted ASU 2019-12 effective January 1, 2022 and its adoption did not have a material impact on the Company’s consolidated financial statements and disclosures.

In August 2020, the FASB issued ASU 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”) which simplifies the accounting for convertible instruments by eliminating certain accounting models when the conversion features are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in-capital. Under this ASU, certain debt instruments with embedded conversion features will be accounted for as a single liability measured at its amortized cost. Additionally, this ASU eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments. The new guidance is effective for annual periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company adopted ASU 2020-06 effective January 1, 2022 which eliminated the need to assess whether a beneficial conversion feature needed to be recognized upon either (a) the future issuance of new convertible notes; or (b) the resolution of any contingent beneficial conversion features.

In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). This new standard provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Issuers should apply the new standard prospectively to modifications or exchanges occurring after the effective date of the new standard. Early adoption is permitted, including adoption in an interim period. If an issuer elects to early adopt the new standard in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The Company adopted ASU 2021-04 effective January 1, 2022 such adoption did not have a material impact on the Company’s consolidated financial statements or disclosures.

In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805)” (“ASU 2021-08”). The ASU improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. The update is effective for annual and interim periods within the fiscal year beginning after December 15, 2022, and early adoption is permitted, including adoption in an interim period. The Company is evaluating this new standard and its impact on its consolidated financial statements and related disclosures.

XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2021
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of calculation of weighted average dilutive common shares

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Years Ended

December 31, 

    

2021

    

2020

Stock options

 

94,447

 

118,412

Restricted stock awards

166,489

Restricted stock units

100,000

Warrants [1]

 

5,122,074

 

7,403,722

 

5,483,010

 

7,522,134

[1] During 2021, includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share. During 2020, includes shares underlying warrants that are exercisable into an aggregate of (i) 1,235,977 shares of common stock and (ii) five-year warrants to purchase 1,235,977 shares of common stock at an exercise price of $5.50 per share.

XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS COMBINATION (Tables)
12 Months Ended
Dec. 31, 2021
Business Acquisition [Line Items]  
Schedule of Recognized identified assets acquired and liabilities asumed

Purchase Consideration:

    

  

Cash

 

$

500,000

Contingent consideration

 

 

613,000

Total Purchase Consideration

 

 

1,113,000

Less:

 

 

  

Customer contracts and related customer relationships (1)

 

 

580,000

Restrictive covenant agreements (1)

 

 

70,000

Debt-free net working capital

 

 

Fair Value of Identified Net Assets

 

 

650,000

Remaining Unidentified Goodwill Value

$

463,000

(1)As part of the preliminary valuation analysis, the Company identified (i) customer contracts and related customer relationships and (ii) restrictive covenant agreements as intangible assets. The fair value of the identifiable intangible assets is determined using the “income approach”. The customer contracts and related customer relationships have an estimated useful life of five (5) years and the restrictive covenant agreements have an estimated useful life of three (3) years.
Schedule of Components of debt free net working capital deficit

Current Assets:

    

  

Prepaid expenses and other current assets

$

109,083

Other receivables

 

526,070

Total Current Assets

 

635,153

Current Liabilities:

 

  

Deferred revenue

 

628,418

Accrued expenses and other current liabilities

 

6,735

Total Current Liabilities

 

635,153

Debt-Free Net Working Capital

$

MediaCrossing Inc [Member]  
Business Acquisition [Line Items]  
Schedule of Business acquisition, Pro Forma information

    

For the Years Ended

December 31, 

2021

    

2020

Net Revenues

$

5,439,093

$

7,527,651

Net Loss

$

(12,510,391)

$

(9,032,939)

XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS (Tables)
12 Months Ended
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]  
Schedule of Intangible assets

Intangible assets consist of the following:

    

December 31, 

    

2021

    

2020

Acquired data

$

1,300,336

$

1,300,336

Acquired software

 

183,072

 

100,000

Acquired customer lists

 

2,162,000

 

Restrictive covenant agreements

70,000

3,715,408

1,400,336

Less: accumulated amortization

 

(768,798)

 

(328,486)

Intangible assets, net

$

2,946,610

$

1,071,850

Schedule of estimated future amortization expense

The estimated future amortization expense is as follows:

For the Years Ending December 31,

    

Total

2022

$

718,601

2023

 

706,206

2024

 

683,192

2025

 

270,194

2026 and beyond

 

568,417

$

2,946,610

Customer list  
Finite-Lived Intangible Assets [Line Items]  
Schedule of Amortization of intangible assets consists

Amortization of intangible assets consists of the following:

    

    

    

Acquired 

    

Restrictive 

    

    

Acquired 

Acquired 

Customer 

Covenant 

Accumulated 

Data

Software

Lists

Agreements

Amortization

Total

Balance as of January 1, 2020

$

$

100,000

$

$

$

(16,667)

$

83,333

Additions

 

1,300,336

 

 

 

 

 

1,300,336

Amortization expense

 

 

 

 

 

(311,819)

 

(311,819)

Balance as of December 31, 2020

 

1,300,336

 

100,000

 

 

 

(328,486)

 

1,071,850

Additions

 

 

83,072

 

2,162,000

 

70,000

 

 

2,315,072

Amortization expense

 

 

 

 

 

(440,312)

 

(440,312)

Balance as of December 31, 2021

$

1,300,336

$

183,072

$

2,162,000

$

70,000

$

(768,798)

$

2,946,610

Weighted average remaining amortization period at December 31, 2021 (in years)

 

3.0

 

1.0

 

5.5

 

4.9

 

4.4

 

  

    

    

    

Acquired 

    

Restrictive

    

Acquired 

Acquired 

Customer

 Covenant 

Accumulated 

Data

Software

 Lists

Agreements

Amortization

Balance as of January 1, 2020

$

$

16,667

$

$

$

16,667

Amortization expense

 

261,819

 

50,000

 

 

 

311,819

Balance as of December 31, 2020

 

261,819

 

66,667

 

 

 

328,486

Amortization expense

 

252,081

 

48,538

 

138,528

 

1,165

 

440,312

Balance as of December 31, 2021

$

513,900

$

115,205

$

138,528

$

1,165

$

768,798

XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.1
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)
12 Months Ended
Dec. 31, 2021
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES  
Schedule of accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following:

    

December 31, 

    

2021

    

2020

Accrued bonuses

$

554,997

$

541,834

Accrued payroll

13,750

Accrued payroll taxes

 

 

5,947

Financed director and officer insurance premiums

217,575

Accrued supplier expenses

 

1,042,971

 

50,972

Accrued legal and professional fees

 

20,323

 

80,653

Accrued commissions

 

36,109

 

2,768

Accrued media commissions

138,028

Credit card payable

328,075

901

Accrued programming expenses

 

1,750

 

16,750

Accrued issuable equity

 

1,258

 

293,724

Accrued interest

 

9,017

 

3,975

Accrued warrant exercise costs

83,519

Other

 

45,915

 

19,758

Total accrued expenses and other current liabilities

$

2,493,287

$

1,017,282

XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2021
INCOME TAXES  
Schedule of provision for income taxes

    

For the Years Ended

December 31,

    

2021

    

2020

Deferred tax benefit:

  

 

  

Federal

$

(2,183,635)

$

(132,480)

State and local

 

(978,739)

 

(641,793)

 

(3,162,374)

 

(774,273)

Change in valuation allowance

 

3,162,374

 

774,273

Provision for income taxes

$

$

Schedule of provision for income taxes differs from the statutory federal income tax rates

    

For the Years Ended

 

 December 31,

    

2021

    

2020

 

Tax expense at the federal statutory rate

21.0

%  

21.0

%

State taxes, net of federal benefit

8.7

%  

3.5

%

Permanent differences

(0.2)

%  

(10.3)

%

True-up

1.2

%  

(4.4)

%

Change in valuation allowance

(30.7)

%  

(9.8)

%

Effective income tax rate

0.0

%  

0.0

%

Schedule of components of deferred tax assets relate to temporary differences and carryforwards

    

December 31,

    

2021

    

2020

Net operating loss carryforwards

$

5,383,659

$

2,702,003

Stock-based compensation expense

 

169,427

 

102,409

Deferred Revenue

7,972

Accrued Legal Settlement

290,948

Other reserve

 

59,682

 

55,699

Intangibles

 

211,651

 

68,733

Tax credits

 

90,952

 

90,952

Deferred tax assets

 

6,214,291

 

3,019,796

Fixed assets

 

(36,902)

 

(4,781)

Deferred tax liabilities

 

(36,902)

 

(4,781)

Valuation allowance

 

(6,177,389)

 

(3,015,015)

Deferred tax assets, net

$

$

XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2021
STOCKHOLDERS' EQUITY  
Schedule of stock based compensation expense related to stock options and common stock

    

For the Years Ended

December 31, 

    

2021

    

2020

Sales and marketing

$

270,460

$

54,723

Technology

 

31,631

 

13,891

General and administrative

 

421,951

 

399,602

Total

$

724,042

$

468,216

Summary of Black-Scholes Pricing Model Stock Options

    

For the Years Ended

 

December 31, 

 

 

2021

    

2020

Expected term (years)

 

N/A

6.08

Expected volatility

 

N/A

55.8%-56.3%

Risk free interest rate

 

N/A

0.57%-1.65%

Expected dividends

 

N/A

0.00%

Summary of stock option activity

A summary of the Company’s stock option activity during the year ended December 31, 2021 is as follows:

    

    

    

Weighted Average

    

Number

Weighted Average

Remaining Term 

Intrinsic

    

of Options

    

Exercise Price

    

(Years)

    

Value

Outstanding at January 1,2021

 

118,412

$

15.22

 

  

 

  

Granted

 

 

 

  

 

  

Forfeited

 

(21,150)

 

33.16

 

  

 

  

Exercised

 

(2,815)

 

2.97

 

  

 

  

Outstanding at December 31, 2021

 

94,447

$

11.56

 

4.4

$

6,339

Exercisable at December 31, 2021

 

66,240

$

9.49

 

2.9

$

3,276

Summary of stock option exercise price

The following table presents information related to stock options as of December 31, 2021:

Options Outstanding

    

Options Exercisable

Weighted

Outstanding

Average

Exercisable

Number of

Remaining Life

Number of

Exercise Price

    

Options

    

In Years

    

Options

$

2.81

 

20,000

 

8.9

 

5,416

$

2.97

 

42,779

 

0.7

 

42,779

$

4.95

 

5,556

 

0.9

 

4,255

$

33.75

 

26,112

 

7.8

 

13,790

 

94,447

 

2.9

 

66,240

Summary of assumptions fair value of warrants

    

For the Years Ended

 

December 31, 

 

2021

    

2020

 

Expected term (years)

 

N/A

3.86-4.75

Expected volatility

 

N/A

58.0%-61.2%

Risk free interest rate

 

N/A

0.24%-0.39%

Expected dividends

 

N/A

0.00%

Summary of the warrant activity

    

    

    

    

Weighted

    

    

Weighted

Average

Average

Remaining

Number of

Exercise

Life

Intrinsic

    

Warrants

    

Price

    

In Years

    

Value

Outstanding, January 1, 2021

 

6,167,745

$

5.26

 

  

 

  

Issued

 

867,286

 

5.50

 

  

 

  

Exercised

 

(2,281,668)

 

5.04

 

  

 

  

Expired

 

 

 

  

 

  

Outstanding, December 31, 2021[1]

 

4,753,363

$

5.42

 

3.5

$

Exercisable, December 31, 2021

 

4,753,363

$

5.35

 

3.5

$

[1] Excludes five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share that are issuable upon exercise of certain warrants.

Summary of stock warrants

The following table presents information related to stock warrants as of December 31, 2021:

Warrants Outstanding

    

Warrants Exercisable

Weighted

Outstanding

Average

Exercisable

Number of

Remaining Life

Number of

Exercise Price

Warrants

In Years

    

Warrants

$

4.20

 

368,711

 

2.7

 

368,711

$

4.95

 

177,223

 

1.3

 

177,223

$

5.50

 

3,998,459

 

3.7

 

3,998,459

$

6.25

 

32,500

 

3.6

 

32,500

$

6.38

 

176,470

 

4.0

 

176,470

 

4,753,363

 

3.5

 

4,753,363

XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.1
CONCENTRATIONS (Tables)
12 Months Ended
Dec. 31, 2021
CONCENTRATIONS  
Summary of customer and supplier concentrations

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:

    

For the Years Ended

 

December 31, 

 

Customer

    

2021

    

2020

 

Customer A

 

85.77

%  

51.40

%

Customer B

 

N/A

26.43

%

Customer C

 

N/A

18.24

%

Customer D

 

11.56

%

N/A

Customer H

N/A

N/A

Customer I

 

N/A

 

*

Total

 

97.33

%  

96.07

%

*

Less than 10%.

The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:

December 31, 

 

Customer

    

2021

    

2020

 

Customer A

 

N/A

 

89.02

%

Customer B

 

22.08

%

N/A

Customer E

 

52.18

%  

N/A

Total

 

74.26

%  

89.02

%

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:

    

For the Years Ended

 

December 31, 

 

Supplier

    

2021

    

2019

 

Supplier B

 

N/A

15.51

%

Supplier C

 

N/A

 

N/A

Supplier D

 

N/A

16.32

%

Supplier E

 

42.36

%

N/A

Total

 

42.36

%  

31.83

%

*

Less than 10%.

XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.1
SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Disaggregation of Revenue [Line Items]    
Contract liabilities $ 395,914 $ 15,000
Minimum    
Disaggregation of Revenue [Line Items]    
Invoice payment terms 45 days  
Maximum    
Disaggregation of Revenue [Line Items]    
Invoice payment terms 90 days  
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.1
SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Revenue recognized from performance obligations satisfied $ 0 $ 0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]    
Revenue recognized from performance obligations satisfaction period 12 months  
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.1
SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable and Accounts Payable (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
SIGNIFICANT ACCOUNTING POLICIES    
Allowance for uncollectible accounts receivable $ 12,149 $ 10,209
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.22.1
SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details)
12 Months Ended
Dec. 31, 2021
SIGNIFICANT ACCOUNTING POLICIES  
Property and equipment estimated useful lives 3 years
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.1
SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets (Details)
12 Months Ended
Dec. 31, 2021
Computer software  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful lives, Intangible assets 2 years
Capitalized Software  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful lives, Intangible assets 5 years
Customer list  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful lives, Intangible assets 7 years
Restrictive covenant agreements  
Finite-Lived Intangible Assets [Line Items]  
Estimated useful lives, Intangible assets 3 years
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.1
SIGNIFICANT ACCOUNTING POLICIES - Advertising Costs (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
SIGNIFICANT ACCOUNTING POLICIES    
Advertising Expense $ 270,000 $ 101,000
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.1
SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Aug. 14, 2020
Net Loss Per Common Share      
Shares excluded from the calculation of weighted average dilutive common shares 5,483,010 7,522,134  
Number of warrants exercisable (in shares) 368,711 1,235,977  
Warrants term (in years) 5 years 5 years 5 years
Warrants to purchase shares of common stock 368,711 1,235,977  
Exercise price of warrants (in dollars per share) $ 5.50 $ 5.50 $ 5.50
Stock options      
Net Loss Per Common Share      
Shares excluded from the calculation of weighted average dilutive common shares 94,447 118,412  
Restricted stock awards      
Net Loss Per Common Share      
Shares excluded from the calculation of weighted average dilutive common shares 166,489    
Restricted stock units (RSUs)      
Net Loss Per Common Share      
Shares excluded from the calculation of weighted average dilutive common shares 100,000    
Warrants      
Net Loss Per Common Share      
Shares excluded from the calculation of weighted average dilutive common shares 5,122,074 7,403,722  
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS COMBINATION - Purchase consideration (Details) - USD ($)
1 Months Ended
Nov. 30, 2021
Nov. 30, 2021
Dec. 31, 2021
Business Acquisition [Line Items]      
Contingent consideration     $ 613,000
Remaining Unidentified Goodwill Value     $ 463,000
MediaCrossing Inc      
Business Acquisition [Line Items]      
Cash consideration $ 500,000 $ 500,000  
Contingent consideration 613,000 613,000  
Total purchase consideration 1,113,000    
Fair Value of Identified Net Assets 650,000 650,000  
Remaining Unidentified Goodwill Value 463,000 463,000  
MediaCrossing Inc | Customer contracts and related customer relationships      
Business Acquisition [Line Items]      
Intangible assets $ 580,000 580,000  
Estimated useful lives, Intangible assets 5 years    
MediaCrossing Inc | Restrictive covenant agreements      
Business Acquisition [Line Items]      
Intangible assets $ 70,000 $ 70,000  
Estimated useful lives, Intangible assets 3 years    
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS COMBINATION - Debt-free net working capital (Details) - MediaCrossing Inc
Nov. 30, 2021
USD ($)
Current Assets:  
Prepaid expenses and other current assets $ 109,083
Other receivables 526,070
Total Current Assets 635,153
Current Liabilities:  
Deferred revenue 628,418
Accrued expenses and other current liabilities 6,735
Total Current Liabilities $ 635,153
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS COMBINATION - Pro Forma Information (Details) - MediaCrossing Inc [Member] - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]    
Net Revenues $ 5,439,093 $ 7,527,651
Net Loss $ (12,510,391) $ (9,032,939)
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.1
BUSINESS COMBINATION - Additional information (Details) - USD ($)
1 Months Ended 12 Months Ended
Nov. 30, 2021
Dec. 31, 2021
Nov. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]          
Common stock, par value   $ 0.00001   $ 0.00001 $ 0.00001
Net loss       $ (10,291,713) $ (7,885,660)
MediaCrossing Inc [Member]          
Business Acquisition [Line Items]          
Cash consideration $ 500,000   $ 500,000    
Share price $ 2.55   $ 2.55    
Business acquisition, Number of shares issued 822,369        
Common stock, par value $ 0.00001   $ 0.00001    
Revenue   $ 154,954      
Net loss   $ 18,447      
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS (Details) - USD ($)
12 Months Ended
Jun. 04, 2021
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]      
Intangible asset   $ 2,946,610 $ 1,071,850
Customer list      
Finite-Lived Intangible Assets [Line Items]      
Estimated useful lives, Intangible assets   7 years  
Advisio Solutions, LLC      
Finite-Lived Intangible Assets [Line Items]      
Cash consideration $ 1,050,000    
Aggregate shares of common stock shares issued as a part of consideration 100,000    
Fair value of common stock issued as a part of consideration $ 532,000    
Advisio Solutions, LLC | Customer list      
Finite-Lived Intangible Assets [Line Items]      
Intangible asset $ 1,582,000    
Estimated useful lives, Intangible assets 7 years    
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS - Intangible assets consist (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross $ 3,715,408 $ 1,400,336  
Less: accumulated amortization (768,798) (328,486)  
Intangible assets, net 2,946,610 1,071,850 $ 83,333
Acquired data      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 1,300,336 1,300,336 0
Less: accumulated amortization (513,900) (261,819)  
Acquired software      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 183,072 100,000 100,000
Less: accumulated amortization (115,205) $ (66,667) (16,667)
Customer list      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 2,162,000   0
Less: accumulated amortization (138,528)    
Restrictive covenant agreements      
Finite-Lived Intangible Assets [Line Items]      
Intangible assets, gross 70,000   $ 0
Less: accumulated amortization $ (1,165)    
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS - Amortization of intangible assets consists (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Finite-lived Intangible Assets [Roll Forward]    
Finite-Lived Intangible Assets, Gross, Beginning Balance $ 1,400,336  
Finite-Lived Intangible Assets, Net, Beginning Balance 1,071,850 $ 83,333
Finite-Lived Intangible Assets, Accumulated Amortization, Beginning Balance 328,486  
Additions 2,315,072 1,300,336
Amortization expense 440,312 311,819
Finite-Lived Intangible Assets, Gross, Ending Balance 3,715,408 1,400,336
Finite-Lived Intangible Assets, Net, Ending Balance 2,946,610 1,071,850
Finite-Lived Intangible Assets, Accumulated Amortization, Ending Balance 768,798 328,486
Acquired data    
Finite-lived Intangible Assets [Roll Forward]    
Finite-Lived Intangible Assets, Gross, Beginning Balance 1,300,336 0
Finite-Lived Intangible Assets, Accumulated Amortization, Beginning Balance 261,819  
Additions   1,300,336
Amortization expense $ 252,081 261,819
Weighted average remaining amortization period 3 years  
Finite-Lived Intangible Assets, Gross, Ending Balance $ 1,300,336 1,300,336
Finite-Lived Intangible Assets, Accumulated Amortization, Ending Balance 513,900 261,819
Acquired software    
Finite-lived Intangible Assets [Roll Forward]    
Finite-Lived Intangible Assets, Gross, Beginning Balance 100,000 100,000
Finite-Lived Intangible Assets, Accumulated Amortization, Beginning Balance 66,667 16,667
Additions 83,072  
Amortization expense $ 48,538 50,000
Weighted average remaining amortization period 1 year  
Finite-Lived Intangible Assets, Gross, Ending Balance $ 183,072 100,000
Finite-Lived Intangible Assets, Accumulated Amortization, Ending Balance 115,205 66,667
Customer list    
Finite-lived Intangible Assets [Roll Forward]    
Finite-Lived Intangible Assets, Gross, Beginning Balance   0
Additions 2,162,000  
Amortization expense $ 138,528  
Weighted average remaining amortization period 5 years 6 months  
Finite-Lived Intangible Assets, Gross, Ending Balance $ 2,162,000  
Finite-Lived Intangible Assets, Accumulated Amortization, Ending Balance 138,528  
Restrictive covenant agreements    
Finite-lived Intangible Assets [Roll Forward]    
Finite-Lived Intangible Assets, Gross, Beginning Balance   0
Additions 70,000  
Amortization expense $ 1,165  
Weighted average remaining amortization period 4 years 10 months 24 days  
Finite-Lived Intangible Assets, Gross, Ending Balance $ 70,000  
Finite-Lived Intangible Assets, Accumulated Amortization, Ending Balance 1,165  
Accumulated Amortization    
Finite-lived Intangible Assets [Roll Forward]    
Finite-Lived Intangible Assets, Accumulated Amortization, Beginning Balance (328,486) (16,667)
Amortization expense $ 440,312 311,819
Weighted average remaining amortization period 4 years 4 months 24 days  
Finite-Lived Intangible Assets, Accumulated Amortization, Ending Balance $ (768,798) $ (328,486)
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.22.1
INTANGIBLE ASSETS - Future amortization expense (Details)
Dec. 31, 2021
USD ($)
Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]  
2022 $ 718,601
2023 706,206
2024 683,192
2025 270,194
2026 and beyond $ 568,417
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.22.1
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES    
Accrued bonuses $ 554,997 $ 541,834
Accrued payroll 13,750  
Accrued payroll taxes   5,947
Financed director and officer insurance premiums 217,575  
Accrued supplier expenses 1,042,971 50,972
Accrued legal and professional fees 20,323 80,653
Accrued commissions 36,109 2,768
Accrued media commissions 138,028  
Credit card payable 328,075 901
Accrued programming expenses 1,750 16,750
Accrued issuable equity 1,258 293,724
Accrued interest 9,017 3,975
Accrued warrant exercise costs 83,519  
Other 45,915 19,758
Total accrued expenses and other current liabilities $ 2,493,287 $ 1,017,282
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES - Provision for income taxes (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Deferred tax benefit:    
Federal $ (2,183,635) $ (132,480)
State and local (978,739) (641,793)
Total (3,162,374) (774,273)
Change in valuation allowance $ 3,162,374 $ 774,273
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES - Statutory federal income tax rates (Details)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Effective Income Tax Rate Reconciliation, Percent [Abstract]    
Tax expense at the federal statutory rate 21.00% 21.00%
State taxes, net of federal benefit 8.70% 3.50%
Permanent differences (0.20%) (10.30%)
True-up 1.20% (4.40%)
Change in valuation allowance (30.70%) (9.80%)
Effective income tax rate 0.00% 0.00%
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES - Deferred tax assets relate to temporary differences and carryforwards (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Deferred Tax Assets, Net [Abstract]    
Net operating loss carryforwards $ 5,383,659 $ 2,702,003
Stock-based compensation expense 169,427 102,409
Deferred Revenue 7,972  
Accrued Legal Settlement 290,948  
Other reserve 59,682 55,699
Intangibles 211,651 68,733
Tax credits 90,952 90,952
Deferred tax assets 6,214,291 3,019,796
Fixed assets (36,902) (4,781)
Deferred tax liabilities (36,902) (4,781)
Valuation allowance $ (6,177,389) $ (3,015,015)
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAXES - (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
INCOME TAXES    
Federal net operating loss ("NOL") carryforwards $ 18,263,000  
Federal net operating losses, have expiration 533,000  
Federal net operating losses, have no expiration 17,730,000  
Federal research and development credit carryforwards 91,000  
State and local NOLs 29,016,000  
Increased the valuation allowance 3,162,374 $ 774,273
Tax related interest or penalties $ 0 $ 0
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.22.1
NOTES PAYABLE - (Details)
12 Months Ended
Aug. 14, 2020
USD ($)
Jun. 23, 2020
USD ($)
Apr. 06, 2020
USD ($)
Dec. 31, 2021
USD ($)
item
Dec. 31, 2020
USD ($)
Jul. 28, 2020
Debt Instrument [Line Items]            
Notes payable past due and classified as current       $ 9,017 $ 4,599  
Interest expense       8,383 207,092  
Non-cash amortization of debt discount and debt issuance costs       0 915,994  
Accrued interest       9,017 3,975  
Interest expense - related parties       0 46,171  
Non-cash amortization of debt discount and debt issuance costs - related parties       0 357,201  
Proceeds from notes payable         406,190  
Notes Payable, Current       $ 151,336 $ 218,461  
Warrants term (in years) 5 years     5 years 5 years  
Principal amount of notes payable converted to common stock $ 4,326,000          
Gross Proceeds From Convertible Notes Payable and Investor Warrants       $ 12,503,750    
Warrants            
Debt Instrument [Line Items]            
Warrants term (in years) 5 years          
Paycheck Protection Program Loan            
Debt Instrument [Line Items]            
Proceeds from notes payable     $ 327,000      
Outstanding PPP loan       149,843 $ 327,290  
Interest on related party notes payable     0.98%      
EIDL Loan            
Debt Instrument [Line Items]            
Principal amount of debt   $ 79,000        
Notes Payable, Current   $ 78,900        
Interest rate (as a percent)   3.75%        
Periodic installment amount   $ 385        
Grant under EIDL Loan            
Debt Instrument [Line Items]            
Principal amount of secured debt       10,000    
Notes Payable - Related Parties            
Debt Instrument [Line Items]            
Aggregate proceeds from related party notes payable       685,000    
Proceeds from repayment of notes payable       $ 0 150,000  
Term of the debt       3 years    
Number of executives to whom notes payable were issued | item       3    
Notes Payable - Related Parties | Minimum            
Debt Instrument [Line Items]            
Interest rate (as a percent)       0.91%    
Notes Payable - Related Parties | Maximum            
Debt Instrument [Line Items]            
Interest rate (as a percent)       1.60%    
Convertible notes            
Debt Instrument [Line Items]            
Proceeds from repayment of notes payable       $ 177,347 $ 95,000  
Holders of notes payable            
Debt Instrument [Line Items]            
Warrants term (in years) 5 years          
Chief Executive Officer            
Debt Instrument [Line Items]            
Interest on related party notes payable           0.17%
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.22.1
NOTES PAYABLE - Note Payable to Related Parties (Details) - USD ($)
12 Months Ended
Aug. 14, 2020
Jul. 28, 2020
Dec. 31, 2021
Dec. 31, 2020
Debt Instrument [Line Items]        
Accrued interest of notes payable converted to common stock $ 304,090      
Warrants to purchase shares of common stock 1,322,881   368,711  
Warrants term (in years) 5 years   5 years 5 years
Number of shares of common stock issued upon conversion 1,322,881      
Exercise price of warrants (in dollars per share) $ 5.50   $ 5.50 $ 5.50
Proceeds in connection with note payable       $ 835,000
IPO        
Debt Instrument [Line Items]        
Net Proceeds From Issuance Of Units $ 10,600,000      
Warrants term (in years) 5 years      
Exercise price of warrants (in dollars per share) $ 5.50      
Holders of notes payable        
Debt Instrument [Line Items]        
Accrued interest of notes payable converted to common stock $ 6,048      
Warrants to purchase shares of common stock 138,209      
Warrants term (in years) 5 years      
Number of shares of common stock issued upon conversion 138,209      
Exercise price of warrants (in dollars per share) $ 5.50      
Chief Executive Officer        
Debt Instrument [Line Items]        
Interest on related party notes payable   0.17%    
Proceeds in connection with note payable   $ 150,000    
Executive Officer        
Debt Instrument [Line Items]        
Proceeds in connection with note payable       $ 29,000
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.22.1
NOTES PAYABLE - Convertible Notes Payable (Details) - USD ($)
12 Months Ended
Aug. 14, 2020
Aug. 12, 2020
Dec. 31, 2021
Dec. 31, 2020
Jul. 28, 2020
Jun. 23, 2020
Apr. 06, 2020
Debt Instrument [Line Items]              
Conversion price $ 3.50            
Number of shares of common stock issued upon conversion 1,322,881            
Warrants term (in years) 5 years   5 years 5 years      
Gross Proceeds From Convertible Notes Payable and Investor Warrants     $ 12,503,750        
Warrants to purchase shares of common stock 1,322,881   368,711        
Exercise price of warrants (in dollars per share) $ 5.50   $ 5.50 $ 5.50      
Aggregate principal balance $ 4,326,000            
Aggregate accrued interest 304,090            
Expense in associated with recognition of a beneficial conversion feature 2,400,000            
Beneficial conversion feature 1,984,322            
Unamortized debt discount $ 393,959            
Deemed dividend related to warrant down round adjustment       $ 1,682,000      
Extinguishment loss on convertible note payable       $ (297,272)      
Convertible notes              
Debt Instrument [Line Items]              
Conversion price $ 4.95 $ 0.29          
Number of shares of common stock issued upon conversion 13,637 80,586          
Aggregate principal balance $ 45,000 $ 20,000          
Aggregate accrued interest $ 22,502 3,370          
Extinguishment loss on convertible note payable   $ 297,272          
Warrants              
Debt Instrument [Line Items]              
Conversion price $ 4.20            
Number of shares of common stock issued upon conversion 1,235,997            
Warrants term (in years) 5 years            
Warrants to purchase shares of common stock 1,235,997            
Exercise price of warrants (in dollars per share) $ 5.50            
Holders of notes payable              
Debt Instrument [Line Items]              
Number of shares of common stock issued upon conversion 138,209            
Warrants term (in years) 5 years            
Warrants to purchase shares of common stock 138,209            
Exercise price of warrants (in dollars per share) $ 5.50            
Aggregate accrued interest $ 6,048            
Chief Executive Officer              
Debt Instrument [Line Items]              
Effective Percentage         0.17%    
Paycheck Protection Program Loan              
Debt Instrument [Line Items]              
Effective Percentage             0.98%
EIDL Loan              
Debt Instrument [Line Items]              
Interest rate (as a percent)           3.75%  
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY (Details)
3 Months Ended 12 Months Ended
Nov. 09, 2021
$ / shares
shares
Dec. 28, 2020
USD ($)
$ / shares
shares
Aug. 14, 2020
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
item
shares
Mar. 31, 2021
USD ($)
item
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
item
$ / shares
shares
Nov. 09, 2020
$ / shares
shares
Class of Stock [Line Items]                  
Common Stock, Shares Authorized       95,000,000     95,000,000 95,000,000  
Common Stock, Par or Stated Value Per Share | $ / shares       $ 0.00001     $ 0.00001 $ 0.00001  
Preferred Stock, Shares Authorized       5,000,000     5,000,000 5,000,000  
Preferred stock, par value | $ / shares       $ 0.00001     $ 0.00001 $ 0.00001  
Common Stock, Voting Rights             one vote per share    
Gross Proceeds from Issuance Initial Public Offering | $             $ 10,169,027 $ 12,503,750  
Proceeds from sale of common stock and warrants in initial public offering, net [2] | $ [1]               $ 11,503,488  
Term of warrants     5 years 5 years     5 years 5 years  
Exercise price of warrants issued | $ / shares     $ 5.50 $ 5.50     $ 5.50 $ 5.50  
Common stock aggregate issuance date fair value | $             $ 993,047 $ 154,922  
Common stock, shares issued       14,253,948     14,253,948 11,756,109  
Proceeds from exercise of stock options | $             $ 8,361    
Stock-based compensation expense | $             724,042 $ 468,216  
Unrecognized stock-based compensation expense | $       $ 875,000     $ 875,000    
Unrecognized stock-based compensation expense, period of recognition             2 years 3 months 18 days    
Warrants exercised             (2,281,668)    
Exercise price of warrants exercised | $ / shares             $ 5.04    
Issuance costs from exercise of warrants | $             $ 381,878 1,898,005  
2017 Stock Option Plan                  
Class of Stock [Line Items]                  
Number of warrant to purchase share of common stock per unit             2,815    
Exercise price of warrants issued | $ / shares       $ 2.97     $ 2.97    
Share Price | $ / shares       $ 8,361     $ 8,361    
2017 Equity Incentive Plan                  
Class of Stock [Line Items]                  
Term of warrants                 10 years
Exercise price of warrants issued | $ / shares                 $ 2.81
Warrants to purchase shares of common stock                 20,000
Common stock aggregate issuance date fair value | $               32,981  
Share Price | $ / shares $ 1.31                
Vesting period 4 years                
Vesting (Shares) 5,000                
Remaining shares vested 15,000                
Remaining vesting period 3 years                
Stock Options                  
Class of Stock [Line Items]                  
Common stock issued upon exercise of options (in shares)             2,815    
Exercise price | $ / shares             $ 2.97    
Board of Directors                  
Class of Stock [Line Items]                  
Common stock aggregate issuance date fair value | $       $ 3,282          
Number of shares issued under share based compensation plan       1,062          
2017 Plan                  
Class of Stock [Line Items]                  
Common stock, shares issued       333,334     333,334    
Common stock reserved       11,889     11,889    
Number of shares issued under share based compensation plan           10,000      
2017 Plan | Board of Directors                  
Class of Stock [Line Items]                  
Common stock aggregate issuance date fair value | $           $ 60,120      
Number of member of board of directors to whom shares were issued | item           4      
Number of shares issued under share based compensation plan           20,040      
2017 Plan | Service Providers                  
Class of Stock [Line Items]                  
Common stock aggregate issuance date fair value | $           $ 500,400   $ 107,503  
Number of shares issued under share based compensation plan           50,000   38,433  
2017 Plan | Employees                  
Class of Stock [Line Items]                  
Common stock aggregate issuance date fair value | $         $ 963,701        
Number of employees in a share based compensation plan | item         6     3  
Number of shares issued under share based compensation plan         167,600        
2017 Plan | Employees | Tranche one                  
Class of Stock [Line Items]                  
Common stock aggregate issuance date fair value | $         $ 957,313        
Vesting period         1 year        
2017 Plan | Employees | Trance two                  
Class of Stock [Line Items]                  
Common stock aggregate issuance date fair value | $         $ 6,388        
2017 Plan | Non-employees                  
Class of Stock [Line Items]                  
Number of employees in a share based compensation plan | item               2  
2021 Plan                  
Class of Stock [Line Items]                  
Common stock, shares issued       1,500,000     1,500,000    
Common stock reserved       1,400,000     1,400,000    
IPO                  
Class of Stock [Line Items]                  
Common Stock, Par or Stated Value Per Share | $ / shares     $ 0.00001            
Number of units issued     2,500,000            
Price per unit | $ / shares     $ 5.00            
Gross Proceeds from Issuance Initial Public Offering | $   $ 20,700,000 $ 12,500,000            
Proceeds from sale of common stock and warrants in initial public offering, net [2] | $     $ 10,600,000            
Number of warrant to purchase share of common stock per unit     1            
Number of shares per warrant     1            
Term of warrants     5 years            
Exercise price of warrants issued | $ / shares     $ 5.50            
Warrants to purchase shares of common stock     125,000            
Price per warrant | $ / shares     $ 6.25            
Common stock aggregate issuance date fair value | $     $ 225,850            
Common stock, shares issued   4,058,822              
Share Price | $ / shares   $ 5.10              
Net Proceeds From Issuance Initial Public Offering | $   $ 18,900,000              
Over-allotment option                  
Class of Stock [Line Items]                  
Warrants to purchase shares of common stock     375,000            
Price per warrant | $ / shares     $ 0.01            
Aggregate proceeds from issuance of warrants | $     $ 3,750            
Share Price | $ / shares   $ 5.10              
Additional Shares Of Common Stock Acquired   529,411              
Underwriters                  
Class of Stock [Line Items]                  
Number of warrant to purchase share of common stock per unit   176,470              
Term of warrants   4 years 6 months              
Exercise price of warrants issued | $ / shares   $ 6.38              
Aggregate proceeds from issuance of warrants | $   $ 447,987              
[1] Includes gross proceeds of $12,503,750, less underwriting discounts and commissions of $1,000,262.
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 724,042 $ 468,216
Unrecognized stock-based compensation expense $ 875,000  
Unrecognized stock-based compensation expense, period of recognition 2 years 3 months 18 days  
Sales and marketing    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 270,460 54,723
Technology    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total 31,631 13,891
General and administrative    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 421,951 $ 399,602
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY - Black-Scholes Option Pricing Model to Stock Options Granted (Details) - Stock Options
12 Months Ended
Dec. 31, 2020
Expected term (years) 6 years 29 days
Expected volatility, Minimum 55.80%
Expected volatility, Maximum 56.30%
Risk free interest rate, Minimum 0.57%
Risk free interest rate, Maximum 1.65%
Expected dividends 0.00%
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY - Company's stock option activity (Details) - Stock Options
12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Number of Options  
Outstanding | shares 118,412
Forfeited | shares (21,150)
Exercised | shares (2,815)
Outstanding | shares 94,447
Exercisable | shares 66,240
Weighted Average Exercise Price  
Outstanding | $ / shares $ 15.22
Forfeited | $ / shares 33.16
Exercised | $ / shares 2.97
Outstanding | $ / shares 11.56
Exercisable | $ / shares $ 9.49
Weighted Average Remaining Term (Years) and Intrinsic Value  
Outstanding (in years) 4 years 4 months 24 days
Exercisable (in years) 2 years 10 months 24 days
Outstanding | $ $ 6,339
Exercisable | $ $ 3,276
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY - Schedule of Information Related to Stock Options (Details) - Stock Options
12 Months Ended
Dec. 31, 2021
$ / shares
shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options Outstanding, Weighted Outstanding Number of Options 94,447
Options Exercisable, Average Remaining Life In Years 2 years 10 months 24 days
Options Exercisable, Exercisable Number of Options 66,240
Exercise Price $2.81  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options Outstanding, Exercise price | $ / shares $ 2.81
Options Outstanding, Weighted Outstanding Number of Options 20,000
Options Exercisable, Average Remaining Life In Years 8 years 10 months 24 days
Options Exercisable, Exercisable Number of Options 5,416
Exercise Price $2.97  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options Outstanding, Exercise price | $ / shares $ 2.97
Options Outstanding, Weighted Outstanding Number of Options 42,779
Options Exercisable, Average Remaining Life In Years 8 months 12 days
Options Exercisable, Exercisable Number of Options 42,779
Exercise Price $4.95  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options Outstanding, Exercise price | $ / shares $ 4.95
Options Outstanding, Weighted Outstanding Number of Options 5,556
Options Exercisable, Average Remaining Life In Years 10 months 24 days
Options Exercisable, Exercisable Number of Options 4,255
Exercise Price $33.75  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Options Outstanding, Exercise price | $ / shares $ 33.75
Options Outstanding, Weighted Outstanding Number of Options 26,112
Options Exercisable, Average Remaining Life In Years 7 years 9 months 18 days
Options Exercisable, Exercisable Number of Options 13,790
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY - Estimation of fair value of warrants (Details) - Warrants
Dec. 31, 2020
Expected term (years) | Minimum  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Warrants and Rights Outstanding, Measurement Input 3.86
Expected term (years) | Maximum  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Warrants and Rights Outstanding, Measurement Input 4.75
Expected volatility | Minimum  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Warrants and Rights Outstanding, Measurement Input 58.0
Expected volatility | Maximum  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Warrants and Rights Outstanding, Measurement Input 61.2
Risk free interest rate | Minimum  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Warrants and Rights Outstanding, Measurement Input 0.24
Risk free interest rate | Maximum  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Warrants and Rights Outstanding, Measurement Input 0.39
Expected dividends  
Fair Value Measurement Inputs and Valuation Techniques [Line Items]  
Warrants and Rights Outstanding, Measurement Input 0.00
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY - Warrant Activity (Details) - $ / shares
12 Months Ended
Aug. 14, 2020
Dec. 31, 2021
Dec. 31, 2020
Number of Warrants      
Outstanding, beginning of the period (in shares)   6,167,745  
Issued (in shares)   867,286  
Exercised (in shares)   (2,281,668)  
Outstanding, end of the period (in shares) [1]   4,753,363  
Exercisable (in shares)   4,753,363  
Weighted Average Exercise Price      
Outstanding, beginning of the period (in dollars per share)   $ 5.26  
Issued (in dollars per share)   5.50  
Exercised (in dollars per share)   5.04  
Outstanding, end of the period (in dollars per share) [1]   5.42  
Exercisable (in dollars per share)   $ 5.35  
Weighted Average Remaining Life, Outstanding (in years) [1]   3 years 6 months  
Weighted Average Remaining Life, Exercisable (in years)   3 years 6 months  
Warrants term (in years) 5 years 5 years 5 years
Warrants to purchase shares of common stock 1,322,881 368,711  
Exercise price of warrants (in dollars per share) $ 5.50 $ 5.50 $ 5.50
[1] Excludes five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share that are issuable upon exercise of certain warrants.
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS' EQUITY - Stock Warrants (Details) - $ / shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Class of Warrant or Right [Line Items]    
Exercise Price (in dollars per share) $ 5.42 [1] $ 5.26
Outstanding number of warrants (in shares) 4,753,363 [1] 6,167,745
Weighted Average Remaining Life, Exercisable (in years) 3 years 6 months  
Exercisable number of warrants (in shares) 4,753,363  
Warrant Exercise Price $ 4.20    
Class of Warrant or Right [Line Items]    
Exercise Price (in dollars per share) $ 4.20  
Outstanding number of warrants (in shares) 368,711  
Weighted Average Remaining Life, Exercisable (in years) 2 years 8 months 12 days  
Exercisable number of warrants (in shares) 368,711  
Warrant Exercise Price $ 4.95    
Class of Warrant or Right [Line Items]    
Exercise Price (in dollars per share) $ 4.95  
Outstanding number of warrants (in shares) 177,223  
Weighted Average Remaining Life, Exercisable (in years) 1 year 3 months 18 days  
Exercisable number of warrants (in shares) 177,223  
Warrant Exercise Price $ 5.50    
Class of Warrant or Right [Line Items]    
Exercise Price (in dollars per share) $ 5.50  
Outstanding number of warrants (in shares) 3,998,459  
Weighted Average Remaining Life, Exercisable (in years) 3 years 8 months 12 days  
Exercisable number of warrants (in shares) 3,998,459  
Warrant Exercise Price $ 6.25    
Class of Warrant or Right [Line Items]    
Exercise Price (in dollars per share) $ 6.25  
Outstanding number of warrants (in shares) 32,500  
Weighted Average Remaining Life, Exercisable (in years) 3 years 7 months 6 days  
Exercisable number of warrants (in shares) 32,500  
Warrant Exercise Price $ 6.38    
Class of Warrant or Right [Line Items]    
Exercise Price (in dollars per share) $ 6.38  
Outstanding number of warrants (in shares) 176,470  
Weighted Average Remaining Life, Exercisable (in years) 4 years  
Exercisable number of warrants (in shares) 176,470  
[1] Excludes five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share that are issuable upon exercise of certain warrants.
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES - Settlements (Details) - USD ($)
12 Months Ended
Feb. 19, 2021
Nov. 14, 2018
Dec. 31, 2021
Dec. 31, 2020
Loss Contingencies [Line Items]        
Repayments of notes payable       $ 95,000
Loss on legal settlement     $ (880,381)  
Engage BDR, LLC        
Loss Contingencies [Line Items]        
Loss contingency, damage sought   $ 35,936    
Engage BDR, LLC | Settlement Agreements        
Loss Contingencies [Line Items]        
Settlement amount agreed $ 33,461      
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES - Employment Agreements (Details)
Nov. 29, 2021
USD ($)
shares
Jun. 04, 2021
USD ($)
item
installment
shares
Apr. 09, 2021
USD ($)
shares
Mr. Leon Zemel      
Loss Contingencies [Line Items]      
Annual base salary     $ 390,000
Annual performance bonuses with a target achievement of base salary (as a percent)     20.00%
Shares of common stock granted | shares     100,000
Period for which employee is entitled to receive salary     6 months
Period for continued healthcare coverage     6 months
Period for equity awards vested and exercisable after termination     3 months
Mr. Leon Zemel | Vesting if termination is before the one year anniversary date of the agreement      
Loss Contingencies [Line Items]      
Vesting percentage     25.00%
Mr. Leon Zemel | Vesting if termination is after one year anniversary date of the agreement      
Loss Contingencies [Line Items]      
Vesting percentage     100.00%
Mitchell Berg      
Loss Contingencies [Line Items]      
Annual base salary $ 300,000    
Annual performance bonuses with a target achievement of base salary (as a percent) 100000.00%    
Shares of common stock granted | shares 50,000    
Number of shares granted | shares 80,000    
Number of months for which termination compensation will pay after termination 3 months    
Aggregate grant date fair value of award $ 216,800    
Employment Agreements | Vice President | PSUs      
Loss Contingencies [Line Items]      
Employment Agreement Term   2 years  
Number of vice presidents in a employment agreement | item   2  
Amount payable upon termination   $ 150,000  
Number of months for which termination compensation will pay after termination   2 months  
Aggregate grant date fair value of award   $ (1,400,822)  
Employment Agreements | Vice President | PSUs | First year bonus on 12- month anniversary      
Loss Contingencies [Line Items]      
Number of shares granted | shares   67,738  
Performance marketing condition minimum threshold limit   $ 175,000  
Performance marketing condition maximum threshold limit   $ 350,000  
Number of vesting equity installments | installment   2  
Employment Agreements | Vice President | PSUs | Second year bonus on 24- month anniversary      
Loss Contingencies [Line Items]      
Performance marketing condition minimum threshold limit   $ 262,000  
Performance marketing condition maximum threshold limit   $ 525,000  
Number of vesting equity installments | item   2  
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.22.1
CONCENTRATIONS - Customer Concentrations (Details) - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
CONCENTRATIONS    
Accounts receivable, net $ 2,291,533 $ 1,373,754
Revenue | Customer Concentrations | Customer A    
CONCENTRATIONS    
Concentration risk (as a percent) 85.77% 51.40%
Revenue | Customer Concentrations | Customer D    
CONCENTRATIONS    
Concentration risk (as a percent) 11.56%  
Revenue | Customer Concentrations | Customer F    
CONCENTRATIONS    
Concentration risk (as a percent)   26.43%
Revenue | Customer Concentrations | Customer G    
CONCENTRATIONS    
Concentration risk (as a percent)   18.24%
Revenue | Customer Concentrations | Top Five Customers    
CONCENTRATIONS    
Concentration risk (as a percent) 97.33% 96.07%
Accounts Receivable | Customer Concentrations | Customer A    
CONCENTRATIONS    
Concentration risk (as a percent)   89.02%
Accounts Receivable | Customer Concentrations | Customer B    
CONCENTRATIONS    
Concentration risk (as a percent) 22.08%  
Accounts Receivable | Customer Concentrations | Top Three Customers    
CONCENTRATIONS    
Concentration risk (as a percent) 74.26% 89.02%
Accounts Receivable | Customer Concentrations | Customer E    
CONCENTRATIONS    
Concentration risk (as a percent) 52.18%  
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.22.1
CONCENTRATIONS - Supplier Concentrations (Details) - Cost of goods sold - Supplier Concentrations
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Supplier B    
CONCENTRATIONS    
Concentration risk (as a percent)   15.51%
Supplier D    
CONCENTRATIONS    
Concentration risk (as a percent)   16.32%
Supplier E    
CONCENTRATIONS    
Concentration risk (as a percent) 42.36%  
Top Four Suppliers    
CONCENTRATIONS    
Concentration risk (as a percent) 42.36% 31.83%
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.22.1
SUBSEQUENT EVENTS (Details) - USD ($)
12 Months Ended
Mar. 14, 2022
Jan. 01, 2022
Dec. 31, 2021
Subsequent Event [Line Items]      
Loss on legal settlement     $ (880,381)
Aureus Holdings, LLC d/b/a Lo70s | Settled Litigation [Member]      
Subsequent Event [Line Items]      
Loss on legal settlement     (875,000)
Amount accrued for cash payment     $ 975,000
Subsequent Events | Aureus Holdings, LLC d/b/a Lo70s | Settled Litigation [Member]      
Subsequent Event [Line Items]      
Cash payment $ 975,000    
Subsequent Events | 2021 Plan | Restricted stock units (RSUs)      
Subsequent Event [Line Items]      
Number of units issued   489,990  
Vesting period   4 years  
Subsequent Events | 2021 Plan | PSUs      
Subsequent Event [Line Items]      
Number of units issued   184,376  
Aggregate issuance date fair value of awards   $ 1,500,000  
Subsequent Events | 2021 Plan | Chief financial officer      
Subsequent Event [Line Items]      
Shares withheld for tax withholding obligation   3,397  
Stock-Based Compensation tax withholding obligation   $ 18,000  
Subsequent Events | 2021 Plan | Non-employee directors      
Subsequent Event [Line Items]      
Options granted   53,192  
Aggregate grant date fair value   $ 100,000  
Subsequent Events | 2021 Plan | Minimum | PSUs      
Subsequent Event [Line Items]      
Percentage of target award   0.00%  
Subsequent Events | 2021 Plan | Maximum | PSUs      
Subsequent Event [Line Items]      
Percentage of target award   150.00%  
XML 75 kbnt-20211231x10k_htm.xml IDEA: XBRL DOCUMENT 0001729750 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2020-12-31 0001729750 srt:MinimumMember us-gaap:MeasurementInputOptionVolatilityMember us-gaap:WarrantMember 2020-12-31 0001729750 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2020-12-31 0001729750 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2020-12-31 0001729750 srt:MaximumMember us-gaap:MeasurementInputOptionVolatilityMember us-gaap:WarrantMember 2020-12-31 0001729750 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2020-12-31 0001729750 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:WarrantMember 2020-12-31 0001729750 kbnt:EmployeesMember kbnt:Plan2017Member us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-04-01 2021-06-30 0001729750 kbnt:TwoThousandSeventeenEquityIncentivePlanMember 2020-01-01 2020-12-31 0001729750 srt:BoardOfDirectorsChairmanMember 2021-10-01 2021-12-31 0001729750 kbnt:ServiceProvidersMember kbnt:Plan2017Member 2021-01-01 2021-03-31 0001729750 kbnt:Plan2017Member 2021-01-01 2021-03-31 0001729750 kbnt:ServiceProvidersMember kbnt:Plan2017Member 2020-01-01 2020-12-31 0001729750 us-gaap:RetainedEarningsMember 2021-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001729750 us-gaap:RetainedEarningsMember 2020-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001729750 us-gaap:RetainedEarningsMember 2019-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001729750 us-gaap:CommonStockMember 2021-12-31 0001729750 us-gaap:CommonStockMember 2020-12-31 0001729750 us-gaap:CommonStockMember 2019-12-31 0001729750 kbnt:TwoThousandSeventeenEquityIncentivePlanMember 2021-11-09 0001729750 us-gaap:OverAllotmentOptionMember 2020-12-28 0001729750 us-gaap:EmployeeStockOptionMember kbnt:ExercisePriceRangeTwoMember 2021-12-31 0001729750 us-gaap:EmployeeStockOptionMember kbnt:ExercisePriceRangeThreeMember 2021-12-31 0001729750 us-gaap:EmployeeStockOptionMember kbnt:ExercisePriceRangeOneMember 2021-12-31 0001729750 us-gaap:EmployeeStockOptionMember kbnt:ExercisePriceRangeFourMember 2021-12-31 0001729750 us-gaap:EmployeeStockOptionMember kbnt:ExercisePriceRangeTwoMember 2021-01-01 2021-12-31 0001729750 us-gaap:EmployeeStockOptionMember kbnt:ExercisePriceRangeThreeMember 2021-01-01 2021-12-31 0001729750 us-gaap:EmployeeStockOptionMember kbnt:ExercisePriceRangeOneMember 2021-01-01 2021-12-31 0001729750 us-gaap:EmployeeStockOptionMember kbnt:ExercisePriceRangeFourMember 2021-01-01 2021-12-31 0001729750 us-gaap:EmployeeStockOptionMember 2020-12-31 0001729750 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-12-31 0001729750 us-gaap:EmployeeStockOptionMember 2021-12-31 0001729750 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001729750 us-gaap:PerformanceSharesMember kbnt:Plan2021Member us-gaap:SubsequentEventMember 2022-01-01 2022-01-01 0001729750 kbnt:ChiefProductOfficerMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-04-09 2021-04-09 0001729750 kbnt:ChiefProductOfficerMember kbnt:ShareBasedPaymentArrangementTrancheFourMember 2021-04-09 2021-04-09 0001729750 us-gaap:RestrictedStockUnitsRSUMember kbnt:Plan2021Member us-gaap:SubsequentEventMember 2022-01-01 2022-01-01 0001729750 kbnt:EmployeesMember kbnt:Plan2017Member us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-04-01 2021-06-30 0001729750 kbnt:GrantUnderEconomicInjuryDisasterLoanCaresActMember 2021-12-31 0001729750 2022-01-01 2021-12-31 0001729750 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-12-31 0001729750 us-gaap:ConvertibleNotesPayableMember 2020-01-01 2020-12-31 0001729750 kbnt:NotesPayableRelatedPartiesMember 2020-01-01 2020-12-31 0001729750 kbnt:PaycheckProtectionProgramLoanCaresActMember 2020-04-06 2020-04-06 0001729750 us-gaap:OverAllotmentOptionMember 2020-08-14 2020-08-14 0001729750 kbnt:MediacrossingIncMember 2021-11-01 2021-11-30 0001729750 srt:ChiefFinancialOfficerMember kbnt:Plan2021Member us-gaap:SubsequentEventMember 2022-01-01 2022-01-01 0001729750 kbnt:MediacrossingIncMember 2021-12-01 2021-12-31 0001729750 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001729750 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001729750 kbnt:EngageBdrLlcMember 2018-11-14 2018-11-14 0001729750 kbnt:EngageBdrLlcMember kbnt:SettlementAgreementsMember 2021-02-19 2021-02-19 0001729750 kbnt:AdvisioSolutionsLlcMember us-gaap:CustomerListsMember 2021-06-04 0001729750 kbnt:AureusHoldingsLlcDBLo70sMember us-gaap:SettledLitigationMember 2021-01-01 2021-12-31 0001729750 kbnt:MediacrossingIncMember kbnt:RestrictiveCovenantAgreementsMember 2021-11-30 2021-11-30 0001729750 kbnt:MediacrossingIncMember kbnt:CustomerContractsAndRelatedCustomerRelationshipsMember 2021-11-30 2021-11-30 0001729750 kbnt:AdvisioSolutionsLlcMember us-gaap:CustomerListsMember 2021-06-04 2021-06-04 0001729750 us-gaap:ComputerSoftwareIntangibleAssetMember 2021-01-01 2021-12-31 0001729750 kbnt:CapitalizedSoftwareMember 2021-01-01 2021-12-31 0001729750 us-gaap:CustomerListsMember 2019-12-31 0001729750 kbnt:RestrictiveCovenantAgreementsMember 2019-12-31 0001729750 kbnt:AcquiredDataMember 2019-12-31 0001729750 us-gaap:CustomerListsMember 2021-12-31 0001729750 kbnt:RestrictiveCovenantAgreementsMember 2021-12-31 0001729750 kbnt:AcquiredSoftwareMember 2021-12-31 0001729750 kbnt:AcquiredDataMember 2021-12-31 0001729750 kbnt:AccumulatedAmortizationMember 2021-12-31 0001729750 kbnt:AcquiredSoftwareMember 2020-12-31 0001729750 kbnt:AcquiredDataMember 2020-12-31 0001729750 kbnt:AccumulatedAmortizationMember 2020-12-31 0001729750 kbnt:AcquiredSoftwareMember 2019-12-31 0001729750 kbnt:AccumulatedAmortizationMember 2019-12-31 0001729750 kbnt:NotesPayableRelatedPartiesMember 2021-01-01 2021-12-31 0001729750 kbnt:EconomicInjuryDisasterLoanCaresActMember 2020-06-23 2020-06-23 0001729750 srt:MinimumMember kbnt:NotesPayableRelatedPartiesMember 2021-12-31 0001729750 srt:MaximumMember kbnt:NotesPayableRelatedPartiesMember 2021-12-31 0001729750 srt:ChiefExecutiveOfficerMember 2020-07-28 0001729750 kbnt:PaycheckProtectionProgramLoanCaresActMember 2020-04-06 0001729750 kbnt:EconomicInjuryDisasterLoanCaresActMember 2020-06-23 0001729750 us-gaap:WarrantMember 2020-08-14 2020-08-14 0001729750 us-gaap:ConvertibleNotesPayableMember 2020-08-14 2020-08-14 0001729750 kbnt:HoldersOfNotesPayableMember 2020-08-14 2020-08-14 0001729750 us-gaap:ConvertibleNotesPayableMember 2020-08-12 2020-08-12 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:TopFourSuppliersMember 2021-01-01 2021-12-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierEMember 2021-01-01 2021-12-31 0001729750 kbnt:TopThreeCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 kbnt:TopFiveCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 kbnt:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 kbnt:CustomerEMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 kbnt:CustomerDMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 kbnt:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:TopFourSuppliersMember 2020-01-01 2020-12-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierDMember 2020-01-01 2020-12-31 0001729750 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember kbnt:SupplierBMember 2020-01-01 2020-12-31 0001729750 kbnt:TopThreeCustomersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001729750 kbnt:TopFiveCustomersMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001729750 kbnt:CustomerMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001729750 kbnt:CustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001729750 kbnt:CustomerGMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001729750 kbnt:CustomerFMember us-gaap:RevenueFromContractWithCustomerMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001729750 us-gaap:IPOMember 2020-12-28 0001729750 kbnt:Plan2021Member 2021-12-31 0001729750 kbnt:Plan2017Member 2021-12-31 0001729750 kbnt:TwoThousandSeventeenStockOptionPlanMember 2021-12-31 0001729750 kbnt:UnderwritersMember 2020-12-28 0001729750 kbnt:TwoThousandSeventeenEquityIncentivePlanMember 2020-11-09 0001729750 us-gaap:WarrantMember 2020-08-14 0001729750 2019-12-31 0001729750 kbnt:MediacrossingIncMember kbnt:RestrictiveCovenantAgreementsMember 2021-11-30 0001729750 kbnt:MediacrossingIncMember kbnt:CustomerContractsAndRelatedCustomerRelationshipsMember 2021-11-30 0001729750 kbnt:MediacrossingIncMember 2021-11-30 2021-11-30 0001729750 kbnt:MediacrossingIncMember 2020-01-01 2020-12-31 0001729750 kbnt:MediacrossingIncMember 2021-01-01 2021-12-31 0001729750 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001729750 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001729750 us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001729750 us-gaap:EmployeeStockMember 2021-01-01 2021-12-31 0001729750 us-gaap:WarrantMember 2020-01-01 2020-12-31 0001729750 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001729750 us-gaap:CustomerListsMember 2021-01-01 2021-12-31 0001729750 kbnt:RestrictiveCovenantAgreementsMember 2021-01-01 2021-12-31 0001729750 kbnt:AcquiredSoftwareMember 2021-01-01 2021-12-31 0001729750 kbnt:AcquiredDataMember 2021-01-01 2021-12-31 0001729750 kbnt:AccumulatedAmortizationMember 2021-01-01 2021-12-31 0001729750 kbnt:AcquiredSoftwareMember 2020-01-01 2020-12-31 0001729750 kbnt:AcquiredDataMember 2020-01-01 2020-12-31 0001729750 kbnt:AccumulatedAmortizationMember 2020-01-01 2020-12-31 0001729750 us-gaap:TechnologyServiceMember 2021-01-01 2021-12-31 0001729750 us-gaap:SellingAndMarketingExpenseMember 2021-01-01 2021-12-31 0001729750 us-gaap:GeneralAndAdministrativeExpenseMember 2021-01-01 2021-12-31 0001729750 us-gaap:TechnologyServiceMember 2020-01-01 2020-12-31 0001729750 us-gaap:SellingAndMarketingExpenseMember 2020-01-01 2020-12-31 0001729750 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001729750 us-gaap:ShareBasedPaymentArrangementNonemployeeMember kbnt:Plan2021Member us-gaap:SubsequentEventMember 2022-01-01 2022-01-01 0001729750 kbnt:TwoThousandSeventeenEquityIncentivePlanMember 2021-11-09 2021-11-09 0001729750 srt:ChiefExecutiveOfficerMember 2020-07-28 2020-07-28 0001729750 srt:ExecutiveOfficerMember 2020-01-01 2020-12-31 0001729750 kbnt:SecondYearBonusOn24MonthAnniversaryMember srt:VicePresidentMember us-gaap:PerformanceSharesMember kbnt:EmploymentAgreementsMember 2021-06-04 2021-06-04 0001729750 kbnt:FirstYearBonusOn12MonthAnniversaryMember srt:VicePresidentMember us-gaap:PerformanceSharesMember kbnt:EmploymentAgreementsMember 2021-06-04 2021-06-04 0001729750 srt:MinimumMember us-gaap:PerformanceSharesMember kbnt:Plan2021Member us-gaap:SubsequentEventMember 2022-01-01 2022-01-01 0001729750 srt:MaximumMember us-gaap:PerformanceSharesMember kbnt:Plan2021Member us-gaap:SubsequentEventMember 2022-01-01 2022-01-01 0001729750 kbnt:PaycheckProtectionProgramLoanCaresActMember 2021-12-31 0001729750 kbnt:PaycheckProtectionProgramLoanCaresActMember 2020-12-31 0001729750 kbnt:TwoThousandSeventeenStockOptionPlanMember 2021-01-01 2021-12-31 0001729750 kbnt:UnderwritersMember 2020-12-28 2020-12-28 0001729750 srt:BoardOfDirectorsChairmanMember kbnt:Plan2017Member 2021-01-01 2021-03-31 0001729750 kbnt:EmployeesMember kbnt:Plan2017Member 2021-04-01 2021-06-30 0001729750 kbnt:NonEmployeesMember kbnt:Plan2017Member 2020-01-01 2020-12-31 0001729750 kbnt:EmployeesMember kbnt:Plan2017Member 2020-01-01 2020-12-31 0001729750 kbnt:NotesPayableRelatedPartiesMember 2021-12-31 0001729750 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001729750 srt:MinimumMember 2021-01-01 2021-12-31 0001729750 srt:MaximumMember 2021-01-01 2021-12-31 0001729750 us-gaap:IPOMember 2020-12-28 2020-12-28 0001729750 us-gaap:IPOMember 2020-08-14 2020-08-14 0001729750 2020-08-14 2020-08-14 0001729750 us-gaap:ConvertibleNotesPayableMember 2020-08-14 0001729750 kbnt:HoldersOfNotesPayableMember 2020-08-14 0001729750 2020-08-14 0001729750 us-gaap:ConvertibleNotesPayableMember 2020-08-12 0001729750 kbnt:WarrantsExercisePriceTwoMember 2021-01-01 2021-12-31 0001729750 kbnt:WarrantsExercisePriceThreeMember 2021-01-01 2021-12-31 0001729750 kbnt:WarrantsExercisePriceOneMember 2021-01-01 2021-12-31 0001729750 kbnt:WarrantsExercisePriceFourMember 2021-01-01 2021-12-31 0001729750 kbnt:WarrantsExercisePriceFiveMember 2021-01-01 2021-12-31 0001729750 kbnt:WarrantsExercisePriceTwoMember 2021-12-31 0001729750 kbnt:WarrantsExercisePriceThreeMember 2021-12-31 0001729750 kbnt:WarrantsExercisePriceOneMember 2021-12-31 0001729750 kbnt:WarrantsExercisePriceFourMember 2021-12-31 0001729750 kbnt:WarrantsExercisePriceFiveMember 2021-12-31 0001729750 us-gaap:OverAllotmentOptionMember 2020-08-14 0001729750 us-gaap:IPOMember 2020-08-14 0001729750 kbnt:AureusHoldingsLlcDBLo70sMember us-gaap:SettledLitigationMember us-gaap:SubsequentEventMember 2022-03-14 2022-03-14 0001729750 kbnt:MediacrossingIncMember 2021-11-30 0001729750 kbnt:AdvisioSolutionsLlcMember 2021-06-04 2021-06-04 0001729750 kbnt:ChiefTechnologyOfficerMember 2021-11-29 2021-11-29 0001729750 kbnt:ChiefProductOfficerMember 2021-04-09 2021-04-09 0001729750 srt:VicePresidentMember us-gaap:PerformanceSharesMember kbnt:EmploymentAgreementsMember 2021-06-04 2021-06-04 0001729750 kbnt:AureusHoldingsLlcDBLo70sMember us-gaap:SettledLitigationMember 2021-12-31 0001729750 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001729750 us-gaap:OverAllotmentOptionMember 2020-12-28 2020-12-28 0001729750 2020-01-01 2020-12-31 0001729750 2021-12-31 0001729750 2020-12-31 0001729750 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001729750 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001729750 2021-06-30 0001729750 2022-03-25 0001729750 2021-01-01 2021-12-31 shares iso4217:USD iso4217:USD shares pure kbnt:item kbnt:installment 13695700 5185204 0 0 0001729750 --12-31 2021 FY NASDAQ NASDAQ 14253948 11756109 -0.75 -1.85 P5Y P3Y P4Y6M false 10-K true 2021-12-31 false 001-39441 KUBIENT, INC. DE 82-1808844 500 7th Avenue 8th Floor New York NY 10018 800 409-9456 Common Stock KBNT Common Stock Purchase Warrants KBNTW No No Yes Yes Non-accelerated Filer true true false false false 64423000 14303743 688 Marcum LLP Los Angeles, CA 24907963 24782128 2291533 1373754 526070 495178 107651 28220744 26263533 2946610 1071850 463000 44756 17166 10000 10000 31685110 27362549 1844544 336028 659362 1106604 2493287 1017282 395914 15000 151336 218461 5544443 2693375 613000 77407 187629 6234850 2881004 0.00001 0.00001 5000000 5000000 0 0 0.00001 0.00001 95000000 95000000 14253948 11756109 143 118 52030907 40770504 -26580790 -16289077 25450260 24481545 31685110 27362549 2737767 2900029 3032133 1117375 3079752 2088538 6117601 4160854 -880381 13109867 7366767 -10372100 -4466738 8383 1135675 403372 88537 25178 1984322 124999 236248 -297272 233 15294 80387 -3418922 -10291713 -7885660 1682000 -10291713 -9567660 -0.75 -1.85 13695700 5185204 3601521 36 3362724 -8403417 -5040657 2500000 25 10605720 10605745 1461090 15 7304815 7304830 94223 1 388143 388144 4058822 41 18889872 18889913 38433 154922 154922 19570 19570 33738 33738 2000 11000 11000 20 -7885660 -7885660 11756109 118 40770504 -16289077 24481545 2156322 21 9703609 9703630 2815 8361 8361 100000 1 531999 532000 238702 3 993044 993047 23390 23390 -10291713 -10291713 14253948 143 52030907 -26580790 25450260 12503750 1898005 20699992 1810080 10169027 465397 -10291713 -7885660 452136 315202 22698 7593 236248 700652 448646 23390 19570 915994 357201 1984322 -297272 23601 148600 940477 1342643 -3955 -73491 79579 1508516 -191125 -447242 211922 1467306 497416 -247504 -7674792 -4805116 1133072 1300336 500000 39414 16000 -1672486 -1316336 9787149 177347 145050 8361 11503488 841376 19354493 125000 11000 29000 406190 95000 835000 -150000 9473113 30869795 125835 24748343 24782128 33785 24907963 24782128 10169027 381878 12503750 1000262 20699992 1470499 7912 574 83519 532000 507044 613000 362625 5411381 285000 75500 -339581 56367 218829 33738 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 1 – BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Organization and Operations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">Kubient, Inc. (“Kubient”, “we”, “our” or the “Company”), a Delaware corporation, was incorporated in May 2017 to solve some of the most significant problems facing the global digital advertising industry.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The Company’s experienced team of marketing and technology veterans has developed the Audience Marketplace, a modular, highly scalable, transparent, cloud-based software platform for real-time trading of digital, Programmatic Advertising. The Company’s platform’s open marketplace gives both advertisers (ad space buyers) and Publishers (ad space sellers) the ability to use machine learning in the most critical parts of any Programmatic Advertising inventory auction, while simultaneously and significantly reducing those advertisers and Publishers’ exposure to fraud, specifically in the Pre-bid environment.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The Company also provides unique capabilities with its proprietary pre-bid ad fraud detection and prevention, Kubient Artificial Intelligence (“KAI”), which has the ability to stop fraud in the critical 300 millisecond window before an advertiser spends their budget on fraudulent ad space. The technology is powered by deep learning algorithms, the latest advancement in machine learning, which allows the Company to ingest vast amounts of data, find complex patterns in the data and make accurate predictions. This provides advertisers a powerful tool capable of preventing the purchase of ad fraud.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">The Company believes that its Audience Marketplace technology allows advertisers to reach entire audiences rather than buying single impressions from disparate sources.  By becoming a one stop shop for advertisers and publishers, providing them with the technology to deliver meaningful messages to their target audience, all in one place, on a single platform that is computationally efficient, transparent, and as safely fraud-free as possible, the Company believes that its Audience Marketplace platform (and the application of the platform’s machine learning algorithms) leads to increased publisher revenue, lower advertiser cost, reduced latency and increased economic transparency during the advertising auction process.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Risks and Uncertainties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The novel coronavirus (“COVID-19”) pandemic continues to impact global economic conditions, as well as the Company’s operations. COVID-19 had a meaningful negative impact on our financial condition, cash flows and results of operations during 2020, as revenues declined and we reduced spending in light of COVID-19 uncertainty. Although we continued to experience disruption and volatility during 2021, which could continue to have an adverse effect on our revenues and earnings in 2022, the ultimate economic impact of the pandemic remains fluid, as there continue to be periods of COVID-19 resurgence in various parts of the world. The extent of the impact of the COVID-19 pandemic in 2022 on our operational and financial performance will depend on a variety of factors, some of which are outside our control, including the duration and spread of COVID-19 and its variants, and its impact on our clients, partners, industry, and employees, all of which are uncertain at this time and cannot be accurately predicted. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Similarly, the economic uncertainty caused by the COVID-19 pandemic has made and may continue to make it difficult for us to forecast revenue and operating results and to make decisions regarding operational cost structures and investments. We have committed, and we plan to continue to commit, resources to grow our business, employee base, and technology development, and such investments may not yield anticipated returns, particularly if worldwide business activity continues to be impacted by the COVID-19 pandemic. The duration and extent of the impact from the COVID-19 pandemic depend on future developments that cannot be accurately predicted at this time, and if we are not able to respond to and manage the impact of such events effectively, our business may be harmed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">There can be no assurance that precautionary measures, whether adopted by us or imposed by others, will be effective, and such measures could negatively affect our sales, marketing, and client service efforts, delay and lengthen our sales cycles, decrease our employees’, clients’, or partners’ productivity, or create operational or other challenges, any of which could harm our business and results of operations.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Basis of Presentation </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The accompanying audited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements. Such consolidated financial statements and accompanying notes are the representations of Company’s management, who is responsible for their integrity and objectivity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s significant estimates used in these financial statements include, but are not limited to, fair value calculations for equity securities, revenue recognition, stock-based compensation,the valuation of intangible assets and contingent consideration, useful lives of intangibles assets, the collectability of receivables and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and may cause actual results to differ from those estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Principles of Consolidation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="letter-spacing:0.2pt;text-decoration-line:none;">The consolidated financial statements of the Company include the accounts of Fidelity Media, LLC (“Fidelity”). All intercompany transactions have been eliminated in the consolidation.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Cash and Cash Equivalents</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains cash in bank accounts, which, at times, may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company has not experienced any losses in such accounts. The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2021 and 2020, the Company’s cash and cash equivalents were comprised of demand deposits held in bank accounts.  </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Revenue Recognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Identification of a contract with a customer;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Identification of the performance obligations in the contract;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Determination of the transaction price;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Allocation of the transaction price to the performance obligations in the contract; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Recognition of revenue when or as the performance obligations are satisfied.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains a contract with each customer and supplier, which specify the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The transaction price is determined based on the consideration to which it expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021 and 2020, the Company did not have any contract assets from contracts with customers. As of December 31, 2021 and 2020, the Company had $395,914 and $15,000, respectively, of contract liabilities where performance obligations have not yet been satisfied. The Company expects to satisfy its remaining performance obligations and recognize the revenue within the next twelve months. During the years ended December 31, 2021 and 2020, there was no revenue was recognized from performance obligations satisfied (or partially satisfied) in previous periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Accounts Receivable and Accounts Payable</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Accounts receivable are carried at their contractual amounts, less an estimate for uncollectible amounts. As of December 31, 2021 and 2020, there was an allowance for uncollectible amounts of $12,149 and $10,209, respectively. Management estimates the allowance for bad debts based on existing economic conditions, the financial conditions of the customers, and the amount and age of past due accounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Receivables are considered past due if full payment is not received by the contractual due date. Past due accounts are generally written off against the corresponding accounts payable in the event that the Company’s contract contains sequential liability terms, with the excess receivable being written off against the allowance for bad debts only after all collection attempts have been exhausted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Accounts receivable are recorded at the amount the Company is responsible to collect from the customer. See Note 2 — Significant Accounting Policies — Revenue Recognition for additional details. In the event that the Company does not collect the Gross Billing amount from the customer, the Company generally is not contractually obligated to pay the associated Supplier Cost.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Convertible Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for in accordance with the Financial Accounting Standards Board (“FASB”) ASC Topic 815 “Derivatives and Hedging” (“ASC 815”). The accounting treatment of derivative financial instruments requires that the Company record embedded conversion options and any related freestanding instruments at their fair values as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded in earnings each period as non-operating, non-cash income or expense. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. Embedded conversion options and any related freestanding instruments are recorded as a discount to the host instrument. The Company allocates proceeds based on the relative fair values of the debt and equity components.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Prior to the adoption of ASU 2020-06, if the instrument is not determined to be a derivative liability, the Company then evaluates for the existence of a beneficial conversion feature by comparing the fair value of the Company’s common stock as of the commitment date to the effective conversion price of the instrument (the intrinsic value). The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Deferred Offering Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Deferred offering costs, which consist of direct, incremental professional fees incurred in connection with the Company’s future offerings of equity and debt securities that have yet to close, are capitalized as non-current assets on the consolidated balance sheet. Upon the closing of the offering, the deferred offering costs are either (i) charged off against the offering proceeds in connection with an equity offering or (ii) reclassified such that they represent a reduction in the carrying amount of the face value of the debt security.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Property and Equipment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Property and equipment are stated at cost, net of accumulated depreciation which is recorded commencing at the in-service date using the straight-line method at rates sufficient to charge the cost of depreciable assets to operations over their estimated useful lives, which is three years. Leasehold improvements are amortized over the lesser of (a) the useful life of the asset; or (b) the remaining lease term. Maintenance and repairs are charged to operations as incurred. The Company capitalizes cost attributable to the betterment of property and equipment when such betterment extends the useful life of the assets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Intangible Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Intangible assets are comprised of costs to acquire and develop computer software, including the costs to acquire third-party data which is used to improve the Company’s artificial intelligence platform for client use, as well as costs to acquire customer lists, customer contracts and related customer relationship and restrictive covenant agreements. The intangible assets have estimated useful lives of two years for the computer software, five years for the capitalized data, seven years for the customer lists and three years for the restrictive covenant agreements. Once placed into service, the Company amortizes the cost of the intangible assets over their estimated useful lives on a straight-line basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Impairment of Long-lived Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company reviews for the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. An impairment would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. The Company did not record any impairment losses during the years ended December 31, 2021 and 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Fair Value of Financial Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Level 1 — quoted prices in active markets for identical assets or liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Level 3 — inputs that are unobservable (for example, cash flow modeling inputs based on assumptions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The carrying amounts of the Company’s financial instruments, such as cash, accounts receivable, accounts payable, convertible notes and notes payable approximate fair value due to the short-term nature of these instruments. The carrying amounts of the Company’s short-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates, are comparable to rates of returns for instruments of similar credit risk.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Software Development Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company develops and utilizes software in connection with its ability to generate customer revenue (which is further explained in Note 2 – Significant Accounting Policies – Revenue Recognition). Costs incurred in this effort are accounted for under the provisions of ASC 985-20, Software – Cost of Software to be Sold, Leased or Marketed, whereby costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. The Company capitalizes subsequent additions, modifications, or upgrades to internally developed software only to the extent that such changes allow the software to perform a task it previously did not perform.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Income Taxes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to federal and state income taxes in the United States. The Company files income tax returns in the jurisdictions in which nexus threshold requirements are met.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company utilizes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as general and administrative expenses in the consolidated statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Advertising Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Advertising costs are charged to operations in the year incurred and totaled approximately $270,000 and $101,000 for the years ended December 31, 2021 and 2020, respectively, and are reflected in general and administrative expenses in the consolidated statements of operations.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Stock-Based Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The Company accrues for any equity awards at fair value that have been contractually earned but not yet issued.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Fair Value of Stock Options and Warrants</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has computed the fair value of stock options and warrants granted using the Black-Scholes option pricing model. Option forfeitures are accounted for at the time of occurrence. The expected term used for options is the estimated period of time that options granted are expected to be outstanding. The expected term used for warrants is the contractual life. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” option grants. The Company does not currently have a sufficient trading history to support its historical volatility calculations. Accordingly, the Company is utilizing an expected volatility figure based on a review of the historical volatility of comparable entities over a period of time equivalent to the expected life of the instrument being valued. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Net Loss Per Common Share</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94,447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 118,412</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restricted stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 166,489</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants [1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,122,074</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,403,722</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,483,010</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,522,134</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.4pt;text-align:justify;text-indent:-14.4pt;margin:0pt 0pt 12pt 0pt;">[1] During 2021, includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share. During 2020, includes shares underlying warrants that are exercisable into an aggregate of (i) 1,235,977 shares of common stock and (ii) five-year warrants to purchase 1,235,977 shares of common stock at an exercise price of $5.50 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.4pt;text-align:justify;text-indent:-14.4pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Recently Issued Accounting Standards</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">In February 2016, the FASB issued ASU 2016-02“, “Leases (Topic 842)” (“ASU 2016-02”), as amended, with guidance regarding the accounting for and disclosure of leases. The update requires that a lessee recognize the assets and liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions. In May 2020, the FASB issued ASU 2020-05 that deferred these dates one year for all other entities, including emerging growth companies. This standard is effective for annual reporting periods beginning after December 15, 2021, and interim periods within annual periods beginning after December 15, 2022. Early adoption is permitted. The Company expects to adopt ASU 2016-02 during the fiscal year ending December 31, 2022 and is evaluating the impact on its statements of operations and cash flows. Based upon the leases currently in place, management believes that its current leases will qualify for the practical expedient for leases with terms less than one year, such that there will be no material impact of adopting the new standard on the Company’s consolidated financial statements. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">In June 2016, the FASB issued ASU 2016-13, “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). In April 2020, the FASB issued clarification to ASU 2016-13 within ASU 2020-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. This guidance is effective for public business entities that meet the definition of a Securities and Exchange Commission filer, excluding eligible smaller reporting companies, for fiscal years beginning after December 15, 2019. For all other entities, including emerging growth companies, it is effective for fiscal years beginning after December 15, 2020. The Company is currently evaluating ASU 2016-13 and its impact on its consolidated financial statements and disclosures. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This update for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted, including adoption in any interim period for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The Company adopted ASU 2019-12 effective January 1, 2022 and its adoption did not have a material impact on the Company’s consolidated financial statements and disclosures.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">In August 2020, the FASB issued ASU 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”) which simplifies the accounting for convertible instruments by eliminating certain accounting models when the conversion features are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in-capital. Under this ASU, certain debt instruments with embedded conversion features will be accounted for as a single liability measured at its amortized cost. Additionally, this ASU eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments. The new guidance is effective for annual periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company adopted ASU 2020-06 effective January 1, 2022 which eliminated the need to assess whether a beneficial conversion feature needed to be recognized upon either (a) the future issuance of new convertible notes; or (b) the resolution of any contingent beneficial conversion features.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). This new standard provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Issuers should apply the new standard prospectively to modifications or exchanges occurring after the effective date of the new standard. Early adoption is permitted, including adoption in an interim period. If an issuer elects to early adopt the new standard in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The Company adopted ASU 2021-04 effective January 1, 2022 such adoption did not have a material impact on the Company’s consolidated financial statements or disclosures.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration-line:none;">In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805)” (“ASU 2021-08”). The ASU improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. The update is effective for annual and interim periods within the fiscal year beginning after December 15, 2022, and early adoption is permitted, including adoption in an interim period. The Company is evaluating this new standard and its impact on its consolidated financial statements and related disclosures.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Basis of Presentation </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The accompanying audited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s consolidated financial statements. Such consolidated financial statements and accompanying notes are the representations of Company’s management, who is responsible for their integrity and objectivity.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s significant estimates used in these financial statements include, but are not limited to, fair value calculations for equity securities, revenue recognition, stock-based compensation,the valuation of intangible assets and contingent consideration, useful lives of intangibles assets, the collectability of receivables and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and may cause actual results to differ from those estimates.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Principles of Consolidation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="letter-spacing:0.2pt;text-decoration-line:none;">The consolidated financial statements of the Company include the accounts of Fidelity Media, LLC (“Fidelity”). All intercompany transactions have been eliminated in the consolidation.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Cash and Cash Equivalents</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains cash in bank accounts, which, at times, may exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company has not experienced any losses in such accounts. The Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. As of December 31, 2021 and 2020, the Company’s cash and cash equivalents were comprised of demand deposits held in bank accounts.  </p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Revenue Recognition</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Identification of a contract with a customer;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Identification of the performance obligations in the contract;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Determination of the transaction price;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Allocation of the transaction price to the performance obligations in the contract; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">●</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Recognition of revenue when or as the performance obligations are satisfied.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company maintains a contract with each customer and supplier, which specify the terms of the relationship. The Company provides a service to its customers (the buy-side ad networks who work for advertisers) by connecting advertisers and publishers. For this service, the Company earns a percentage of the amount that is paid by the advertiser, who wants to run a digital advertising campaign, which, in some cases, is reduced by the amount paid to the publisher, who wants to sell its ad space to the advertiser.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The transaction price is determined based on the consideration to which it expects to be entitled, including the impact of any implicit price concessions over the course of the contract. The Company’s performance obligation is to facilitate the publication of advertisements. The performance obligation is satisfied at the point in time that the ad is placed. Subsequent to a bid being won, the associated fees are generally not subject to refund or adjustment. Historically, any refunds and adjustments have not been material. The revenue recognized is the amount the Company is responsible to collect from the customer related to the placement of an ad (the “Gross Billing”), less the amount the Company remits to the supplier for the ad space (the “Supplier Cost”), if any. The determination of whether the Company is the principal or agent, and hence whether to report revenue on a gross basis equal to the Gross Billing or on a net basis for the difference between the Gross Billing and Supplier Cost, requires judgment. The Company acts as an agent in arranging via its platform for the specified good (the ad space) to be purchased by the advertiser, as it does not control the goods or services being transferred to the end customer, it does not take responsibility for the quality or acceptability of the ad space, it does not bear inventory risk, nor does it have discretion in establishing price of the ad space. As a result, the Company recognizes revenue on a net basis for the difference between the Gross Billing and the Supplier Cost. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company invoices customers on a monthly basis for the amount of Gross Billings in the relevant period. Invoice payment terms, negotiated on a customer-by- customer basis, are typically between 45 to 90 days. However, for certain agency customers with sequential liability terms as specified by the Interactive Advertising Bureau, (i) payments are not due to the Company until such agency customers has received payment from its customers (ii) the Company is not required to make a payment to its supplier until payment is received from the Company’s customer and (iii) the supplier is responsible to pursue collection directly with the advertiser. As a result, once the Company has met the requirements of each of the five steps under ASC 606, the Company’s accounts receivable are recorded at the amount of Gross Billings which represent amounts it is responsible to collect and accounts payable, if applicable, are recorded at the amount payable to suppliers. In the event step 1 under ASC 606 is not met, the Company does not record either the accounts receivable or accounts payable. Accordingly, both accounts receivable and accounts payable appear large in relation to revenue reported on a net basis.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021 and 2020, the Company did not have any contract assets from contracts with customers. As of December 31, 2021 and 2020, the Company had $395,914 and $15,000, respectively, of contract liabilities where performance obligations have not yet been satisfied. The Company expects to satisfy its remaining performance obligations and recognize the revenue within the next twelve months. During the years ended December 31, 2021 and 2020, there was no revenue was recognized from performance obligations satisfied (or partially satisfied) in previous periods.</p> P45D P90D 395914 15000 P12M 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Accounts Receivable and Accounts Payable</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Accounts receivable are carried at their contractual amounts, less an estimate for uncollectible amounts. As of December 31, 2021 and 2020, there was an allowance for uncollectible amounts of $12,149 and $10,209, respectively. Management estimates the allowance for bad debts based on existing economic conditions, the financial conditions of the customers, and the amount and age of past due accounts.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Receivables are considered past due if full payment is not received by the contractual due date. Past due accounts are generally written off against the corresponding accounts payable in the event that the Company’s contract contains sequential liability terms, with the excess receivable being written off against the allowance for bad debts only after all collection attempts have been exhausted.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Accounts receivable are recorded at the amount the Company is responsible to collect from the customer. See Note 2 — Significant Accounting Policies — Revenue Recognition for additional details. In the event that the Company does not collect the Gross Billing amount from the customer, the Company generally is not contractually obligated to pay the associated Supplier Cost.</p> 12149 10209 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Convertible Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for in accordance with the Financial Accounting Standards Board (“FASB”) ASC Topic 815 “Derivatives and Hedging” (“ASC 815”). The accounting treatment of derivative financial instruments requires that the Company record embedded conversion options and any related freestanding instruments at their fair values as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded in earnings each period as non-operating, non-cash income or expense. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification. Embedded conversion options and any related freestanding instruments are recorded as a discount to the host instrument. The Company allocates proceeds based on the relative fair values of the debt and equity components.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Prior to the adoption of ASU 2020-06, if the instrument is not determined to be a derivative liability, the Company then evaluates for the existence of a beneficial conversion feature by comparing the fair value of the Company’s common stock as of the commitment date to the effective conversion price of the instrument (the intrinsic value). The intrinsic value of the beneficial conversion feature is recorded as a debt discount with a corresponding amount to additional paid-in capital.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Deferred Offering Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Deferred offering costs, which consist of direct, incremental professional fees incurred in connection with the Company’s future offerings of equity and debt securities that have yet to close, are capitalized as non-current assets on the consolidated balance sheet. Upon the closing of the offering, the deferred offering costs are either (i) charged off against the offering proceeds in connection with an equity offering or (ii) reclassified such that they represent a reduction in the carrying amount of the face value of the debt security.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Property and Equipment</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Property and equipment are stated at cost, net of accumulated depreciation which is recorded commencing at the in-service date using the straight-line method at rates sufficient to charge the cost of depreciable assets to operations over their estimated useful lives, which is three years. Leasehold improvements are amortized over the lesser of (a) the useful life of the asset; or (b) the remaining lease term. Maintenance and repairs are charged to operations as incurred. The Company capitalizes cost attributable to the betterment of property and equipment when such betterment extends the useful life of the assets.</p> P3Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Intangible Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Intangible assets are comprised of costs to acquire and develop computer software, including the costs to acquire third-party data which is used to improve the Company’s artificial intelligence platform for client use, as well as costs to acquire customer lists, customer contracts and related customer relationship and restrictive covenant agreements. The intangible assets have estimated useful lives of two years for the computer software, five years for the capitalized data, seven years for the customer lists and three years for the restrictive covenant agreements. Once placed into service, the Company amortizes the cost of the intangible assets over their estimated useful lives on a straight-line basis.</p> P2Y P5Y P7Y P3Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Impairment of Long-lived Assets</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company reviews for the impairment of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. An impairment would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. The Company did not record any impairment losses during the years ended December 31, 2021 and 2020.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Fair Value of Financial Instruments</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820 “Fair Value Measurements and Disclosures” (“ASC 820”).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Level 1 — quoted prices in active markets for identical assets or liabilities</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Level 3 — inputs that are unobservable (for example, cash flow modeling inputs based on assumptions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The carrying amounts of the Company’s financial instruments, such as cash, accounts receivable, accounts payable, convertible notes and notes payable approximate fair value due to the short-term nature of these instruments. The carrying amounts of the Company’s short-term credit obligations approximate fair value because the effective yields on these obligations, which include contractual interest rates, are comparable to rates of returns for instruments of similar credit risk.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Software Development Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company develops and utilizes software in connection with its ability to generate customer revenue (which is further explained in Note 2 – Significant Accounting Policies – Revenue Recognition). Costs incurred in this effort are accounted for under the provisions of ASC 985-20, Software – Cost of Software to be Sold, Leased or Marketed, whereby costs for the development of new software products and substantial enhancements to existing software products are expensed as incurred until technological feasibility has been established, at which time any additional costs would be capitalized. The Company capitalizes subsequent additions, modifications, or upgrades to internally developed software only to the extent that such changes allow the software to perform a task it previously did not perform.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Income Taxes</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to federal and state income taxes in the United States. The Company files income tax returns in the jurisdictions in which nexus threshold requirements are met.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company utilizes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s policy is to classify assessments, if any, for tax related interest as interest expense and penalties as general and administrative expenses in the consolidated statements of operations.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Advertising Costs</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Advertising costs are charged to operations in the year incurred and totaled approximately $270,000 and $101,000 for the years ended December 31, 2021 and 2020, respectively, and are reflected in general and administrative expenses in the consolidated statements of operations.</p> 270000 101000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Stock-Based Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The Company accrues for any equity awards at fair value that have been contractually earned but not yet issued.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Fair Value of Stock Options and Warrants</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has computed the fair value of stock options and warrants granted using the Black-Scholes option pricing model. Option forfeitures are accounted for at the time of occurrence. The expected term used for options is the estimated period of time that options granted are expected to be outstanding. The expected term used for warrants is the contractual life. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” option grants. The Company does not currently have a sufficient trading history to support its historical volatility calculations. Accordingly, the Company is utilizing an expected volatility figure based on a review of the historical volatility of comparable entities over a period of time equivalent to the expected life of the instrument being valued. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Net Loss Per Common Share</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Basic net loss per common share is computed by dividing net loss by the weighted average number of vested common shares outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of vested common and dilutive common-equivalent shares outstanding during each period. Dilutive common-equivalent shares consist of shares of options, warrants and convertible notes, if not anti-dilutive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94,447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 118,412</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restricted stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 166,489</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants [1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,122,074</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,403,722</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,483,010</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,522,134</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.4pt;text-align:justify;text-indent:-14.4pt;margin:0pt 0pt 12pt 0pt;">[1] During 2021, includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share. During 2020, includes shares underlying warrants that are exercisable into an aggregate of (i) 1,235,977 shares of common stock and (ii) five-year warrants to purchase 1,235,977 shares of common stock at an exercise price of $5.50 per share.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.12%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Stock options</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94,447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 118,412</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restricted stock awards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 166,489</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restricted stock units</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Warrants [1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,122,074</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,403,722</p></td></tr><tr><td style="vertical-align:bottom;width:73.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,483,010</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.31%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.9%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,522,134</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.4pt;text-align:justify;text-indent:-14.4pt;margin:0pt 0pt 12pt 0pt;">[1] During 2021, includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share. During 2020, includes shares underlying warrants that are exercisable into an aggregate of (i) 1,235,977 shares of common stock and (ii) five-year warrants to purchase 1,235,977 shares of common stock at an exercise price of $5.50 per share.</p> 94447 118412 166489 100000 5122074 7403722 5483010 7522134 368711 P5Y 368711 5.50 1235977 P5Y 1235977 5.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.4pt;text-align:justify;text-indent:-14.4pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Recently Issued Accounting Standards</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">In February 2016, the FASB issued ASU 2016-02“, “Leases (Topic 842)” (“ASU 2016-02”), as amended, with guidance regarding the accounting for and disclosure of leases. The update requires that a lessee recognize the assets and liabilities related to all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions. In May 2020, the FASB issued ASU 2020-05 that deferred these dates one year for all other entities, including emerging growth companies. This standard is effective for annual reporting periods beginning after December 15, 2021, and interim periods within annual periods beginning after December 15, 2022. Early adoption is permitted. The Company expects to adopt ASU 2016-02 during the fiscal year ending December 31, 2022 and is evaluating the impact on its statements of operations and cash flows. Based upon the leases currently in place, management believes that its current leases will qualify for the practical expedient for leases with terms less than one year, such that there will be no material impact of adopting the new standard on the Company’s consolidated financial statements. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">In June 2016, the FASB issued ASU 2016-13, “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). In April 2020, the FASB issued clarification to ASU 2016-13 within ASU 2020-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments. This guidance is effective for public business entities that meet the definition of a Securities and Exchange Commission filer, excluding eligible smaller reporting companies, for fiscal years beginning after December 15, 2019. For all other entities, including emerging growth companies, it is effective for fiscal years beginning after December 15, 2020. The Company is currently evaluating ASU 2016-13 and its impact on its consolidated financial statements and disclosures. </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes” (“ASU 2019-12”). The amendments in this ASU simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify GAAP for other areas of Topic 740 by clarifying and amending existing guidance. This update for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption of the amendments is permitted, including adoption in any interim period for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period. The Company adopted ASU 2019-12 effective January 1, 2022 and its adoption did not have a material impact on the Company’s consolidated financial statements and disclosures.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">In August 2020, the FASB issued ASU 2020-06, “Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”) which simplifies the accounting for convertible instruments by eliminating certain accounting models when the conversion features are not required to be accounted for as derivatives under Topic 815, Derivatives and Hedging, or that do not result in substantial premiums accounted for as paid-in-capital. Under this ASU, certain debt instruments with embedded conversion features will be accounted for as a single liability measured at its amortized cost. Additionally, this ASU eliminates the treasury stock method to calculate diluted earnings per share for convertible instruments. The new guidance is effective for annual periods beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The Company adopted ASU 2020-06 effective January 1, 2022 which eliminated the need to assess whether a beneficial conversion feature needed to be recognized upon either (a) the future issuance of new convertible notes; or (b) the resolution of any contingent beneficial conversion features.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:none;">In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt—Modifications and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU 2021-04”). This new standard provides clarification and reduces diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options (such as warrants) that remain equity classified after modification or exchange. This standard is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Issuers should apply the new standard prospectively to modifications or exchanges occurring after the effective date of the new standard. Early adoption is permitted, including adoption in an interim period. If an issuer elects to early adopt the new standard in an interim period, the guidance should be applied as of the beginning of the fiscal year that includes that interim period. The Company adopted ASU 2021-04 effective January 1, 2022 such adoption did not have a material impact on the Company’s consolidated financial statements or disclosures.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="text-decoration-line:none;">In October 2021, the FASB issued ASU 2021-08, “Business Combinations (Topic 805)” (“ASU 2021-08”). The ASU improves the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized by the acquirer. The update is effective for annual and interim periods within the fiscal year beginning after December 15, 2022, and early adoption is permitted, including adoption in an interim period. The Company is evaluating this new standard and its impact on its consolidated financial statements and related disclosures.</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 3 – BUSINESS COMBINATION </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On November 30, 2021, Kubient entered into and consummated an Asset Purchase Agreement (the “Purchase Agreement”) between the Company and MediaCrossing Inc., a Delaware corporation (“MediaCrossing”), pursuant to which the Company acquired certain assets and liabilities that were critical to continue to operate the business of MediaCrossing for (i) $500,000 in cash and (ii) if the acquired business achieves certain milestones in 2022, up to 822,369 shares of the Company’s common stock, par value $0.00001 per share (the “Earnout Shares”) (the “Transaction”). In accordance with ASC 805, the Company determined that the Transaction should be accounted for as a business combination after determining that the acquired set of assets of MediaCrossing, the fair value of which was not concentrated in a single asset or group of similar assets and included (a) cash, (b) prepaid expenses and other current assets, (c) intangible assets as detailed further below and (d) an assembled workforce, met the definition of a business. As a result, Kubient has recorded the business combination in its consolidated financial statements and has applied the acquisition method to account for MediaCrossing’s assets acquired and liabilities assumed upon completion of the Transaction. The acquisition method requires recording the identifiable assets acquired and liabilities assumed at their fair values on the acquisition date and recording goodwill for the excess of the purchase price over the aggregate fair value of the identifiable assets acquired and liabilities assumed.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Earnout Shares consist of up to 822,369 shares of the Company’s common stock, depending on the amount of revenue generated by the acquisition in 2022. Each share had a fair value of $2.55 as of the acquisition date. The Earnout Shares were measured using a Monte Carlo simulation. Key assumptions used in the fair value assessment consisted of revenue projections (which were used to estimate the number of Earnout Shares issuable), discount rate and standard deviation. The fair value measurement of the contingent consideration is based on significant inputs not observed in the market and thus represents a Level 3 measurement. Level 3 instruments are valued based on unobservable inputs that are supported by little or no market activity and reflect Kubient’s own assumptions in measuring fair value.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">MediaCrossing is engaged in the business of providing managed media services to agencies and direct brand advertisers, including media planning, strategy, contracting for media, developing, executing and managing campaigns, reporting and services ancillary to the foregoing.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with the Acquisition and pursuant to the terms of the Purchase Agreement, the Company has offered employment to ten employees of MediaCrossing, including Michael Kalman as President – Agency &amp; Brand Partnerships. In addition, the Purchase Agreement contains customary representations, warranties, post-closing covenants and indemnification provisions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The aggregate preliminary purchase price was allocated to the assets acquired and liabilities assumed as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchase Consideration:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 500,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Contingent consideration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 613,000</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Purchase Consideration</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,113,000</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Less:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Customer contracts and related customer relationships (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 580,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Restrictive covenant agreements (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 70,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Debt-free net working capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value of Identified Net Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 650,000</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining Unidentified Goodwill Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 463,000</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As part of the preliminary valuation analysis, the Company identified (i) customer contracts and related customer relationships and (ii) restrictive covenant agreements as intangible assets. The fair value of the identifiable intangible assets is determined using the “income approach”. The customer contracts and related customer relationships have an estimated useful life of </span><span style="-sec-ix-hidden:Hidden_SWwgaGWS0E25ngwCiTvkIg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (5) years and the restrictive covenant agreements have an estimated useful life of </span><span style="-sec-ix-hidden:Hidden_4vCUGgQAMESltDnT8TA-5A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (3) years.</span></td></tr></table><div style="margin-top:12pt;"/><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The components of debt free net working capital deficit are as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current Assets:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Prepaid expenses and other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 109,083</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 526,070</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><b style="font-weight:bold;">Total Current Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 635,153</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current Liabilities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 628,418</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accrued expenses and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,735</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><b style="font-weight:bold;">Total Current Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 635,153</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="font-weight:bold;margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><b style="font-weight:bold;">Debt-Free Net Working Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Goodwill was recorded based on the amount by which the purchase price exceeded the fair value of the net assets acquired and the amount is attributable to the reputation of the business acquired, the workforce in place and the synergies to be achieved from this acquisition. Goodwill is deductible for tax purposes.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The consolidated financial statements of the Company include the results of operations of MediaCrossing from November 30, 2021 to December 31, 2021 and do not include results of operations for the year ended December 31, 2020. The results of operations of MediaCrossing from November 30, 2021 to December 31, 2021 included revenues of $154,954 and a net loss of $18,447.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The following table presents the unaudited pro forma consolidated results of operations for the year ended December 31, 2021 as if the Transaction had occurred on January 1, 2020. The pro forma information provided below is compiled from the pre-acquisition financial information of MediaCrossing and includes certain pro forma adjustments for the amortization of intangible assets and transaction costs. The pro forma results are not necessarily indicative of (i) the results of operations that would have occurred had the operations of this acquisition actually been acquired at the beginning of fiscal year 2020 or (ii) future results of operations:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,439,093</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,527,651</p></td></tr><tr><td style="vertical-align:bottom;width:68.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net Loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,510,391)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,032,939)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 500000 822369 0.00001 822369 2.55 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Purchase Consideration:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Cash</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 500,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Contingent consideration</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 613,000</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total Purchase Consideration</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,113,000</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Less:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Customer contracts and related customer relationships (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 580,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Restrictive covenant agreements (1)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 70,000</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Debt-free net working capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fair Value of Identified Net Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 650,000</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining Unidentified Goodwill Value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 463,000</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">As part of the preliminary valuation analysis, the Company identified (i) customer contracts and related customer relationships and (ii) restrictive covenant agreements as intangible assets. The fair value of the identifiable intangible assets is determined using the “income approach”. The customer contracts and related customer relationships have an estimated useful life of </span><span style="-sec-ix-hidden:Hidden_SWwgaGWS0E25ngwCiTvkIg;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">five</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (5) years and the restrictive covenant agreements have an estimated useful life of </span><span style="-sec-ix-hidden:Hidden_4vCUGgQAMESltDnT8TA-5A;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">three</span></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> (3) years.</span></td></tr></table><div style="margin-top:12pt;"/> 500000 613000 1113000 580000 70000 650000 463000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current Assets:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Prepaid expenses and other current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 109,083</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Other receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 526,070</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><b style="font-weight:bold;">Total Current Assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 635,153</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Current Liabilities:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 628,418</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Accrued expenses and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,735</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><b style="font-weight:bold;">Total Current Liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 635,153</p></td></tr><tr><td style="vertical-align:bottom;width:81.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><span style="font-weight:bold;margin-left:0pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:81.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;"><b style="font-weight:bold;">Debt-Free Net Working Capital</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.24%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table> 109083 526070 635153 628418 6735 635153 154954 18447 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:29.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.13%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net Revenues</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,439,093</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,527,651</p></td></tr><tr><td style="vertical-align:bottom;width:68.13%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Net Loss</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (12,510,391)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.45%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9,032,939)</p></td></tr></table> 5439093 7527651 -12510391 -9032939 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 4 - INTANGIBLE ASSETS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On June 15, 2021, pursuant to an asset purchase agreement dated June 4, 2021, the Company closed on the acquisition of a customer list (the “Customer List”) and other assets of Advisio Solutions, LLC (“Advisio”) for consideration consisting of: (i) $1,050,000 paid in cash and (ii) the issuance of an aggregate of 100,000 shares of the Company’s common stock with an aggregate issuance date fair value of $532,000. Under the screen test requirements under ASC 805, the Company concluded that the Customer List represented substantially all of the fair value of the gross assets acquired and, accordingly, determined the set was not considered a business, such that the Company applied asset acquisition accounting and recorded the acquisition of the Customer List as an intangible asset in the amount of $1,582,000 that will be amortized on a straight-line basis over its useful life of seven years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Intangible assets consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Acquired data</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Acquired software</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 183,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 100,000</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Acquired customer lists</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,162,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restrictive covenant agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 70,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,715,408</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,400,336</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: accumulated amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (768,798)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (328,486)</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Intangible assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,946,610</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,071,850</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Amortization of intangible assets consists of the following:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restrictive </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Covenant </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Software</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Lists</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Agreements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,667)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,333</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Amortization expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (311,819)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (311,819)</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of December 31, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (328,486)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,071,850</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,162,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 70,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,315,072</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Amortization expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (440,312)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (440,312)</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 183,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,162,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 70,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (768,798)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,946,610</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average remaining amortization period at December 31, 2021 (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restrictive</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Covenant </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated </b></p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Software</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Lists</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Agreements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,667</p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Amortization expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 261,819</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 311,819</p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of December 31, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 261,819</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 66,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 328,486</p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Amortization expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 252,081</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 138,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 440,312</p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 513,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 138,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 768,798</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The estimated future amortization expense is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ending December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:19.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 718,601</p></td></tr><tr><td style="vertical-align:bottom;width:76.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 706,206</p></td></tr><tr><td style="vertical-align:bottom;width:76.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 683,192</p></td></tr><tr><td style="vertical-align:bottom;width:76.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 270,194</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026 and beyond</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 568,417</p></td></tr><tr><td style="vertical-align:bottom;width:76.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,946,610</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 1050000 100000 532000 1582000 P7Y <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Intangible assets consist of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:25.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Acquired data</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Acquired software</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 183,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 100,000</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Acquired customer lists</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,162,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Restrictive covenant agreements</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 70,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,715,408</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,400,336</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Less: accumulated amortization</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (768,798)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (328,486)</p></td></tr><tr><td style="vertical-align:bottom;width:72.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Intangible assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.54%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,946,610</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.53%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,071,850</p></td></tr></table> 1300336 1300336 183072 100000 2162000 70000 3715408 1400336 768798 328486 2946610 1071850 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Amortization of intangible assets consists of the following:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restrictive </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Covenant </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Software</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Lists</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:7.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Agreements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.94%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (16,667)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,333</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Amortization expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (311,819)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (311,819)</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of December 31, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 100,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (328,486)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,071,850</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Additions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,162,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 70,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,315,072</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Amortization expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (440,312)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (440,312)</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,300,336</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 183,072</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,162,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 70,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (768,798)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,946,610</p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Weighted average remaining amortization period at December 31, 2021 (in years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:38.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:40.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:40.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Restrictive</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Acquired </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Covenant </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Accumulated </b></p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Data</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Software</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.95%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> Lists</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.51%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Agreements</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Amortization</b></p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of January 1, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,667</p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Amortization expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 261,819</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 311,819</p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of December 31, 2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 261,819</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 66,667</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 328,486</p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Amortization expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 252,081</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 48,538</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 138,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 440,312</p></td></tr><tr><td style="vertical-align:bottom;width:40.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Balance as of December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 513,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 115,205</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.79%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 138,528</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.33%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,165</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.34%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.61%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 768,798</p></td></tr></table> 0 100000 0 0 -16667 83333 1300336 1300336 311819 311819 1300336 100000 -328486 1071850 83072 2162000 70000 2315072 440312 440312 1300336 183072 2162000 70000 -768798 2946610 P3Y P1Y P5Y6M P4Y10M24D P4Y4M24D 16667 -16667 261819 50000 311819 261819 66667 -328486 252081 48538 138528 1165 440312 513900 115205 138528 1165 -768798 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The estimated future amortization expense is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:76.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:76.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ending December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:19.8%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:bottom;width:76.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 718,601</p></td></tr><tr><td style="vertical-align:bottom;width:76.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 706,206</p></td></tr><tr><td style="vertical-align:bottom;width:76.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 683,192</p></td></tr><tr><td style="vertical-align:bottom;width:76.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2025</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 270,194</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:76.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">2026 and beyond</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 568,417</p></td></tr><tr><td style="vertical-align:bottom;width:76.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.44%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,946,610</p></td></tr></table> 718601 706206 683192 270194 568417 2946610 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 5 – ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Accrued expenses and other current liabilities consisted of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued bonuses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 554,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 541,834</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,947</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Financed director and officer insurance premiums</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 217,575</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued supplier expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,042,971</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,972</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal and professional fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,323</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,653</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 36,109</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,768</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued media commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 138,028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Credit card payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 328,075</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 901</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued programming expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,750</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued issuable equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 293,724</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,975</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued warrant exercise costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,519</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 45,915</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,758</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total accrued expenses and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,493,287</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,017,282</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Accrued expenses and other current liabilities consisted of the following:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued bonuses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 554,997</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 541,834</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued payroll taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,947</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Financed director and officer insurance premiums</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 217,575</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued supplier expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,042,971</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 50,972</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued legal and professional fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,323</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 80,653</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 36,109</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,768</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued media commissions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 138,028</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Credit card payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 328,075</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 901</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued programming expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,750</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16,750</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued issuable equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,258</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 293,724</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued interest</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9,017</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,975</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Accrued warrant exercise costs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 83,519</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 45,915</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 19,758</p></td></tr><tr><td style="vertical-align:bottom;width:71.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total accrued expenses and other current liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,493,287</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1,017,282</p></td></tr></table> 554997 541834 13750 5947 217575 1042971 50972 20323 80653 36109 2768 138028 328075 901 1750 16750 1258 293724 9017 3975 83519 45915 19758 2493287 1017282 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 6 — INCOME TAXES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The provision for income taxes consists of the following provisions/(benefits):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred tax benefit:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,183,635)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (132,480)</p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">State and local</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (978,739)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (641,793)</p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,162,374)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (774,273)</p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,162,374</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 774,273</p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Provision for income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The provision for income taxes differs from the statutory federal income tax rates as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Tax expense at the federal statutory rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">21.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">State taxes, net of federal benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Permanent differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10.3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">True-up</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4.4)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30.7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9.8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Effective income tax rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The components of deferred tax assets as of December 31, 2021 and 2020 relate to temporary differences and carryforwards as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net operating loss carryforwards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,383,659</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,702,003</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 169,427</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 102,409</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,972</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Accrued Legal Settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 290,948</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Other reserve</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 59,682</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 55,699</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Intangibles</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 211,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,733</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Tax credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 90,952</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 90,952</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,214,291</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,019,796</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fixed assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (36,902)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,781)</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (36,902)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,781)</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,177,389)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,015,015)</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Deferred tax assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, the Company had approximately $18,263,000 of federal net operating loss (“NOL”) carryforwards that may be available to offset future taxable income. As of that date, approximately $533,000 of federal net operating losses will expire in 2037 and approximately $17,730,000 have no expiration. In addition, the Company has approximately $91,000 of federal research and development credit carryforwards that begin to expire in 2037. The Company also had approximately $29,016,000 of state and local NOLs that begin to expire in 2037. The utilization of NOL carryforwards and research and development credits to offset future taxable income may be subject to limitations under Section 382 of the Internal Revenue Code and similar state statutes as a result of ownership changes that could occur in the future. If necessary, the deferred tax assets will be reduced by any carryforward that expires prior to utilization as a result of such limitations, with a corresponding reduction of the valuation allowance.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has assessed the likelihood that deferred tax assets will be realized in accordance with the provisions of ASC 740, Income Taxes (“ASC 740”). ASC 740 requires that such a review considers all available positive and negative evidence, including the scheduled reversal of deferred tax liabilities, projected future taxable income, and tax planning strategies. ASC 740 requires that a valuation allowance be established when it is “more likely than not” that all, or a portion of, deferred tax assets will not be realized. After the performance of such reviews as of December 31, 2021 and 2020, management believes that uncertainty exists with respect to future realization of its deferred tax assets and has, therefore, established a full valuation allowance as of those dates. Thus, the Company increased the valuation allowance by $3,162,374 and $774,273 during the years ended December 31, 2021 and 2020, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Management has evaluated and concluded that there were no material uncertain tax positions requiring recognition in the Company’s consolidated financial statements as of December 31, 2021 and 2020. The Company does not expect any significant changes in its unrecognized tax benefits within twelve months of the reporting date.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to income taxes in the United States and in various state taxing jurisdictions including New York, New York City and California. No tax audits were commenced or were in process during the years ended December 31, 2021 and 2020. No tax related interest or penalties were incurred during the years ended December 31, 2021 and 2020. The Company’s Federal, New York State and City, and State of California income tax returns filed since inception remain subject to examination.</p> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended </b></p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.68%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.77%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Deferred tax benefit:</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Federal</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,183,635)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (132,480)</p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">State and local</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (978,739)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (641,793)</p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,162,374)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (774,273)</p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,162,374</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 774,273</p></td></tr><tr><td style="vertical-align:bottom;width:71.3%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Provision for income taxes</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.29%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.47%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table> -2183635 -132480 -978739 -641793 -3162374 -774273 3162374 774273 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Tax expense at the federal statutory rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">21.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 21.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">State taxes, net of federal benefit</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Permanent differences</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (0.2)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (10.3)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">True-up</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4.4)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Change in valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (30.7)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (9.8)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Effective income tax rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.44%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">0.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table> 0.210 0.210 0.087 0.035 -0.002 -0.103 0.012 -0.044 -0.307 -0.098 0.000 0.000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:26.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31,</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.54%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Net operating loss carryforwards</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,383,659</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2,702,003</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Stock-based compensation expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 169,427</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 102,409</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Deferred Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7,972</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Accrued Legal Settlement</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 290,948</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Other reserve</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 59,682</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 55,699</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Intangibles</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 211,651</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 68,733</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Tax credits</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 90,952</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 90,952</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,214,291</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,019,796</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Fixed assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (36,902)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,781)</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Deferred tax liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (36,902)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (4,781)</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Valuation allowance</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (6,177,389)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (3,015,015)</p></td></tr><tr><td style="vertical-align:bottom;width:71.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 6pt;">Deferred tax assets, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.87%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table> 5383659 2702003 169427 102409 7972 290948 59682 55699 211651 68733 90952 90952 6214291 3019796 36902 4781 36902 4781 6177389 3015015 18263000 533000 17730000 91000 29016000 3162374 774273 0 0 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 7 – NOTES PAYABLE</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the years ended December 31, 2021 and 2020, the Company recorded cash interest expense of $8,383 and $207,092, respectively, and non-cash amortization of debt discount and debt issuance costs of $0 and $915,994, respectively, which is included in interest expense on the consolidated statements of operations. <span style="color:#0d0d0d;">As of December 31, 2021 and 2020, the Company had </span><span style="color:#0d0d0d;">$9,017</span><span style="color:#0d0d0d;"> and </span><span style="color:#0d0d0d;">$4,599</span><span style="color:#0d0d0d;">, respectively, of accrued interest related to notes </span>payable.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the years ended December 31, 2021 and 2020, the Company recorded cash interest expense – related parties of $0 and $46,171, respectively, and non-cash amortization of debt discount and debt issuance costs – related parties of $0 and $357,201, respectively. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the years ended December 31, 2021 and 2020, the Company made aggregate principal repayments of notes payable of $177,347 and $95,000, respectively, and $0 and $150,000, respectively, of repayments of notes payable – related party<i style="font-style:italic;">.</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Notes Payable</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">PPP Loan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On April 6, 2020, the Company received a loan in the amount of approximately $327,000 (the “PPP Loan”) from JPMorgan Chase Bank, N.A., as lender, pursuant to the Paycheck Protection Program (“PPP”) of the Coronavirus Aid, Relief and Economic Security Act, as amended (the “CARES Act”). The PPP Loan matures on April 16, 2022 and bears interest at a rate of 0.98% per annum. Commencing May 16, 2021, the Company is required to pay the lender equal monthly payments of principal and interest as required to fully amortize by April 16, 2022 the principal amount outstanding on the PPP Loan as of the date prescribed by guidance issued by the U.S. Small Business Administration (“SBA”). The PPP Loan is evidenced by a promissory note dated April 6, 2020, which contains customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. The PPP Loan may be prepaid by the Company at any time prior to maturity with no prepayment penalties. As of December 31, 2021 and 2020, the amount outstanding under the PPP Loan was $149,843 and $327,290, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 0pt;">EIDL Loan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On June 23, 2020, the Company received a loan in the amount of approximately $79,000 (the “EIDL Loan”) from the SBA, as lender, under the SBA’s Economic Injury Disaster Loan (“EIDL”) assistance program. The EIDL Loan bears interest at 3.75% per annum. Monthly installment payments in the amount of $385 per month, including principal and interest, will begin June 20, 2021. The EIDL Loan matures on June 20, 2050, and is evidenced by a promissory note, loan authorization agreement, and security agreement, all dated June 20, 2020, and all of which contain customary events of default relating to, among other things, payment defaults and breaches of representations and warranties. The EIDL Loan is collateralized by the assets of the Company. Such EIDL Loan amount will reduce the Company’s PPP loan forgiveness amount described above. The EIDL Loan may be prepaid by the Company at any time prior to maturity with no prepayment penalties. As of December 31, 2021 and 2020, the amount outstanding under the EIDL Loan was $78,900.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Separately, during the year ended December 31, 2020, the Company also received a grant of $10,000 from the SBA under the EIDL assistance program. The grant was recognized as other income during the year ended December 31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Notes Payable – Related Parties</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the year ended December 31, 2020, the Company received aggregate proceeds of $685,000 in connection with three-year notes payable issued to three of its executive officers. The notes bear interest ranging from 0.91% and 1.60% per annum, payable annually. The outstanding principal and accrued and unpaid interest became immediately due and payable upon the Company’s initial public offering. Effective July 13, 2020, the holders agreed to amend the terms of the notes to provide for automatic conversion of principal and interest thereunder into shares of common stock and warrants to purchase shares of common stock at the public offering price per unit. The Company determined that the amended terms were debt modifications. Upon closing of the initial public offering which resulted in net proceeds of approximately $10.6 million (“IPO”) on August 14, 2020, such notes payable, along with accrued interest of $6,048, automatically converted into an aggregate of 138,209 shares of common stock and five-year warrants to purchase 138,209 shares of common stock at an exercise price of $5.50 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In addition to these related party notes, on July 28, 2020, the Company received proceeds of $150,000 in connection with a note payable that was issued to an entity controlled by the Company’s then-Chief Executive Officer. The note bears interest at 0.17% per annum, payable annually. The note matures and is repayable in cash by the Company on October 28, 2020, subject to acceleration following the occurrence of an IPO, qualified financing or sale of the Company (as such terms are defined in the note). On September 24, 2020, the Company fully repaid the note.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Convertible Notes Payable</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Upon the closing of the initial public offering, the Senior Notes and Junior Notes automatically converted into common stock and warrants at a conversion price of $3.50. Based on the foregoing, the Senior Notes and Junior Notes converted into an aggregate of 1,322,881 shares of common stock and five-year warrants to purchase an aggregate of 1,322,881 shares of common stock at an exercise price of $5.50 per share (based on aggregate principal balance of $4,326,000 and aggregate accrued interest of $304,090 as of August 14, 2020). The Company recognized expense of approximately $2.4 million associated with the recognition of a beneficial conversion feature of $1,984,322 and interest expense in connection with the amortization of unamortized debt discount of $393,959.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Upon the closing of the IPO, a down round feature was triggered in warrants held by holders of Senior Notes and Junior Notes, such that the warrants, which have an exercise price of $4.20 per unit, are exercisable into an aggregate of 1,235,997 shares of common stock and five-year warrants to purchase an aggregate of 1,235,997 shares of common stock at an exercise price of $5.50 per share. In connection with the down round being triggered, the Company recognized a deemed dividend of $1,682,000 during the year ended December 31, 2020 on the consolidated statements of operations, which represents the incremental fair value, estimated using a binomial model, provided to the holders in connection with the down round.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On August 12, 2020, a noteholder exercised its option to convert a convertible note payable in the principal amount of $20,000 and accrued interest in the amount of $3,370 at a conversion price of $0.29 per share that was not subject to the Reverse Stock Split, which resulted in the issuance of 80,586 shares of common stock. In connection with the conversion, the Company recognized a loss on extinguishment of convertible note payable of $297,272, which represented the fair value of the additional shares issued to the noteholder as a result of not applying the Reverse Stock Split.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On August 14, 2020, a noteholder exercised its option to convert a convertible note payable in the principal amount of $45,000 and accrued interest in the amount of $22,502 at a conversion price of $4.95 per share, which resulted in the issuance of 13,637 shares of common stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Due to Related Party</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company repaid $29,000 during the year ended December 31, 2020 related to a non-interest-bearing advance from a company controlled by an executive officer.</p> 8383 207092 0 915994 9017 4599 0 46171 0 357201 177347 95000 0 150000 327000 0.0098 149843 327290 79000 0.0375 385 78900 10000 685000 P3Y 3 0.0091 0.0160 10600000 6048 138209 P5Y 138209 5.50 150000 0.0017 3.50 1322881 P5Y 1322881 5.50 4326000 304090 2400000 1984322 393959 4.20 1235997 P5Y 1235997 5.50 1682000 20000 3370 0.29 80586 297272 45000 22502 4.95 13637 29000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 8 — STOCKHOLDERS’ EQUITY</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Authorized Capital</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The authorized capital of Kubient consists of 95,000,000 shares of common stock, par value $0.00001 per share, and 5,000,000 shares of preferred stock, par value $0.00001 per share. The holders of the Company’s common stock are entitled to one vote per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Reverse Stock Split</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A 1:9 reverse stock split of the Company’s common stock was affected on August 6, 2020 (the “Reverse Stock Split”). All share and per share information has been retroactively adjusted to give effect to the Reverse Stock Split for all periods presented, unless otherwise indicated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Public Offerings</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On August 14, 2020, the Company consummated its initial public offering of 2,500,000 units (the “Units”) at a price of $5.00 per Unit, which resulted in aggregate gross and net proceeds of approximately $12.5 million and $10.6 million, respectively. Each Unit consisted of one share of common stock, par value $0.00001 per share and one warrant to purchase one share of common stock (the “Warrants”). The Warrants are exercisable immediately upon issuance and at any time up to the date that is five years from the date of issuance and will have an exercise price of $5.50 per share.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On August 14, 2020, the Company consummated the closing of a partial exercise of the over-allotment option granted to the underwriters in connection with its IPO to purchase 375,000 additional common stock purchase warrants at a price of $0.01 per warrant for aggregate proceeds of $3,750.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On August 14, 2020, in connection with its IPO, the Company issued to the underwriters warrants to purchase 125,000 shares of common stock at $6.25 per share. The warrants are exercisable at any time for cash or on a cashless basis during the four- and one-half year period commencing 180 days from the effective date of the Company’s registration statement. The warrants had an issuance date fair value of $225,850 that was recorded as a debit and credit to additional paid-in capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On December 28, 2020, the Company consummated a Follow-On Offering of 4,058,822 shares of common stock at a price of $5.10 per share for aggregate gross and net proceeds of approximately $20.7 million and $18.9 million, respectively, which such amounts include the full exercise by the underwriters of the over-allotment option to purchase an additional 529,411 shares of common stock at $5.10 per share. The Company issued to the representatives of the underwriters warrants to purchase 176,470 shares of common stock at an exercise price of $6.38 per share. The warrants are exercisable at any time for cash or on a cashless basis during the <span style="-sec-ix-hidden:Hidden_OjRuiWQVT0SuspJCvfE6gQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">four</span></span>- and one-half year period commencing 180 days from the effective date of the Company’s registration statement. The warrants had an issuance date fair value of $447,987 that was recorded as a debit and credit to additional paid-in capital.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 6 – Notes Payable for additional details.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Equity Incentive Plans</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The 2017 Equity Incentive Plan (the “2017 Plan”) was originally adopted by the Company’s board of directors and approved by its stockholders on September 12, 2017 and was subsequently amended and restated on June 5, 2019. The purposes of the 2017 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our service providers and to promote the success of the Company’s business. The Company has reserved 333,334 shares of common stock to issue awards under the 2017 Plan. as of December 31, 2021, 11,889 shares of common stock remained available for future issuance under the 2017 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The 2021 Equity Incentive Plan was originally adopted by the Company’s board of directors and approved by its stockholders on June 30, 2021 (the “2021 Plan”). The purposes of the 2021 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our service providers and to promote the success of the Company’s business. The Company has reserved 1,500,000 shares of common stock to issue awards under the 2021 Plan. As of December 31, 2021, 1,400,000 shares of common stock remained available for future issuance under the 2021 Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Founder Employee Incentive Program</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On July 2, 2020, the Company’s board of directors adopted the Founder Employee Incentive Program (the “Founder Program”) under the 2017 Plan. The purposes of the Founder Program are to offer near-term and long-term incentives to founder employees of the Company that are intended to keep such employees in the employ of the Company, and that are based on individual performance, the achievement of financial goals of the Company and the total return to the Company’s stockholders. Through December 31, 2021, no awards have been issued by the Company under the Founder Program.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Stock-Based Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the years ended December 31, 2021 and 2020, the Company recognized stock-based compensation expense related to stock options and common stock as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:28.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:28.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales and marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 270,460</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 54,723</p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Technology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,631</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,891</p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">General and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 421,951</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 399,602</p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 724,042</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 468,216</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2021, there was approximately $875,000 of unrecognized stock-based compensation expense related to awards that were determined to be probable to vest, which will be recognized over approximately 2.3 years.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Common Stock</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the year ended December 31, 2020, the Company issued an aggregate of 38,433 shares of immediately vested common stock under the 2017 Plan to three employees and two non-employee service providers. The shares had an issuance date fair value of an aggregate of $107,503, which was recognized immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the three months ended March 31, 2021, the Company issued an aggregate of 20,040 shares of common stock under the 2017 Plan to the four members of the Company’s Board of Directors. The shares had a grant date fair value of $60,120, which was recognized ratably from the grant date of November 5, 2020 through January 15, 2021, the date the shares were issued.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the three months ended March 31, 2021, the Company issued an aggregate of 50,000 shares of immediately vested common stock (10,000 shares were issued under the Company’s 2017 Plan) to an employee and a consultant for services provided. The common stock had an aggregate issuance date fair value of $500,400 which was recognized immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the three months ended June 30, 2021, the Company issued an aggregate of 167,600 restricted shares of its common stock under the 2017 Plan to six employees. The restricted stock had an aggregate issuance date fair value of $963,701, of which, awards with an aggregate fair value of $957,313 vest over a period of one year and an award with an aggregate fair value of $6,388 vests immediately. The fair value of the awards is being recognized over the vesting term.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the three months ended December 31, 2021, the Company issued 1,062 shares of immediately vested common stock to a former member of the Company’s Board of Directors that had an issuance date fair value of $3,282 that was recognized immediately.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 4 – Intangible Assets for details regarding the issuance of common stock as partial consideration for the acquisition of intangible assets. See Note 7 – Notes Payable for additional details related to common stock issuances. See Note 9 – Commitments and Contingencies – Employment Agreements for details regarding the grant of a bonus that is payable in common stock of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Stock Options</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On November 9, 2020, the Company granted a ten-year option to purchase 20,000 shares of common stock at an exercise price of $2.81 per share to an employee under the 2017 Equity Incentive Plan. The shares vest over a four-year period, with 5,000 shares vesting on November 9, 2021 and the remaining 15,000 shares vesting ratably on a monthly basis over the remaining three-year period. The options had an aggregate grant date fair value of $32,981, or $1.31 per share, which will be recognized over the vesting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During the year ended December 31, 2021, the holder of an option under the 2017 Plan to purchase 2,815 shares of the Company’s common stock at an exercise price of $2.97 per share exercised such option resulting in cash proceeds of $8,361 to the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In applying the Black-Scholes option pricing model to stock options granted, the Company used the following approximate assumptions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">55.8%-56.3%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0.57%-1.65%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected dividends</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0.00%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">A summary of the Company’s stock option activity during the year ended December 31, 2021 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining Term </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1,2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 118,412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15.22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,150)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,815)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94,447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,339</p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 66,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,276</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table presents information related to stock options as of December 31, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:49.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:46.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options Exercisable</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:23.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In Years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,416</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42,779</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42,779</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,556</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,255</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26,112</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,790</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94,447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 66,240</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Stock Warrants</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 6 – Notes Payable – Convertible Notes Payable and Note 7 – Stockholder’s Equity – Public Offerings for details regarding the issuance of warrants during the year ended December 31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The Company used the following approximate assumptions in connection with its estimation of fair value of warrants:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">3.86-4.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">58.0%-61.2%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0.24%-0.39%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected dividends</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0.00%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">A summary of the warrant activity during the year ended December 31, 2021 is presented below:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In Years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding, January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,167,745</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Issued</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 867,286</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;">Exercised</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> (2,281,668)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> 5.04</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;">  </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;">  </span></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Expired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding, December 31, 2021[1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,753,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.42</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable, December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,753,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.4pt;text-align:justify;text-indent:-14.4pt;margin:0pt 0pt 12pt 0pt;">[1] Excludes five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share that are issuable upon exercise of certain warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table presents information related to stock warrants as of December 31, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:49.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:46.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants Exercisable</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:23.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In Years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 9pt 0.05pt 0pt;"> 4.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 368,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 368,711</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 9pt 0.05pt 0pt;"> 4.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 177,223</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 177,223</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 9pt 0.05pt 0pt;"> 5.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,998,459</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,998,459</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 9pt 0.05pt 0pt;"> 6.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,500</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 9pt 0.05pt 0pt;"> 6.38</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 176,470</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 176,470</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,753,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,753,363</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">​</span></p> 95000000 0.00001 5000000 0.00001 one vote per share 2500000 5.00 12500000 10600000 0.00001 1 1 P5Y 5.50 375000 0.01 3750 125000 6.25 225850 4058822 5.10 20700000 18900000 529411 5.10 176470 6.38 447987 333334 11889 1500000 1400000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:28.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="5" style="vertical-align:bottom;white-space:nowrap;width:28.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:12.96%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales and marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 270,460</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 54,723</p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Technology</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31,631</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,891</p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">General and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.15%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 421,951</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 399,602</p></td></tr><tr><td style="vertical-align:bottom;width:68.44%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.15%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 724,042</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.82%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.18%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 468,216</p></td></tr></table> 270460 54723 31631 13891 421951 399602 724042 468216 875000 P2Y3M18D 38433 3 2 107503 20040 4 60120 50000 10000 500400 167600 6 963701 957313 P1Y 6388 1062 3282 P10Y 20000 2.81 P4Y 5000 15000 P3Y 32981 1.31 2815 2.97 8361 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.18%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.18%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">6.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">55.8%-56.3%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0.57%-1.65%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:74.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected dividends</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0.00%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> P6Y29D 0.558 0.563 0.0057 0.0165 0.0000 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">A summary of the Company’s stock option activity during the year ended December 31, 2021 is as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining Term </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:11.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(Years)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:9.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at January 1,2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 118,412</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15.22</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Granted</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Forfeited</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (21,150)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33.16</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Exercised</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,815)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding at December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94,447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,339</p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:52.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable at December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.01%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 66,240</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.15%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.6%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 9.49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.92%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.37%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,276</p></td></tr></table> 118412 15.22 21150 33.16 2815 2.97 94447 11.56 P4Y4M24D 6339 66240 9.49 P2Y10M24D 3276 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table presents information related to stock options as of December 31, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:49.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:46.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options Exercisable</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:23.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In Years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.81</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 20,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 8.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,416</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.97</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42,779</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42,779</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5,556</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 0.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,255</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 33.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26,112</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 7.8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 13,790</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 94,447</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.9</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 66,240</p></td></tr></table> 2.81 20000 P8Y10M24D 5416 2.97 42779 P0Y8M12D 42779 4.95 5556 P0Y10M24D 4255 33.75 26112 P7Y9M18D 13790 94447 P2Y10M24D 66240 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:24.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected term (years)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">3.86-4.75</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected volatility</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">58.0%-61.2%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Risk free interest rate</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0.24%-0.39%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Expected dividends</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">0.00%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr></table> 3.86 4.75 58.0 61.2 0.24 0.39 0.00 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Intrinsic</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In Years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:8.66%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding, January 1, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 6,167,745</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Issued</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 867,286</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;">Exercised</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> (2,281,668)</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> 5.04</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;">  </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;"> </span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="color:#0d0d0d;">  </span></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Expired</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;">  </p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Outstanding, December 31, 2021[1]</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,753,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.42</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:7.2pt;text-indent:-7.2pt;margin:0pt 0pt 0.05pt 0pt;">Exercisable, December 31, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.38%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,753,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 5.35</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.64%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.86%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> —</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.4pt;text-align:justify;text-indent:-14.4pt;margin:0pt 0pt 12pt 0pt;">[1] Excludes five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share that are issuable upon exercise of certain warrants.</p> 6167745 5.26 867286 5.50 -2281668 5.04 4753363 5.42 P3Y6M 4753363 5.35 P3Y6M P5Y 368711 5.50 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table presents information related to stock warrants as of December 31, 2021:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:79.99%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;width:49.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:46.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants Exercisable</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining Life</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:23.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise Price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">In Years</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 9pt 0.05pt 0pt;"> 4.20</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 368,711</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 2.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 368,711</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 9pt 0.05pt 0pt;"> 4.95</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 177,223</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 1.3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 177,223</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 9pt 0.05pt 0pt;"> 5.50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,998,459</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3,998,459</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 9pt 0.05pt 0pt;"> 6.25</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 32,500</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 9pt 0.05pt 0pt;"> 6.38</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 176,470</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4.0</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 176,470</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,753,363</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 3.5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.56%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 4,753,363</p></td></tr></table> 4.20 368711 P2Y8M12D 368711 4.95 177223 P1Y3M18D 177223 5.50 3998459 P3Y8M12D 3998459 6.25 32500 P3Y7M6D 32500 6.38 176470 P4Y 176470 4753363 P3Y6M 4753363 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 9 – COMMITMENTS AND CONTINGENCIES</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, the Company is a defendant or plaintiff in various legal actions that arise in the normal course of business. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Settlements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On October 6, 2017, the Company entered into a Master Service Agreement for Buyers and Sellers, and an “Engage Buyer Addendum”, with Engage BDR, LLC whereby the Company could gain access to the Engage BDR, LLC proprietary trading technology platform in order to both offer and purchase inventory for the placement of ads. On August 31, 2018, Engage BDR, LLC filed suit against the Company (Engage BDR, LLC v. Kubient, Inc., Los Angeles County Superior Court Case No. SC129764) setting forth claims of breach of contract, unjust enrichment, quantum meruit, accounts stated, and breach of implied covenant of good faith and fair dealing. On November 14, 2018, Engage BDR, LLC obtained a summary default judgment against the Company for $35,936. On February 17, 2021, the Company and Engage BDR, LLC entered into a settlement agreement in the amount of $33,461 and the Company paid such amount on February 19, 2021, which had been accrued for as of December 31, 2020.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">See Note 11 – Subsequent Events for details of the settlement of previously outstanding litigation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Obligations Arising from Employment Agreements</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On April 9, 2021, the Company entered into an at-will employment agreement with its new Chief Product Officer, Mr. Leon Zemel, that provides for an annual base salary of $390,000, plus annual performance bonuses with a target achievement of up to 20% of Mr. Zemel’s base salary. Subject to the approval of the board or its compensation committee, the Company agreed to take appropriate action within ninety (90) days following April 9, 2021 to make an award of 100,000 shares of common stock to Mr. Zemel, which will vest at the rate of 1/4th of the total number of shares on the first anniversary of the Effective Date and 1/36th of the total number of remaining unvested shares each month thereafter. As of September 30, 2021, the award had not been granted. Upon termination of Mr. Zemel’s employment for any reason, Mr. Zemel is entitled to (i) any portion of his base salary earned through the date of his termination date, (ii) any expenses owed to him, (iii) subject to Company policy and the law, any accrued, but unused vacation pay owed to him, pursuant to Company policy, if any, to the extent not inconsistent with applicable laws, and (iv) any amount arising from Mr. Zemel’s participation in, or benefits under, the Company’s employee benefit plans. In the event Mr. Zemel is terminated without cause or that Mr. Zemel resigns for Good Reason (as defined in his employment agreement), Mr. Zemel is entitled to receive: to six month’s salary paid in one lump sum, six months continued healthcare coverage, any pro-rated bonus amounts outstanding at the time of termination, and immediate vesting of any equity awards that would have become vested and exercisable during the three months after his termination. Mr. Zemel’s employment agreement contains an accelerated vesting provision which provides that 25% of his share award under the agreement shall vest if he is terminated before the one-year anniversary date of the agreement for good cause, or if he chooses to terminate his </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">employment with the Company for Good Reason (as defined in the agreement), then 100% of his share award under the agreement shall vest immediately. All outstanding awards due to Mr. Zemel automatically vest upon a change in control of the Company.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On June 4, 2021 (the “Effective Date”), the Company entered into two-year employment agreements with its two new Vice Presidents of Performance Media. The agreements provide for a bonus paid to each Vice President of Performance Media of (i) the issuance of up to 67,738 shares of the Company’s common stock (the “First Year Bonus”) on the 12-month anniversary of the Effective Date if as of such date the net revenue, as defined within the agreement, generated from the Customer List through the respective Vice President of Performance Media’s performance marketing is between $175,000 and an amount in excess of $350,000, which First Year Bonus shall vest in two equal equity installments, the first of which occurring on the second anniversary of the issuance thereof and the second of which occurring on the fourth anniversary of the issuance thereof (the “Year 1 Equity Grant”), and (ii) the issuance of up to 67,738 shares of the Company’s common stock (the “Second Year Bonus”) on the 24-month anniversary of the Effective Date if as of such date the net revenue, as defined within the agreement, generated from the Customer List through the respective Vice President of Performance Media’s performance marketing is between $262,000 and an amount in excess of $525,000, which Second Year Bonus shall vest in two equal equity installments, the first of which occurring on the second anniversary of the issuance thereof and the second of which occurring on the fourth anniversary of the issuance thereof (the “Year 2 Equity Grant”).  If either Vice President of Performance Media ends the Term of Employment for good reason, as defined within the agreement, or the Company terminates either Vice President of Performance Media without cause, such Vice President of Performance Media shall (i) receive $150,000 prorated for two months following such termination and for an additional year for every year the Vice President of Performance Media was employed by Company, and (ii) payment of any earned, but unpaid, performance-based performances due as of the date of such termination (“Severance”). The Company determined that the First Year Bonus and Second Year Bonus to each Vice President of Performance Media represents an accounting grant with a performance-based vesting condition pursuant to Accounting Standards Codification 718. The aggregate grant date fair value of the awards of $1,400,822 will be recognized over the respective vesting term for awards that are deemed to be probable to vest.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">On November 29, 2021, Mitchell Berg was appointed to serve as its Chief Technology Officer of the Company. Upon joining the Company as Chief Technology Officer, Mr. Berg will receive an annual base salary of $300,000, a restricted stock unit (“RSU”) award of 80,000 shares of common stock of the Company, and a performance stock unit (“PSU”) award of 50,000 shares of common stock of the Company. Mr. Berg will also be eligible to participate in the Company’s Short Term Incentive Plan (“STIP”) and his target bonus pursuant to the STIP will be $100,000. Provided, however that any payout pursuant to the STIP will be determined by the Company and its board of directors or compensation committee, in its discretion, after considering Mr. Berg’s individual performance and the overall performance of the Company’s business. Upon a termination for any reason, Mr. Berg is entitled to any unpaid but accrued portion of his base salary earned through the date of his termination, payment for any accrued but unused vacation pay, any expenses owed to him pursuant to his employment agreement, and any amounts owed under the Company’s benefit plans. In the event Mr. Berg experiences a Covered Termination (as defined in his employment agreement), Mr. Berg shall be entitled to six month’s salary paid in one lump sum, six months continued healthcare coverage, payment of any Annual Bonus (as defined in his employment agreement) earned but that has not been paid and a pro-rata portion of any Annual Bonus earned in the fiscal year in which the Covered Termination takes place, and immediate vesting of any equity awards that would have become vested and exercisable during the three months after his termination. All outstanding RSU awards due to Mr. Berg automatically vest upon a change in control of the Company. The RSU was determined to be granted for accounting purposes on November 29, 2021 under the 2021 Plan and had a grant date fair value $216,800 that will be recognized vesting term. Given that the PSU contains performance conditions that had not been determined as of December 31, 2021, the Company determined that the PSU had not been considered granted for accounting purposes as of December 31, 2021. The PSU was deemed to be granted on January 12, 2022 and both PSU and RSU awards were issued on February 15, 2022.</p> 35936 33461 390000 0.20 100000 P6M P6M P3M 0.25 1 P2Y 2 67738 175000 350000 2 67738 262000 525000 2 150000 P2M -1400822 300000 80000 50000 1000 P3M 216800 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 10 — CONCENTRATIONS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Customer Concentrations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 85.77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 51.40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26.43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18.24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer H</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer I</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 97.33</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 96.07</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Less than 10%.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, certain customers generate negative net revenues that resulted from Supplier Costs that exceeded the Gross Billing. As a result, the Company’s concentrations on net revenues may result in total percentages that exceed 100%.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A reduction in sales from or loss of these customers would have a material adverse effect on the Company’s results of operations and financial condition.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Supplier Concentrations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Supplier</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Supplier B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15.51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Supplier C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Supplier D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Supplier E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31.83</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Less than 10%.</p></td></tr></table> <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each customer that accounted for 10% or more of the Company’s net revenues for the following periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 85.77</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 51.40</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 26.43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 18.24</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 11.56</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer H</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer I</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 97.33</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 96.07</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Less than 10%.</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each customer that accounted for 10% or more of the Company’s gross accounts receivable as of:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Customer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 22.08</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Customer E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 52.18</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 74.26</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 89.02</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s Supplier Costs for the following periods:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">For the Years Ended</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:23.92%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">December 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Supplier</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;"> </b></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Supplier B</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 15.51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Supplier C</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Supplier D</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 16.32</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Supplier E</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">N/A</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:72.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.89%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.4%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 42.36</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.41%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"> 31.83</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"/></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">*</p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;text-align:justify;">Less than 10%.</p></td></tr></table> 0.8577 0.5140 0.2643 0.1824 0.1156 0.9733 0.9607 0.8902 0.2208 0.5218 0.7426 0.8902 0.1551 0.1632 0.4236 0.4236 0.3183 <p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">NOTE 11 – SUBSEQUENT EVENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company has evaluated events that have occurred after the balance sheet and through the date the financial statements were issued. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements, except as disclosed below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Stock-Based Compensation</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Subsequent to December 31, 2021, the Company granted 53,192 shares of immediately vested common stock to non-employee directors under the 2021 Plan with an aggregate grant date fair value of $100,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Subsequent to December 31, 2021, the Company issued an aggregate of 489,990 RSUs and a target number of 184,376 PSUs, all issued under the 2021 Plan. The RSUs vest ratably over four years and the PSUs are earned based upon based upon actual net revenue generated by the Company during 2022 as compared to the targeted revenue specified in each award. Depending on actual net revenues generated as compared to the targeted amounts, the grantees may earn between 0% and 150% of their target award. The awards had an aggregate issuance date fair value of approximately $1,500,000.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Subsequent to December 31, 2021, the Company’s chief financial officer surrendered to the Company 3,397 shares of common stock in order to satisfy a tax withholding obligation of approximately $18,000 in connection with a previous grant.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Settlement Agreement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On March 11, 2022, the Company, Aureus Holdings, LLC d/b/a Lo70s (“Lo70s”) and JPAR, LLC entered into a Settlement Agreement and Mutual Release (the “Lo70s Settlement Agreement”).  Pursuant to the Lo70s Settlement Agreement, the parties agreed to dismiss the litigation (Aureus Holdings, LLC d/b/a Lo70s v. Kubient, Inc., et al., Superior Court of Delaware, Case No. N20C-07-061) and resolve all claims among them, including potential or future claims arising from the letter of intent that the Company and Lo70s had entered into in March 2019, as well as a consulting agreement entered into between the Company and an employee of Lo70s in connection with such letter of intent. On March 14, 2022, the court in the matter entered an order approving the Lo70s Settlement Agreement, and the case was dismissed with prejudice. In the Lo70s Settlement Agreement, the Company expressly denies any and all liability and the dismissal of the case with prejudice was entered by the court without a final judgment of liability entered against the Company Under the terms of the Lo70s Settlement Agreement, the Company made a cash payment of $975,000 to Lo70s in full satisfaction of the matter, as well as the releases and covenants of Lo70s and JPAR, LLC set forth in the Lo70s Settlement Agreement, such that the Lo70s Settlement Agreement fully concludes this matter. During the year ended December 31, 2021, the Company recognized a loss on settlement of approximately $875,000 such that, as of December 31, 2021, it had accrued for the $975,000 cash payment.</p> 53192 100000 489990 184376 P4Y 0 1.50 1500000 3397 18000 975000 -875000 975000 Excludes five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share that are issuable upon exercise of certain warrants. Includes gross proceeds of $20,699,992, less underwriting discounts and commissions of $1,470,499. Includes gross proceeds of $12,503,750, less underwriting discounts and commissions of $1,000,262. Includes gross proceeds of $10,169,027, less issuance costs of $381,878. Includes gross proceeds of $12,503,750, less issuance costs of $1,898,005. EXCEL 76 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

/;U)2;T]3G %HJJ>K!7%0 O"-HJ*!0? MD0;L@""P_IPJE BW=#J\JAB8WH>C=H^_PYSZ)O"Z;@*_*?/IEG7+8@BE-:Y, -.#USHF_%]9F@Q"+/CL3_.-8_YS9T_+S'WGW@>/_\!Y%!]QX^TE?_22\_ M #5&/T(><@4OZ=[=2'F*-U*W$]@=U2]F'B.>R.MN3CU@[=!?PI75$L*3*_@! MS+@7'.!X2N%T;7!0_D_>JIN\=C+[E9*@KSWLCTS(7A\.AP[A#N#AG>+NP#&A M#H608AWHQNI:)=Z=3 +CO23H?3.-R8PK=+3QK).5Z3B7*/D-^8W(!!7$.'%N!24^G'0'M+0HVPS#?]MTHQK84??0X@-';<+ "+U+7:&7 M+Q3X:I2>UB!A=!2H0"([EEL3-%$15!0$H3-?T,.F!:,5P9!,#!T\HTC'YJ"C M_Q$.YJI/2$5\AY@NM^?7NN)JHOM0O(*-OGU\; M>@1_.$'G9>:]0!AM!D.!KV!9 !UDA% # :18)FQ($P9.RGI3,T8P3>@4H$L^ MJ( L R>UI'D%1]$O%91QTB!B$4@,7<70-N8 D+(8=Q3\XEYPA)D'!5,^2\:^':4WFJ,O@H!'! 763$F;M(. M:M2I@!Z"$N;,_$M.CP5;4BRO7V&3C8(H&S3JGV[06RYE56$0D(Z7-;-H9P9D MCZV:TX':*#/SXO#JISO?EW0X^3!S"%35-P'8?XZM"ME)_4!H_C=D\^'[R:U9W:2J='T++:F^.X%(/MV0/%=$]M; MQ+8@8H3! (/(1,!$EC87%!MX.-IKCM:"^EEE&WUOHKNTFG@K'_%($V=Z5,G M'2NC:4;8FNFWL$7U3ZPO(#?"GB+-#F^)JFZBYJ:0),X;O79-9TDV_/!L:P"+ MXC\QQ&3TP/^*/24(Y+1 X8"Z\Z>Q5"",@+K"_I<'L*PST0 ;L37% M!1$'/Z#%NXZ[PG/-#(_G2&$,FL,Y:S,U,2$Q2S6_K/_8 :5F3R3=DH (7Z#^ MP$P8"T&6X;OXI$V^*O-Q/HJ[>!P^#\;/JP57X'),4Z3K Z-LV83@/[ MX*PYQB*KZD)P2B1G]GIF1!QS2>ISRMN$[5?AUITJW,9/3%(,:/^<)+F$$?C_N#\;ZBHTC28T MV?!99VH9+%%Y-B#YZPS0A):@BMX4V!/60E&4LF%RI928*Z& 1@OH9Q:,_$U3T%3A=R3V@'C:NW:X6V+[WJZHFM;EV-[R=V";.U5[H@^(1+M;DL.[ED^<#N4 S^E4^0G.B4IYE05 M5DA/>!-^)_<0G=85\28%3^TB_H%LZ+;^T__]?^T+C69?"(WV]A_;Y@?=;?3 M))/_@VT_HF&YO0KT!DV'!J9!?32J0+9^N[_R+QE.E[QK[U3NT99FB?SW5K>+EJ#]^&6 (V-)"9^U>KRASD[[$M*-XEZ/,ZL\[0^C#N M]/%V[8CPU:+RX3ID =X$8+;/_$-<]6JDIE()44BF"#Z%IRB>2N )/AG'XWPR M&0-2(I; <;!7S]0A,_I^&;*\6D#[L1TQ;YW@MRN&9YSO!S%"ITLL5LUB3+72 M0F;V>GME?&_S.%X\*?2-S0?TZZ466.RHDZ !-#9J]V*U:%-/*>)1K/ <)?&Q MZI")U%/T41WR"PE.X/^D#R!#=%ABH>?XUNM I\-('' M$\G/A0"H!7=.HK#O_'\0Y!^BRDU-S3F?CZ)A&['"W\U7N?I<.[WE+HL7VR MBO@&N-.-0K.8I9E6M='DD\E$-)$Z&_+TN9@/CZ6Y+(T:BCG&L@*:7SM7'+Z! M1.]("'4GZK_28)O54IO--%MT-LM4R\XL"Q^CXA3Y26\C(!OIV[8'5R .IQD MNC%S(&%-2Y!15G8R.925O2V#<98XA-ABD+5&M<9"_YMM\O$4F202Y\H$>5_F MXE($JAGZ% T.&_<*O[O5NW_")U2G+H&SSME=ZXZ5T28TPW1+ MJ[G51#0NR=GAV/Q>_+ _TD/?[?!H"OF@/I_[L[ MQS)^#Y8F4:8K=(YUTK$HLN":S4*U0E=F=8$=64JCM7(;O8=,[HFN3OPT3-0O&S5+VIW-H5Z/9G549D*QG'6.CB3! M"ZK_/9 /0368;0OS_$(T$WMOAHPD[\&0);,%J):9 EUJ0GBX"AOBICS]8T;8XW,AV):MK3J>I\%XR54RCWI@T3&;U3PY1B\G0E MQS810#)0J]*Y!NL"I%-HY6F&J7*55HA!/]A*X]:(W9W%NM&<_AZ&:+1'K%$M(3WLS'UF MG$F=>)P@XM39 G>V)_B=XG4%TJ!-FX:NNJ;)F1R6+C#?=&I82GFEFW&Q6GB:HRM&X5FA 3#.68CJQOP851F MRE!,27'/0W*+\]4,,$>U!0N:.=T>E'3+1N961>:Q4_&V@/;I =[^6A&T*S&5 MHC[IV@87BSQ6BWQ$M=W%'!Z!9PH-UMEFQ'99AD/)\6HV6V#8!HJ?G"I?9V] MP6_8-;@>@3)>V4/S)\9NBB)6W:*(;J3)Z,84E8H!6 X57D#)F7/S,;<[VP&K8IMGBV"9V\K"X_9NB[-?/ES M1 ME?:!^H6J-080HU MNN1.[[;H2BO+LLXB"K;1AL'$^<)V]JZU[[1W5R-0S5 T49E"@Q:8Z\X"X*TR M <82=Y3-:O,$%8O'R,\GL[!"^]:MSA>4E0N=HD_=:V8@QG;SA72A MU>2C9"(6P\]6]&=OOOIV?%^#0.QR".7$6SUX8%DAUA2'0++5^]NE?)[HA$9. MXF@5 H$7FURY3#=Z?#R52$4_:0<"TG+V5JKO%(U+TB0+/_CY^$@1:]H3^.;5 M37L^,?PP\D5=1:/ZZP?YX]V!)%/?<%SNALO-0JY"MYSU:209PU.?W/&];>:V M^;E?\O#KSW8-T>$F(>G&>;0)^QDKQ\ZV0*_:G*.#6KURF?+=4RA(*F""SP@* M'L?(/(Z1"8$VN- Q,F*.AQN;0 MXSU_4-&\ MOON^S;;JP&DZ\0Y8-0Y+-HT[V\D]M=,#A ,XARCF]0Z>-FJ([ M[8)^"5MWCVERCJ('HJ[I$W2$]BZC%?\<60C,8!>>L*QMH/%-='0\K'_\-QS& M!LJ(/T'2>F(V-71WJ:]#@,W2>=2&QTY;%8R?#C6W&-0U=&BITZ)S\J<"I<@V M;>>-?4@G18840;" $ 36 AV>BD88?)D#8]&RG=/(G3H /^&SHF!#P#B+D%VD MBXHAVA-T%B9J3#; S';Y(^G.*:JZ*-J(E X410M(/[U^Z>9N/R:"TS74?T,1 MU">,5DW]I\L[]XE360>YC#"QJTOFT-OSS:Z'*\I>'.0/;4/)40E[RP,PO.EK, M=P0D,9DD99(7$B+!4\D^.D\.Q/AD"OH0DM@7R#X>'D>@U: S+'(#FC\QYS-6 MHXLA7G"FKJ*COI&];V@IH Z MTK&\/UVKN268H_\"_?R8P=R:,K1A%Y6/0,W#QQ*4RR#(+"I)_H&9SA'P2&O# M9QS]$="E;^@UI&Z0#H.*!@[$<4R.C-BU*Z@-: 8!4D:P5Z@WLJU"M6I!G8]B M$-=P(N(C[87B$U58_/0;13)CNG;*TF]7Y22EN$S$B!1/@B2,/1*DR">C_2@? M2U%Q429E /IB>%2.LZ\/*ZY0B M"*) 83&$_HF-/.431<43.>ANF=AA3>9=78"?>U=L<_\*]. VEUQ1[$C;4@B7BLOZ -A&1@6+)!(^U;:K[J$_/;%4(>N6@2)&6S6 M[IN*I C&ZB>6522 ((F5 ;SB-5DJ,;F_V1&(02GJP(^14K5:1-^WY5"^BC^O MG O7TCIR@H0,AC,FLE 0>E)$U?4QLH;FMK8*,BI>3#P!@N9$O*XC*P.HQ:'0 MF9OBDDB/.^*)HN5 &XHV1V=G.,!%I230/*NAF)[ILS4OK+*<@#-[O"\#H*$W MJBLWA@9(F&3;0KLEO0C$BQ2]B_)F5A===RN6P1;A!\>?AN]%484:? 4<&R00 M-'1HT@.38<#C)SJD@)_B4,_8;-!$KW0<%S" (NF]7-]42/L9Z(B?KOJY"MA6I RH')&<6"CXGP[D&[%#!%P?SW MOC#NV1K/8*#,F>;FXY#$H+N;.P-H+5 >2Y<5"TFN^]T=Q<^ +41OT1P3(+@N M&A(LU\Y:CG488NCXYI]^R]A$6;JIP.WC@CA$"M"Y/$%V'!D$;ZAN#[R'(2.5 M_9W4_HS]0W >@G-<<#P;$9 #)PD#,:T@V !91E;;]TPAWX )[9P@81(T#O U MH@/.@:KWH;@H,%"#?IWW,%-M%S(1(H5!2DE@HH@[@JCY3N[$GD#;B]([FIO'WPJ\F\7?GC+L3O\)'1&@' M=*0PD?__P- #0V]@R$0F$UU#H3BR=YZQ-KT@N$@7@O#RYM61,45IH[? =6.K M^Y3'>KW'>KV[6:_WT.S_>,V^=4O]E4X: )YO:MHBC'=,-(N\\E>^P=L+5]5K M0Q3TP*=TU?9*(T)G P#+6U3DM//P*Q[H>P-]0[0D"Z') (Z+J@$$.'22P R= MU.&L*T3Y?WV%=H*C%!D,EU['2 &O=AO%/Z#W@%X0>LXBP+FGK)PL%!"'&O32 M!BM,L2.B@>097&- TM+_ #$TM@H&.9$%53,M9#XSFX/P99P%%@K+_Y+'Y MO0E:5K<[M?>52V-Z<$"!I74&XH^S'ORM>5-G_?&FSO/KZ-DMQN'L:=C]V9>')V";B3XNYWYX"JW447[OI%)Y/H;_GPYL0= MIKDZ;<=8!E=$;-+I/P\GP?TNN(L?O'6>WJSO_\_>F_:V<65KH]\OD,Y0I)B^M[IBI[3N07Z9APVC.# HD7AF@O#TR9S-?4D++,)[<(8 M7"RM% MSQ??H55/U^H '%T^;:@.T<1)\:F'CL_N."FT1!1GJ'/E76/!RH8"\>1X;W>XD[P='^[OOMW;3=*W1_OT/VF:[NT>'!\?[A_MW)W"O)]_?7EV M=O+ZG^NJL]/"G1,2_&ES55;OK'0'570UWR;,8)9R(:=]B4^?%)+*K4C&HA&2 M:%25[Q DU_:<9,+&6,UEUQ=E=$4.-%]MI7^F+\!^' <4:6,)*4G2LK[H_Y). MLMQ"_VA7JY-,2/*>_I&@IX7E<_AZ*5K5K.=Y64YT"AERE#.Z7!G/TG\JUZ^E M!NZV\^9M'(BK5H7=,))GM1D6$OO&WC :S0@%4T3F;KV8&HI[_D6Z(7JF2BE5&3[!PF9 Q2HO,JF:&B M:AR=Z&[2E]:]=H_*9K'\3>+X:1.-_%_=/<)!*N@HM5SO@DE%#S#]DK[\,*K: MHM!,?N)NV0/M?8NUUU.>_E!UGMU-Z#HF0';LZD=T*"MDANL)'. ;1^6K%K$C77<[8FZ0!-VC%73.D_ZU Z\3WK M/%"%];KG_41J3I#AK'H=\% 2O*CQ%(G/!QT!,39KY=!S-Z[_1. 5?7\RG5^Y=[38Z;H7 M]&DK=>'CGMYVHB"%L9ZFE=0BT>J1P,=90/4VSW0DE=5,2 _(?I,=P0^U8"A' M-PC*><92I"=*4=NCM!"([JKJ@/!S_GVAM,+!Y^M>O5]):!7CZT6=ER?GXJ(X M,\:G_VD=QN]83A=.))/K7[RSQF5IHJMJ"YNQL+9?(P82U8FUS,*T8DF>Y'7I M6V^6CP%F.XS_LKIV%H^WH[0%1X%I,$!G0+EOLX&S[E5_.2NR+=RN(K5",SID MW4UP'\OR9;74=$]$(I+)0)I'2N.=25?;P83."$6!OJIFEV'X$R_&SD_Z7W** MX^B21%(9PT-ZUY1S.?%01TM_%#2;N :P*1FF5_P1(@ 9E)7;](ND=JJ:9L#* M&I8R7O)@RN7N;++&ZJ=-LXILW#I-A< 4.R\!#?L1]S2PNUN0-5D%> D3<2>K M=)SR;7.]Z@VM;%TGSA'G%\&NYL?0;:<_Z=!XR>5%9(NTLQ&] 0<9)^'AND]/ MQR ,MGGQ$KNK$?@!7C7@>^Q/Z#%*U!BNHU:^938LKW<)DDQ>EXLTGT>T5L78 M/ 1>J5J?@R.49QQ6D:K*)+_^3ZI-H\L453J=HL%_.^[8+-9ZFTE-"(V6-FS" MJE]FQ5<#TJ'.2RESFR6U7O#8-;@T:9[">X8PT'6[ [;SJRK=&F63Q1VC#\49 M% ,F]![9B'2.HB&D))/8 VK,JZRL'%I),A%;#Y8U; N5B^ED^SZB9&6;0II- M(;>JC$7EWA]K6TE;&PFT65"YJG D&AP M"YD,];&U1<3>4Y,QGMPM-WMW,-BBM]&$T5X#,[F8E%>+,D0^-V.9EJ.:? XASC0J)OV5RMRZDC30ODXEW.1QD7%:Y[TNX>JP";-H)DGO#-_Q9F&O_ MTA@]OY0@4EV_CW,?'T.5-J/&KJ?]HJJD:\3 MNS;;F.4;L_PK,LLU@[Y[D Q'P^'NV^GNX?';O?'1^.WQ8+#W=K0_38\/#HYV M]R8&0R>_8(:;M[N'@X/#H[N36@\8H(/Z .8?>/3;V;,7IV=G;_>/CW=W#C[O MF%>/$&-1]*?MR,9TB\?K(X;R\A*(<^G5N@PM YN*&"3O01?]JH] L@A_%8)= M*>C(4KRKAZL@K,BWX2!M@#U)ML%S4 V MN9C5DHY\R"L4^$;^"^@)E!0DS')?$@N,HAF;KFD$<5TXG$<]86.@5@'F"?E< MJ6HIKE=.,/!1U1=@I"L47F=(>29%6K:UPNP&AY<3_)-6SVU9I]W:F'766B\MU,Q> >.O.3++V>:Q4L MW,!1.T'^ \6^KK(BLE-K64IWXS-:B_(JU1J#29K._:%-\O.2AG,QJV/-8#9 MTZ07HT*1X_:=9NNIO7#\B#&O3[',RX3/,B[?\A< MPA5C<1I?L%[><1J_Y1J5H&89-;#TV&R&FD^^ C%MMI,!=&&G6WZ4M$@L LFE MK!#XLPRA?S2J:=GQUY"3.UJ=FR3K-VUSSBK)>!:06B/ TOP=Q->>P=8 M+O;4(XR23H;$ Q!+XJM37^#^(*[2DVV^UC#6;=-=F%D@KS,?&KRF^0QM$/NI M"58#_:*[U*D;$VK-.4B?2W#BCM7ZP/WT(WH@14W!/4;+OC:UYX+ZLQ+AH?X<%++ MU4958-T+[BHP5(Y+$LHLP O&HJ+H%[E4;BCBASW'8=_XQ:'O3-K*KE1H?5FD MC+8;LBQQ=9.HU._TC'+9?_O,0)3BO7VK.&F;PLR ,@?82RAN%! M3 ;^SK!S.=PY'I5)-1&S4CBIR9YC<="9;@*TT(S/N996I-$ES?\A&P;53(@8 M(.YFI"%$-Z6PO-PE"LM',Q>4YX<]K[;M169U-5F#VRQ@4LRO,.-H*+JJ-'7# MESKXJ?187"V=Y(H=BO4/9PJOZ#\G.S@KG#8EFD (KR6M?J CQOT@"9L])H81-5^G4R M6U^RX.8KPLC'CU&AQ.8$^[DGXW^WV1:Z>M=\(5[0R>0+L3M8)KBPI*9/ZIK4W"LS6$[.2?Q(+LC@$WP('L8?;\_&,0#,J7INT 5%-7Z(*,_ M99I0L4?ZCFKIVZG=2VC+R&8E'<^V**WF3HS:9!HA#3K>/3@F.X1FZ7#@^C>2 MM/Z,J07*\3LS:)X56/-"_0QODT#1)>KFA3,ON>K+NL%Y+V"5T%;X_O#^*H2( MMU\DV%*0=" M/\ERME"JFX'?HR_-5O+;7'OBQGE9!Q#9G5/4O1B(BE4I+YW0+)A#N[ ^SI-] M?F:WD[;J^9D4)!HR,);?F@TY?:X1FRVI>92TGEK]B1R&:3EN%7%W4M$FT%\4 M!0ZGBT,RNK5L!FMI'K_;6Z09NPW8M,;Y_ LF(9?YQ1W'Q5BW8(0&< O\9CZ> M.%WJS_! ,,AZL3+?82HKE*.(4SR'[JNY1GVKP=:,Z2R1 MNDL$11L.2 5M'>(IRF#':6K%VA'3&M6XN9+V'4ST(J2%45YZ4'\]7=* M/R*C4V1J2?,WLFM@W1":#"MSYM9<*1$W0Z6SM&DRJW^*R!*8Y.(1Y+K9AM]L M\<,9>S3W,1TXW"0#-\G KR89N 9#% #N$FPS#6 EU"3_F'D1HNM?;1%806SH M2)B'I6733B1!PT*3.2-"V128./,5E>1Q-$\R9!T0K;7_H*4;7\3Z?[4YAA19 MD\VR_V@"R0R*TL:Y NY(?.2.]#(^!YO)6O&%T Q?)16Y]')?%Z2&H!H M7J>CO[!R;O](=,>R61$8MWC>V9Y&;\0VC<\E3 MI0#T P,'J)#C8K!7":DY6%F7*6D\]Y,J" EXUSYA*WW!.Q,[^,9G8*A"I[?@ M., _ !5G@?AIXGPUYU0X'T(X_,20Z?"!+IMSB <]+W/$*>E?W*'(5S%=7XBM MA"U6S5 MH3TO4[R4E<>.VVE]IXUY+)8T#A*1+L+-J8N*PX,(^_@C2JZ/6.J\23<<]%]* MTN_F>R,_M(49A2^+-0;%,H_.W0 K]9+.,]\\/H%FGLHC%V^JRB??54 M62RZN(@4N[(R=O/L]..)X(@EH3RF=?J9K.)Y&DSWU6^/NM-UV\CS=9./%\_6 M*[K8 &C,HQ/Z2<804S3$Q[#AM!7J3%M<'X=1IA?_/#O]\?'OC[E"1.C^@NXI M [M0+/'>?$]RR+<(PZ=IO-C^?3N8R\F;Q]VY>-TU&.Y@.D_)OVYQ1'A^%VGO M#B_NXFG0U$MS^R5[![8,=Y-=5VK'6EE09ER^CA0XB<;)>P2<68@UWG=V^GS. M/(F__OHXIF<5Z31K7I'MID&!BE=VFVT?Y T?E=R(96I%ECIZ=/)P<4AE#C<^ M>I1 7I: ;%-&R4%-_K@X,ZKK$Z-HP/!]$E+VF>;1&B9NTRHD,^[5PBFF4"?L2=# M/\OE3158U."?TXI*71:#3& .]L$\I2\T[(;0?:C:N8-=[H+\,5V:(E4HR&!0 MV(Y.H-=D)MU,S07:>CA-S$=E M..#P;*5(?AK?[72DAY@>]GKU%-5.VF?+>^>&MSK)XTGL)#$DT%XR .\NVBOK M*"_'5AT;GCF[%?#\I"!MG#.M(-\$*]O@@+OCRO,.CW\\PC6,]":G1C=O 8*;:=]L,C9C MM[-)WN-P"U.#G(.=I-A)J3@,&G(5-#9VO0U:CULQ@"W'.CB #J50YOTB@4D; M<(![6>O&;;A$>&$B^%'Z2?= .WBIN>;[8]0-8S(!5C&)D"Z1I/& M..&(OO#7>O +QC!232Y85/(D4M=9W6?=#93!F+O3%,#3.5Z7:=W,NOCL*#?+ M&A*&L6E^Y&'QGG#T\JW8\WHNI1>)G9AFV/>XWS#6J?%0SIR+<%@./_\Z0U0R M9(&L4II(H1I"<"W18S0550K[.ZS)H],%FZ)CL8U,N]ZPAZ*2.UIMJ7YVH;7% M4^#UK +0![,VP/(;M5)'BZG"G&)CC.!;PM.EEL(*H@F?.$:V[%H1O,(*&NX2 MBSCE'5H8+/L(!P)0SVN."HX9IY4#@P!?3QQNPQR7A"D8X-Z3D8SF,_:G4@YP M!'@;K1#!SP3Q9:2Q0GQ7T=;=4@3GT)ZH9J>9WGF'' #@C0",MI[($!W3.7R* MZA:K,R>%8L4YC:'P#R%?P(!$0H>9G&%P#%,."5:V]*&8Q^-5OD#%KJ3-SF0?F(9N5_X#"0^'I2 M_NC:5K8><0O(<]>J2M?O)4V"$5+/@)#J4&_65F=-PUF%N=UI0W4@.ZO;E#@+ MK_%?#1KGURY&S8U5LMD"5(I^5L3AQ!GC[;3NV5$VF712>E-!%?:U,4MZET5* M)DO;3M6@=\]#(M3%?#1TK9B1Z[%53K-(EY\O1>H6DSXS.R*37ID4.#:L&Z;#T:QTIDFTB./U M%CUH(I.%0KD$8$@@IFASD8_4 )K8+V+5\-$*X,&P?S->3?X2]'O$>3*S!_K- M>FO33"_#$\TU9S6#B'4;W;:L-U9Z='TCL&/] ^I54Z4S*)6X(EB&:KL)P29O&"AC<..P0+Z2-F2\/D]8@8&_AZ^#M'-OV M5HR4\YKRX2[@(,(C46/?\)R%#<]=O.B^H$!?B;3B2ONMGD8^ZX++RE=5(^&^ M:R@D:!3$5:W-K@JQU+B!^)(AIUP#,9]W98682G+=4;S )56]R8W$X,@9<80A MZ/'"T_@>^'M7+X@_-!O4SFJ7=>53L[6D/5(ZBL,K[YN*UW7T.^ "-4>)Y+1. MTJG$"VO?13"5@'[211OF?EHER@XMW1[=B'Z'Z/%P M9W?XQW#P;C 8;O]K?OX=7;#F?[[[N4KF)#N_ZX.E95Q5MC7*R_&[G_JQ" E> M[![M;G-D(OKA7@*5[6X"AIN X=<1,/Q<&_.!^4N^=62&:]W@%D2'P"U^]]P(24&Q(@')ZXD/X89JKJ8==_*3C>+!DUH!"A5L0Z93@%O%3FS" M@4.GN %>)H5<6:W_X7ZAU7?0>.B !3@1X\6OZO](N-)%3?W.U(1*L<\J9N&X M#OB18G](O]^/A]N' WK<=F2Q8=[LE[M+?*ET*WZA^/VH(UV@'C*2>(A=A<+UA\@HU\:28^]\1Q( M,B&Q:I*A3KI1<#,7H*E\G4M0*6T%29;:GJ/5F ZBMNP*>=6-L27.HEBKN*%R MN9#E>^![K"!="A[-Y&7#FBE.]#ZZ6TBFNS^JPC5[W7F;1_*[&;Y9WAQS/8\4 MP-,%*7%E_69-ME4=95.D]I/6>,YZ9)9W.RT4?7[XD.:O!! M'ZP. +.&,5<\8CHNNCZ^2,*0"^ZN:!U_("O:=N^L9^-WZ^Q:?++D"LE(F6P!$8&T4,ZDS+%A&>C_%"&8 M %[]4:G%U)JPX?V@#4TY CQ%<*Y#/R@5BW67JT=H9GIORE,:I]09X0'\0LE MLFVB#'T!)R$3'P1X5Y+P(K=*0Q 1H[^+.=5[UZ-2N BN$F[U9\M)0/WD%+F] M"^ESA$IO$G HA@2)\N<95WNQ=N0RVVOC5 [X!RWC):O@)B /[C NT#"A%%K( MF0"O(<2$"U*C)KY47D]J?4-]@<9%>B#S/#+(&]:4C,>9B^>$$0Z[-CG3QI;^ M9"<,R0%) '63Y$@H:_)P0=0ISHF*Q<< OT%WT_JNP3]Z,9]EFL5=8$,F2?^@ M_:]&(1$K:K_D"0A,AMK,1^\%4>XZP(PTOC,'HE20:!(EK%#\GR5L*05V37 MUAV62(9D?7+VJNX0%2]Y2BS^ $#VO.K%CP63LI'"7N-?\_P6ZH"J M%\!8GG8/B%4;5:9<_AP.VG"@UUKGI25%LF"J\)N_U2BFFS^@UM"NN%0OGCM>7M\C8R:HTGG M*"_Q!KO+V>'HM2RM^J@0X)7O$>]B%BX'S%P(P'IJV(D!\":6XQ5@7K7,KJ6< M$\!K!JVP>-Y8D%B6BI'6D-YM80O%]#SO<8[^/9-2CZ'&*IL]*C- M\F8K*U9G\-B9)CV0((F>7VNI07.151-9'*T.[V]-Y\B%2ERR!]H7C,I^#Z2] M)4/8U=5TF_LAZZO NBD>S!81[EC$SNP M7\F+N*L 8ZU*7+%;T-1".PF!O%#3T)'BWM3%B1:8XE6KU>DX?X1J?0YG6"ZT ME416:&C*<6-S9;6P1[5>][XO,V(2:8)!((+L1>7&P:%SA&6DC$KEM$&40PNR M98)56WS0%/M.K6ON6<1U+6XXHQSBZ9@5$(#VY7X$O^$0V >^!\(2&=B![V==9(F(O3.5:%JM37XL"C!M/6"^UW]Y+, MWW-V\71V'446FVI(*--25FFHQT#1H2&:4!UFT:KO=2FFM3 M9-N13DXJ7I=/P]R?P%0R%PB&U2@%(M668)7 +/35K+XKP@T(^<<*N \]=L:1 MMT-X16V*AJ"O3!C629 5_C4\"3:/N-=XLN"EM@O97)L^51J=NR_C"?2)P NTK;B45G0&;/0T^#Y5/UB M=C,UQJ=AYMR6([KO@,:4'O;<6IOEK4$GCB.5:EK9UW(MUV+=3V([703J\7Y5=HU-Q">/C+2N=U1KF5RU475W* M<%=BH5UO6"1):[B_7!][4[C "MY<;1OL^;3)I/;PJ5;#V9?#,$LR<1$1RU]J M.6= 6R+?K%*781(D=4XJ)+7_+_Y.CL%JN(PU(@>[IU4KF+D< ZUI?EQ++)!Q MSN<4\E@0%K"'(88 @]I('X?@ NK+2"Q=NOC>PB."^$$O=/%P?9U")6.KH58X MTWFA6UV$K9;?N^)JUE"UQ1.Y?;XO"/J$7VRDP.-+E*A,I!T-[S]!Z0B769"/ MUR*S3/+\/!.>%N%W<&@\'*_.BJ#T&XL DTD*#)HT!4 /W?%$5GU^ 4D2 MQ$DY4W_%@(9=@(%_ ^7'&-/F:3H)>='(\FDK84L@D?./A'MBR-%L)/$X,02! M>U05+XK"@M[PVJ(/''*E%8F91A8@\W:0$!*8\5O["#$WB"AKU5 "2S/-O_^[1?Z>T6.QCU)BO 7#M8-%3!11.Y,BM M2Z2] -$\HF.3LM^;Y)L_P)RN*BI>S >X*FUE@N)"/<3*S7(4M29P#DZML:SC M"'U'CV9-R&#&Q?#!0EW+P0D?)2 26D7DSVW%I *&TPH4,7=[Z-5WEZJ.Z[25:\N00L!R@*L-N*ODY2YF@6,@RSLL*&I>N>-!5 MRP*?F2!-VW 43RG.EOE#X6PD+1YSC@+IO:A(&]GQ,%.>&35"=KN0N@L-F'\R M M$/#[U?T73/5\=T^W>;C=]AO2?)G*.DG&&V.IO$U\T%A0N2T(&=A>AT)K27 M.+5Y6;[S.? NRF[/67W*H'X)A"H&W4S*KE:(M:;4U7=R(C(*RN]D@/&26DW MG-=;2DR7PK= <[L4>**@+I$;I>5WJ,#()-1"AR$HTJ.?S.:LQ^2A%XK\',". M@?B3W*>&N:AE4RZQHD\X3ZQ4;$K25NF=:M.7) MRY=_<^$6W2V.)RGP[>K$D2?;4D@:K6@E2XSI/)078RFUGGJ/++"LR(%34%SQ MAY?FV=0 (#J'?#MZI+?C1J$1+Y48?'H\%0Y4-!TA+$$@8BV;Y05?&/V((X@# M+AR:RB_K,9(6L$4K T:VCQAM2+M\E<\P9:A,%=@2LXA7KQ-7#/)L^[$@P"NF M@<^E$A>UVP+^IFPQ70D1"XS3Z-IB"5T)/\7K*H><Q\MZZZFUU^;H5&%KS M/;H.-$W";?*W[;K?(B#;:D:?7YZ?/5PW3)N'221O>T8'%T6E02$(<_:HDX!* M$/,(G%()?3$F?C(F".7M4L'C %2UIT\ 4I1:+J0@LAA?)C>3]GI9G,H]G+Q# M8=]D_RR;9FJ[RTN<5I#43XIQ"J\0$Z$Y] 7/<=(D NOM-@Z]!7AC65%C/K&[G1X^+*QS460OUZK. M1&O"MP3M-IU*=)#!RCC,"ZT(6CF7(JRM\J?N#-GQMM'SM"F:C8A$L[1V9GPU M2:>LW#JNQP$S0L+4:2B$8J'FXX\B7GS/^KW,R>YO5[_L6).G6S@/)N&P3#\%UXL7%X/8(O.:5.&/T^R/=*F_ M&6RTB0LY8DU%_W]BD]"O'CW5XL;*E8,'O PT0)P;R-(&!4%E)JR@^[6U+<6GJP?<%AF(L'W&%Y M#,C=!44-,+Q+F];4L? .B%]$E678\1]P5G_@\[ZY>YN[]]>E7BZ.()+4SS0E MA6SC>J[B&\UYPJ$(J#];@#3_)UU(E@< 5[X<=&M*SK^/)Q@P%'>FP2U9N@2& MG43>!E8"E9O0A8B0< (*^53F:89;VO=H_"W<7+[-Y5M]^7X5JEVNU@$$U'KN MV).. NGUSB<\LBWF]RUZ(-A!7@@1QW?I=<29>-]/+^7D<P/QP:S.57C4KA M29NZUJJ+E"Z:![226A\'VL>%*DR]UHIS?6'1X7 \O1X.IXI9W2)=>WZ>2Q@& MEIM\$[?7&\1QGP+[E[W9O>2JEBD("77&-W M*=:$BUVZT*\$]!1YF>.*$I:=D*01[M9P[^^,*!EL),G=DB0G'.67L N@H_E MJ(-*5Y/_4PONUB1#D'3/9NHI"]8J0Y-<*&6)C#N\UH@5*7A@#^:H3E-NH_U< M.8T @3\$B64 =5H3OL&,I5'ULW2_ATJ"X&$(>]< MPNZ#:IC6E[7;U#%MZIC66U4Y3$&7[P^DI*@0GUL,*/L0+6[XKX187L MEDHD-! \/XL]G>ZH$K0[R[VR@Z64LMJB /G* 7Q/VFGEF%; N22J*' +290G MW/.!G#3G'\%-0O_?U2B<>S!D5RU%]N.EMX!H0U)L$,*N63=%[L;A32N\%?:D M)(R%;217"'"Q2PVR0FKV$\85^VSZX08ZS.$[F.JB)TEB&3JKV#!:$Z.!=('1 M[0.4X2NYS]=K;*A@GWW*==F ]F#Y*6!7VH@&MZ%(-04EMT!:O4-H<2M"#I'$ MM9W9BJ:PIUQ"U,E;N=A!", "#" #U^Y49(4^T9;5?7=J^5ER+ADNXHQ.P"\' M,US9WMZKG+_J+%J=_<',E=!O6HF?8D2U"^,$7T[\+O\J8LH$D#Q@'OK$L G<>^QC#I#XU:U!N%:E84N@F^H46W4L4YMZ!E#]A^H? 55AIX_DY-'V3+BD+77X$@ZW7 M@]&%B^HS(_"@F:%!4)6VVGD _!I0]QJKC36)([22&@57_SK:EZIT)G :G=NE M&$B@#)B6H;KRL($.@4_P<'R]=.=6BM'O._L8;TL<9^DMT_"5PI5XT@2N2[:X M>S)#63,C]J/.V#N]W<&U<\7=TX=>"\K6O>2N/-@4FFT*S3:%9I]N504RAW2 MMC PV2/)D&V#K3AAKVY<92..=P@ Y"@EH1]']F7(+)\Q@*K4MN>K?FV[<28# M(W:N+&)61<,QAE 2.LDGM?^+BK!KGJP30Y-5YE+3Z(,,HWH1GUB1M^J+GNNR M5/6GF5&T=

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�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

LVH+N( MK $XBIZ6-CO?>S]V_G;D=YQWI#H*"KXDP2S/PA*G 0B("$/\; C@D1CSPR& M1_#HSP9!R 8A&T V> P0_.U84#7>OQID'H;_F?>DX_=!\EI"?G/)Z/#?Y]1[ M Y@GD$8_>^OZ*_/@H:)Q.X*-L"_\8&QG=#K75OP?_3N+NQ#*>26F^.6]]U> M>2],CFCD@T Z&P\%OE-P8P^?+A$O5(!L[L#=#X\=17E.B9^0L6Z.L:ZNAHC/ MLA!.1.+D([$0C%<=P2DDFPN0#?U@9(.=0\P^7\3^_5^2I"B#P54E+RQN\"/# M8)6FP [T9V.,&SOJGI+Y1M_^QL#PW^>+7%WA9#L<[86F=X]*'A[UO;<#/CLD M\3 +LJW[-B1SHFROEQ>#+,9>M6I#T74 '=:02QO&X_P$3G")8)X@U_B28Q6^ M(* V7ZFO$M'9I[L=!;D413Z=:@E>?7ASH"D)HR673BV9MXD) M+GWZ!NBG)!@W*_.N>>:-5W0O&;Z;$FE?,8J>>2>X&!)(LC5>8F0ANU TT4ZY M0MD-V]*!GS%K'E)!N@K)UX?9YH"/UM2":D]*=&QU/?[0\-NWLA.YV6>5TI6 M"2],^D:V#HL]@36#DT],_#49\! AHXQB*):H^R4G\D0U@DX?=>#P:[?"5M#!I6.U%DIPN!!K:712!/\6C%S2\0EGTXV71;1[_IF315RR^ M]\DB9=:B&[4Y[VAHM3K)ZZNN$1M\NJCNT[(H-NU1N6Q[+O*NF4*+XBIO20LH MBX#]1\;C3S1VW*WYKL-9L"PI]&*_(CGWY 0)Y(1LNK"RXQ;DY#FS@=<^YTT) MQ/=62'VS^,K/A^ULB:KV,%K6I$IGRAJ\ +L% 5,J1E!/&/6:^ JY/^3^EPRD M:Y_SIKC_T!QB$DDWS%44*%UKKSHI#C7ZZM*.&E:Q M/@3<#XP7BF:>"/QXZO"!\?*W5Y5XW#'S&PIJ#[EXOQ$GK+1][VW1*U3_OMC! MPADIEN(U@+GL'(FCOA9\C6N5FP4TB;EL+VL..U(O&ONT<_^NBMZR::[W/=G-PL0GV42MBEQ=XY-5U$']O-\M%R)+5F _ J\'!OASW^L]T_>*=<&O\(";\0C>!-:^LEN^ M#><='&#Z G77)P;4PK+S;T.:7Z2=-JW@([@.W\$?6TGJG:4S&O# C9L[ VRT MI*N+7W^("'DH69Z;5-OWUHC []R">/T(KBQ^4L\MS+U^WZ?;#V GQP;"?D_; M,3@7F>#TEOJT+4=HJ@[L')#;-MYX;K\3D&]UTP$JB!A\O&>:EB6KN3$#1**2 MR"1G^7+:F8\^;:2_,&K,[][S@5EC;I,S"*92S/.-#M/-KC4@\UW8Y(YYHLCC MRS,[?7MVYVO[/+S? .)$OQ8HPMZ)8& 03H2\1D\6UC!G8.UUUZ"LN%TS"N=% M[T9*?1ZO?718UO\IBXD(5P ]?!U!,D68517I9F* M*/(=(P\.I>WE1B#\ %G[T;&.:Z,X1).$T,^)%02(?6>T:3Q4$BVP[3TOY/IJW[-N MR:UQ^S(EPK\D8$>SRB"UZ6>6' $V E#\-$%2'">M=<+"M$Q7&-*3N9 O+:^N M_ 6R.<+F0J+"M[M8);]"<]5:G(7U2$\8]?ZF?2]H>F^DS87UR:UC]3.:Q7]X M97"PW:;9'ID3'\=MQ>_(^(('6YR7U[W!J.-BR54F@\TJ6**[&FYF]AP-X?/> M]V+_TL2FN]\6;L=:!QEZ$^2_=.N?H%-0/ +/:!:;\=SK2#8H#7LCGWO;NH[]Q!/>#U"LR+ABM:*P2/ M[HI_[VO.,]5XH0Y?%SP/R=F=#W"/8W+(<$Q.."8G'),3CLDYYY@<7%LDEHF: MN]2(]9+K+M!96W=JI\;DE$AC6DIU^AJ?2<=VI,3MZD&[/N=,Q@ M;HR0[,2*GZQRBU-C)F;]9CR>*7PT5&G=G),3K=HY0I9KJC->EBV MP&7Y'*$=#[_QM%[#[/?TG#*AN,(TSC'VV%YDH7>U_\0I:C+LTK0L;>6R;7O- MNDUV#9]X].[50#1I<2"R'%'O%;DQ12TL9PA6'IV\B5+-_"0K)GC7$<1:LT+4 MJZW%T> =;Y>)"IF=FPUCR8MQ55NN$XZ9J1WMTDVT !BM(J.A&!53\C4AI3AP ME,_1+M/Q^I17"V81:]!80RJY^*HS&8*51[O,Y,4Z6IU.JER[3Y?*RU5O$+?8 M4T-_Z,XT4[!KHP3?)D2)F>:IY7A^//1'(*D^'9,&I#"@L9A ,7U)Z$319KB?R>3CT*7:X4AWQZ5%G*61XPDY6 MVC)=2>;6)ZG9+C(9-[W@.A@]&(O$=)0WVT8>KZAHG%?7@[3<*7>6F=D"K(P?KDQ:T[9<3R5B7++.#IV^ MP\[+XY,CIWIK:])MKELLMK+R4K)D9&=%B3W%2PVLWUYBK- #_%DHK/ER;3#E M(=<=[7.Z4/5&B8BG-=%=YUR"7O07731N+4[2_9)H) M*5LH *Y'124>'53&9;LF,,352I'2WQR,JL-:2R)-=9 UF/'KT_G\YT9 M-19Y+C.OXVN&J>9%U5MZ]'[;BNK,(,EGN3:+F?U2,Y/JJ"QPB+_V5&J\\9+A\/15*"H]$B;<4*[VNG%ZS/FT^GZW8_+C.'&L1DF>KMLIOF#HO?(R6V;[PZN' M#/.CC, *3LK05HENI9%W!6I*>$'L5W&RX^_OA L/0TW;\.&_O:L1QC8YY=># M07C;K@YG^GA308)TB+W)A\A^8&H/TT%2Y)F-KS,1^O&Y^Z-1JG&MA$<365S0 M"J32F5-X8IE-#R%S8W!JS#$EW6DR9&\PUK6U#+5#A[1 8N^BPZ]G8!/UYBQ= M*S4,7NF*^GI6ECC=^O0-Q7.)LC53']"L5%ORA"LG>$/NQ/(,%&5T[(D^18%P MDJ2E2E";[*@:Q[[NO8>;Q>GW9M4GN6@M4>WG2 T=:9-*NC;HC9< F[:Z?.72 M@Z\Q=A%[0UKC9C%[!761[&?6/<-N#CE"D DNGV\M.12@-TZ33S'LN$3S"6+& M4QE/FSN6"]49[6/UL?&X^48+? /V;*;B6&O(B>0$K=CS]#PCUP ]1&-/)'[BXAIT M X(+LG"J%GCECJY]]7KL@Z+OQ#7> \F\1=GIMUG@34,O>)]8/2^IBBOXD;<7 M[Y]@_SZ:=^_IJHXUJ^24JLFY6"N^[-.6G&(!"DW#OT=Z>%G7=P(,GYU#;OX0 M.3079O ATYO(P->4+[5:G; V63:OVZ79'9^+FUM@8T>M",ZHE6;AF[@,4@=?N;]2' M.%W9<>A'7#*F@9TN$?C2=8O>HI/I,BTSS:L)D;;6\RQ/SZX>=!*K1+KAL**- M)1TLVDBN%+/=8>$L4XP^+E_\0,P)1C2\XP \^E=NWG_CQJ\/><<%S\M%,.Z6 M CXJB_)U*3.?,&0"$WOIC$G2L1%= P1 /A',"0+P*W=N+RK1 $($9M\1RANL MBN/_(#D#H'^HPLL,K&TKCNU%T60X6UN'^Q\"9&VDT);(#B_[@9-.1'ZIZ+TT@FRW%MMNS;\G &R'[/AH4RJN/=,? LB*27MQ@JAJ2"5VY6^0K:&ZO* H/"OY/P M"GS\VU#P2C72-PTWX% 5 L<_@VKL;W*?U^^MVLCC+:3B#_N\_F#B[>VS^*G2 M(@\W,+#VFGD?E"SB0GR_J8AO-:VFRK,E!HRGYLAT;4 ]#64.;Y,H!@>(W%EM M)QE#8VW32RZS&A/E>+VE-2JE^ *5)V@J5ON(O=T6H6GMV*PAU^%5%+OB.G"2 M/22^)K!2=H35TN 2NEDL.54O&N'NZ?O<:"".^BBXN %$50FC[QRV.\)-( MBG9FI9(BC!6^DB0IO#!H<)-"#=:(,L>Q)!@O\-%TF)8ZB/7Z<-B=;[X=4AY@ M>3<*\:[2W EOMFU_>5L^*G1;EJ?Q#L)#!6-BIU*8VZR_"%A=:'@0*%/XG;/ MG+3X M/3DFN^J"94UK_"?EJR^4&=)S\P<$E?Z$HH^:11#$_8?QL]_4/T!+J^ MY7DR6Y'HP>LD1U'=GI.0*QJ-90;U^'16H^,#!>;S7I5Z&^?;/-+I^'9XO:5, M1-6 JWX\5KUXO\FV7 [(/?Q^J M-H4! /ZB'Z8 OP#R ;;O-J9RA+([%7*OP/N]$FZ+ESU1MUNL4^C,!3+96FH% M5>W&.&G:*8K#H%[W-5'G*Q;?H+./4U97*\EYJ5W?E_'(.<:TE%6J%)=$<6;2 MRSIX@;AV8HJISR2,2B53&J%08DY,-L8YR$TD\10_84L\(<"E_ 8;[HSLD]#K M#CIRV"PW2S"-RK HDG%L\5D;S@.M9ZN=3N,.%,[&AYT5YZ:$1+J@S3J9)$S* M1TXTP'\VS-YJBK(;Z VXYP9"O:]TRPA"O"-3E_U (>#MP'=[X8+!!?VY]S8' M?B>I>9SGVQ<[9$:K_0$Q6.<);K+"4XN:-= 9FOVX;[=WGV#C#?A\#C@P:\\3@T=>\ME,1W*M[M3XN \[EQ[>%@+5,C;HZI$XSOT4-.6-!#Z,;%8Z^Y<1MDR(CM M JD1,!: L:M[(@(&[T1[!"\62HHBVS\:76](;'M630IFBRYQ*-N<%*N,0ABY*&-B0@8R$G^S0 N1,NF)BR MHL/-!M';P,H*0HO[\487$A+\8&#JNKF 7]]IP@7#WN[$__YO[[CG;\FUC["4 M:DNZ:;N6$GALKQFO]DO6:Q-L*J&#P__:U .HZP8Y' C]+#89$58KW9%:5AV\ M70%4,8419LM5ON>F__FZ]7D=![<5NGZ?20F@49S:RN_-#[M[@S6M03TKK..3 M_)+0346R5SXKNHZY^< OGO4^V2NQW6E5&:QY+F)F_,I8Q]KL:U,_ZQ_\?>V= M8U2$B+_6%G6G-G'G^=!:&@ BW@!M\SL*NW+^]LN1H9/T9B5P@ OOQ9NE8M\V M===1OJ,$^#TSP/'WT\E.5?>76[+E!O(3\"8C3?ML*L!@?D $"XJP;\, >8M +S6X,/O 7S\[W,K MC^#PP!N $/G?7^2OSTXJ("\]KI%Y3^N3]\,F;5H^,(!WZ__@M4'Q?_1ZH1Q! MZ3(RZ^(D3RF^/RKT#@B+8_")*S\?X5!WN=639L,A8^YY#XTPMB,Q0( MM\<.CR$0SJ#VST2M?NS@<7@;!IO/!)I[H()W&']?\I$?BC"P>Y'P5[,7/JC)1_GTT>W-AASS;1-5 $WW^ZC_%X^6_V45%YA5E\ M@9"_=:1_(._\OBM\FT^WDYZ>+R-LYNJR,35-V 69HW6"9WET7G' MO3R;XGL4MKD_OVBKV>8F#&##8]Z#G?O=2NRVA-I/M,)<%K^JRUE6)U MT5%*JJ%.W,GVIAY*[%S5&SA371X8\PE/I](U?JVOZ'@:-M2,1HZ[;/R%ADBZ M%)+$Y@BQVFK:2O5&?[Z@T6BQ\4@CV3=W!:*7K-MY#R=8)K=>H*C.=.H:MT: MU4A[U7WT<8W5^6R;1Q&;=QQK\5J#*89L/X07'X9:[@!)8:CEP4R1#QNGZS(8T4V=5?K-[EVPVZTR\55$5 ME1.SRXG3%GD^(;%7*MED$P?1 M[QRDVK!-I5^-&]30GZY5;S@8?'C+>(%N"DA7FX0+Z$$0A"$+?LDSO+6: M\;;WFR+[4&#!<<6AW:A[<6;5 MY(^)N!===!,-T(C/-D"#=LOE6WJ%=LOU:>6'V+7;R5X^@<"^$F?VM1^81KXN M3^(1\IZH)6ADW]U@WZ%(6V9Z'"KQZKS.88]=H?/J'"0O&BZLS<&?_.Z_9^*:&ZN] M/EOE;F")7;41A5>CLWM<\O"X%Q@&>S"R\O,%GV82D\SB?-S&&O,L20VD).[$ MAA\?^/KEDL_ ^-SA!S\N>#CNLBD)6-EMMZ:I!,^CV331G^#19%>&[2*)7W]P MG'FB<.*HR/-16>D*]=7>[8,; \-_G^U.P)T+D[-,P+VD./F6^O%C8;*)(P<1 MY+U!QR=$S)J85HE./-70Z#B&32J:.DI*+! Q42!BHA'BYPB8L^GJC7MS6_SU MPGG/=^J'QJE_^>'&3O?]*M&_P'"?E'V;L>^O.U89?TCX/00>OMM?NBU[QFL\ M09Q/UOXLT?,]=X&_QT#X[CNY/XPXSVW)W8%R"['U71=4;TLJ?ON-TN^UONXR MTITVK8&BGM,DNS&_X[&CVD?'1?YU_K#V6ZW;/AN6&A=U-XI7K8)6&'(SJ4<4 MV-KRBE'N@!=< )><406X,.4302@ZM6QIY51,Y"9D/)=I-25^V!T*-(QS$_@3 M'CWN97B>X7 WR%QAG/L2QO:-R9CO"79?3\B<-?9M?US&?# (GDL.[6)4[EF\ MRJ>ZT^HDVI7I!9 _T5]_2#*"TV$0/ R"AS@-@^!A$/Q&?:Z-A _#X+=U@3OT MMC[D;<$WY&S;5>24UX;:MV8\Z\?>[<.])?<3QLPX/8W-1VR1PQHSL6%2--K1 MBK M/'2FGAC\>/3)^7RIGZ4( L?IRMSUG5[4#0N2T*4ZHTNUD2^?=:@20[3! MK?&6JA'9&B9,>X,9*T,9!!PJ(A(_'I#U$!(HS#O]2&R%>:<;)M ?E'(1NIE6H6_@0FV%#DS7* M5GHX8V^['B,]CA?SKD8/>=KB>UP,DT9U>2@PT+6*4T\4=4'#YL98[8;25%?G MR:O5:US]Y-=WR+Y1'MU'08;RFFQ9FBWC!L7EB5!H)\1*?Q&:0D6) E%$1ZFB$Y(.RT?=K^A?SC%=G MMTMK^A=3BU<_^47\#JCKL0PA:DIC-.?<9%6*R3\ECUU'RVWY=7I.( M4UD=/=%0"BK:U=QZ?YDL+#JIK@9=#QS[]8=^(LGX*WK]-K.^MR5TKA^0_/XS M?T^5U&V=^2?B^?JU4U[JS#\H\1:$ MY$3HCX6)MS#Q%B;>/N(%[W#/BXDW8]$;LH[6E36ETF_I*:VJI_-#X/O"S!M- M/Q'4<878H_):F'D+,V]AYNT[Q-$',V_Q\=".KGI52E.EME(QZLV1VZQ!(17] M]2<>H5Z+T#V6B HS;S\^\_8R&[V4><.WC"08A5RNNE9D;B*.J/S:48MLF86, M!%-O1"0>IM["U%N8>OOQJ;?SB*?]U!M^0K$GY4DM066ZFD:[_'"863=(,;> M\@@FW\@G(O;:I1HO$/*W U_UYTAPG9LW#H6&_Y=MQ0Z,9+Q7CH"=0D)0#5<, M3N3-@=^9=B_I0'% QAK]L_\>$N[D$N/N7^S&3U ;N;#EA#1*4(=3[/_S/W;W M_\SLJ&3JIO5[P]$[!QOY+?P)C[F'"MJW%%%#Q0%X]V]17X@K>R,_&#^ Y4F+ MWUNI $&!1",,\Q?R_",$R!$T)^(2W8'97EC*_];F(T\*;#XS;16BY[>EZ !/ M^^I'F(<<_J;P",T)!;P:W JG(I0%\+4@;@FG_'R/R(RLJ!H^:]F)?GK MU( G^#/@$B *]+W)7\%'O_XTO5";.4"@"0'+F;:$*_K$>_E!JO^\,>RAX/95 M\)TG)&=(D>W0A^OOJVPZX%V."4'G%>^)P#)#TJHA&I(JZ@A0$(Y?(O:-F_9( M! HGY!TG2)L6XHP4Q)NY@G"&#/:_";DB)/Z$0#6% #4'?\">YVV\*KWV6>^( MIW9Y!H]$-W0,]8,@164&9P:X$*6(F$!)$B/T\0$CT#)#XT1:^G1\EIW@(4K8(2 MY%9KC ZKT1%-%8P8N("K(P= MKFRK9*DW,49);B4,\UQQW""3-3C4X.CM.FFD9-=LXKQ(6LM),U>HUHB%WYO\ MX.V\O.BPDX2HT7R>RR2$G-4F8!?SH[?+=2S/SRQ#P=!,=;!NUY*V5*D)T6/( M$Q6N,)IITDH37699P?!17>*&8.71/JU)(1]SX[FIIBC9H=VT:-Z26;#R:)]H MOI^3F\7:2IM5Q)Y99=IT?0J?>;3/13I!X)K8DK%,<:QFYJC9LPU6H(_W61SA MK>DD66*Y MO(+(1):AD=#(78\4J^V9V-JVDJC16(-:DI=C:_+L ;C4)2I1-X1>D2F>0 MS97X28PVTE%*:+4'B\,G#AFQ;F0;*Y);->8QKL";6=N%M'FTRUG:D&-.8]K& MU 4P=JV,T\5'<.71+@M$N[-TBUF+*PPTS)6KB6&:6AS1IK?+9E2*W.KK"BU9<$Z/5432FL:?X8ES0RE1N)&L:H3*Y-MKM MZM/ZPN^8L+-24/I]1I1)1>CW:46@8K&^("J$+$@2A47[&$W@S-$N>EV^OJ2X M1 -K6^GH:-5OX^4\\!V..;[KQ$?5!3[(L:5FU1-!+1,'#^SELF74)Q,-K0)J^36^8(6'N7RCD*1D M-S&>4AQ[BN[39D=)"6/,Y"<%T2:(1+Z8'IZ4WRDL.8S1K-WCQ5P\/1#4!MKS M=$+\<&5F.1VEEDFF&4%":RB)-1K+=3E=G1M&]Z3\+BL"L#4H8XI5!FPGVYMQN5$6- M*8 G,^G'YD2AEYW43M%^K=2CU>E8&F*KV721BYM8L9F]E" M85!.")4A6'FD.9/DU*C.Q')44PNUE&,.YNGUU NN'[U^W5ZLUTLFAV,*S]*M MZ'#9XBQOZ;%6R/0TQHW9/:R0&>LI*IO&9ZRW] A-"ME;B9V2EN8:E8I*KK&" M)O1KFR# @=!EF31M*F.%;\^3M);BB>;4&,(HRC%4U_GU:+6,KS0"[R6STY$M MEF1OZ=%F>7;-]3I2NL$KEM+M"V4IT;19N/1HLUU=3+0HH\0 #4MT)D;%-(K) M&ERZW>R!>^]_LR^08EYP-*O":171E'AL W%)EUWEI-?2GJ M':57W2IM.H[6+N-#"LNA5_".!F)77;^_,U#("2"D A"(@B)P"."Z&.HO]T[TMMQV=1;X[(](%#Q"/E0 M,]2#Q"RR4Q1YIGGJ%^>8;YZG3GYVGCI%^[<['HUF?(#MI/0_.V3]NO;V!P%S M)((V[TV"9_0M%;PGJ^AS!1X4OA.XNNA)A/PD@QV>]XB0?K;>OAY(OHE,OLI7 M(>&\#)('H9,SZZ7-C==[,6#N@0*^P^0_FZ2X3*%D:)Z$YLF/U#*/:IZFB#!2$IHB-\Q/H8BY?Z7C=W+P [/F(-0](6$$ MA+&M_O5IHZ@.0LLDM$S>(S9.)DN)=R5+"3(29QXI\;6YL8AX5Q;OA8&^)T_Z M)4'Z."02Y$9#V@AIXPA>.<.'CU="&5+(V13MXU#(2>EQKO# C759^4CWD#UY M<%L3P.^LZ]=FQ9DK-[RW:WW#$8[_5C&4X.5EQL+7,:EN#* MX%@0G!JTO*Z@"Y=P6WQ[C(T$8:HFEAHLQ28!;V-/P.@(N?M!N?L*/06ORK39 M3-?D:Q)3YV:$S=@")W:53NV+#0T_R:,[&;332OKM\6*.?4,JT.LS;.!\K8FTJ4:W, M>WBAEH/=3&*__D2?*/S-;H%WD(*_A$-]3WSZ\[SGYL(,7FZP2=H065S5VG2# MBU?P0:J9'#ZH]SRNC[D2;JZ:&FK6 M6/NGJ>"/,/8-J.#W^<5J3Q-()J=QM$XL)JG./)Y*0*X%?C%%/,5B%VG&'_)M MZ/&>D1WQ+!.KB^/Q5)N-:XWQ8%*25(:]6X]WO(QWTH,Y/<,*:F\>38P3O877 MJ!)ZO%@D=C&/]U$8\IM+H$)%^MB*]%V^[#Q59R>Y%5Q,E9;I5*P-Z8 ML7BG&#\4:X&X2QJ>CT=?BTR%[WS-[_Q />H=K)\4.&JMS;(?/I./5 M>JYE\%-L<;<^M,,7%J7HTFEID_62[UK-10U?P';=O@\=9HW#K'&HEV]0+[_+ MUT[C')&:S-L85IGF15Y.EW*M.;2ZH:_]1$1?,[O#O/%]<.K/OAJKVAZG:=SG$<5V@2O*XWN+%E213/;>?U7M0 MU0*'&">?8O'7JIL>-/G\E6YF%^M?=LLP^L:>93<&AF_(;NRK#!*H#-ETX2RV M4&=\4&<(W4RK4+?P(3;#AB9KE*WT<'9K4OM=#E)RZ78*9)710JXATM%_6 M519.R@0>4IQZHJ@+7IK_>2QX4QQV!3]J7-3=*%ZU"EIAR,VD'E%@:\OAW7HR M WLT7X[=:(P7B5J668WRS8JX@-P#71DB3/&=,<47:J\?I;W>Y7,DE]7TN*.J M-)^,"?&,K,_[E.5I+^!TT/030;WI=/SMC:/]<\2HY^:90TO7_\MGYN=>A)OA M!DX9Y![1 [R;OCY ==50?KL0E?"G?P[_['WKMQ>) $_RL(VT1 M'5A\>*R&HB!ETU%\445O&HLQ!([_X_TA&$U6%5>0(O;_#C2 )\B@O#E>BP!F MWGEV;/^['A1&IB[#9IG@H]@_-L+-7(#F_755(,V &JX,!N"PQM"&# AXTA%5 MW48L90B8W)L@/5(0U;9=F,J":I\&[6_#5K&TKCLT:!,]C79H'[,\6)",:\%G26U?F)YYO@F0/ M%AN@;7Y'H97TNV\IHH8N )C^F0*; 5+-;V]PO#I7#IX9X,)[\6:IV >RV764 M8(LXYA_T+H:P@J-M__V2C8E'F'B(EQO$"Q8A7\W2A(@)&2;$RPY>B$B,"A%S M@XB)8"%>+H>7]V<+WV>(/?Y,SKL$%8G'[@DV:3/PX[>>OM<: M/ABL#OW],S5*?TN*7;Q+_&%4.>3[F^/[VQK:?39I\#C# 8Y"?V>=I1"*B%!$ MW)>(^%)HXG'$ @QQGTT&?(-M>:O#9 (7_*$( WL4Y? .POCLT)Q=[7%C=S&X MY521')AB4ZP)\B^8!K3_?38^O['#GNWBR4;"7_7.UCN8M_PW^ZBX_/Z;P!OI M?>M(?^=EHJEK*0*J92F]1!:7V&Q$-^--L[G*8*^7*&.";3G"<]D"_*VD&NK$ MG1P42009[0G87,SA37D.E0-]LZ5V<.#'-X^*H/O M"GIL9G-^ 47TZ^'Q>RLWAQASF#$J6-K-JV.8E&U4(/-TRY3]^W;18\B?._/X]X: M2',3ID_@,>_!#?IV6^BV=. Y#9^[9+3+I8E#D^8CRM"_CMS:RHXS*,2Z0I>C M$SL;Y2U<11/-;/RBQ/F8M??Z),Y/@^ M]5]W;-=< )5+=-E?<:LYCJ'M<5N7NLR\@[-70R6Z)#&Z*0L%OL+%8^5<5\:F M K!M:#QRW/KBKWL(^MR:)7-C=EQ=M35D8"D*HD(9K-@.8@$J?M2801C_>1Q< MAO&?QS.6H#A* VF4"X11'3Q!XWQ&TZ.(XSN.",E>QT]# MMA\BU! &A.X!2V% Z'MLG"]G/U*!<#B3TC.42B==CH_+7*/<5FQ8Z!W49".0=N9@CQ^N5<<1U4:FP.*$[(8T4 MV=65RF#+7L$)7BC0'M>68XO"BJZ&6GIMWC?&F4QCZ LFU7 5F75>62? 97A8 MSGWN$6T1,R#"WBI=7 MQ[J$>+D.7NA(+&R <(-X"?GE-O'"1.BP_\$-XB7DEQ O(5X^HO=#]^5FVKB\ M%7WY$:7:K[IMMU!0>;E*V[>"";=1J/[^ 1\_D8!>II%SG.VR(U&O>+:W_,_; M(/UK]VAX8 )XRZ&ZM2X"FTD*YVLQ\;"H?>2SO6$_WYC8NN =M]!VO;CI\14( M7$EAW8=%>VTH/3+A;!O6$9]M6 A MDZJE2G>C6&]9@O@&U>,01L[8F909$L@E;*S'(9:6J+O*&>RO*_3SVVN)$HL0 M&\"H!K"SG-^H_]%KD-EI&_6$Y$7#A6U\@B8\9U.]-];I\'QW>0/#ZZK]9+WN M-[OG)0_/B[RSUYH]$BW%%C#35K-HL;+69M5NE(TGD[.ER[[1;6V^2*&Y(B4S M6%)R1JEN7+9L8Z^[&?:![F9)7;3M;1>FBN6U.-LAU1,=S2I](M$P$JD27Z@, MHK$5HTM]?2C0 O'K#_V$T[&G&'6A\2XW2.)7:#+HJ<<; \-_GZT8Y\YYW.]E M*/"-U(;+C12)M59#7>30U7+)H6K)&'??ZJGX-I>_IX>AUVOM)(MO'+\=5M]< M( WR]YO@JF?ZGQ #(@7D1'ZHK;%D+5U8,M)2)?M0#$1__0%:^GA,UZ.2_IEK MD6Z^9_I%RG0>%:;KOUUE>!@/\ M"^+$$-"'H.1K.1,/P;W?7LM_)5_AZ^Q['M?!9]\/>@WEV+@@#.W:C&]D<\FX MO>P*#4BF;EJ_ M_PN3X7\[-^CD1)'E=MCRR5[05+A]TC)K5A3[.Q[IS;882MF/94\MU%D#>>(X1=CSM,F2J MU\;X-^9$KGW4*Q+WH\22P\#_'2'K^D<) _]AX'^OX.!H^*__ PR- M_!_^_QXU7/D-]0?[NI4$NE4V73BI]S:5Z\4+%'"!KW&M(L,CA M;*'V^^*0@$'*[@0\2SI+)FJ'TE%;D7[+KK521.L<=+YMR0C[XVRI.U53VXXC MKAP^PZX=U\QKL1Q5@]0= R* C&R+^()3/BQQAQKR.S7D0]C11T&JF\P9W!S1 M_[Q8\_>4E-S8H7\BHG]DS.\[*BYNZ\P_$<_?DWRXK3/_1#S_Q#-_2][B(D?^ M.9F,($PC G?@U4S&HT9PPS3&W:8QWGUA&!*WW_/\1!PRAN.%5JHINMALVA[5 M6)6UK=D0[C;,:(3QFC"C\=,R&CLRXX,9C8)<[18I/3;$*DDL(Y7&N84]8N$9 MO(P&>:G&;;<7] TS&K>?T7B9SD]G-.:2E6=K3JK!%\IC*RV MN/P__/]Y]L[ -!W#=!1D.=%_ZZ(Q_-]?BH'R#5]>"@.)E/K1&"U(40(3*)F2 MA;X2PP6ZCTL2^)R(R1ATOB7=E<&A7E$0[S:$3FB$!0"ZK1B'][XV*H U9$\E M[&:WFXHU\<]0!JN$1!QC^KK6E#6U;EAT4R,&K4[MUY\!P#0*%\D30-(+QN\T_\)*,R<83L6.+CQ?$_ JDSAMH(. M/OBAF>@!M>*.:W2OJ';X5;*2K0PXUQP7A[_^D#3S!-S1(S,1\>&"F , @LG$ MA-K'E#1$=!"@B93 +$6FT"Z%B_[[C@SR5^\B[EG\C2@(5/VA%01^AW!4#5<,C'Y/QNW(64D'C 1UX>A @I-0YNR+YPMW)26H MC2K?2KPT2D3]DSU+Z/_\CW?IB9V#!2J#\.3R4$'[EB)JJ#@ [_XMZ@MQ96], M?B9";,HB!RHW (_2!:O6UQB4P=:")R&>\_(^(C"S(F?_5K"0/S%+_(?!G0(N M _6]J5;!1[_^-#TR!X2=A(SNS:H);%;1)^;+]\#]YXVY!@6WKX+O/"$Y0XIL MYQMC@.@\RJ^1* /D+1JB(:DBCH"=)JC3)3=^3_?U%!XQUAY]01I MTP(R3T&\\2((!PP@>9L 0,A@>@)0,#+\ 7L>+?&J]-IGO5,\)?H&$BT2 YG" M1& 149) 87%&B&,4(\0DD91QL2])=/273XCBQ@4=US.%?&V6[6IB=5081=,8 MVJK4@/['#E=F=7EBI(<-7*-9ISI>9U9HF1B"E4?/7%N8ELI;<8:<;87*[%11TL61Z;>-[H\F89KHP=KM1):MKIMN)5;H57G1AI:;D4 M6A.HX[>7.OV*)LN$Q4U*;15;R EMD!J"E4=OS\0GT4F2&!E\99PW>@Y7K!DV M?.;1V[L%=J7;Q%+$"E6T,,OUNA.%9(7H,>1MO%*E485U.:5?[1M- Q]G>S6P M\FB?JD!.XW2NW\((%QNWG<)XL5"&8.71/OL9I:DS2=[@VQA>TP9ELM\GX%-%C9./]IGQ>3=Q+P3[6J945EAQSG=%E=#(7:" MEDHJEYRU& %3*)++D:EB;5FL"J546R6'E@-_A?[ BGF!4>S*IQ6$2TW/VI8,IZL M"7 I]>O%;XUKR[%%84570RV]-N\;XTRF,?2^A?\Z9:*XYZF: (Q.C!UW5P LP+QW'I@C2LV%/^(:OA& M,,2')PB!G 5ZPS?AM]Z2Z)GW1PE83PC_OHSZ.'F4/3-BWQJ%BN6]/3!\&&SL M0S]: VQ#79S:RN_-#[M[@Q958$U!+2+Y!LG&'O:,-Q@MV'S@FV[>)WL&WJ[? M[Z]Y-J%C\4@\[IEFCK79VDXDX]<7XE1$A'SU=L>.NMQYHPG>,@!$LX'DYG<4 M/OFW;R%#%_Y-XW0GX+-=*O:!6>(ZA^&=JTW1Q-]//+NAH/?%#WTD +O\U8N_ M(18NBX67N(.,Q,@0+[>'EY!A;A0Q(IB:3GYV:3-&1./&( M1.-#;.=.U&='*7\V0G"-:8/' FGSWB1X1M]2P7NRBCY7X$'A.T7#1D]BY*S7 MH-YG:EU-7L/S'E'2M]P#N[@8NC^0?!.9?)6O0L)Y&20/0B?G5DS!G=Q[L6#N M@0)>=T5N3%)+B5!$4!H44<;_&R9DI M(HR4A*;(#?-3*&+N7^GX'1O\P*PY"'5/2!@!86SKDWW:@%7*(76$ELD[Q,;) M="GQKG0I04;BUYUE=1D+3D&\XKJ0@2XL7A^'<#8ITY!D0I)Y)\GD#+_*[%Y( MYGNN8WQ)(3\.<9R6)^>*(]Q8\YB/-$79DP6W-1 V?GBN[^D!%I2/"0WXC(1H M*W+2G$P5P_:JJ[Q/;=9U1J8%3B'S!N 0K[[,[\E0U47#3JSVF@K416.HL$O5 M%F#').%PTKC?>,!02EY5EC"?Y<6BE4K%>+="EROMQ CO%R\PZ/SS4U4*1,GI MBZ-!BVL[^"+3+[::*EX3: '_]8>*$,<-$,XFCF^,T<[6@NPV&? J;3MOG_TN M//TL2=2T24]I=3@WP6/I=AXM#[,+P%WDR\U;0@9[# ;[0DWTM?EFBF6ST:ZM M-[#VLHYU*B*GT./:%7H(3M!F3URM5K2&NK79=)XO\=R0!?P3!0*,B,0NT$+P MX7DG>ATC-U1.%U%.Y^EI+:/I8C,OHF.^HFTGA7L+/ M"IVJ;V*+"V7W9*ZYI*:X129$5XHBC?E5)7< IU!6YD4OQ(4BEZL MC)4^9868[U3%+]+7^?IAT7,;>*%&NCG&NK"[)-;+D_ILWEEABF:)B;PMV]P, M]E@"[A(>BST1Q$7F*H2L$SI"ISDBWL.PW*AI=+'*LM[7"&)M+E/7<(0:B55J MLL*7I$;'HJ3$VD*:[@Z%./2O MZ @1IIKN+U[^N&KI0YQU8<=I$G,8?#D7#:W =YGF9&D-"^L:8!SH.!%/4>R" MH8F0=4)_Z(@C.KEIKM%.9 2MD.TVNNTQ(:C+:PSNM9AJ%J^7IQBWRHPMBJ]* M66FV )SANT-TF&L*X$XPVVTFJQK>INIM58K;(R] JB[U#N82Y MIEN.P?TL5TB=;\((PVRFDU^WYG&ND1FVNKF9*Q>QF[IU-W(=9=09]_)%[/G*-%YXEDIMT5^(R*9>D"OTX5HHLK>%X8 MQSKI^90:8"K9&U13%7"R>@UR$'2]J @69J+.EHD*%=AC*K#S.'!5<:+'BYE& M%RM$-7.^[I4UPY^W&WN/+GN$/-576E@^?M/*']*5\NQFS)[4)8'4E4T73O[] ML6*7KW&M*2F5[5)KB,L*X"LQV' M9COU%(N23R0=UMW\J&3(2T/9O]TBC@NQ4<+%TBNN8I2'+(KU>\YZ"(G33T9$ MPV3$AWM_A5+W/5(7_S9;4UF/FF;=HG-<,K].%A1]NEYV/0$<>Y\ ]JS-OQWX MDC]'_' >!!ZU8=NAF!<;(N);,M^Z6<3T_1W-P4$@#E7#%?T#GYT6QZ[MJ(/5 M*X?Y_/;/+WP/-+TYF:C.1 %$QAK 58. &BJ&I"IV2K4EW;1=2VF"=R9TX*0% MQ-87LC$R:[-)T<;H85=51KFJS+$+GUL I($X=EY9)\!E@#,40,13L!G'7KZ!B YWF[;,">* YR&.Z?W_"7%&"@+=:]%8(:J-B$#P#!0@U@P' M,2UDJ@-5"!XZ0%0#F8N6:KHVHBM#44=\YK?! T0' 7^Q%;@&/LZ TDH'B'0M M\*$Y0/JNK1J*;4>0HBIZ% MH PHU!!"''6 \(!GO4> W9 #W*H'W3^PG! @V M\'V/QIX0^/VA1[A/R ^& %R&)DJAJA[#X:_F6 C%F*#+4C>,Q7$4B2H?&1D M,5(,1'7@::>6V8?"*C@$>+*_O14R$FVDK\"%AN1:%O@:?"H\G3@Q70B<@?_; M=F.(!)BU#]\CVJ8!GKH"Q E@+ ++(G)&A+^,W3UYX=&%#,_L00K5 :!^NS!6 M G_ZY_#/WK=^>X$G\*2&XCBZXH%[5Y)<@6(K!E*1'!/H*X1^0@@,C^V3K-?! M$V '4*D)$%@2;? [TE"LN2HI"#NT%.\8'K$EW)5B^>314'0=_/SD_0* !KF6 MP/[AC"$P /V%" M%JNQ.O+_A_SPA"]49(9LEJ?H34BPF(3592G^UMRE ^;J, M# 'K "X!]&=[[ 86''X9T-_44A5'M, #+!&:.XBC2"/#U,WA"G*? U4_9"S/ M<(+/ 1I@!*AO '[SR!Y0."!6R'QS<% 3/ F>%;X-?%WR3P^(590!^P%HLNX0 M !TA<0^:S-/1G@:J#N!INX!#1'@$L'CW;/\Z7#^/( 6WKX+7/"$Y0XJ 3TT; M80$_ZX LDI!95DC#G0): /L"OUL.DH0;+IL1I)'$B7B,IOZ-V(#D/+8W+7 ^ MG^\]V0'X28(']L0$-#F>@!D&"0?@'BBTT<1[\\P%$LN=($#)@9T_0;C#-]N M8B$#^HA^?I8ZF>JJ ENI Z")/H2&IBDC Q$B&2X&/UE & )"-88>Y,I@+32< M$)QZ"79FWP$0@\(" ' R@6@%XE1T=0<9N_+0P\4IH$*,_?<[C4V8O\9"X?U;N0+M3 MRPI]Z??[,M1RAN92G$R7.(U#]90K:* MNA1$1GX " 2^]E66*7$"7B?W3!=H'1;HNX> MY=7+P) 5U,9RE,YP*P:;N:W%ND:-9_/8XM/?_R0?1MHNK[@ ?Z M,K$JBPXPT2J#'7P\/^I9%VREJ1T\,KK2H]DLFZWPE9S&QA<58R)8GT[T/I]E MYY4>=-F%"#4WM%XJ4*]71'+60([IP7P(07:4*"D=10$QY&-;=IP^[8R#G0-EM6MR_+.D\NP6%6#9 +M+CE1E@%0M4W8E!ZD, M!L!.LIZ0D@6,P]\1W_R#6)@GL K8SYYP+<8P /6D3[4WK:H0YZXI-RC MA&>QM_T92KVF"BBS,L@!&@3[ UMZEE;>\8+3!8<+A)52R2='8UZI8\EIL2RA M(U/++#Z7U&,].,#,9,.#PDE11.")K".WZ@6>1FV4%[@\EDD.@2B*8T_8B6N7 M3\!><^T-C(&YY.W% %9LWS1!018"T.%8!?"1QUOF50=PJ-PW>B AB- MBH!J64HOD<4E-AO1S7C3;*XRV*W@(E=.OQ<;5<6"C?R!OJL,?,Q4GX&7\&'7 M!J!K>G!CG\%6&9Q (4KLX##-EZKY>LK(=18D2P!U.KN*\5M'82FZL:BV% 32&8Z?E!.(#VO>( M)A,3JD-3TB#JMN2WL5 \G3!7@+5!A^ MMGF!;^ .5 M^WS#4.?"8 YGO.;/ !P5;FBM(RJ,X8$KA?Y/TR\^U-HD50$)P M4]#-]%_EN67@*."[T+Y3Q %0;Q&$]4[94*9.8$QAN[K0)U!HA!FFXQMB0PAS M18X@_!3N7K$FJN%ST$GFW-&6OH9;!=&;I^?%,$P$%D!Z]#CM7^J_O853X*<& M#QZI>WP.3F-!'] 96=";\?8J!W"'2W>W!3]_ L\,'JHL(:%!V"_\MXW4B?=G M\'?[67ALK55@RTBKK1&KBXLG[S&!/?J$]%T'P!H(0!F9BY+_RJFXVG\\4 8V M])Z/G_R$J /XP*>-Q (,#($%X:T:@*-MU7:V%@80/^!+7C@-["2(K?Q+G?M' M"^SIO>C>,4:F(LPJJ5-_JRI !,!+7S&4 92)GFVW)P(/4 ELW6 Q#'X8=@3) M^42L0#-W'ZD;-,"((-@^L&H1271AP-+RK9_GU8!$@9WFFT$9&"6H>U2"_ L8 M^\"_]SQ^(&4A M'8ESR*U A_G?"4+LRG.>$@% \R*BX,7WBUG. X!G&=@M[YRL(>]D8UFHZYK/ M\-Q!=R^/R85:?2'Q,XXAA3(M&MU&[= GAGNX\5#21U[7?LZ\( 0OC MDYX%*$F*KOB4L<&JYQ+:GFGI61A;%]'#[)VX'YM06,L_E/>5UR^=>NAK NM" M&NVU-.FYU<%H.IP/.6*-]QEJ&<T=E_V^CL'QJ=WC_!>;R\O_WL M%IWV;1I]"8OVLGV16_6C,ZE)#(O-*) E)SHU_+4Q73QS+3"\/&7L&V);Z@%_ MWQBLX@$+^_ _X9Q.^D73P?GAQ971P-X"$$1C_V@HPPO^Z MR.63_=%S!+6Y?/.075EX/SVO[7YR+MWL_D,>(N0Q'Y;BBY"7P(^>^^I'F(<<^I= M;(.Q0?!K<"J,9-N^HV)XD5Q/KJ0! MZQN2"IS-!LSV!1';;]OT49#ZM1.D@^2L-U44X0QX(^$P6X![EA!,&SQ/EOS_ M[+UI<^)*LR[Z_4;<_Z#3^[P[NL\%%C-FK7U6!,;8QA.V ;O=7QQ"*D"-D+ D MC.E??S.SJJ02" _='KNU(_:[VB!*-63EG$_>R[WB5R_I3JVD,-V?A".3:YZ0 MBE-\"2;Y<'1#T6'(!ET-JMYCK<6$S!>R*IV/K,#P8-V:1RI2'83ZH@ 5&#NW MQYY5VCF8=/9[9F=T-R^-$53^ V@O067!ZB=G;JE5'%K??U@_#OJ!M2"OV?.H M+]*>L98Z15K\OA10C_O?DB MX#<70/FGZ(,QX6TK-X KYLL9BRGQ2@" EXO]8@P\B@FNQ<"7SG6MYIZ.LOG+ MSMF!\[VW^)Z_;CS:3$P8&6U!E=+'O8.A.[@8Y"]KWKRSQ;:/C<,&&($+ES3H M-0,PR:[SHR#@(UFW3]S#CF@ M@4,F'31/NNX,8TOVVT["!!+#!&>WI?WSJ[9>FF2#*(R& ]1("! M7GR1%KT)&8ZR>=HQLK>>X.%^X@_B]$-U,4H4-AQ"L5C=*LT(JM44,,' M)N1>;VL\.;NX&>6;P5;[8C3HLMV]GT[<^NFXV(GK\- 8]XBU'3_PYC3//1ZV M2:3[MG[6^Z:[;)+O^M6.>WAP?#RI _NKUC*U!" 5)3J6%":(1C@0AC$3F@#E$9%/@[*B6:!Y&(>8H]LU4D5%B#:FB60T M.%WA>:-(":T%A+D+/%X[LBA],(HNP8)G8@:/N)]1L$7Y!C2$"2,/'P:S6+# M<-J+97:D-_4E;ZKT/\M9'\NSY=ET('/N,"GYR%TP#YV9_AA,TR-K:B5+GJ.. M^[5Y:U?Z^4M_]^"[;HY]?S#"XO-*Q1)_6AG+P_KK=)UGG7O=JWFEKEUJ6.:9F53;A2/-JQRZ9C%]FCK'=.OX6>X M3==;V=)LKUMP+_O5^:1?Z70J@^+6*"6R%R6R^_3DGU8OA/N@XTA-.]IB6%QG M2$H&"NA$BK1_?/_ZPS3&^Y.]H^VK_<.N<3?:7VQ0K]D-INB)R*9"37Y&R9@! M;L>)UC6P@HA"HH[(K 7J,I,TB5!=IBP8BJ":ZD\VCSG$NHI$[61M3%7MH:M4 MT+A&IM$6178^S]](-?F/>]'>E29_TG'+H[YWE&UUK:_-QM?1=>?R=O3LFGR7 M7Y7-JGRQG*KR;ZMX\2-2[FJQ_/O=5;:[N_PQO>LT^\5O>Y6CVHD^GUYYH^/9LGSVZ=]BM?BQ=?F4I-Y,F>\LCF>S8=#.YO?. M>^;7PY:=/0^ KU>*R?:A5.;7&/5/:O//YZA.Z>MI]/4.]?CZ@6?-6L%!-E_M MW9X?#]JF.[O[0_3X8J(>G],X,$5[J#&+4!$>X\-G#F5K,@VC4?A(*YXK3PE9 M,EG^015(Y#S(H&&8K>4_94JQ+.T,5\D>\SO.53 B(9*MWT!R?5"&\' ([/$U M=UV/7FSRE-EDVZ%TV.WL5@J[D[W>=.E>9Q?UDP,,]V]P M&&$@2^C<0'MI7/K)<6G)?$G(^3+%7SDUE:M?6K8-)WM/)G.VP[8.2_KY=K_J MMZN-N_GX\/*6L^5->11OT<,2$E,;+"6G4GP@,RZBPK1VJO&1%388(LVH1EB64ES43WBZB![:LS+7 M=6UQGT,[%G/TX9<1(^\I/-1D_$=4:"2R\]?DHLUV,S>(!BPSPC M'&\Q'@J56LF2U/65RWQQ?+?%ZXZ4,J-&-(YDM@@58EI#2U0IU0I;,C@-E#W" MS>)OI'TC;(Y;1(D(TX5Y2LZ;F"6_&8?X">;^4IZDL'RRAZ6$H>:W"\WS1[E>GA>/Y8;6]:Y6PLC)3SN2/BA/ILYEKHQ\,9PWMOB7%A\A!'#^A%$$4B+W$UG8T78'YW>;EG MK&9Y\R"\3([/ L]!JFNOCSQ0*%P7HWQ-Y:_'9&Q&"XLG;7Z=U.].6&G_6__F MYG3_Z*)SW3P^_KFV4(\"()C\*+1JL\/C;_F;T>Z\>]-T#SL_$(!@0V$Q"#ND M\0"D+Y7FDF<5=S042>?=?NA,?8WR\'=\#&_D0[^;YXO!Y;4[G#3KC?K8.MP_ M&'3@3+>>5BL>OZT"!2WF1$XX_=/T]-\*(Z#T_>;R\&OSZV%_KU__IE?W:H5Y M&=3G3=;/HXX]M\)N8?4DKAA($TN(JZ@>.T1W7 W$=,>N%W W0=O!G&UDV=B$ M(=)D>^W3B'* U*@XD:.8B!1#13?$=^ O0EG\6"[_]*3\-Z*P1[T%DDZ_E MWG99/Q^PEE[/EK/#6;5S>G*V&74BAY!!F!H*=L[873"N%*&V0ZA92W3,W'N* MBKVR@I9(Y<.@6PCXDZ%F6B#Y ]?ST6^T"0?%@0F0V0E#$3G83RH'$TEQ&]>,X0E1GL;:##R UT(;A M=#R+D0&M:U02#X/V5'OY22 ,-"CW""*K4\XBK*%_'-1 5'+_4(G]BN> 7V1A MBC]V\O+<\>CHVB$^;0A[0C,4,IS7\NLJ#:V]50QF28 79!#<7V+)NFY^8.N[ MC4!#/D<6?3^%_Z_*Q]_&@6;=;1^/!MO>9:MXM 4'UBH:V>/1ST$!K)8S@5J? M4-)$-^47*IK(>X-#+XC&(V\5*1D"J8?SIL@;!(QF1C7=;H*IJO 2^I.4#-(G M="3]9/_0'VLCOJ%/)B&+?_ ].ZLVOM7ZAU?CT]9.7<^[7X%\BX5J9BM)@^7\ M8MT;HWI>Z)I.Y/\$"R4"L%!E>.B%]"7W5$"C%-I,!N]\E%^@T_ "*0XE.2)0\X'N<&S2(OVJR'&.$2(:?XE_*+=[ ?.A M."+_;01L6N$_SFUH=_#QH!-J*71""IV00B>DT F_"IV@WIE"KA*VLWHBF +" M(ZSS59U^>6V8U?*@;-2O]:UA_KI<*!:O]8)>OZY4JL4"VRH:M:WA)T[BNFS5 MLW_^8V1TCF^R^O4:9O3XWX#V[BL/EF>UO-G\]'I;NNRO+<(@O.=B>4M MKHOK3\Z<_-W5[HD>M*IVM5.;?NWL75FCZ])U?O5)MIQ\W3_6Q[?]93&H;6=G M>N.FC$^NC6D>N$[Y^/;K[F3/-F=EN_>M=IV_/-C= ML@H'V]\.+L^NR^MO+PX;,]NVO4&_:MMGWT;%W:!_BT^65I\T\EES:)6;S=9R M<7I^-3_>9GE841E[=L6?/!@?U +WO-;(=YNCL][7#JL9NXWKROK;QZ<5/;_= M.]Z>3*^]0C=_,)X':@ZL?V_GN&3RY]O;FX*I8 M:YX7>OD]H]B\.C*6Q]][C>OJ^MN_?2O=V3?E R??89?UY>'".3@P\,FUMP^S MV\Y@?&[F^ZQV4#/TRZ"E3Q?PY-K;KVYO*]7&Y?9^JWJ4G>[>7=ZR_G!T75M_ M>W_?/RE6;O>KK;V9/2CMGGA#N[J )]=V/CLX[P^_^\MY/MLNL$K_H&E=G)S! MDVOGWCKU6MW^Q&,MZ[KU[;;<:MY^S9]=;ZV_?;]VO#QOV%\7_>'^S6[=S.")]?>?O.C<3DW^L;Y9,]P.X7] MZI4FW>G76 MTV^^?N]NC^#)M;U<]19-<[@<4*/RM==[K.9/#GXT9OWY M[>G9MZ5[4=S:7HB>YO%'1\RZ^-ZW&M66;E]?G/U8+ \;04,T;U8>O:X6RK7J MH&Q>UZLZW$@SSZZW!F6@^>I@.*QM#8J5:X7_U^ M?37;;B2Q*/,R./*;HWQG,FV>H'$T.YR#)M:T=!8-L<>];_JK/=G:Z[>_+ M'UZ]>9;$S,SYX=?O.UOY25ZO=8W+"_;C>+9H)#&S;WX]N&NTZOU69[(8]HJ' M_EYW&Y]M$I9HT*D/^\/SRY6]P4 M=H++41(S[6=/L%V>F[@Z6/[9V=_')M;7O+LZFW=G=N-=B6X/.XN[X M;CN_>Y;$S!RK4ELL+[ZU6Y<']>/@ZMOYWGB"S&SM[>W;F?YU7"V>]-G$.3VI MF;W*Q2F.N?;V=F^1/;TV+R;YHE_88>ZR-+9[BR1FYLRNMXO';-3/[^UM?]\> MWN7-,_,,GEQ[^X_MUN[$;1S,6IW]XU*E,/IVM0L")V)F+]_DC&(;?*ASRY]L M;&VV!W;%['H$'-7LN%:QO_PZF?PXMNP3_::Q JETWZ/OK\%9(4_-Y0J\Q5GQ M'_%7LW/2;)WTSAN]=N?D.3N;O487B+ 0)W:^_FNVS^L:8V;.;4QMCDVB,T0R MVU[B_^[J& ]))+3+UO*2W4QJM;P^O5C6SG?*D_WN:AN]^QX%-O MI3O+)#]J&HE-1WS1 LIRN)^+$OZBI#5#GAB//G%_BO"N%/+_P9#1%$$F-X1M ME-(M/VR4%9M6 =>DSG_TM_Z'.#3T"PK)! M*\C@!K7TYY#S ;V_\@/N>J!/8@X*I5.K>"9R 6UQOT+@R7E)2XHO_'']UFO% M7/'>+KB*9:>,C[&+(9RJW#3Y=Q:;TO[-G3GHMW_0CR+.@EXL']4'P$#F 7L- M!\KFSN_Q_J:/;68:^<1^L:5O(;=53\_E'9Y+/E=.S^7]G4LI5TB/Y?T="UZ7 M]&#>X\'DZBD?>[ESH5[M]/_/HX:]V29L/6$37E3A^>4=V'IH ^Z+CLCVXZO_ M&\5!Q.+!&, =^;^?2I]^CB_SO(@\>01CQ MI?ZDP A3*O_^+\-@;#A\4Y4J#.PUGHWGO[,5KLKY7V7JK[\ZY<)2Y$A=;FEU MN2_7FF=#]!;3^(_U[ZXG2888T1DC*$\G/,(Y*[G M3C&1%9>$=7R/'W8--T+^=.U9,=;^3:/4/]:[=LO:WYYL5T[W]B[O8F /Y2?4 MO:Z]):I4+*S5&V(.HJL?7N^ZM1^MZ>6X,YRVV]]J-J:N%#_]NU7)U6IK!0#/ M)9'?V:7]3USZ/IOD_=,O;SYV>?._V>4US*-)]FI8/YPL#T>..0U*TXYU]EJ7 M]WME:\O,WICC_-*?'?2OOAK5RXK(.ZL4V^W]R&ZV4"/:_@A6 M\&NK/^^*79[\]1Q:ZTM;I$]S:[Z.*_>A6&XJ^_A'NQ]'^.6O#H_R^?UZL;57 M6=:WKX=6I76R>"WAMZ@/\K?79Y6@7SV?W?6WKXN-P?6"IST7J[ERZ>6$WX>6 M=.],0%N:%\[/K2F6WE?SL ':V>U#T9M6OUB[6^H @+6 %?6I%?B@KU M(M^Y%?DN/>8['X=?6IW#']O;@7?>U[_=Y=MGU6K)M$:OQ2]'0;YQ53T?[.2G M8^=J9_GM]JR;QZ+L(O#+0JY2?3&7^3OAC;^5$^!YU-6WMPM_6CG]O:S(_=_5 MBGP;X^/]VQZIN?G'F9O/R;)_ES/_P/9*.[57WE4FYQ\;%7OVW(^/=(;_)]6" M/[ 67*57$.[K[ZH OWP8)7Y?2W!?37>.V!WO\L*^*R=2SYWM6K]YH4?XYV!5]G=;4T'>6]@[7E>X?42 M->_VYR>+\M!G>6N\UYG?U6KMV_H(KWD9KGDUEW^1-.MW:>&NQMC^(GBL&+[# MS[\[%[U=WF_Z1($*SA7J;)H ,1''C7@,(KD";;$^'()[YW-5)A7&8B67#Y'( MX9Q9N$G4R4'+:WE\KXH%\3C^!0X"W.4V4/9*[X^W:"^)C%8+8#QJ 7_S6@&4(>./4(D M+]=&S&'8F5ESL*LK]@J+0?(1JI_'_+E-H'XX8G<^F]D6833Z@7B"W0&/,1GO MVD1]T[1MR[;AQ'):P^>-#&&(3"(&H!'#>L1."+$I3/6E^#EUR$%K!W$!!>>- M34##FYR3,)%KF. /P2X^'J.Q]'NC,H[H!,7/?-'XDUY-S3%2.,84CC':R]\; MEBF%8_S=SB6%8WR7YY+",;[+8TGA&-_KP:1PC"]Y+A\OM)[BMJ6X;2ENVPON M1HKDEB*YI4ANC]NN%,DM17+['9#R:\" M?35$/.H\#$>]0,K(=-;;:V5GET3:O6RL;]3=+^;A07'+BT6<_FMM! [ M+<1.2U#>1MZU4@OP>>I0WGG=V+N4FJUW+37WC)W=K]>-[TU0[9=V<="]/=A_ M/?B2_L@Z.]BRW5[>:MU^7U3-PE&^BXWE06I6BKG"RTG-=W:1WZKBY)U?Z+2Z M_F-7U[]$*>CO)&_3ZJ]?*/+LC3WVZ^5?KR)ELXWJG;ZH>FR2/5OLC _THKGX M\6JV:6W+FO2:K=.=?G;L>^/@O&:U[=%U%:5LK9PK_J8@82\D4M,[^PL5FQ_H MSCIFUAEO=F=+S=U^T*_VO_5OIL;IL5]8GAU?""#4 M%W:YOQ.'TEK=FEHX]?QS>;ZBGC>HJ6MH'C/G_(9;L 2@)I^7Q;F>9F/5%"^I M\IE28[=PY[:IC?5;IND:4#%,0[= /V9&@&5O2:58O/*-AG5G3-;( M 3/1AI:C.P:.!.=E4@:N*$9<*3WD6:U*[JYA,]U#&AVOE$"6<)$OD;R[,8VB M6);$&94M9HM;JSFY_^__\ZCB7&5A(N>Y2'=KQ+(\M5D?PKO_UNV%OO1E%1:" M'?\GJJ@5$\.MT"JYK:W_:-$_HV)=9398'J;L6:S\B_\J7@ F/GL@OUHI1"T6 MJ_7,Y5SYA4YJA?1+T;G\CZZ!3 ')]%^]3C,QV1;_#90'C-J.)=R*C\ ^ MH2H\(.4F+Z?SP]NLO]"-7DO:>2A+YW ^L. W&:WM&+DP6>?MYW7B!HSJ.V'K MR(^@8SWG;L@#0,$(V)3OZ:M->I4[/K7INR9SB+52(:.A*4*<+9XD=B_WBE^] MM3NEWIE"KB+I&$7_=;&@%P8U1&/8JE6NRZ5BZ7I0*1:OA_JP4F&%VK X*'SB MI*E+9>&RU-[[>EJS#_/-QH_^T%\<9#O7M_=?,O_ M,.]F\&1Q_&MQ\/6W=-'@>0?S)KQ>71]>#L_9^ MBWV[G?7OYJV[H^\83EM[^V5[;/7[M=;II#L_^Y']H=\L"I=G// 6?]*Y.?AA M]>&DV#HV M&MRP6UE11[\9?M=_Y/,W^JAX;9XV_&R )N#:VNVMT6VC897/\T7_Y,RL!/7E M)5MG_:Q?*CJWUG5]/#R#)TNK3TY:H*EO>\%MOWNZ>S2[ MV>M=[[?QR;6U+P?GY9W":)J=[.5/O^^YQYYW CN_M?[V6OOKMUZA,#,GG5:L/LN%:Q MO_PZF?PXMNP3'0@6GRZ\E&Q3&9;AO_Y9_9J+ M/>+),)*"CJ"B&JAJZY.A"=X[VH OU_QS: ,K@!)#(2>B>8#>:[FFG\(.I+ # M?TKY80H[\+N=2PH[\"[/)84=>)?'DL(.O->#26$'7O)BS 0Q\G(+(!(?@1RH-?7FH@/1:O],=6"/F%$TD11-)L4.><-S2YY=BAZ38 M(2EV2(H=\CBZ*-1_%WGP9R*%A)&>YZN+?F.H;9QT,"^H_.G?0B57*:1()!_!C1/E5GP$ M*^N/1B))^ZFF&7#1OS[,]5Y]-EJ<7AXWR5Z^E5QN\.K-0S9520,2/ M988\'T#4[R1>/Q)2S*N#4_Q9C%>"6'6FR[OSX.MUI[5T[+UL]6MPU]P>O2+C M]6I5;[P\^-ZRC*L=>R]_8N5-K$XJ?OJW7,R5?E,HB]\B[I;:M7^F7?N\\$_O M;'&OC<#XQP/._)ERN.?.=MVY)[^0R#GLUMLIC-E\.K&N3QLG)Y>76V7O%>V@ M;:MVVBTW[_S^5-\IE@8'QM&W_<7UULN+XW?&!MX*O_&/9P=_IC]D SLXV_MA M?+LI7)4G-Y7&_LW9XD\N3PJB<;V?-3C!:Y5?=^3M9(V3XY,&%S$P3V8V@GN>$\ ?&@/6-X/W!MZGT6ES5*!2DXK%5+!3^T;K][6[KK-\ZZ6FM"_C?[ELATO4B1 UM MK/L:N]7M.8%#,3H:#LI!X'.N8:HOD70:'CP[(BI2],H5'?04KM<) ML,Y(H\1/<-VKRFJV?[9SLZD.*OYRU9QO]GJG/V\'AHM M4B4@9:6@(Z_MPP).HC,CF"/:/K_MG!)BSY[G^GZHON:Y;#C1/>]Z]\HNN7?L M\' RM8;ETWQC,+\;-3[]6REE"O7UF)[&SQD!A*SIE)D6W%Y[J=TR'VG%<*=3 M%Z\0D#^2&#(0>1QPIX&7!*[G:W2-B-@(: [/05M8P1A8D*:/1AX;(;N.;UOSYJE1,YMW]O[= _;5'T*/^4=0 M(\[KF4F17*/TT0X<[2Z<[ 4>;")Q3KY56:-0SO?Z5JU5W*X:6Z7J:/3I7U#F M,Z"HKU'G<\J)E^.L7%#'B1W(^JT8+1W5&E6=PXT&C15N-0DSG(-_WNV_+A'; MM^5Y,/A1WVI9MYV#XM<+NW7C_D+J]4]3<@OTFF#9=F!/YJ2L=.! O1[8!XDT MGDC,[N"D<,5*)Z?]YJ9>7R=F#;:;XPOK6@"4!UHA M+ [)ZMT1"ZR:S@#T5]J_593S%R:3[\/SNWSW;MS*[]GU[9W9HG>TZ/Q"A/9- MR:2Y/^X/:B>[PY9^7JU..GW_<%(!@5S8*F=*M77OLG8*9)+1=-N6C"5!O.8T M-$Z(H%!4:W#48,(N-41_T9Y@H_XV'$2AA:S/C+_-N8>H-SYSGHT8Z'\N8!,L M9\3/NZ <\XWE#HSL[C=WLC>I_E@:P>E)4(1C'KIS3ULB#LKBP"1D=N 9O MU. I!TVDR.!3_@GD,0?[R@&VX:&Y!KK3B#F(6XX_6<9MP;F'Z(YXJ&A]&?@Q MFG$@R_ QSGW@;SF0/X.+,[3@$[#G"'A2Q\7F0/+!#J$31TN<@:],X;[WZ%/J M=<#%)C=$X+=3?4E+!ILP6##FO+BC/4[MV.;A' ^=R(Z:/EB.-9U/5PCU7;+( M[N%.X?#\XJK5U_=.FGNSWO?VV7%,'2P^5AV,'.*=88].C%:\YAPG,K=N>X?] M=KU[VMJ;7NT5"J,?V=T%D/FZN/L/T?>;'ZE^]U&.M.3NY'O+;?T\/VTVV:PS M/)@<&(V7/]*[R^_'A:S5+/8[EUN+=K>?/=^Z10%523I4CC0+YIM0802C0'%$ M__2UL;ZB"Z,8(U=8@NVGSV:>"T?$S0WH@CP%,6/P M?AMP9WIQ6#XRAHO)WK8QS'_]<>99NV@#9BH?V0H,,9>-L<6&BD/4'0XM W[E MHX,8-;E(/DIQ_=K*/S+&GA78P!W:(-UO+1/D>L@RF[B L/U!AT__=8G_1^L\ MK^_GC8.\==0L&+LM\RA;^(4@,+_ I[IE[KI>3[^[M(+QV+51L8$/DB]'(O%^ M+Q=JQLQO@XY7.-DSJM\\X]O%V:=_2YE2O7:?@EZ1W2!AR,P_BQ=?Y=>1/6T%Y$2NDY[ M$3T7M8F%I+V(_I1>1)^2.W\\E /QH2+0+ #Y2P'X!MA5]*]7CC[#+#J.=JQ[ MQE@K\(,LQE3@C-8 ,QZDU#X7E'Y&.SIJ:N9?@[]T[R(]<47 /="UIY?2+XSFYHT!*,Y#$VF>X%%NRICA^3(F]:_M2BY"*FV4"80F7[_.!>W.:T M&!O*:&A.V_#?[ISZLF#;EKD7("?= 5('-H1=]%CX \_R M\1'JNT@K@IW@$0J+>#E/$5&-%WPU7Q :_K'#LR2Y(+Y:^S7TBNX^C*X46$,&N;%WYV@-OES>//J_'-:1,-EE88-VFJ1S@)Z M(OY*3D>7^CHIX;<6W]-[:47Z=@T\K@7/@$$R@=%HW M@-W!;WT?C "3.42*\D05684FP--4"Y6N)+Y?N!S[AS( MD@Q:6X/G1SP+:*B\*]RGD6XY?IP\^F'P IZ9RB:>CU[M5#>QM2=,&N;+]?(7 M31DH71?*H0$4_8%VSE%XN?$.1I8,O^CRGA_9QLXVK6[%LHE^GI1R0!MA1L\\ MBUE4OZGG]9W:),AWO2NV.VHR^/K)/B3R*,*2Q\(N0OLG/+?PV)+-Y>+LT#Y= M-JW^7L=O>$KIH@^O@Y.6[7]TUD-3A_BVNQN3R:+$?7%]46OKR M4A\'$Q;4SY^<$"-M_CW@7$>PNZ'-K\PIW&R@<5"-_N^G;"*Q>P=W#;NZM=SK MZX731K8XJ5:__QA]^G=K$[&'5$6D3%)^C12L@/O3#<.;B[YO2!W/?<@-_[HS M? ^G6C^UQ]GJ3NVJ51QM37;/RN=?[>N?2W-J4-"QP7<.F);"PA+/SVDXYK>+ M\ZU"_G)_F^VSRWQ_<'8?LU*%4N23>8D6WT_R6J^;[#^!IQ_.&_2'F:TO>27$ MTQ:!9HWT93S#*F@[$K/,G]02Y@-YR$KYU$.V[B'[_?QAO^K\$&V72UMZL:2S MK>NJD<]?EP?5\O6@4"M>:MUC&47E^W>?J/9[/1/Q(]>O48$Y\?-]'I.$_/4VB<:S%2+357# MN6I\LKT&?M YD7^V3_;H![NXPF:[<80_;1YUNOWSUHN4(9 ;SV$O4^/PDT@, M@D(J^7)^6#7UZXI9JER7:V;ENEZO ZV8U7R^:!AZK6:L4TBCV3GIG7>.NK"- MI^>=9FL'MJY[7:T6"M7R.Z"-!A"'F"&==#3'URDSN<\=V@JK=4C!BPIGD!=X MKLW-DE//-9@)'[^@6_=AD=N9>V"K./I(6#WD) B=7H8U"]>!.6T4]M-:=\R8 M(Q_21. O=/$U6YV8@X\_'[FRUY[?#9_/**565/(T'*)C!RPZK.(3[U>*D QU M+V?A7E+A$1M:#L]K.Y_;\%FAI&<+E<^,3ZI0,<5?49)E%U;D6>3E:]T98\R0 MT!H&65J%>JE,RCIHF62\J4Y']>%H)7KH\H!?R'_RMLMDI(8N%S 4&X[#/9HS M%]U^C@9:ZU0KY+.'.:WSR"7#=V!XPH%S[R3YJTPTCG7?=4@0Z3Z,0/DX9-&J MG:<7C 8(R[ZX>Y,JMW '/9J8+!/#JB^4:YC:,)B"H1)M86S?8&%HQ():86;X M5-$-AD;U%&@1+=N,\%_BZ,)!)HSR *A;-JF.9RF2Q4\GBK_%)80;W6TUI0,. MYDE6EKI(F ^84_/IW.9YBPZO M>5@ZD\%?Z]A=FZ9.3CH#6+3KX":,P"3#0<+]C0Y4EOFA<8\35JO\R+F'/E,X MX+D=*&X0V!B@EP5H='0SX. -SQK(*KO,ZFQY49_T3HC]V6AZ/O*24:TB%AZ& MMU03?I)$FK/9+;-?J?[O/L9\'!YOF+D3W;LVJN;H[Q1Z"2,W)8 E3(-')?OX<]O 4;2Y+T\%N!3Q+L4+&V6P@R@)>&BGBQ3M MDM.TXXUTQ_I!IQ,R^AX0@ DF+/^5[Q-W7[^]=,&+_^#'(YZKONN! %^XWD3[ M7,P72E\4[FL%OM@,SOJ?( K&E (?8ZY/VS@,PZQPT@U;&4HW/4$,6,X3WLGN M+%^D[T?B0TZRU8ISDG[=GBMXE3'>-J3,3_AG.'NZX'S-#G/EUX?-RV@ $ #8+6 MYV-$U\YIH25['Q:-0BZ$"A*ZJ-Z L3:2;B5*,Y2@AL4<8YE!Q1G#X-,![$^X M<_)[V+^,J@A/F4Z2&YXYG8-<-\*C:$1;V@'B\_'0M&T79&!H6ITV&YWMT!AK M /NBQV640&MT-7@,HPU/X!PK43$"K" =-93)(!BED&J S+MHEI#DB"8_23@UV8+&!&P)FZ+K7Q@>Y;OLS] (+V M66S+@?@X,QS JC/B<&3(7J%W(\SZA&V4BC$\#XNGG__4+H@,%$/-_$I<\I2. M^*EK?@=*!KL#"RZ@_#:/"; !7+,?6A?QTU#*V%3!.Z D"-T)E;RHC#9D&@\P M'Q-5O2 *W+RI*=( ?0>/%WF M$'XC3AG(R1(-!7%K5=N^Z[E3=_2_NC=[[+0 M3)=Q=8:?'*.B(&6I7KA4KB695&N(=.)%RY[Q9:MR Y:M*/F/YE*CIITF)(:MSO47I[NF_2FOTDE?U=&-PPQ9V0 X%TC+8\PMK"<[&F,Y&, M ?^",Q)L.E[D$Y[2&L'Z2R"B*9;0$3P4IEO)%)$,3\1CH9-5F0(&D_8O"T6$Y#IVGH M].'0Z1O(3CK64QJ4>8LU8/,9\>?$J[AZX0@RZ(1N'+'\UM'?W'NNV.YBR*):VN+_2DZ3BHZ_FY2!B$+F?R,<.6 MP;I@#(>O#.PC^+?0KVU0UQ&>" MJR,2]6A/\)O%92R2-)R0CSJ9;MY:ONLM13@IS&U'-=#GCZ+U QO&0VDROB/\ MS](;N5@T4FPS%($4#%6!'LW78,0 M!C <'(7_2>1P,$*1^VIY(GQE++G'#-^<4FM*K8]DZ(HAEL@#?6Z:$/D#S]@A*8505-'44_N]>?!#)'6HAF1D^IIP=P('%PJ=)@(0(>%? .C M/YZ2P@"G8DW0=@,-;>T'F:>]^QWX]MH.[B+H D<8SI-A>T=KK:86R#S(5W;L M*5&)L,+*E_&9N&'AK'+KF>8=C041R?"I',E 6*>4XUGB18J!1L]0?3.:)#LJ%- M+FU$:M>-0 W:<2+T@;X,'GL"H]DBK#YI[0_@K(96(&!L!*N@<0?\%Q8'-9)N M%>%S!.%GN'X S&$["O"2+U*2AJV0!GH:[56?J$];SV(IM.$,U)V6F[JZI^J0 M!*8I>9Q/OE!:TM#3YQ0\8Y[GPH9:0XUJV>GJ#K 64;5R(W@;UP #W*(Q#>; M._=I%K)HEE8I\P&!HB9DH>D8 8=C 8-QJ:0MDK,1';Q\I=1@0 V5ZZ!QH]^9 M3QOG/[5@51.6TQJF:7'A8"\S\0W#$[,\T%Y$S%!DW5@AJ@_ZD&A;?)=G7@+Q MPC$,D-G;]MR799@+EU[I>OB0.T/JAK\'RYB'&MB31QL"Z[;L84^88F+!U&++C6)@&2']R3L.93CD.&7)OX<,B1FJ-79?R;46!.^]P M$%(U)C3R_0 *6Z4:1-#DLZ/H,DEA/@4=T;VH !PO!,5D04ET8:HBYPTI+JJO ME\7UKL-/Q/^'\VR,S"HG@T"8<+2XXTJ063EL10A%8]&.\^N/]:<"94HZ"WF% MMVM;%$F%)Y6437P?$C5B#,";'G]#Z49GH_2D54:IQK,Q?$N\("10?M/PY9R: M\2A$%#N\8J\H F*:74);F:>55M2*Q;)IU(O76T:E<%T>F.RZ7L^7KHN5NEZO M;Y6J%2._7EJQW>GMM\[;)[N=\^-&K]TYN=[*UZH56:;SEE45VSF-)JN\]5Z^;I&ZXI-@JM)\YK!.Z.MS:NB[G\Q60](/"=:%:K]2Q+JR<+\1$ MP6GCO-=NMZ]+M7J]_,)EDD]!;\-Y<1$/LU.$';7UM-?N] M]D6KL[O;;K;.L?BSV3D_[;R]:E+(HR 3\\QHX4PU.56J J7)GC=Z+6VO<]$Z MQ^+?YZSW?<+,=\)&23S7:Z5BTG_+_G8\S9_\5=SYS'B%2Q"OF>/&%:\(4Q<3 M928)F&-?E"P0Q!8_KF*=XVSEGAI?Y\M"/B4N)5Y@@U_\.$_,1[Y=P1'794[@ MR;A&;?$'9:RE3Y=Q9=U']S28(-*QYD MXHKG/GQ4NC]65JRV*'U /6/66DA/=3?;Z65ZF^P5 JAW-LD>(T[Q9NJ M%[#!LD:%! ]T55_=E=>V31$6/(*!?1)%;UYR@+W'L1>-$[S=LKGX>^JZ"A_X M+!NC]"A76-%'/SW&R>O*MI?HS-W&P6 MO-^;]-;,X%2?V_"[ 4S3_V.X\'L0?.7*'[/=[T'H;8"RRPC,NFZ 61*C9?3Y MJ<NDVW)+H-A M?/T_ '$&BIN_DC:P>O[6[^6"S\XQJP M:0STS6?^,63<@>OHP1C$W+;KF)^+7SZ7O_R>K/75Y52U_'MNY*O+**E'?6BC M]10+9[5&#NZ99[(T+OJJOJ2?";*\]:0_KB!\EOOZJC/>0_ *!P%TF/.Y\.5S M*16#SY>44/\]-S(5@S^SB)9M^?J !6-M/Z?ML&/=\QG>N.+/7[JW7M+'E8O5 M5"Y^N O\NE%-?>$QA(79USW/\E/S\#F5TE0NOJ-K]=:\X8#ICF,Q[7C^2PKH M6R_CX\K"-'?V/5S:!/C/GW]G+GKK/< MT*=_@24F$?E;3>>8R<9A"6TM-E#T'W9@Q7=\8-L2Y7@' 8W=6=BD!*S1"2,4 MWO0T8Z=9>L>GV0R;*KI.>F[Q*D1_ ]"HIZ=2Q:L(:?*\5S;,YI8WFWY:G94&7!]H MZEA?:H4*8DL5ZAELIXYPN*X&-]@8:T"7NB'Z6E.C[N02KTWCPIBU#.^2Q9AL M,VJN2!GLMX>]M;#)5*QMO(#OSVG'7DZN7%DM/M(6/6TWS8OZ_G5 L5;:?N(.[[*!-]<]VJ6M3&R1.#+Q\@W+0N0^ J@[=6%.VC$V M/=*.CIJ(RXQXZ2#.M6DHO W1!H%#Z3-[AHC5'FR][,,4MA5#L'&8HCM%!#*" M6+:M(2/*U :V._+C9X'41T\5*M1G,5PU]6BRR%.&6-W6",E:H]Y,&0&IK*/@ MH.9F0]>8$Z@]KECGK4P'<\LVH[DC]C+M,%+6C$.I80>%,9N-F2<:V+H^4QX' M*V0![T$@:1P7V]N'@.J68Q&NM&@WZ@Z'C/I3(EYWV%$T1TUB:7#$_QX3A+:T M;@1J6[A* MF&?^'KJ4V$K]O8>CHZ!%_(;<>$L3U:TN]+AW0",*BI2?L2 M/@NT(W>$^HG6;74RP"V,G&;^-?A+#S_G4]Z#0YUQ"CN8V[03!=P:^4CY$VQ4BERDF,]7\3?J!["=5_K8=?\7_\'GDT9WIW'V]]5^I_.% M_[P!#-?&1RNKOP6FM.\&W]V!GX.-RVA'@1F-L-_I'3QF!*2%1D @[\?\]D4S MEVP1GBRLT$&^$M]@[-K@F'!<1]@@M>W;.&[?L:C]8;!\-;CQ7Y>B\9)=DJ(K M0C02$4VOT[4+&#H2 MT1GQ6H;4V]2G \\RX6:T%11)HE9L6,OW6&!&:OZ,<2'*+[W&S+FAA[PR^BMB M%>OS)D)0UZ%.G6[7K0X: O#KV"W3P[YZHIO.2@=GM9=>ESFH8G O >\? BK* MZN2IQP;\,FPSU6TU:1T]Q+'"#IVPDH;L%HA,>;;&WOB-4%?WR-4 OT61P#M M/W)9#ZSGG,'/6X3J3\O8=_T946D@]!LQ*:!2I(EM'0M=7>*P78/+&-&? 93 MNI?33;YB_MBZU94;R?MSX$AP#\ :!%IKHD 86FL]T'4G%")=FAZ\$J_KE>M- MA8_75ZME+S?+[#6"X:%Q(JT @XB7"#^@,,8-JK- MP";!+-JDPI.4\CG;WM3Q5*J&*DOT0<7%9F>P*]C')#10$Z9)7->92W\('"2- M$%H.I$/.;-U )?;8I69,R A0,T?NB;NC+8!C\2V)=-:$=\'XARY<*5*%2%/5 MS2RN17V-:!E_C/C+W&B,B1*X5%S82!F_A=_3T\+&'#/EB!Z:SX7GPE@Q'?'B M_/@+3BXKU&@#+*7!?&E19]MPFFL:?3675FU/\J9=7HZ!9,5C$)X6P-^8F'C'ZXR MN\ MY;VQNKS]5^A+Q,\^GUQU6W\W+YI(71KUY8"+'/Y$VFC<_;.ZT@8L$O88)PX+ M.,E=Y)15-'I-N0K%"EFW,[F>.Z* 9/7"8" M)+1O?'NU[<87=3+W:'6@>K6%@8X:HKIL\@)/9W-,E)>/$U?"+5-UO4#;G@^' MNNWBD1[KV$5^=0^MB!K4CY.&0WYDH01##=Q*&%MA:TI+ MP VC7^J@KCJC@#@,.BNT'1=CW_C=Z=@"B>3.QLM[=F;#N*=6$/B#N3<:?R"# M- +*D-T_-TGW%<@"(=JY^8\>"N["E()=7#!+NM68SKE[H,,CNKV$B^RCN]<= M>?H4[X2ATKWFVL(*U^)B,ORK$&//&T7.:6P2\-Y3R6[E MDH'"=UQ@G^P"CVB9D:(2[]K.Q1>5?:NL=UU02H9:B\TS'\Y3U_9$AU9YVV%^ MZ&2V@0#H HHI$:\@E\JQ'HR%%A&]6>$NDJ.2FQ-.!(Y;.+V(]G'4)-=>RTQV!6!V.YQ^O2)U_F!TV'7E%W4=PPN!_2!^"Y-J-CO?O_*!20 M) #/70,H2MN=,WME:KO]UA%-+7:E2-7)"KU-:A$9WD5Q3IUIJ6&A#(T8*[VU M^<6/SD=>??0!T+V'#81%UG/*PI*$30.=>/>Y"A[#YNGW"53U@9CMPW $'V(9 ML1I5U2BD/JLJ;T#I,7!UCUIX1CUGN.B@FUK*9X0]0^J*R_U&H-%%K$71G1U3 M\>>+P$)$KE-AF/$^P":9<4RTN('9 LU[;.8!@X59D:N?9$E)!(_PA9'5F=/V MD-D8E#RP/#Q1GH\RE?%_ @AC[__]:GLW^T M4]T+@-6#$)0!"U0J1QYO0K^Z:#)9B%D#ESF505(,"@7,P>:DI*0^Y87A=B>9 MB8D+VK9&Q'DH#6#N6-R?R\?3/CON@K=V18FZ8FIT\_BPU_U; WMC M[^H+<"OEF$%?L,WP)&V@5E2"?9?\W\KR25;!T8CX#3RDDX6H60/@9SY?FS+N M$#8E"&-!L7%4)NL#99-M!YQQ#EJ-8*ZX]S:V\8ZX,#P* \#@/5XOF"W%+(_7R5YDZ&@>%FAT1(7(_G<9U#W M>N[4]3Q7$+7CWG(&CDVF03O0B8:YX-8=:975$O2-V-OAXH41?B!VW+/NV)HM M@;G(*Z0-Y[:=17I&,1^[0W1S5!V(-%&?JQ.2$,(S?M3R5I2/FF(PHT:WOH!P M]J3:%?SJ+*9Q\.BMY?C(D/U0IO,[$=/ M,>5(D.&<,5'#UO:QQ70#"8@;\\),#S7'O7VNGHG C#:; X?P&:_T*4R&^N)$T?CIM?L-&C:.!5NE*W0 M I+ZH]][VKCLJC=I7[==5.F W9/J"JKM3-HWAII]0Q?I?LTRLNI5Y?)S-\AI M1RXL[LN;-:5^7'H5QR-P@K$+%,!!"3+:@9?[>?U*S:SB1Q>7](G*_H8* M5FYX1CP"X\$S/CSB,=<;Z4Z8>89N%2!)'#]./=S0<)_O?0 M#_ A8\^U-/:Q9L6!.0T<4U[N9@^OU-0O%?IAW!]==Z'F8QX@_5NQ_ M_)8_&GE>Q<6-,S]L-&N!M4;C$1/D@6 A6&0)BN2',;804_#S*[&_0HP%<:?H MXYT#9-7U/!@+>0_<,#L;P%Z#"N11C @94.3I4-5@*5Y(.'&1#[_W9V!<*3]) M"(1M/9*!QH5NM"(R^RQGVW9O*'1GNW,S.]#1GIJ"SH8R:Q?L+\SB 1$G5NTZ MJND:QC%)L'KQ(+LQ]SQNF'/QXH"\$GZ>Z(Q1HOH/6(_QM:U$Y>,GM*.887 : M%^ASP "RCRF+= GU(!QD>N5IS%@)B_3@U!N)ZO5VTSW;09:H^?JIJ'#&KC9%@KQ[>V]-B@]\+T[ ML9>.UB7_.ITH+,G(T)UO.2.;'[EM,U1?=CVX4CF'!9@)ZN;P5G0,'N_$Y\[9 M+>A==[';=K^*GO"6#^2\54&)?EXI#U4@F;IY#.2,0T;9[/>DPL!5&(99H=$M M(8J;AO<,K&),>O E7["0>O'*T2-2TXH/I"O.=N*18*<&OEK4A7IQE%PSE%FB M^-LP'S"C:KM@OX"$PDL>F:XK1%_T5[KY"S^(L$, M8R]!/1MV(,9(T)?K.@L>QVIZ#+-(I=-0V]YI:NU(10Y-$I71A9RM[)D,"BI_Q1A>8I\59#3Y N M105EPLQLIM0=:*@743$##R1;1N2+##A9P7VSE_ ]:AE\?-=;3^@MK+I)*WRE M7/K/PHP8'''F>B#K;,L5%Y.2S,+P5=POJZQ<=3DNQ@Q,/)\"M;:FPZ7U!7*(/38O84=&".+]PN:Q$-4_$=U.M517_"UT0#1W<3)!?YK3OJ M8*?RDBL"O[)RQR,;EU>BK2IBL3O5.&\URE'<1?)7JLE1E"X1;8GG1=572(!< MO7(F:BD M@U5#>/Y VQ2-#QT&,IU::\*YAU0!.SSQ94Z[96/Y-5Y++D"BS;TG=XA.]\AU M3"P*P(JI,9+8AXS,)N&@J0DQ3XQL"D*M/<4SYDUD>T.,.V(V"\P)%/F MQ3ALX2N;%9\/:(FPZ()06..ZU7JX"8D"S$<7[] (^#K99MP$Q/7;RY!L1*@Q M@R'5L<[LZ&>A;BO,)OC1(V(//,"!2(R_=MJ-V>R$W;S<:.-2FP7R8?K6Y^[E]OPR1$0XPZ:PI^/ MVAN?;["5YXPT\?*']BYUDX7OVYPYX 76MW2U#_UW!,X\/!H29BK M^]<;*]@#(NDH%V.8]X>&&-B:9"&'MNV3DH[V=>\62>I#2K85S,!?$&KQ=)W& MD]SM7/8 GS1XGK>H!J40+]4^Q(ISZ1Z"_@7',=5_N$ZHLX1<27&M .CFB:8R*9&,M&5(?;)0M<+(_:$OD;NP,*$ M&\KGY#=<,$V>9Q3FNB;'K&6VTIK*+97*M3B9F$BHWL:\=,?2E#^-3*D]F_^B MR8T;_)9T7.YE!;42RR=4*TB7!8S"ZT32(!2%*.,C"#&G0(\Y0]2$$.O'NE2H)4^)@QPZTT9IC&#-]ES/ G4I,CW-9?2$Q.--^5Y(5\HO4.[US) MQKK'T4S!QH4#K&6"8 J8]A=&U33,(5WH8*22O@."&ZOK4&V*TOW:R#1-81NO MYDI4[YW?FF=!5]RA9((='!]+1W/H@6WN=B)]@!'$64VL4[^A#.[$D17S; M=2<^+V)@)J@2OB]E.\*0N2.;\4>DOK+N6,G75\O]*M'B'S$1I:1&NN3B!16A M7%0+^+AFY84[HB@>X:'DZTD.SW4 #IS%KA)<"94 K$O!%'%#P-Q@HBA/H^MP M_S=6/^LBQSDQ]"AIX%ZQME[7UH3+!E3AX$M=4,F=$2-PH7=D0ST!JZWMW+KV M+5?G0:M 6 J$ISEB(_1X>:[!&)G];V7A]5QB3A/'7=C,1%O5$>GL^+$,%BL^ M!"^J?A=0+!X9#1G-Y*56Q @P*@QB@2,4D[?F;UKAXQ 8GQ&*$)>ZBD5(D\C: M^M*=!W\/K3MF)NV9(J"D_L"E1!P34@%Z7&]P^$L+>0ZTR?_^KWJU5O_G 0S( M-;GW2Q?C8>6!1 (( 6"J 3>+029X%B)"VLC>Q*4@IR\^ZL\'Z%7F^OH,2^?1 MS$GXP6=V)Q5R8 =(G6#)N;9B48+Z >P#?DB,:(@N(_]+!.?XDY"A*<'^W@0[ MUC&NO-0&NC/QYK/ 6&+V. ]1#,'ZIFI)H"A]!,P=6=\X\OCCYS-$$/""$"&" M!PGO2V_,PNU=YN(.7A0(N MW^?FB&+R2F(NX)R96%Y3/-!K'$DY/0?6O%]3_R.2]G=.?DM$]Y3/0;REB1&6#KL[Y29C&1.GRM^+W_,H.6,A" M8 4G2BB+-(*#U9C&)-?:!$-$@,L""PF4P"DW=6,;CT*4+D MSC#D$:#H"ZP1)CE^P809FR=)DL!'9&J&\B4TQZ30?MIEQ8\\-IKS,?C&K7U, MB<@B^2=*]D7%W KFW!2,"4HU[B-6#U)V'M .DCC'-%:"FY)* 6D(H<( OY,I M\!G]C K:-ZE*Z5D\'W6 M,;%\2!GB"!9R$1,Y'#A*:-CR)&\O= M>$3*%\R%%/]5@T"&K7*;[W-R)).4CS"&^@:N;-A4!G]02(P"2[ :. WT8^.^ MS+F^.&"VN\#/!>J!],B?,^$F'%LS7U0<<87RE.BSI]:0R)X8JJ_\$3YRKE * MDS"TM=3J%'X&,MF!(-Q:P'3@@ MV^86!]P4Q.JQ9!H,C,V3CC&'GB*^H8$?:2$@3$TKY&]A)0GH!G,[\-\H2+7+ MD?5C5^#- E)4A<(/64+^>_&[23JGM>3]-DTC29UTJ3>0*O M2.S4UKG%# FV>&.Q(-/K3>$5(EAV;9H *'<\^Q4\7C)*'20":[HS7AB[PBQ@9$FCR%.>") M %2V@2D;$LF0'N2D=XM]F'0KK/I3)ALOW,UI/1$? MV*X\O#D;ESS#7GP-QJGS@>S5XYL1?5'WXQEVZ5-;:1B"A5 M6SA.%M2(SO"L >.:*$>H)254%)9C,T9+G'5R2AU5J7,\+UZ_P3\*!WZ0[C+J M@?&7DQF0-5UC3F20HP(1S/0/F!=JQ53@@[9JK*]ETJLR(3&'C4N5V6Y<6D:< M?@+[W9M;)N/]TCC8@BS"; MJ 5'B(_"3(K>)FT?>-]$5HNV10USI$)JJ''(Q2S8 /@'H8:.@V#F__W77XO% M(GZ#92MK9(<:-0PFP9V^)[-B\\D\=O%7_NX>U"LPP,!TW4=\QG MZ SS\*W\0A-Z*.-6%._4N+8A9ECOBOO0" +G[X3',IK8%9D1:/SE:FH;KXQ6 MR>>U&EB)'!EM]"\-5(?"%B=9\F[Z2LO)\%Q,T\.%6_$K MJ9DNXX$0 0_"C:.(I@?(SJEUE,%$YXNHY8 P@N0[0"BZ?'2/8:5@[DU;J'($ M'F2E0JFBPS[B"+Y@96 >)$%#L _$4=6>J1*![?Y.IIDG-E'-84\,N BCL<*A M4;M]GN'OX^NHWH46ORC5B1J2^/HTRJI!0>(2W0H[G7@[.>YTV3X3-2:XCV$H M C[QQ8(R4GQ4PN43C)82>RUIH-SQAY2]<8]?XT8^,\5WDD^)7*%2EQ(Z M-J[9CNZWA'[A%: S3-#RT&<6U@3?>W ZHH<1*#0=(L-0DCC&>TJ"(\@<#'M+ M=RM%N)P(H96KC+QV3L<2@1&6?I%92"7%C@BL3^EL7>']8&*2LM:.-WW%R\C? M'1HO8(4X_DI"_Z.(71<%[ECB[0JC]FFW&WO*L@#3MR7Q<6FZ$7EDU(PV@EDFF 1V)UHVHZM>QRYK81$0=J?T V:N];T0ID-,J24L MA(=M"=5R&! (D=BU0*:UX,U=P1Z042!>& DO\(=+Y:&D*8 M6Z221JU_PD0=Y-Q4S4W%!V/L'OJY](6GK88@_>0O%CTQ*# OW!$3FSL-4X4 M@4&E57BBY=;ABY64.=E4!5/[?#6W#Q:NVY2D)P,[X:DD+&HM&(?/2)D#HQ*2 M"+7"&.)6@;Z#?F3M<^4_7\**#2Y-2%JM<'E1J5F T98JX# MZ[V98S7.4M3-AHWA0RH+?R.M0FN8D0J1.[,<12790/Q)')WV1P HA3:(8+QJ M+$!XMDCON B$\UGT-T=:\6>#K M'DV'SC4 /=*A[>'N-=F)4+F#"(JC4WMUL19M6Q>(3ZK=)I0/4JUCSZ.C#(2+ MQ$ZV/*5#?$9$GIU.HBN,6U1 M:$!$:X,;O7Y=Y"T)&1LL'9^4R0,16\7;0NYK]!)+*!=^8>E:@]U 7R.;C%D. M&S<;BRZQ;%! \B5L("V%1D1<,,DEHS53HS6%C2'\%G>Y@@HFD.T,RS/F4YQU MZ'7>,!^3L2G!!2$B'S\$N1!<&4^>CLA7+;;GYA:Z1'E^W,*)VS9QG"=)QXF+ M^I#!P5(^#0ZFP<%W&!PDMUHHVL]=PL74SBU_0B%"ZB)#;"+"G?SPW@;1D&0Q MQM5RL>"1ARP>AL@D(>22FA1N#(SJX59-8Z"<".Z"3$VQAC>,9.I+N ]9^(_Z ML!@555B#2_6Y"&$D,&7L,TT^ VE#M*-8.T\>&LL>L^AZ'^FYR154FQM!Z M1*@NQ/*+&+E(@,&^/DJ23(:G\&2T*'H#ON.K)P.P6 M$PQ)JCY"Q!R1.2Q:6\AAWM8_WHP%I)#PUWMX?/B;RZTXV=*-3F[55MZ(0QSO M#1A[/CDX)0$,GF34BU#C2I@B234E#2<&+WB/(UU&0TV>#9G3CL7%YAT+N(?9 MCSD7>!,>KO9[1*)A>2K_*BJ 4S1ZK(I-]C5O\L--@7E%7?:X=JG&NR@"&F1R\Y;PHA M0(Y42E9D4I..RPK2_^E9GC:)N3!>HJR J8B2XX2YB)8]4=X'-S%9)!ZC-4D9 MHP_0^(HFP&\,%79Z?'R3YTH2Z B1'\-^"8'"?#&D0E4H6$D2CK3B"5&))1YZ MW^"]%V(Q+@W71: LED:IKN9G6Z(>@\<*>!/ZY!?! TIR$ D;\N%:0]'_,K,F M@<('Q;HMV MB(D&7X0/LCX:_J_B+'+@-B6R!R;ZC?30/I2=7.Z)N:SD@A#@H(M!0#S[4*#' MU86W%;T/H% !:R 1%4KH-W;G]Z+HHI0ZJ_YF%#EJ.XN,EH1_S06D@JBEP((3 M6?I*$H@B(1MHL@J_EZ0O[K:4+6,E44DT&V6Z"2-F0K:SZB)A2Q)/Y'^2?A!2 M#*?X\]PKE$[KI9H/J7U.*4?".IQB7S MXA.@+8^_NRCJC[M:H/DC; MA**2KE0<^"4/N[!P/58H'-$V<"EC93AWEFTV7R$8)OZ/);M!,!V,S'? MK%)D)3(WE1$VK%H&JC"@X<$6,"*,Y M[QO,*JUB?+$J1KCCKB5[#\TH5!*I-)'51P6()O45\'WYQ&HP!@GT03+_@/ " M*?F]&/FM6&[8T$!2TI.89SR8XD4)?6@:S&2.+8\7A10=-W[0=D@)-"70.(%& M:CA/2^2V(?Q)^O**U1IGBH^1^:1X.,Y<-+T"Q0WSO;&31X*@5[/W9<$K9O6G M%)M2;$2QHN)'K=TB!55HI;S4*D&KS2@D)1]>*_CA?-2,P7U1"; L+V!47I!2 M9$J1B4(^1I'<4I,F64HS*-2=XFH&RHO_)S!S5KO8($%-Z MB:+?2TL%'4DV(@I(]9&2;E,=,:5GU6KA<5"5.NUE5"\4UQE%'O%P^%07>[QH M+:7 E (W>7HB7SC"3.H8=Y(8HI*OB7H.%>WL'_SM.Z*J?$I4;TM4,P^+LJ5[ M>S4$RWTO$8#*8$EHT11L_7APA=B?-D*TP.($_I=LCID)(XYP!O]CW9<18C+L M:&)-+5"5K7\3Q^*P?V%M#^89^3(][VE"88K]2P=,7'D!8XA%L@:3 Z[F:+S3 M1)H0\&-G);$S:D?YCK-LGI*62JD1!ZZC$S%MNUBP%>7@Q!)P5AKXQEM/*WDX M3WF]2-=*8^ZI4/@)H2 2()=AJHG'>)(K01D@*QO.[2&6K(;9BOX8!07OB^&, MLE1F-W)U6['K!,R.4E> PZ4Z;DIYBI6E /MQ7X $]N.P#4B)87J'CBTT><.G M88S"J%%X2E@I8:G&$\I"T3T(JTYX3#L2G8.Y.6*IQ9T2C4(T0M&28C L,:,/ MR&WHL;' H(DH2<#E3>=.F XM1-Y'[.N4DM>+D16=X(G _YS@?<0[?MKWON;%)\2)J'[F';O=-T"/K]6X;G"O MK]:W\DY+6(6H^-:3WY'36G% R7NF@\"ER8!7&2W>K Q!'?DD"M5!MA0K6DQ& M>13UL8B4A@4BR2.K]8ZBY%2^I?AY^H7_6\COMLQ6.&<$:1XBLA?J6U4.KS.E M)F^\= ^4R2FB/DC$W =W J: N=HHW0-(&>TR/\9 M>?I4U"2Z$I*/MR$0Q;[KQRP"=-A>0V#()W7ZBA>W\_#(&@X!W[((XR"G=3D^ MJ;%QY9LV+PW'I-+MWL2/F"=3!;/1135$B.SJ1RJYJ(%>+9DD0B1 XS725\A] M_5JDZGQ*GVK09L+M/T&80I423#6!Q9,:)EH&4QO2-=JTT>;._*84L"(N$8$94+8<1XJ8?Q+3"U>ZQSZ).+\:.4=Q;2\(RWO2,L[ M4I[[/#QW1>ZK..>1[$^=>RFI;:JT)#^(B9YCS)B5_@',3@Z66=ZN"0QH] 5B MLP9;)[1,WG_G/7CO[O6$P,X;7%?BO!]K,"S\9N[=J^G MKJD@O*'WA)Z+^U0D:N^&^2G]-@F65X&%Y&=[BSX\FTF#E;\"EX$84SP!6K<3 M\$8UV=R25Y@EF!0*>IF^#%L(M2VPV+/VF(T1FZQFPP;+\"8_QY; MILDF'_6B1]%UD6,B[-UVUTL7+^"< MC1(=S:BV<9-7AKR0"X95#KXVMJ:(HQWA&6^X"-22*+H-3..Q8%V!S.++VPT1 M.>3R$.TV L E(-((4'P%K2[0[RA_2D6(E,&]>!LFOE;)FN)I,7*E.6W?7;!; M[,=UWP3#3C9Q+[ ^Q9EQ>TZV#TKDBYM>WKGGS%5H/K%_F\Z+[S]V--W87U54 M'?*C%:<4]6#<%+4X45LO)9") @=_7ZLSWAV6SP_KRE808Q^8LD2?Y7V^$[=R M X-'FZ5T:?.%#D[=OF-M M!AG%9X0^P7FZVO&4"@C#[@#)!G7J!D_I-Z)?J1NG>"34 I:/!.G\3U*F:]ZJ2\)AN)^_?.;EJ1%"+$T5! MBCR5BJ;T9/V=#&(IQD#YN<56-]3JTHV;K6%>"W4&L&2W2K4!!!^4)V>1*RV0 MO<;"%/?[3/C[S]J8V]C)/D.Y>Z#*29=.U$F&C.NAVH4MZK\K\D]C[AIJ?!QV M]G3#M,2$[5II5*TZ5Q'?/TK#Y_X<[A[M/7DT4!_02[NB/SS4:>%O2J'SFD,NI61:U)5$UHW6TGV]FAGS?48YZP M,Q^S@6DI#>6GH?S7:F#Z-%@>8!:A_' 3/)8KC%3$;\25QD)<*7,D83QN(^TO1GQ[*L) QW6=U;?0!:-8P_C>ILHH$DRA C@M:&9-A"YZM M9 FOP=+6%[+['_U;8A*)[D?J&["G*HSNC_F,)9>&AP0WIZ9WH2O#C_7GQK$D M2IZ[,G&",#)!#B"V-THD7(6'V^;(R8L=BGRG769X+*"@")=D0]"[79YS8)H> M2-"_7]6'2K>Y2B1[JL]M&'< VO!S-N5\TAPV:"]O-1V!O9'A=09MQWC='DO* M3"KYO%:#"]*@TH:WFL46S=MW7/1!BJV(&..Z5ZTTRFOR7!GR_L/5V@0<> M7<7+3OP :T-UR\D(I5&TC">&R=N/";[/&UERW8W+*NXLH(XH@C&A*BV52S5Z M.V"R:X# 34/N=[?4PJ85(FK=@N M?W,)I4]EQ@-Q,KE4E1<+=AEYFFGG>#]6?38#L>Y'KF%WXO_#55E;]WGPV)G+ MLB5_K",VKKN@#K',8< I>,,V4K&')(,\+GYP3Y59_!/;?=XO%#7K6UY>9SE^ MX,WY?L4&%N]:'S#L]1=5YE'[9SB6(2P,! G-ELX*K0C^,;T2!J3$#_Q<0 %A MVT_X4OQ;]+I#LY2%.RK6SMV3-)%_Y,AWRPQO)*%3&[XHUS>S:LEYL>9GL5HK M'M]<6^:8I".II_C4K4LI+LO-\^%0#X0CBZ%XL7[Y''!Y4^8/L>16'MK$CFXWOW4(%0&.!X?82/)@,,3HS\HX4B"?='^V11+B=X= MWWT13D91KZXZ<:K>)J*3NZ'+SKCXK&V!1H8E<;H7P(=T9##RAI/"<"0N?('5 M9,I^J+/BS@SY"C'N/]+.E7Z?K$1>'0J5;^,;J]P@LE4;7*_IGCQ0XCXU:?*KJ*HQY1WX=$P@&3Y^H$1F./['8M:! ?+M])7.D_.C+@W M^Y+7GB>XN<@C)0')@!U8PG4:ZYD-3!&$%"P*9FW _X$C$V1)!;Z0"/-1Z:* M)7OH=*1XFX7MFBV'A 4!HO',$,JG7$GN\N=P]84/E6+=X8\BIZ_VF9J^8@F] M\J$*"")>\.4GW,,9GCNIEC]&[U MT\P]+EP:) +/_JQC_HI0' R=%S??Z@9F MDJ$/.VH_^84S2=7!309_H$_$S1$I;YA.NDSR6L=LV#3-Y \--'?330_66 M42]WH6\0V&5&="FC1T@G2*/H*0VIS54BEF\Y"M=4$0F(6P&S)T1RY*_4:SMT MJ7K(,:=D'X9.5ET@D-O++.G5/ 4]12U,:6\]@T.:(22-/;27!(:.%B=.FS! MT"$^1VH#AH>)&7Y4WI!25TI=B9R-%%6NP$D$G@W!(=WA'K>4>Z7T]1 ^9N"Y MU%>#VQ81N:5DDI*)(N2D\P'9"Q%)8/W_[;U9<]M(EC#ZWA'S'S)<51/V?!1- M@+O=71&RK.IVM1>-I9J:GA='$DR*Z (!%A;)O+_^GG,R 22X:2,)0,R):9=( M8LG,L^^16#:WT5N9C- '%\L6T&"E@H4]EV$ /:4Q'=V1AMKSRC^=P1E9:)!P M$Q+F"3K2<(1?YK+-D^YB6*ZP!VN@@6[K,=9SA1S]M7./R](^N,P=9ZEK> LI M<6)LN*)!R$T5!A-0L&1L-(V.W)%)7;<\N8[)DS-Y=,RS*_L28G8]\M1 MCEO0]9)0F\GV[V1\C2Z1^J7RG\G C+=H;&R5)N- L 1*T=$"/VGY9- MO37HU,BS%[-&E63#1Q'HP!YY*AERV+E,-G RB,,P@-5NC/8HHI%.8Z6-I.! M0:5V@UR2D\:* 6T45U'66UR5I(>.*Z,^$2E7*2!90G.F,#RV:@QDZC\\(Q)9 M(P..:2@E!4W?IWF8G_.*U NR<@""KSS@I7CZE-](.$]A MZPC\0IPDU7_IPTJDI"&S;R-D^UJMQU(1!HY3R9(GY(U2#<;OL ,%1>,7A06- MPH 7[#^5ETHMB1-\I@GY; )?XKA M2)HIG2.TS!6A-6MKC!)TB]$4M+0_CL/#$(LL:+%NR,8)Y1&I7LEI,K +9X:Y M2C(JE;*Z6S<:![-"DHI+J3(L\=T_$]V!HIIE9_G E*J1TV(ZS4W2(!*\YQ5R MA)N,BHKTVHUY0(/;81UKZXLVL*M"!K:JHTGORN"_5"R4AM<;&?TWD#5 <>B.DCA+ATL[/V#*"PVP(N:WX2!I?0K)TQL5LN6 Q=R%,.1+1NIR M:D*D8RHB.)^G*AI'C2%1:9VZ\V8N04X-+BT 7>5&ZM7T::)-L0^$1K^G]*JTG=)*.=WJ$O*$ M+JKUR APTUZRS+="I1LV$$N97C.#DK;,2&9-ZA(%?I>*UW+UQNHB5=5>X2IU MYNEDQ?65()1J*6-DBE6$E(TA>3T+,#-^015G(B@<+!!Z?-GW7L_IR])?+4EEA!,;Q!DPH M2.*R:/ESD*;S1U/0#>F>571X@=>=5Z M"!VWM5$E'7XRV%3[\#)7B=;AUZM&-L*>J&,M3&"3(;SM8+@G.V&%.,LL1/:= MT1.3&\M$G88J 'F5T5VH;2N4(^H5?VNKO]<4,R=ID8<\ZX7@ '[BX>^%0TJ, M_*%M-9C=LJUC[PCYUU'AG<6Q1E\#J59*%07G[;C1'^P+:I]3&=RUU*-;/!A$MZK9;[2P^6.JPL?DW;5#2P M#U BFY%BZ51"3R$JU9Z/G&/&_XT9SOAFT&.#"&FDH4S$W'0#-08X6U:II'MJ M9,63F&,;!)E'B\UHZ27XF\J(IQ?D!Z!VEJL%<'S"O9%M(6CA*GM=:7!9E]JT M#0>Y[_(&>"O#?*3)+:V3#%#P75YPD?5'6H% T<9HK("%_%/TG1N[UTKGE,.! ML_ED>O@.'4ID463'F;$I?$RAE>-<*6< Y7>T&">N,9FG/)@ ,E XTA?YZ3. MLD06=*A'EB;\$=0X_R_6$NIE]GRT5 &8=JGR7-!KQNEP>'W_]%DV=(D4JN:8 M.]'L=MPQ*.D76D-?E7R_824D,=4(JA5P$631D1E%TH6P!'Z 1Q"AG4(3Y?)6 M%"EPM%9%38UCJ6Z?RTO*"$!RD.+,Z5SQ !C(65]T?]980Y%V/LBBT 0Y/6)] M%D:1T#,"3J=A:/Q'?$K(E:,.2COG%" S#>P-CR+;C47CHQ< M]UL/5.]WJ I9U:)S:DK+&(KT1("D:R7QX'K"U&*5/;F50)&$C+JHDCTZA4FF M+6M,\T55X-OTO Q9V22[L*"0KVQKXPF!.O9R:5K(M0F0GVH3BX/ MY7WVB+X:L;N,:& *LZ@17?@(K/TD77?3XA5K)(3!<>&:J MS:3.XDD2^EA9FR@MPPGF:@@F^D$VG3\*B2AS?2YHXX?T#+RC>%<$(@)D%GED M>#I4%%;^"ZVNW5!_=.21R0_==,?2WY)$F_PI/7[2WN!/:: Y5 CP4*P, 2D/ M9JG!!9[.UOFO6_'ZP=X'Z3%137SHW50$[@O4F,BIJ136C42B\';!4D32-T1( MGF^V0:J86FSDA'X%[*,Q!Z@OY/'L8GUGE%!RE28,&,D!MD8$&!0U*'H7BA8&?FS# MTLZ*5PP#L]K<5(-M!MNV8AO(:'V>C$$V@VQ[1;:5<44&XPS&[568GDW1\/@E MI""4P3:#;7OE;]J8-8-K!M?VS]E@.QB.O9PA/AF,,QA7ON_D*:AVN+J]8B[> MMB2WLV LD]S2=*HS;>#5.95$'2S!S6JMQ*A_%[(:B8^#.>8Z\*S9OZ,6GN6! MZ9.Z5"V7#'G,YYZ;#T[0^V6FXW/IEMG<"Q:B.)A1IK726#"JN5AJ&=30?LQ3 M@=;\J,TPUOJFJ?05CZ8/AUG$3_4!EEDS-,V;31+?4?5=IUD#3">8+_*Y,V-* MQ9@'E*"KN@"O'1\;:9GN>8K8[ZI/EUXK,86:>UK@[4=<;.*"4S_ MB-TXH5:V:>Z,*E?(G[*FJ[SJ1(^82B5Z>:O>-$^E<.:(>,#TTW*F]-4T\<.- M552.4YMH^;:]=-2]*XA98,=K6FG<,[^7,W?\MQ??AIVV:,,9?A.VT_[6 6GP M;31NC;Z-+#[H]KM *N/N"YF](._X<'7^R;+.__?\[+>K#_]S?O;ET\7YY\O3 MJP]?/G_KV7VKU5>7'SQ1 5>F0J,6F/_I"IF^Q+(R$D[)BP_B#"^XQGJ<6XJ: MI^4-:;SXUR_O+K-8,?%:R6GC8&5(3,[_"EEQ6D89)MY'\D2([3I<55P@.MBM MMQ&(6T^D>;5J&);LWD=76&^IT23&;'$L%W*TL9@0/:G:%NT-.#(M\:XI!R[? MSV6>RB!W17GV?"US"+KF2PRDT5V1Q89*#,G"LC *;MRT8-EYFJKF4"$ RRXM/UN>KQ(K=4N3B498,<"OYH M47)-SI8;:6;K=G;T /M8'@*BOX(UXH4C\2EE741I/(F#] M)9_1-@1I;N>FH MKEGE=G&8+BQ%+F409W;EDLDJ&:=ZBMUJ6MV?=%5GR0K5D%U[/FK2$X!8JNND MGT_0\'TC6=*!V[IF!K+6QY87WU^I(H 8-#L&$#L$!&5H M%S/HGY0TL.<,K*WG@.GV*_DP]SV8O>J0QWDJ=X33C_-0#H,JASH#)_#PR[^] ML%\\.GPP[!DL,5ABL&3W$9]CPQ(P7 ]Q('5#D[NLR*-#DZTN\">?QN >*+*M M)O'+/&UIG94>&F&R4_A;S>Y^I 4Q]-@$EPN>>'#?"%8:[8Q?E;VI'1)@OY3=W(&:V*+BV0#K,6-O M=Y&75?:^?]S!3F097;D(2HU&]'XM[4*OHP)X-RE0;;O; (Z_ZU!XV2 VJ&U0 MV^H.&W9WAZ@MW0EE@_CPJ"T+),O>]RY06U88UA^U>_:@,>SO$+6EO5,VB.^U M]Y?M5SN55N7PNIVCMJI0JS]NTV1Y>^?)>67#N RVW2D'(7:/V[+"J?ZX;0T; MW6[G6;-MHVP_HD#F&6!VPVK;C7YG%;FK6;*B[3;]7T\^WRWF^.#?;[#+N^O MKV=35TS8>=9]5$V29B\[H)2XM8@[[-MI5[Z'KE5/,)3%1FO',^]J855-!MFW M&IWNX/G4G!@,?688VAVV=NL*+KO>9:,'H;M3#\+V[F$5Q="[>FU5$D/;W4:W M-WP^E38;$;2W*5Z_!M$TX>QWX48FQ!G7?*T8Z'/)@VFW M[$;7I'@9U'Y^J&W9>W%9E0UBD^)E4KRL3KO1WV7V8@5S!3;ZO_HFQ!F- MQ*1XU0^W[5YCV.L^:[9ME.VC3/'J#ML-VUI%[6>8X/6+ZW/?<;F7)W@-3(*7 M2?"J)Q.M'<>L9?J,W0/V.+!-Z-=@:$4Q=+!C/W#9^5T'](S5#D%KF=_5'S:Z M@YV7QU30OS4T^5TFO^MXA+S)[SJD'FHW^OV=.Z">.8;65 VM98Y7IS-H6!WK MF>1X7? ;X;%/8GPCQN+FV<0R3)97C8!EO/,F%<8>#!M6KV]BJ@:UGQMJMW?< MHLXD>=4=LY]+DE=OT&CW=E@37L%D@8T^,*MEDKQ,DI=12$R25_UPN]MN]-M' MFIMK63ODV\]'V7XN65Z=3J]A]XZBC=>5<*9^X 77BSS-B[#;Y'F9/*]:J0@U M#5_4,HO&QB:>@QTV43 8:C!TIQCZW/IXF3RO9Y;GM7/7P%'D*)A$KSJCZ%%( M>9/H=SH/(Q0FB;T+A<6SFGC&#UD^X2VUQN5?OQ F\ M('R3SLE,GXA 67D1H#2<>7P1)_&;B?A=C_:#4=A1F%/V#3UK7 M$I$0>L*2MC#QP0IIT#3@(NTMT8Z.RD]:KN9E](-PQCWYC9I=JKYZ\?/55# ^ M TR*(Q:*>1#&8LQXE@ MP81^C'!,=H,%,DY"V#?=LQ \C)CPQ_#U>^&(V4B$K&TU M&";%T3/0]]9@P6S>>LE].+]^QT\LS=A7,78?UK4&3 M7=$VT@V. ^8'L;8;AT=35IC>.^?NF 'NX[)\/J,W >:[XX1[Z>. 5$[H3NW@ MM./AU]>AN,;3V7I0<$<>GE^1NI@_VW$+F,^F;!3 MN J6@@?Z+O$\ 7\QJ]5OLE^"D'$V=B,GB2+ M1'HAK:K!(B'HL_8H8#\ I\\!;,\F*-&?@_3X''@V#O$E>$VR N8HAB]F L_- M]1TO&:<(YT;LU/?AG-E70D0&KX#ESV C)_]L9HQ[A6GO1MPH.CSQQ"26I$L4 M#M"'I;XYL5;'J#]"73#L\VGLTZX:^_P@,3AB4\$]H,Z1\,7$!=0F/C(!XALM MB!C.@*2YOTC);()X#12F;G/]* F1Q@V:&S3_F08*5@K-O_CLU\0'-C^4,KG! M/H5-IF:%@X '5@[R!!BY!5IV>]!CT92#?$MEB$+^3&:!?)L%OA)[2"2PN!O7 M$2A)4::(<9.51 @2;/].HMB=+(Z(-M9LOC;DTJD:N>C$@:@-A $D$B0A^X!A M97?&-HWMFH3!C'UQXD#3@%NH4&5JL=5+2?!V*J0P ?D#AY=I;8AT=NNM*U]% MGZRW1*2AF 6X&'J+MDA%F"QV8Z\T$60HKWZ4UZT:Y9V!S>%&,4F>E^XK,'U^ MM+L4?92VWBCP$Z0#:40"7>54D$DG,0&11-8)FC"^<(BP,N-K69A]N/C2@'=M M?!D\9J?OFP"F!KKS6S52 M6&-YT0 /G0ALJD@S1&"(8 =$,*@:$>0H/Q+7\&IT%8O9W L6Z$=>4970<9S9 M2W8;"<<:&M0V-LQ:;!]6#=N7;1BK]5#>+GCH@U 8+31AL11NVQ!M:Q7EPCU- MDGDR\EPGLT<8G+\S98X71/"* C$.U%M>MAOM81\W(Z^]!>G#$B]V9V H>0MZ MU51XXV7W.5A0&*B+)MK6,N\%_\X"6,@UEV&M-8N/$G@71;1>*9O-;MBV_=2S MA1\_\1 >;=MJ?_,DC!(,_JE86"S"&3U_B77QZU!0,$RWX7J-MCU\R)J4$J#, MRVQ-*SITM82^BH(8@T*D9&4VE1D1*;8P"&F 8]MQ,4^W)-"M9L:^ KD+Q3K)X]O) !^Y%X% M]O)CUVKT>KUFK[\MFBGSZK3-O&\RZF!.ZY[M'N:&6L$G/: M?9DZF><$_L=?[I69J&U+)2G:A+C7XF04"O['"9_ F]]P[Y8OHC31=-"T.SFQ MIE7Y%*:;I=RN9DR^6GIHQ#]MJ M]O8$E:5*XK:6[\K9-!23O[WXX>K+V3IBOD?:'S%=0%(P-F+,Q8,]+6/ F^\?"B6G1W*9\PRI%@J\(3+9 97+HA2L]0^VC-M;H>+ MDT>MZK@WKRZ/]!:61*8>X+:T6':]-OW@UHBSS:M=Q:AU::-K5*=\9ZA'N7$L MD G?N.(VTC( 79^B4%F"*. 4L&\].#43F!JI G4*ILAY@27'08CRL?@V0&21 MG3 \ KB*-*_@Z7@A5ZBAOWD>"OB>D@^!\?C<\Q:4X+EI']R+@FPS^3NR[8<" MKP4E49F?J#P6'N6!NPNN$\[H,087 -ETL4X"Z2,IR& M\!'[X&Q<\@?QF.+RA#2AB+G:_ BP%# J J,)1'-.$$"#*2L+!;JNY"D#0/.+ MI-U*>(;)YBF*N$ ST@*3&)J#X"%[<:0_$KYP062 .,*C&O$HHU5\]E(ZP?X$ MV1:IM:7#RH;DW;&8"S)FV>D8K7RTWB_XXN12Q)1+?Q$&0-!1UH"E'L(9;!EI M!VVA=XEXB)\@/9,8*7[Y4L F+^;HFOPD0C3 /GX\8R]5=IG\2B67O6I(-NP[ M4U@WTDS*P$D*XC)R? 8]$KG+U)VS6/"9U #4"L8N2#20\,#X)6] ("RC6C0- MPOAD"]]6RR66 (P3<%=GFY(S9^4J6Q^6$T'.QLF'G'T?)7.J5=C*D!4?D\M' MUJ!(*C-%\=1$G(D0H,ZEX\Q@H DZ$/H\-4I# &D4)"&*'Y+Z$P\.S';JO%8'\>L Y#)89*-,2\D)B61N\O!)#,WX&=SDLB$T6UF?."#%.Y MQHF+)IHTY=<6JP(E67UU-=A H-*AY9I33I$\^!Q4Q.]I.D.KV?U^8L,_4@ 5 M?3_2R4&WR\BBGO! .CE2'RG2N2E(ST%5TD43=IQ@+3%>/S.>R&%/[7T0(44M1H@TD,9J9H2$T1-5)TJHFQRZ7ZK0*B2;D MHJ3ZKK1)DIQH97A[#UWNVZ#2#8K,NX;V-+HM,[$PTN,;"\>-I&?R #Z&AZ'/0]T.YWD<\C1-_XG>@NZ)]B RG0N^D"SGMSF& M+0 D;EK=!1H'B-QK<0)B#D,W8>#MPSE1V,03B:G EU_\_+N0^C<%&J7W/5B; M$:4XZB]$"!SK@B=>6@708+\&T33A,N-)XOE' M HZQY)_DI/@,1,$"3EO/QM;3:D2@OE49%1Z%F-UD!E5Q&?@"6< M3R9":BOOT=2!E^49D%EV&&ETE+D!%@N*'H$W<#^MD=.]C9C$T6Y1^BUPE]6. M+0G81YE'].OE;ZD[5*:8XNV#Y=S=0G[9.CV0%V3XFO=SVA"E*+Z\^7.1+A;VA MD1JC A"KVLCE-%F\0RX*UO.C)8^^B6[X&]!!Q@TV#6Y1W5'J+RH@4@G:^J Q MAF]FKB]6THE)@P5),PK4.68.:+8YWV$"A"6RCQ@ZPV%K@J_;8@1IW[EIE00.(LU%0'5.=P:*S@BP^2(: M"!:BZ'0UZ>/Q50E 'OZ\X4[:QO @7[I, M-BWOE08%H%")E#HL(O<[ VJ-IWGD4QXY@0>>'/B@GR_==?);QGL2I^S2B\/5("-4O2_&M,#@) M,2:AX=#*6]7#TC8X0$+P$Q4DP%>Z^;MZVC'_ R !(,. ,U'NC*Q20,$;(:TN M]49E[*B&6K3HVR#QQE+S'*&Y(>\10M32+%MUU@5N>8UCB7DD7QJ4TZ@&4K'6#N)9%^':$T M7 'F+[RRW?II'=^4+E4"-354JV7 M5ER+[BKT6;WPWB(C+;2NK-2( ;VK)C:T0TOWI2+/J*,X''; J6\Z-?++&/I MX_M[$(S95X+$ ^5+UG'F82(&41KE"YIH>+* UW0A0DA=@^L2@+=LDGB*6ROP M*6?@BK]QJUS*DP)XZ+DB3 O=-+FV=57:=X5'/FR)< -5@&';1$]&]1>&NE MGZ:4%E&N'>.;5-NV[.T29;@O$X@DC&1VA*R/ WPYC,C2CG"MP&KL!=[-E=X, M,AU+=?H,5)])M"N2$+@WD$&[W6BW.P\IQH$3^=%N#OO(*>5]DD^ $G$C3FB1 MTN/96%]]1T@IMRS]J2D$(@=X:X*Q*4&LA_KQJ=R9$%8W#Z1H_QSX)_\-;-^= MN"BJ9*@\\^!EG'5%F#=DOJ>F)*PJ".G9/4%'8%_\3'Y::<^,#>+"]1UD]LJG M*]MM4KZ3"('O++,(B=V;N2CL09G)!!L4CK-EF["IN6U33CD!%S;9?306U@FZ-[,3NI9W*JW>CF\IG'=+YL2?%MBI^AZH&7:I:@8&9];';IKL,AG]FS+C)5^G-*T;[FU61[8_L%%P M.U+ "=W4\KEPZI1RF=>4P^Z&+5 O%FD;3V301>C@RF;T"#\/[ZE(V$-T1L7K M92H$5?O(I]$:B=LKGRE5#/WG#]9@\-9ZW9'B,4ZK_QB8MWN;;XU%#, +.XU\97X4T\CX2NE,KI.!/'2)OL?D691P6)ED8ZL,A)*Z%\C MSA BK5)'KA9LZQ&FZWLJ%UR+6:2"'37!7 U;7GT:8,R[?VQ8DJ[*8JUJOJ[E MI@)$D[>@.5"84ZJ[]]:(-Q"IT8@W:L39B=U+(Y97[T8CEL\R&G$E-&()C*=J MQ"4H"MNGRK]#HKXDP.XX2_!!B_R05Q/FW55D>NG6&L5-':79HQ7@2.NA:%CI7;"D6;5JN,9A^E9MU-Z++<,4MU9QV-UF?^L(75&13+%Y[!%]2 MC#6MIYM_9S30CZ6NL<..YQVMJ]&A>@WL_H12926.^-?7HX?,Z=60?-/60;[Y M$?8-\N/#;A\L]%[K[>J_]]C>?5A6?4!]A7:2 >Q]>5=] %NP5@"\45)< 3VS M3U[9E;O1),@\M\@44SZYYL34&%YX_/(8Z*\K\I0 M_I&U95K/KIG007>A5V ^ MUJB%MWVGA[XPB_9&T),O7V& [\3B-L/\39W@MQ MELU?+SBVE4Q;<1^M@-BL!I1 UZN]SH\6+IL%]Z')7TW=H9'S!1:0MB[1W#2/ M?W$S?_66\01Z6DK3&HK9&L=1T2%TG\0FS6&U^CAZ=;,G9CG[RILC^8$OL@.C ML!EKL=:R(VHG![3M>#*G_=)QW6<2UU+VT=B-YAY?O'%]LB1'7N#\0<>NCE6: MG?ICR FWBL:I<8DY2><81]T0[U@.[6* -4]-X6,,R,BXL]I.7=/XB,J5UBUSUP'QI CE1'WD+[ -5CEEI/$4#24# % M#E6+ 5E[E=7G/S@*K35\&LFCD'D82ZT$7.HH?^,&\$Y,F\!^-'D?)*V7$<64 MK7X:#UT?62X]RGO?Z@:]3E3K'[&FK\9>"Q%V78(@M9DO/OM%C,($5R;IUEX= M0RPKX//]_6AUAPV[VRHM)^3!,,P+*9XW!+LZ"/.RG%4 RG+O^@"P,.WLGD D MY0_AX*0-(H!382,_U<)0-=./)3A%T2415B)NS4 MB:^;R;9RZ.UN?N8U*RWHM$QI@2DM.%2WKL?J<5_S[E67E"%^2FF09>IUZVTP><*[FP;OK%&G&C9>Q1[BIU"5!KF')D8!/NAFG[?IPY MHB:_%>M8E0U'[05PZ1AJGJ#:*86E$I4X+Q<5V'GH;N[]5*R9I9.01SA(CU". M2.!9EC]IOES5SI+6Z55S;9] M\!CK!P^H7FDWH3E\RSF8E?'6&\[FP>.T-TW)+AL%="&YLLN'3XE?N\W'CGPG M\;AEXOLZ@\Q>8Y!%-!!.]9LNLALY,OXA8]&Q83*94OG4>$YCXFF\?.!1-4@^ M,IY*U;#DR5N $3B@\]QP' 6($ B(XZ&7-HFT"0ISM,#H->AJ1"]2J2)I5=E: MTYVBNQ-$,IK6WC0MY:\Q>M8#]2R%ZWA2TL/S<"U+]?-]NI)5:-6S8Q5K)4]D MJXJ5D^DZ14N>V1/5K&T/J8:2M88S%MQ5F1UJ-09#PQPKS!PSL%6*/RIX%Q:8 M5XWC*I8P:TW(<-V.'AJ+K&BA*G;1_4(G?J8%XN&Y*O)'LD/VCO^%JP1UJY?5GL "M5FN@#ZO@S O^LSGVA:B^U3)3LY^.>*5 MNGK0D!1)M5R^O:(@OU1H;/7LE[-7.9\9BS+!OGE5VG!A2J>(T@YR\X Z:*!9 M 4Q!ADA6AW\CP+_C+%D984KGI4DPN2H> D!5&H2C^E]G.*#4B2;;LD(25*J3 ML@JA7<&JSI)8\K!?@U'$3ATRY8$U#5@4L'0H=:YAR$)FK7.X6I*F=IQ(@:%O M4*U/MD+$*55,&NRKB$&?E?H1, F]L7\^!:OD8%3F46RW4C56 M5S$+.B@'K1YGP\OV\YF>BGQ620KL+($-5U6FT1VZZ8,U.:52KDD6H,X2:Q97 MW U)G,*JN&K<%"4S:3Y8C5ZOU^SU2=.E,7,T5P[;^-#X3S4^D)(-^'<198,, M4]\:S?8FOG)F.: [2B+8%CQ/C5&!)7U:F MK>NI*)/$FX!T2,4:'GCN^XNT)D+KST[+YEJ[/&HBY=()9;!2;3RP\0R:""C5 MP33''NUZ*UII1.2-9G=( 8\EW2]:NYQSV<-'AHO1B"1CY!:0=CL@FE22LW.Q4> MJ5+;]),&'LD&16,?);2ZY$%]7VK_::L!3,0?V*WVVT>.@WL6] :Q?"C_<$^\.[?&PLRVCV.P80%0#$H-DILU^0 81&$5T#B H 8M#L M&=94!4 8BJ@,(%HUZ=+US $Q*+<9G &$84T5 X2QYG8(!;TA!1CQ>.7?7EBM M%_YF0X'#+@H:SL];[8 ML5?[_A#P?D(?O*=:S:6C\^=T5,(#^QH^5N#5'I[;;3X#S[+@FX;,= M8KW1D#9H2#6N?GSYPRO#%O>N.1D$.0($V94^56=D^=$@RYZ5K!IC!TZ]WHGZ ME34I?O.#XP@QF1S6>W7!$R^=][4SS:KL3>VX0KZ$[6BH24TDM1>R=J$+=H&N M]8W,0W&BQKNS=KO1;G=VG6?PC,#<*P=K=PQF:KIK[SR?I&PX/Z:WZRYZA96] M[Q]WP\'*V MIWTJ0M7!J'OQC$&C;0_JEERY3PVG?O!K#VL-O[(TEYJJ*37#SW8;,*K6^%G3 MUD5W ,]NO[9L5#>&2^K&:YKX<-!&ECA9RHRC6/-\T\#4C*-XKH PXR@J @C3 MX;HB@##C*"H""$,1E0&$&4=1"4"8<105 81A314!A+'F=@B%8QY'\3L/0^[' M9AY%72J[RIY?4/$2K:.=7U#1H).!YS.?1W%?=OP\FNN8Z1.F; M>?WCZ*8.E(4'%==;C@X/GE\U>"5EPG/" :,$&27(*$'/4 DZNAD#1@DR>&"4 M(*,$&27(*$%&"3)*T'$.%#!:D$$$HP89-9 8(&-W(S)(P&M(=_,', MDCAV1.R3&-^(L;BIC7MJGTI3=7#J?H-J^HU^ MWTR=J,;4B1(UF*-05VJJF]2,I72:0S-FHGIC)JS>ZU8'58QVK<9,['I5="*X M@!2EW>+Z\.\W;@Q'ZL"O7^88;&3<'[.T.^2Y"D9'?WWM'F:)GP-?L&#"@B1D M/I^),1/?A9-@.U+X>N(Z(HQ85E<#BPFPLF,V%'U'HEUUX MW,];R>P!;:^F@LGQ)B/A!;=L'@8W[EC@ <(29W(5^/\ $"$7Z.@+G.,"&8\0 M:.^%(ZAM7]MJT.F_V=>J'R-5ZSK$I6V&N*QRU?LSU5UVP>X,#""J (A.LV-( MHA*0,"11%4"T^@8050 $&'$&$I6 A.%-%0%$ISFP#"1V!XF'1DONLB">9=7X M=N)_CEN^2RL^S@2T6F/"TQ,T+;LY*#7F88C_0,2_7<:6GFJ93?1@FWID&[%F M,+LTL7;'GM/'GL&B1Z$+C_F'\&X$;@0?R?WH9"W%&*PP(LZ _$A$7"AFW/5A M18S?<->C>-,D"(V4,\A=OI3;O_YVG/ V\NOH0/X\Y=>&'+=)$B>A8&Z:JT+- M_1DS0LU@?-V%VJ:LSCA@(XGQ8LR2^7('CN-$@3K(N2G>- M2&H,]Z,2=FM3'(VH,_A>=U&G-1:C[.HXBKD_WN6$IAJ#_!A$6[&OW"X'J]<8 M\,]3MKWX62;EOQ3?'2]9)7(CP0Q6UU&"J3*?1E[D@[5*AH\=AP#3=!:688(! M_O,58GF8@85BX@D'#'/F/KH;ZJ:#.)!X>W#:W'%G'#P5>61=\^J_NV(8%126 M#T28I= U?JA-/.]@V'$,@K6@31D\V"V7J+2,W>0$E?\'N)_,?/:2OWJU"_NQ MQCUBL0B?.3P6UT&XJ MM/$[K.'QZOI2D)6+'O0YJ:PMAOKL6PL\-*78F0&N- M(".#('NQ7FN-%,YNQ&K);2O/-_>$F6,O&;#91XLT97#!IK!Y$48OK5]B_Y^JC%"_5$; M-M+M/3?,WB4'(\EZ$JZ"F'L[]3"5 MO=T#&-1%=&\#NH^#!"MV:XKOQN+>L\5=.L(H*)))I).FFCB;!J*R=]>_'#U MY6QMZO>=Q'A%#!?P\RR@*111AJ#\9PW F]"R>*KKCLMP]%US](JQ<\5Z19AW M-EC+-1T'#A76Z2T:F\:Z-)A4HE;9IGR)[(-%C%UK@\76=Q(IOG\SW]T-D18X MBK64&)AB&'WEPNK\^,T)7?1DF]20U\X5)KLV"I.F<,"Y-D"Z;J*<3>1I6P\C MST9G^WL>0:'I$O9-H6M0YU>0\[UNWJE!QQEDD8=HM4 ]JC MZW//6S ^!AM&AL+13AD%/!PCN8S=4#AQ$,JR"#UBCI<1%:F(.4Y'NQ3P$"1" MZ9.Q[ :]L4$WXQNC9!2)/Q,X0'SG3 !AC67!A0 K!A< 3_DU\85\0)?N'S89 MKATL*U#9)!47I"4CBRA@/(Y#[L3J>3%0-ETW@D=K! Y&5!3XOO"(U%,ED)Z* MJP-;*G:!2<&"YO"UHJ$&F79R)AQ#]HKWP%5NA@SP.YV("&_0:%/7JG.3-\^" M6-"*HL1Q1)1M!"?=<7]!D9K^VXB-D@B84A0UV>^"3<$JQ,7 <^%TVNUVH]WN M;+,JX5W$.1F_!1A&BGGA96O4B]*G+2[3&;#7#72VT\F+#Z*L*YWQ[X=P$.7! M5)*":Q.ZIRMX+NC>'FY'=JO171'?#T+W7%;OEDGK(NMQB+]6A\^S6V_3 MR]5O]*WU]M5ZLVT=X2P]("6?8#*!+WW!PY-8A#-"7"\ FX@^99A.3KV)>H10 M2U[&9>F/PP>[Z)9 H09W_2'$')%_JMVGB%1^L?04*2:S1XUX).4AF& N4%<" M! C43.-(877R[+DS=<6- $D:X],FP)5\!PGZ.N#>RC+E\X72PX%I)*&/*UT' M19U%[9*"'H1TY]\=4"F(=:T!90,,!>8D82CU">(>?K .BC+K+W6&?N*A,U6( M3"J&#?@,-RH60L\9">&S&1_KVO_2ZTL[E>TBM=.R7O[QJG2I^;M0),:96A'" M *D3K:H8T>X2N .F9*K?,V0="X"4!Q(K\;R3&);$?O-=9!^7J"-&&CDAG0A8 MD(NB#L4.1XO:G<-E*:G-<\9 [P>\<.,(!!2(S.\,I]F&[BB10A&D<_8$+ 7& M+%%XJ@ L)#W51QKD,T #K!/VO."69&R.(7+M%_HS<(FXD04#9B)[-^"E;EA\ M=T61Z1]B?(VAA8L /B_*UL*6>=0'T%CPZ*]"/LY7B!BX2I@ M%*I 29S%:US_)O!N\(*U'##OO(&,,\" #X/7N3?D+M9^?\N$?\VOU9NB:1#& M+.+>BIQ8]^B7;E,T)3/'6_ .GJL#(=$RN/5?%5\[5:""/8)Z M)&+W_Y,)SW &?L0=N6.*.:&R!Z2WD?-GBVM(\<6)7.;<';,;'KJIGX2X92/M M%1G=\CE\(B>>T@.!;J;*B>1O*-=;1 Y3J=;%DW2$T4SG[L2K7;X=%4F1;(WP+V"43H M60""$3""M(\$3 /2Q]TX!DT.P U\#:4UDDIJ'(P!J #Q7<^A?^BI?(;=D8-P MH!],H38@WTFJ*=WCW#35MFC-?@[\DTS)78LG*V;B6I'BZ*V&@ +\4]2,:KM;23@_&AT!S&*B1L!VV0+4)*5 ME@0:E>REUZ K F"FG@MG1J]L9+*1W@HK5AK5-7;6V.#+O4?8KGK1Y+:))IMH M\AW19#VER6IV]Y0.=C?K^TTGNNVLI8'F)G%%+Y MF=29-1.@>: 6LF3:T@WKWPW7H9&+Y@**"WB+!Z"0. M76J IIP_J!U->41775^'XAJ7-T$A=,.]1"RO6FHSO80GC05: MCA04R@QP$G4J.2?5*+/<'%+.UH>74K,5< N5?51OI/-,/6,,1,[4+G1DROB3GT^A6?_J)2%%C-=;X)/E&="11LGHWTH/Y&-$ M)'(CD+9'[KS45B%&_:H)4BUS!FX%Z"H$Y9$7]0DZ>*EHJ(-R0WDYY'"(DGZA\1";9HS6KRQV<:Q<*!S()T-B+WI03 MQ*: WCZCV%IT>35AH_00]W_^,.SUAV^K%N8FW?CCV? ]!-."DNJ!"$\"%%/^#M:@3ZEJ^A( M-=C.DM;K\\0W,DNB3!_&,/7.[\94SUP<2LSK#TR5-:6!T,TN^8#76LJ:4R/5 MDC R0^Z[]2KK-OU,I8*3Y@K'\H>(4P46E"1;:J>8_;UV,:DC@#0[I0^BK[F@ M6N+\IBRCJX+S5EENZ&=YTC[,.6&9#EC34CZA;2;Z9N"=:VG6LIKEKP7>JW1A/Y/LLET MK5H!RXO[ENIV!LWA<.VC-UR6RE E *@ M"93L4CZ* B^)E\MZ#M=CW+I_EIQ>\[/KDCD#FZK IM4%IU84-Z&F&;BH*&\/3 MJ@R;EH%-16$S:+:Z!C;5A(WA:=6%#>AIQB]04=CTF@/C3]LO;![88?4Q89OG M.)#UX0R]],%H!YRCV&\>'$>>>CJ_8-+=.0]],=Y1<]Y'.)Q+/X7#XDCM2.@2 MLR+VUKNY^OL_+'K4CGJ^S ME508_]H@?PZ;UT+!$Z<>#U<)?,&OH>:/(9BS8 M,83[LKW;\;X&LW:CUAO,,IBU'X.@QIBUMEN'P:T2N-:S$X=KQI ] MW6PI8[#.KX'/XRG@SKO 'S^;<4&''Z6U6E=0U^'5JUGX]1QJ;%N%LL@]F$)E M0/BE]6JC4VA7F99UQ=S57.MZ8NZ>)K:6#>)2F/(S0>W5E%N#VD>-VJNYI'5% M[=7,2X/:1XW:JRF%=47MU02\>J+V!E7Z<1;O0:'X]Y"[OB^HH>G.2/+YTU_[ MP)OUPU!IRM4,0S=HE_6,5)Y[;L1'(IZR]^(3#R-A M7"PF6OELHI6=O1B"94/81"M-M-(PY:-#;1.M-*AMHI4&M8\!M4VTLFJHO4&5 MKD&T\B._#05.=_@'#T,W,BXE$["L&G'M)ZOV61BEM4- $[D\)A991PPUDD8N?Q7<]UW!/B6[RT$M>T\F9FEBEB9F>6R!'1.S M-$SYF:*VB5D:U#8Q2X/:QX#:)F99-=3>%K-<,\?]\4MOYF!(&R]IW^!@>/H( M?Z?S'YK64,S63'8HCFO0ASQDT,#YVT'X)NWGE$V4^+[F+L M;&H1!3#W17;"#&=PLQ9KX7OUB0P/F #^- 3>N8N[X(V20(F>#. ME/V9<+@A9,&$P2IN7$7[]CIY1F["N:NP_K68 O2:F);0R7+EBIN%";]B*F)HJ8PX?_P MG4ICTOMVLK., #]@CT8/CA!HTQ_#Q\@%=&87')'/G:LVG_,]:'C_3J+8G2RV M+/ES$#,^GWM !<@%D*L $GG$:!!S$,3 2@ *KHB:.USETX_U*RWP4 =7YEG= MM; "ARGR6J*(>]IFG+GCO[WXUF_S5G?4F7P3+:?UK>.,)M_XT!E^F[0[[<&( M=ZP1;R&-\?2.#U?GGRS[\OSLMZ\?KO[UY??/YU\O__'AXLLO9^=?KTX_?'YW M_OG\EP]G']1-!\?E2_L]//[]FGT\^G M?S__=/[YBCY^/?]X>G7^GEU>?3G[YS^^?'Q__A4NN;J"R\NB8^3Y$Y#5P2TQ M92G2!0@ T"J!MR(7'PE?3(#A<(\%MZ!*1%-WCAP^2$+2%@(_9?01?OV)A\Y4 M'IO=)0YNL]'B#6WPX"H#H?'.= 9-EK]8,>1+5RC^\X=AKS]\6S&E@BP3PH\I M4!OPO#]@'SY@!$LB9(4Y=GD+Q"\V"T+@D=BAM_M3BF8 J2@&&:@X989R;RND MG1I4JP2J*8P9NZ%PXB",#(H8%%F/(CZ?@4$AO@LG08<Q9@Z5M-7M[@LJ2+M_6 B^<34,Q^=N+'\"^6$E1UFL9G=/X:F[C9[?!9MRH-JQ -2"18$86&ODK'$VH4$4 M)IZ(I(6C'%U@&S;9%;G)M!^OX9DAZ;7S,+AQQZ36QL ?YO!\4&'=:*U])?WW M3A+"Z<$9N/ I :FE;IJBE16R:,I#(>^?![=P$ZC2-T$L\#?)I.@W^ IUYL(3 M&W@-7#YV(P#1\AWR6P)<\;8F.TT_+9C2Y6$'W(O@44+,I&]Y)!K*#N3^@OR" MC8V;1+ZJ;90.A[:Z_!K<,QT\H@Z^A3M_)K!D @D J=>2!SX&%L&(7\CGD%LR MG@+;N9ZREZY*<\,G ><.'3<2Z4*#N=QPR&YYB([*!EROW^ $/@BX2)T*SY9( MU^D79M (Q4WPAX!+XQ 0LH$'ZX0"7\/#!>%5XL<$2A=0GH>,7GP-!RF_?NG> M:(_%$. ,J,AA$F5YG"WE$<]OLO/OC@!Z@(/%^SS @]35"Y9_$/N 2F2>P?E& MRBV $B]*1O\F3 ETCQ::9(F/ -$!SR%/SQ^"XAVBX#W7'&C4)_4KQ3[Q[ 0 M=^+F+Y:O06!'@9?A+K[6A<./8CH9>;X! (,IN4R>9DD.T10MR&!.&"QTNJ%4 MBO[;B+2^@_G8UGA;)$AA42A20=_ MT:WDC;Z8YD,=,7*K*,T4ZT8V[TCQD&HB)#@11=,OI-BD;PK"54M/4->L*B]Q MF"XLBY]+1?;129R=9GMK,9@FSK17(HY-O. V]7VFGRF'X8U43F[AZ.[4"S0] M/KN4CP#'DW@YJ^!P&C]:>R)WX>)(?X+DY=^HA.O8BK6- UVL7^[V*0I>__ M=9O/]+%N_WQ^Q]FA2P4]Y2=K7BSKI!**90,:AOJ6=W [7R._RP#/X:0]J[T'1^-<@FB:<_2[<*-K-_-ICT6JJ M@X3WX[K]AF7OL$M=-N-#[\E]%D:Z#)?A2!S_Y/S(3'J.B_CDK0<2NR M_4:KVS9*;*T!O3M>60_ U5-+_>3&SE1X'GLGPNN7':.FUE$M*:>Y837@;/14 MHZ?65$^]P'(X=NK'T\!?L'?HRX\:[->PR5YVC=I:+6WF?FIKK]^ _1O%]?F# MNMNT!L;Y6EFU]N\A=WU?L+- [&(D2C54':/2+C+*.:LZ1ZZGMQF X-'IJK2%M]-0ZZ*D? M^6THL!OC/W@8NM&S45\.5IM31E7F/GANK]'K[)SEEHT%%5)BZX,N1LFM@Y*[ MM;#VU/,>TEK[9>]5KWFY85K?1L2RC2A\Y)MBMYF"WTMWD M,QR,FW=_8M1K17;O-ET1:N,]+(5Y50.N%=*\CQ !JL#1GK'N_CL!VAKJT=D(K1X]WWD=L,N%+\+K18.=^CQB']Y]9I]@\7_ H_GN(H.U M%;7UT[6> 6>OU*D];VRI)O^O+0)473-?XO^G'C+[/QOLJ[O@XRF[:C&KW;4M MHZ/51$=[5.I(H]_N-X;6;CMG&6!7$]AVT^K633U_O%=[S;C;QZ^DF2/=EL'( M^H31IC44LS7S7HI#7.XSHS:;,_-]S>/HU2,6(W6WF,YC]P!?9@=$01]9B M+7RO/J?E?M/XLG&W+^Z0:H\:O;Q3MK %0AOB]64MYJ.(:/*HSZQ-Z+N;M13& M(%I9GW+7QS&8;TZLU0D(C^"I-9]H_Z2%[8((J,]LI6:/?_ =+QG#DU^ZKUBO MUVOT>GUM!FAA_N=4>&,V6M! 5+U[+K-;UI"=^GZ"(UJOY+A8N!E.QIFR3V$S MNQ#G^;(YAX/D7CZ5-)13;E^Q=KO1;G S\I'4?>LJPN+@>>+4UL!HMZSY;,910'B6TJT8)*YAH=7L& MCRJ/1YWJXU$;6&O+2.9JXU&W:GA4U+/M1J>_$852-?LJY/^FC.5%FEG18!\_ MGH%J#4>D*=>RD1J;\HC=!#%B'BJT8S>2OH0;P>;!K0@S/1?47*O=Z+4'!]=S M*X3P:XSU.N-[K[+XWK/L1K<_O >N:4K?_A%NY[[+?X/5ZTX6Z\(O!+ E&"C< M(V]-ZP$!5_+G:3Y%QQ,\1$_N= G!V_C4?Y9HU^DNSXS^C[_< MRR.J;4LY1VU"^FMQ(F=M\PF\^0WW;@',:IN#0=/NY(2:+@L/@G6;@\%/+/\S M]Y!JJYGQ[R?:B14\:O*N]"MR5*??W3'P6^,RMM7L[0DJ2VC7UB('G$U#,?G; MBQ^NOIRMXP1W$_.5)+L).X-? >91AI+\/FA9/-5UQ\69._[;BV_M<7\R$4/K MFR/:UK=.&_[B@];@6ZMK]?K==KLW'+5>R+?*.Z[./UGML_.O5Z'+Y\M_?+BX//W\GCZ?O[_Z>OKY4MVTFZ->R4A?.GO4I=39?X %RHQNJ]UD M:J&LL%(&2V5JK8P6>WI&/S;HE_S6ZUY7Y) M0C8*0-%&Q,V+OU!-XF.0-;#:V]"- 9]!/])V-B_N#)V=H;AQ89'P'.XO6)QO M#G0J%%378@94@7))(C7L>NK.P6106MJM(!FF7)^."[03-^C)? ;,#XV+F\"[ M$5B6Y@@QCMB/EBW-#%Q1X!/Q!;"AU;*U1KZW_$^P6&:N+P0)T^Y/4M:JL%H*OLOUU=\SN#I$SZ^+8@.,HF99N/$!(,F*RT>X V^"=\(N M2:[A,@,6)7 2_-Y ;^0@O\>9%1Z;GI_$N,)E,]@1?#8"F0DX M%/@XQV>$B%D-^0%Q&TP:7!!/QFY,2B 2GVBRWZ?"%VC2S$-\NH/"IJ%. 7<, M K>1DB"2@WP@;(64P,!Q$KS5#4(%.;"7"'+X!&W-3890']]PK.Y?]SA7&OHK MJ\B6*E\H;VVH/?O,!345C"TG%!(Y9GS!0HX(N Z2A05I(.!>%. U,Y>T7GCK ME+L@?GVDPN(J8&OY\N\Z]OM ,U.SW4@ 6.-; 3PQ?]],"(0!<(4H&:%%2BO M'<(I$3:HF%!^"SP-]^$#3::W-]DI\,Y[+ )8FW\=H$$ A^OS&#AQJN[K".[0B"GD8Y#&4-PW-!) M9E&,E!-MH0DBIW1G;YY#P%@SN%^LI!24;O7_YP_#7G_XMF*6_P.0;S,)O:V0 MJ\B@5!50BAC3=Q=U2#9&*(<,A':2\;ME3?HYHM@:"66PK@I8]VB92PY+ ##< M>HVFJE);\\>BP0E+F+AD:8"(CPS>&KS=BK>W4P$X%*ZB&MBAI)#&_ ]0\!4R MPN&#;0@VDP/&690Y&D9)Y/K"8)O!MH=@&]BO4K]PHL&4P\MS^=)B-X0P%$9#I>F.<8T\HS4.%*8B1PMT1!3M_3$.<4/GLB37AO)Q<'3% M33:Y"_3'NJ@021DC=2*I'$72'59\E(8,OH&"OX M-,KS. ,3',L-L%7?9"'038'SS-WC^E$<)NE5\L[+\[-,N=QR"II3*$S0FQEL M#HED8!W+I>!K)L 8@UOTQ!66.@[(3^H 8XXQJ)&Y]=>X_#/5%[V$8LJ]";ZZ MN.9(^C%1BHA)$*+ODL1%O-5;B,XI1? MYR$ZN)]B2_+F5XIG1<4HX1J3$2-,L"5*)%O#!BFD@RK\<5U ')8 M"I_)'1HEIK@%BDLX @B*:"Z<@R2GV!KM(O'C-8_3:CRU.I"7QE9\7_GA- M?!#A2?DZUEOU'_:CW9(Q7!F#33T&%+G /J,1,N\;X26T7H- [R# ?(UBE$DZ03C=YY'JE4L9G-)RR/R-V$Z&O$+Z0UP M\'@HW$<. M=W I"\(5/=1F^N6]=8S M66\FZ^WNK+>2K$$5BB8J'RLSKJA;2_F'X@<%DH ?4IF\IFUV-.4KP?EQ(>LC ME6S9@W(C3PE8V*BL:'QN,*7A"&@*72HW,8"!M<9RY M5=&KA4O!!ZUYX32X+:H_*]=(50'S!\@F1"M9)A[-$(D1',$HYF3/D::;^!P MYKE+CK,TZ2W57%??,N&NS&GR,^VH:,:3UT0IP"A80O0MQT%C MK<6O6<4-TEJW67PAZJ6X8YGLDP*8WN:1"J8GI332?*-5&.W2"?" _,DL1Q(= MEJ6D2$H&@/DT0CIDL^.F)16M_"1,J6H!7(U)^?X>%%-4XEG;:C"[!:Q]AVM_ M>LN7FND)?:,G&#WA#CU![SAC-;OIHBE?ON>(P:#5'7\;.OW^MTZO+[Z-G);S MK37IC,<=QQJVK4$A7Q[ST:W.Q=_G)]CSOSE M^=?_^7!VON=\^8!/,"<;.)DGLEC_F;+Y05Q]XN@Y9Q\_7DCW9AA,0%< = UACL.^B;(@R7" M&]"]4"+Z,H3Y(K0HU$8T= MB?Y%SM#*S63%%U8Y;QRF;\T:(4GC_WYM]:QF9VN;*HWPM.=C$>4$()4*E/0S M-=-Z(]GH+1S"G1Q,\WUDE_)1%'A)O-P+ZB ]/^6%\P>6E*E_G]@OS.X:0%0 M$$ 1E@%$%0#1:FYME6@ 85C3<0'"L*:J ,*PIIT"XJ'-H._26@^WZ\$#=KU7 M)OSD+6==+]]KZ8-G[_G$7.R%EJEH3/1XU%K7?:_2&.VTA;U#;H'8E4+O7:[3:]I.'N)2@ MMTN!D\9J4?#40<^J#AD>=),[&^![EX%>22JC]&F[3C:C05.#IC4W2*[X=V6. MV,814C:<#7X;_-Z#+#JL89+5F4GQT]Z=^#D.6BS/L;M_ MPBQY;_600@;-#9K7 ]4Q,*,J1A2*/T4)(9 M2KW3H=0[P/"#]>=YTEIWT8&B'DB*T>IYX]DK]2[#QXQ<;VT4ZOJ4RB;1 21T(I2 M]SZ6[^@:"0Q,(P'32.#>8_;ZG=9@.+2ZW_B(#[]U1L/>-SZ<\&^6U7:&]F@\ M[(S&A;8!%Z=?KS[\SS>KT^UU[8/U!EA)-I?E]OF1X[(D6_GP/W0^6I.#[OG_ M_N/#NP]7E]_:=K_;;>UWU9O7J+4OZ#99NJ@'U-MG=+8B*C>*L#O,^$>)Q9W2 MSQ9EXHYZ@I?\U:8ZDTJN]_S[%.1-C")OI?!AMS*OP$:MK&[#!8O*C]^%CMKAI*Z*]';T+ZA10/],TC>DX\P='5;[8[*Z$?]-7>Z!DY(KL0PQ#[V,SPDUDKIGV1CQ*^5';FT,G![B: _N0.YT-(6K MDNBF8JKW1KKW(G)"5XW[KAT"[*0X\)$>]L&Z@'J54&'KZ7S(^L;*QI!T*MMN M^.LH9*]_OO.RKSAI5>"X@<=@T\;4Z[*/:]_(U&[VJ\U7[G$ZOY#'X1%0MX\4 MZOWFH/9 7ZLZW)VBDH-?*G#5S#NZGZ#;ZRK7(=\#UJT4%G.\!U >\^THW:#Z MIW[H1>[UT*4,K?ZA;Q1W-3QT*<)*/?.*"YMVTV+'S O+D$!_Y>DS3R+AG(CO M<-N$-S>O@YO5I MZ$S=&Q&]%N-K'KX>\YB_MOKVL-]MO08MSK):G5YW:+=:0ZO;:[V.9W;+[@TL M>VQ]$]_;)U9S&L]V$-.\.XBIS0?YJN:#L+/B5)$/^E01_.*?R<@5?MQ0/G[? M::X$1(X3OR?H?"L^*2WM@]QMH\%A%D MK$UC;1Z%!*J=M6D;:]-8F[JU:=N=H;(VAVU+69OVH:S-)GLW MYJAFC3:/&?^-.7H4FL#@==^8HV68HW9M- %C%QEK]%@DD+%&C35Z% *H=M9H MVUBCQAK5K-'!H-6RI37:Z=K#<9NLT7:IL<]W"X_?1B;*63&A;LS*@XOT_NMV MR]B59=B5;1/FK ^&&,/R6&20,2R-87D4$JAFAF6G:1TS*S1V9=&NA/^T.VV* M8Q-5G\_$P=)EUP8H5\.2F!$+W\!.V&4<.'^P"P\6-J:KOSAQ,!*AO-AN M,+ME#?^?,41+$_KOOUX:B7]8=FZ]MK%2R2R)B? MQOP\(CE4&QD$ M-4;1KS<[/Y>;#\V(\NF)618*?7H9#C1FB R!=?_'KQ;Q,1I[@8&Q>B7#F^K*WSR,, MSP%:GG;+6)YE5FH:B7_0_?1?VZ9.LQ2[LUT;D6\,(&-V'HL$,F:G,3N/0@+5 MS^SL&+/3F)T;(YO]0UF;Y[.Y%RS(LERR,2]XXL'#1P#"2%F7G_B"V3V*:/9- MZJP):1Z/3#BP@R=J:Q,X]"!-7/SNP9.]/8F1MCF %-!4/8&8:0=4 MNI@W,4T3TSP200^2;++)I9CS4)9F8DO:L\"/$B\&B*P8G2(&^_*TR=X% MX5A$#?9KV%PR/MN6K-0TUF=YDG]@QJ$ MBP0RMJ>Q/8]" M7/]AR8,*AN$VCG[]R/^'A@MFJ5=!_&0NT//EO)G(>7/JWLF&< M)@!Z<".T;;)MZX,CQ@P]%C%DS%!CAAZ%#*J?&?K@-*UGQ0R-&;IDAEJM7MMJ MO_YC!(M '18^MKZC)3H^V%3.S;FV'P48I_\'7W@-96R>SD/78T,T-"UC9Y9J M9_ZW$>^'M3,'KZTAV9E&Q!]89MJU$?#&W#%&YK'((&-D&B/S*"10_8Q,Z\&- M)YX5-S169FIE=EKMG@5697O8ZPY>C\*I8[5:;= Z<:KO9R/SDQLY4>!Y[ M)\)K969^#FY4]Z!.P]B:)JOVR(0\UG0.34C3Y-4:JZ=R%3@Z!8>J9BD? M18&7Q")%_U;K)[SK-=R6_;L#YGO@G:YN#Y9):RIN<]\THET(/]Z78NY]]G?A MWE;%R""?0;Y](M]6Y>6Y(5]5-FIP[VXM[KGAWD8MT.!>&;BW39&M$>I5W.ME M8@ F\G(L+AD3>3&1EZ-PR-0P\F*;R(N)O&A9?G:[W1FF67YVK]L_=$/-?R8C M5_AQ@WWPG28E[K'S/Q, .'X!/\ NV(7'?1-B,=E\1R/,6_W7+=MD\YEL/F/= M5$Z>FU,W-N61B"%C4U;$IGP=\Y$G4G^GYC%U/,%#=/%.U5-.E ^UO2\_=@P& MC#HG5,]%F"[?[BA_<2OS%W>&R[[J__A+P=_+G3^NPR#QQR=.X 7AFQ]:]']O MM6TI/[--AW\M3J0[F4_@S6^X=\L7D=KF8$"R8(3M]L,WK719>!"LVQP,?F+Y MG[D'65O-C'\_T4Y,@?K$$Y/XC;PK_2JD):GO[O!I*[!@:,&VFKV]1Q?H^-LY M#,#\E&;B#U=?SM9&'NXTT:X0^3#E[0Q^!9A'*[;85K0LGNK*<K'H*OM&1*TV)@F#(DSA(OY 0I&\*<-9H M7%VS2D?550BIO5[5-1/)X%;_K;SB5VU'3J=E#UMYN6;;&AS8D7,:12)F%PDL M&%O09JFSC>4"S79+%F@VV&A!W6M'(KX5PF>?Q-CE9V$019AG2_X@_#F>"N \ M,UC_PCB!C!/HR+1ORWYMMTT/H9+T<.,/JA6>&'_0L8@CXP\R_J CDD.UD4&V MU33%G<8RS8H[K6&KU[NUC2,WK0R>Y?"L.*BVQ@RQGP\%B%DS$=C/AZ% M"*J;^=AN/M3/_:QXX;.T'K-))9;=MKZ+[W9[?# C\"SP(^S? Q;@)QXZR8Q] M_'AAK+_2!.\^]V,D=)7W8T1Y6=NIN,S?+](]*XY=BGI@P&,$ZG/8C1&H5=Z- M$:@[VU?;Q&"/P(IN6P>THJ>NF+#S[\))J"#[RV3B.B)D9P@!^)-C2C_F_D8) M=L^- W8I'/Q.NI_:+3L-P5[R<,1]$9U\^>Z)!3MUR#2W6RW[OXQ5;MSAQZ0; M&'>X<8>;X& %1;DY=2.#C PR,LC((&5-FJ9AQV!-VH>U)G]Q?>X[+O>,-6DD MN9'D1I(;25Y%%'E6W-!8DT8&&1E4K4,W,NB89%#;-K')([ F[0/&)G6K,4HM MPTT12VPHM,G^G&L6IS5@OS4OFV?-HNUIM;NM!N,1X^-@CEV-YINLU&&K=P\K MU9BI1D4P*H)1$S=%J?OA\^5\/H^GF<%#'AHY# M;%UYX(7_[[NO']D'/XI!#Q#L?> DV*_PL:IT*?AQ>?:/RN/'/KEI:6ASQ;\' M?C!;@(H)?"?"@,6E,Q4S7D\\.CO]:/"H(GATQCTG\600[*/K_S'"=JJUQ*KW MY[\8K*H(5KT7$]=WGP%2?3Q]9Y"J(DCUD8^$5W-\NOAZ;O"I(OAT$0JLUK^? M[$LM6&WNP.-7V,S7>**-(5;?Q&HPM#ZKH&D-Q6S-/(.B>7F?:1?9*.7O:QY' MKV[VX%7*&])MMK(I%W[@B^QD&8XS8"W6PO?J\Y'WC9!C-YI[?/'&]3W7%RZV[W5VY^TJGLZB7,_*_WG%]<38S85H;AUXVF3$,NB[T=0I1_;_B2;T7?A##>SB#=_!K&GS G& V!\;&XR!<,-B0WV#H MIL+8"PM"QL.0^_+2@YSJ/>4&9^[X;R^^=3L=WNE.K&^37FOXKJ,N[[7:P]Y@:+^0<0MYQX>K\T]6[Y_O;IT^G7?WWK#?O#=GK= M;C:H@V,4>&-MQW)_?SZ]^NWK^>4WN*XUM/;+I#:B_AJVE2]MA_Q#6\"_DRAV)XLM M*]!SKS&"'8H_$S<3&B;=@#D\B@>-^W A>. ]">OU(L @6#3^ 2>#"ZT=BRKT)S@["!P'] MBU!>0$\.1>+#7?1 T(>G00@G #^YODP+P,'2L!(\MW\%X1\-=@G6ABA^%6_AG.YD>IKUE5W*1U'@)?&R<:4;.:FY"V>/ M#.9O+^P7]]EMM]G=:OQ6>[/W 6>GV=\:/Z_P#G7OT4/AVBH_L:'J2_[KJ/!, M75R]^/F?O[W['S&?"]T<_K/7N5W^@3W&?/=F]WNV8?)A:J25-W ML/<]+/K=XLT]_*_K>+12(Q3'M.;?&;!)=\Q2R^:@VW@=O687//'@WA$L/3*( ML^]%?^8S\43404NQ9+PY+IS)PR@E(,R5&WN/QIB#KG1#-G9#I6)?@B48B^M% M_CT&@EQT]:J$;>Z&\%*#3]7(S2T=GU[^U5WCAW)C6)X#/\]#UW?<.?>8R% N MD*CUU]?NSZ^JG0I;07_/DCOG_+LSQ=#%LE_'C=A7Z;A!I\X(9SHKW\U(@.V8 M^FPF@0>? $/87(01%6WXJ5M'O2S,_4/( )3WQN%S[L@EX+?*3X/CI2.X9(PU M(&)\RI:6],FF#=9NK_I[_JOM5> MTR[3X[)?,&[F]<\,C#B\JXY0?$C*E>(X91N>VX(C=_FI+N$N'B>A*+JG]L"2 MJEHZH?A-G8%(ELPC /@P9E15 $I.4V?XO0?%:[-[^!Y&Q#T9477<'-L-D%7G MF5L[WK37(O@"RZH .'?NH*@'^]KK> *=JU4 Q!3"9^V6C.(_+D6]R*8JL*GM M;,BPH"=8:55V6QGNQ5<3<->$9OE*K_1@^4I7MU-"S\T"; MZ=<@FB:<_2[@GX0[3I#X M,89^C6%3&7YR'(:-,6.JSE2,&6.XQC,Q8WP>3^%TW@7^V*@KY7.6]VXHG#@P MAHLQ7 YNN!A64"E68)2,.G$,8YH8T\1PC5J#ZYESC9J9)A; >9"F7#5P==^M-!2[. M%%"CB=XB/,V MIDN;:^-+BN.$]CQ+Q$[)6_T/7MFUM%73O__QE\( <>[\<1T&B3_& 6Y!^"85 M7]JVU F.P99% 3VPI?H5AL2QJ]%B=R.!.?P'+?\)O ':NC&0R: M=B<5I6]:>$IJL:-@O(#_3..9]_/_#U!+ P04 " "!FGY4];VA( 8X !K M/ & &MB;G0M,C R,3$R,S%X,3!K,# Q+FIP9[6Z=5AZVUS_/2\P\ H9*+CY_WG(4A86%BX.+AD>'ADO+24M+S_Y?'\#4"$B<2'](R"1 = M)D)"(4)Z[@.\^ON=:$C_&H#_;2 AHZ"BH6-@8F'C_+T 3@A 1D)!049%04-# M1?T[&_AW'H!*A$9,RR.%3J)ICD'G!N0-22S I)>N_P[2FO[%P&?A'HJ%_8*4 M["4Y(Q,S"RL;OX#@&Z&WPN]D9.7D%125M'5T]?0-#,&65M8VMG;V$ ]/+V\? M7S__L$_A$9%1T="DY"\IJ6GI&9F%1<4EI66P\HJ&QB9X_L'A^<7EU?7-[>\_=__P0@*@(/V/\>_R(OK+ M"QD5%045XQ]>2,@^_UQ A(I&RX-.+*6)8>Y&0L<;@@F43BRH_XY%SZ?U"V3A M/HW]@H%_D_'\'VK_8O:?(Q;Z/\7LWXC][[P0 %P4I+_*0R$"2 !N[U@*/V+_ MSX(U;A-=52?I$B-^)/.SA7/_:HABJ_^";19[,MRN?[!E3W=(75B 5\S>PS#( ML3QV] ]YDL@W X(]>9JY6&S6:!JW?O'\_$(H"^#_?TB[2>(HJ+%UIBGE2 C# MG-_+];"*7ROA)?U,+&G5<5>#=5)#HDE>G<8/9![PX?*0G4J=Z.1SF?E1N[NZ M%I7#M@D$T1IB?!*_]N2A2CA\WS'3_O;TIUI65@, P/^FL>-$F.18]IA-@:YH MG"?I6Q9L(Q6_]7!X J(!J7?:O(H'V065)SSJK+>OB9;Y8!3D-^6FQ M(;1D2K>.Q_U9$[NOT?,,R=& FI+_RV!C?"38W/[E!6\W==#"V]T ZZO*!/KP)HL^]7K9T"/E!FB]N:#^UF6N??*Q*K7..]*GS!&^NF@MPG;'L63@#_7.8!_Z@ET;68&?T L8,*)=9&'!OQXG):FD< M#G7>4WRNL8\Y#KWA'%W,C) @/N"2?)-8;M-S*A%PH".QB0=_&D\=4OIN]47! M&%\>+O4ZI&HG(UOM$#L%&T,J^QF@Q$F]Z>=/8 +^^O4'.W_;ASOYN[EAZ3L\#X/NB0I>A<&%\E7CN+"\$L8U M>'VT[A8JS1_Y$BU)NL_N-*C9=/%@6(G#IRQ*M=DA7B5_.3:O^E0S, M#%&^+AE*B7 R?Q/T7U[X;B85"K 'E*-Z5P5&,">MQB!=TE;'>.@((!,KF&XX MZ5 7JWHQP#.4<.M>:>N%E1M'H/J'&30@8),YF&Y'VBNRD.9=8+2,TSRDA!JF M>,7_87_RO';/$)Q;R=A4;X20;IQD%N+\6#0W'U)X8.W.2?_H(/Y7_$DS,AVS MG-,9).:?LI'%FXI&W;H=2 P.+[MNE\[R#4K,VP7E5FM86L]!\!H8!U.]H<%*$QEU9-=;EE*& M'0O?ZQ,N[:@S"\L6'XR6:B('A/%W%9]IP>WP[X<.I$^$L \_>@X^$OT)<%LA M*R5 7ADXG#813F'K16DE*YPZ)VO@^, M;3ZG_E+.'MC 2_?R W5*D8NHCP;#N>#^JK/VB7'?>PPX](VFR(?EDT/VHOJ6 M>\9L;M*-'9C)TA$T@W$*ME$.@;*4L[ 40@'_6=1Z>* 5XXE>8&YK)@WF%\.[ MFCLCQUM2K-3/4'0ZWY4-5]C-(J2_OUHXR8VC[M008DHL7-X&P8>D\GWCB$=<^#H)LK^N?3M0GWW@ M@_660A+4#IDZEB/6'[.:?R:\5-^6 D7+:5^$_^D 9K0HN*9\E01R3? ML?=;4TU-=5&]J:9&(1W-)%6WUYMK[OI_G,GY =8?UJL?#U?G3FHP(@L5OXR= MH_'"GD2]BE),V.,S$#>K70/7U_0 '1AH?+7%AR4(Z0B1X1Q^%O]P&2U)_7..:*C;ACYZ M5TS9$CK5&+L8H-"AW"PYJ5166(^C9U05JQRP@9!CL)8.,BNK=EC0*W@&T"J_ M+H=%[$Q:H"WT.;A;O]=2YQ*@,I[U8N522TH>4M'&,$TA^*HTHHRU?GIZRLRD MP+0*ZPUE5]=L5Q['5NL:_'VG[Q!KO_IWC^#2Q9HWD6_FCMO$/TTE)/=:,/^>:ZQIT9KJK= MFVP"H.DK?O$>0U1'#L?;N/A&WDNPS84KYZ:# F;B$\XQ&#*IE'EI,NOYAQYZ M>BKTTQ43=1$O>$?9I5+53F*:_(*S0QXUQ@I:==.B7GV$Y1.(5C$$9$;0K;7Q M/#!EEE:[>M@6K#ED.L7UNOE0!BSZ6SUNGN@(2+PX: _*H+H8:QBD1U,MJQ7X M;%TF+;#VXB5FFT%5ED/#+[^JI2(4R?E;^?O6L[D?M6O&,QJ2NY-R\#;HZ1IS M> M]'&:9.JH/5H,.KMA!:M([@4X7YY%IHHN4 SV'-T7\:Q#;KHAY:I68]&,U M65W V=+V:%K]\7PCHM)DA>.<,.C7CGI!14Q',LNUC. B*E59K9M^XR!*M66Y M38R2*Y7: @BTEEKDQQU@HK(B'^.XG)WI#O6'\K[! A '8 ^[$"Y5"E)E #>+ M<5(PCG0E&KP\]2\%+'F!YHVC [X5+]K#B\E]4AB<*.B >[9;3?7963,N_@J M1S+39*(_CG:4*CIPB M[Q4GG0?K^68X24EVT ?Q8H!30/#!L7NJ7?TY'3=URGTP,R[2=[K63[_6NPG> M5(=;L]]/3L!)Y.9)51+%E_2<@S1\70;AE)6M'N*#,LQ1$^;KW68F*QZ(DE4Q M^3WC#YGHA3O,T3$>'+3ZO+;9EWG@ H*(!YG9H5O2,HK/^<2>0EMY#/]RW,?> M.1VBM>^<#&= M7&)O]K(GR4%S.S*QP0,VP^8%S$%=9=7'J2Q=[-\:).IQ_07V^GW52 MCZ0#]=4ZVIIYZE0_68INE_!ISI=,O:ZBMR]KYT09419'&JS&QCO&MZ=:].=F M#S6EVLBRS;MG%?IHC+07C"861,/1@DG;L$9-XK=QB;<>UD4]8A*&D#F%U= / M^,-WNU ,G. >6(L$!][ZHQ<7_?*QK S-6'XTG:1ZM!!G7S2QPOS!9*3=:O@ M$6UR=MSOXH-AT F=U\FG49+X:FP]V2%K\Y-Q#_]UY^N 0'%]JQ:[SRD8U.97 MX[J109\K>IW,8L['PG/QEA'R%P5:[1N:PJG>PN?D* E0 AAPRY7/8 /1GO:( MG/7TI-O?UAH@F'("55Q^H],*;U.L^:3-DR3Y\;JT%[,]C?E1B1+I@VRPU$%O'12*&NO/@ERCGD(,MRJ0) ,@R7+R*J)JBL;>ZBJ3'+/32]-Z M(+5R^PWO(>5D[%V4&B_+>DYW_.2WI0E[KY1Y+[^E_EL!K7K:D)DP@_O#U]2W9CE<=YZZ\/5FO%-JB)%4S:Y"T/Y*3,2W)L>JW/HB%'M M:"4AWY3&"VHLT*Z^<-=NN9>3V-KTI667EY&QI<5'5[OX?N%VQI(F&9ED_BHK M%+LA1Z1,2#*XK%Q\6HRSX.BU VI5U:\BWBM&J7X\!Q1A@M.^A>Q,@9ZYT[P4="&D,JHA'WU%-Z08<8W6%:N.^E;Z]2O\&: /39KH$9IAP"(/UYS" MMD70D5++G>\2Y73/#S%U>2_I% ;C/^<+BQ;8*R) M?T%:TI0%(J6X$1HM#BJ2"-V65QF<[&9X_MB /1U;95:TO"&\Q"O(>D*#SCN0 M,,S8S/-963?6>QQ!RSG7$&".:)OW[Q;$UMAJ;TI+-A3-GP$H,$WK-GK#'$O3 MC(]WF1KO<$,Q;VKDC*P6G/<+ZS..\^>=?J1W:M!:67C4 M;9=" M,UY&"(:L3AWP"VCR-6^EMOI]<.%/&.;,^1A,1\*QN4'AZA9RI(7P[3F\,.RL M!!+V8F;\M.>)B=E*:TSX&R$27Q;]5H(L0/M&:^G]@DC.(@3/]=?O48T$6A,>[)&:Z;PW#7=/.LN= MOEHCZ[LB,FR'Y#+VXN830L"N[,@3.A^ UB*.1%1M7WM^BO1*;UU_?;=YYDSS M.=7.^/JH Q%CDW.](FTR+ME'?ZV?EMHJAW;%9\I:!G]U /B_ $E>>S9_WG&\ M>N!#@Y303=5*+;;]8MH;$J78IT0R12 E,L:[>/ ^2VGQ0H^;ND>6"Z:A !3\ MLJQ'_#IP%>J=LTDEHI**9;X.1E[QH7P\A4]KOLO.TW0OC"@I-3I,Y;07HF.B M2>CTK/#/BSB&*VZF_A#<+^+A(K T\M3(,L(KGO#UE58!ODW#L;?E[$66@1B$K+=U$% :K*THBAZ:Z:QL>'NHB8[; M,8^TO"((:6K5DAF;H!*M;VML"M!._B[LWD_'-TZ;.+^Y MNVYMN,1V_'(@T/[KK]0#)G/,E)CP&R><]9Q#[B;4EE^Y.4Y8$=SW*MUN>[\K M)\IH^;OTUM85/P,^M?=G?#(? M*:!(C\$ERF6MM6LG_H-GHJS:,F>^+/SJRXZA+\T]N4U.TVV&M9DW &' M#(3PKI#/.KQ:C@:__M+O5U9;4Q%2-%1N!]K]KIR,>X\RD30AMZHZR?5L2KM= E^$ M4\P3Y##%]G')K*A9YQ/+]8\%\VQ>;*U+,'BJ=F+'-E5BI(TY*"B?7X)V:Z;5 MCL$@_"PK&]XL@YC(2N#+8B?>X4TB@2I9I+78HC!]N\)C#NC R%SW-JHU]&1B M??W+;.DRG]S ITEF;3.!S@$RM4K75\/?\/N:A8_H=E[LEN2BEEFTE#8?D>D M-:U@)6$3B2U:W),-&U22A82)7$SF$:> MKH4M%=!<*( U1E)+G6PWTA6J3(C193WJZH(.3&FA,NH(9.T75$Z2"6CQ2[Y- MV Q**; +UQ>JFN]LN9?4=VT5TJU\(]P?D<<2L;5IZ'Y.P-]R.77*.0VY#"QQ7*EV_ ^ZVD_O'A3O MC#G.NAA1*(J$A,H+9CB=KFX;HP4':6CC/?+ 1D;76 ]C.U-B=RO.D7QU=CZR3@BKM+*OO_6S^38J M)BAHN>NB*PZB%[>=4Q63L\Y-O:0_+@JU;Q%+3PJ=FVSZ19UB[YU&6V)/0L:Q MGL.V^D0R>TK(?O8M?7+Q=ZR J'E)4S2%@DQ,UGG,CT#[P7Y!1SK?BU\=()^G M3:!X0&2;A4(GGR6QS.=6S/D4O^,U2)@O@1(M@!>FLR3ITLF7:\]P/I'=(H3]_=:Z6^8/P;"S78.2:/V#S%"^M9X%/E2\UP6\(=DB ^EJ)X-,Q MA8;R^$4EJQY/I;EAI+2L"RLN$M4!Q"_#. K,4EC\GVG[(5.D$^^N;0:W'NH\ MLN?^]5=V!<)T/4%,[VR459^:W!AMU>I/6[F[_.M4=9D+(A[4\]*8[-^'*IK? M$\QRN(C/DGDPG6SP3 I,:ZKG2N_(OWP&8%+R09)65\?;D145OEC:BQT9/KPV MZR4SX^Y$^=[O8@%U+DY/$Y(_^&^C-LDFOTJ#5WB="[PNSKW,+>4G7\>DM4GB?($MBT MFH4&A.XN,&KO%-;>%X%DM^VBL7E%RJD<]#*G*_%EL?4P@&/A2]D12:_-?,M% M>Q$G7]DZ%T8"6?,L7QW/7\KDZNE>&CP#1JG'X&=-M=4CP%93W]J32U-)52O)':9^F4 M'QDIE).XN H^RQ0=>/6O,\=FA&TV0\=(,UFPYUR+GHJ3%9'E&/U.X3D8+4M? M)LCC&?"OA]F++CX#\HK^Z$P9;J$2Q*[(0; *PE_3R"6P"[I^72\\1T_O=@B> M''Z _?/2^!U]\8'NT/CZ6CAIE.&7AX')A\!7(\EC]-6S03[2T*NA4!@OT-A)RY>LK"SL"IZ8SNX^)B_&M] NS'JOZ$/* MH.8N@7%0_YT!IU/F]Q^/C86RM-X7)$9&*PHO"S\ED8J2G!EY-GD,?8C:#=[$ MF:FGT?7"Y?E^<%56%LYQ4L70TLR91($VX4FICDW# M] :1HBKE>YI5B?LFZ=FZKX%4@'YA*)O2_UQOOEB,!847 M#S*Q>W8\U?U'BO;C"32)$SP3*&>$N8/N&V$8R,ZTV-,SJ)%TL[!M-=/X$NM5 M %-A9 _ZAN[33+Q&\@G:J!!]J!B/OMTMW<6Q,^*0\+WH$?4;S_*;EW4=97R8A(O?W%1MU!_Z.SSF+DQST7(H*9BZ MI.5IKF<#G5D]#!9GKQ7.3E)-KYVFBRQ'^8DY 5*G91 MNW;?+PJ?N.)[ZL^>^4IU*J(BV9]:VG\"2B'<_TSS[>M5A:L2M:NZ: :O7 M@*K1[VM:!RK46;+N%,B8HB5YDKH'M !6+DXSJS8CN3998K_O^&&^68K)(_%(5&F8-O'D2]O/)'5P686=O;=E6_,* MU1QG&UEO@3SXU)_#91-QN*[MY MCR("W96=D>/UM:*ET:@N/)05I7EQU1@Z\W7J!(ZGA-,1TBH3+NT_/RSW4SZS M+V\ETS5)Z&GQI>W@RP,M*O W0?'%%ZZ^:XN@^-=A/U**F8R=+7I12N4P=G2# M-]%5%\)=C!RQFD+%SR?!7PI6?=(L"UKFC[DR7E# EG\.ZZX-/[!E=[/.;)+* M*4;=LW]*L&R[JM#K)E)V>B^R[=%A$Z0*!U]^2WQO8CSF0O:R>%T'GZ7I=>M[ MO:5]?<-9*.F]E22 +_4@#ZSL!.G9PLAP)M+UR!DL,4/\IC5KC[-_C5O ",(TMS1'UK"OD>L+^HK?UO4GL]RTJUIS9DZG03^B,Y=,.J<23#*9V MLCRM*O7W?3'GQC4%/Z+!ON'%(_5#@^,CC^L\_6H?D)$=5:5ZTO"EJ!3(BE*I M^L?%!S7NX*$B1>]EL"FY.6=JZ-$U1J0P"JB.XEI_<;=A4:;E=;Q+$+P(*NOR M\O8^LG>@Q [2T4!35G0T-@I(M2N$)H7^OS1,_DM(N"H10.L?TZMK:E2 A760 M _8^&+K'EU'P<\R*L"[E>.]E)O7*3K\V(^XE;J6DY/DQS^+%HO=TZM?"G#FZ MHW+PW50*#";_D_8FN2="B,$:@3FP':?J?(9I2,:N!,[T%O:JR7FI;- '45.@ M&I>J[6#Z[*F30BM$UQ2)7'==>6]?[HOK-%F!,[2K"*530GPXS\N)?]/JE$D5K&%C^!&OR (@.25=,C MAYF"GZWM5K:PCXMI5MW56P1\>A?=1LMD'V7_1\AR#&/^B=_47!W3)BIXW Y* :A0)K=U)$L2XPQ^.(X) M.1S(VENU%5+QU]*4) ZL3[#>%GH&V&;FLFI9KT;25=R4DOU2-*Z\"Y,D%V,E M4!K+TPV=6 P"( M==F6$/*MG7;Y5RZU)4JIKYSA,1">RO;FDZ)\ 0M$#V(<,U1 )3MY-:_:" 4Y M8E&*<3Z&>T 2G9_&$\W^!X ; &S28BF'J2PLD(P4,1(F2& /S&8X><+*,'%; M4,:\Z3[ZZ*U!9HNRQ)V-^YENU"U> P.5F]S &$CR)C%%_!D/./V78'+<>%_JHI M!_S=(XVZ;K^UH&FKWD)\R^NA,[VBN:V.9D-.TZ"GIR]"337\TT&*2;1I0A7/ M $?;^T1",7 15DOR)<^AJG!"_^6IQ-+@S)=UWL#?OZ_?V^?LY^.X#275Z.P6 M5UUDGYJFU'\'62!\'*,N^HSQ7.HWZT4#)C5&B+(DC"]1 ^@<*@W;,4UKS 3-!8]\H;3ZR M#;8UTN<:_-1)T;LY9<=AY;(:5EADP"XI.UI(._])@H-K;EH^KO6IN";UTZ6L MB*##M*'IRH(I GULJ*#Y5)\YX@:8BGBL&N>ZH#.X;$N?O?%8[]F+/?'0"S-8 MR&68/:VU@1-7-%DY66P$BZ=8'8'-COQ(<8$/:P0E^-D+^Q^F Y6U92D4@570 M?HK?$6[@]#/#LXBHQ*FXM.R5FY9#XH1(1:*3$#'OS0D,SO0P.#X@^]Q^DC+.Q^ML&(PV(%SU*AX?_;U MNJ0?B"%YD$B3/GQU14Y=^Z_Q_$L24K"'N8 M:ZGW&B<#6&O!+LCC?ZL%.>^G:^ M);]+TW:8LXECX#O%:]S;GII96E_OH#!4Z5_0UQMZPG4S4M["8QFDR!J:4^#- MSU6H-'5I(*56SR/-EG/; -;<%:R,;5&N!28A$ 3B!IU?-]AK5VG.M<;=R@>= M=K&83!K>G*:XFI9R.Y0_K-TO!@XVOE.I5O=;#U=TDR>YB MXV\BLL1@@;F0;3[QL'.(W7G[OUG*CX3P M]'5T&]?[T NA 9;F7S*NHSA9"5MOW_RH77]PJ"F=O>N7GPL: &P<1I] &^VR M."TQ9BI:N4;)#I<>*B4!Z&@6XX1-FK*T$2RPDEP6C#YJ:M^ M1M)/OVXT #T39FM9LUA]58(R52^KGW2!>"&3Y#O7LH96GYE-A/CXXJ]XL!*V&!\JQBXNC]P19"XG/;3.3>C(E MZ]FR/6%SZ)-^@_UP43G//M<>_[%O]0;-^>6'*62D![*:U)S,Y<7RU7'-T'WW MF_<$T 4/]K'X=!6#E5FQ_KIP3&@EU0UVY>6;:E;RHUTO.W.[)P(-< MZX0;]"(F$:L=:OH);M"U^B95\>\T*A:, Y(#ZC/5V@RF?([O*LDS=+\T.;J5 MD744&S<_ S3@ @+ZD(_"2&I5G_\IN,@?RN_T+O<6Z?EG.@5K.%D2J47@B.3<] M%29S-O14B?4P_U&60G\J2.?/HKE[]QZ1->-._YS[JFC/CDQ6R'N265#)YGUE M<](.$^\(D3OEE>7) =CG=F#A<)T_VFB7ALX M_=!)92WB8-1>U=Z]('V=$^$_YO.U\->Q%Y:RK.D27P6 Y2[^T M:*V*Z')E'5!U5-9_.ZXLY^:<:"C;I4R\F944Z ZAPI#,_6[S1I%"Y!N1FKO4 MRYI:Y&3D/!%X^%"M1YPZOCIMPC"NY2-0.O^&ODNXMS?MQ2*OWY\OR6U6!+>^ M!R;A9&43O8F4L:_0RX":S9,;E\ MNT).L,6?FIHL4$@1C8%0&.6]*G/B8K]B* P#GM>R,=Q2:OLHR=^ECM/&EXI4 MO'[O,>554-B:Q-?$)HB/M9=973AF"U47)6CJVV$H\G+SJB]R09*V"NX.EM*S M*PP)!VHS!":*;)^&VJ'DGJ=K%]:TQG0;8-#K3-/N>Y0I%]"]33B(]_T@B3F,^ ( M"BZI4ODUZD)5^ PH5OEA.^4CX#&: [3"$"_,:8\6Z<"_F_X]^T;Y&2 *SME1 MI_F!^3A.&^N#^77*2T"@B=&#(2^PG4!*M_;$UDA0, YMJ!>YMQ:N6&I:6@!I MB*/\T/#ZUJA+&VR"?3,U]=>FY8":LH!_@9PE'Q?/R0?R@NV=>0LMC>U+$%Y7 M:OF+;,\S+K$0PP]K&[[4V?IR.M3Y6C^T=YD&F;G"/*<]\2+U$!04'X'@WXZ# MY9_#D*,>8D-,6@B7Q[U:B_O%O2EA.[M3.Y>UF"V*>C;ZFCE=;,TIME[VM2OR MKF&T9#OR@%?:1R:Q3-/9VYEOU\)2\ O_PQY5Q6*+] SRWADU4 /EM0!F-0!C MUW))3R6S?Y1G)1PDM31T/.'>M\>4])$K&&*R)VYM& E.5#]+<[T&I<@"G-Y9 M@]8+!="3QY9:HX/;CL"/E:D-'0Z*OKSK98?+$-%[[_MH^Q I>0$T%"^J4 M1 _.YA1?9I[FHQ;,8V$"E87O%?[AA>O+REB'HQ=Y[Q#93H$R9TXXGO#D0N-) M@8]&!9^C)@;%6\_ LM\**D60_8V3"MMV$::W!!)$]$. M,"D48U2Y\*)]J4EPX$DN;)+U1=@;'EB?T\=TL:,Z7=U7+"@':B>JHUHZNG'2 M)G0_#LUP++XO[GD[QJ7_T/4H,F9.:1\;)>X[Q^RU="#IU7>1_2OKJ*V=7ZL7 MRXJ4]2_2.XV,@LT7"EI_7:_J^W 2OUG&_=X'69/C,9EG5GJ[Y$Z?3(XC>&-G M\C$,@OP,X'X[P6=8;NMFZU8Z*"J"LW8J2YG3>F;RR%^1A 5(G$J3?:MRW'>]FI4=9,=:\!J9\]]?,9SB[2M:.-7N M/4WKB'SC*1?/J%;1#5"V@C?' >]AW&SCQ!N21FC_7;JQG$W@H/S;8:;^1#<& MR<#M(_"L4EW?#,\/[)U39^I=]V.W011$9FO5YV0'[;=]2D2!JN\>RWR> 6*0 M'&"$_;MJM6RE@D&XXXJ)O!?U[\DY?WV6U:V2YE8'^SYHP 4+2G5A481N)F.B M/Y'6?R]9_BLP(%_MJ"$6'V$/:ELS W6A7K'W RQ-3(V6&W"BI4GO\V_++7+9 MHQ84TD'.GZCA6I>J]U8]NE]HES3#N-S%NMC%/G 1\RN<6EM M0Z'R@_W,H+/2=TL30A&(?P9@CIC%-RL.K_J)9D)^FTLKX!W'&(8A*V[EI+G. MK6/0S^G+%RN\'T)Y8$9N$"C%S_TMPT/EW7R/Z%CT: KH[/H%O.U3C6B:B/']W:S5'"$Q^;LKT&?8 M6G1"$27M/ON;$V(0BAB&*?@T',TRPNMZZF"@@/!)$ 2AV.IS"EP?:-T0-SW3 M^;7.V[KJ=LI6(H4ML+PNY?DJ+G*FFAV]1F_@]Y!WVUY]]9']+2YU8>NAUH[P MP?SN:TU94$CKW^1/" B(^::K>#J/CS1"VL%77O+A=8/LIWN&;[(S^NE M?;!'.!3\2N.^8RG,;WP-3G9J*+N-]^Y+ GBNAE=025+A8/T@-ZN?LUXZ4G5RQDE@,'1*M,**LN M=N4Z2+&9%2P)3Q2/M7;&3?.XI/N"NU[:1*'NYU2@*41 MCGG!;0CAPKXYHQ4 MN5,R/80@LN^*B0RJ5[.2F&APXR#L#D:^R\VJ.>4[;\0.SDJC'9]&V2.B+%]2 MP68V85R-UMTZO.$\"57JY5?%Y.,9Q$0T3'P15$>"+GB(08QQ]R%>WKTNA6ZR M:%,F'QID($&P*=@[JI9>;U:CI1-E).'%@-)>HH;#BUA^93HOM<(*>W(5;SX2 M)U=*UMZ?'D9EJ&97Y=[=X>PKVG&%<)>K5"WKL 0_=D-;F@0I5/\9LB^:ZG', M&_PS,&V<"POV?0: CWO[^>*)F&*6R8;^\".49I3)K! =&11F M[NHJ^AX0D6S%MXZV6GH__54(N+%-OH2%+3VR\]ZL.5ECM_VT"IO3&2BV.H[X ML5!EI AM7GUDA]6UKE<\WI%OST9JGYEPI0;)46\UU@*G2]!GA=,G9,7S(_/+ M*\<"G+T(GP!. M91%7#DGZAD2.G8G]>2]2<(;21RGFB =V/K@0G('8N.J@:26V=U1"TX2Q*6OJ MU;=%BI)N:@DWZ!&'[[OK&DH9S95(I[3]0NBV"';+PN[N?(+7(7LZVTB_@3L^ M9LU YR*0_U^R3=H>^$C-ZPDD9P9L6U/W?0%H/51.5R]T]XR=L<)5A*?7STN MHD+X2O"]:=U5/HZ>X#/ MDE'(J"\XJQRI614TAV[>4;A1^:,P.1X&4(Q0$31 MEWLRF3KHB @*69,YFYIQTAL6O^[!=XN9*2V#G&J,@$*^H5Y7V7\0+A=N7S/S MP171WOTUHR@\D89W<4&Z4#%]JKKGQ(/TK&M495^(@]WFJ*(?)S9]O#Y/J'*3GMH9^0@^(8G4G$.]\5W ML7#C4-\:"T-SUWU_(N/KEO"33[Q.Z:U!RCX8*PCX50=*V4KZA_'MMQA _G8\ MP?&_KEIL_N^L+.C>)?::RT!.Z5OU.HN M3V;;8P'7/(#MAZ78$,SF\ZCE@2:2R1W?9X>T9P"\!H#D#;M"AJ5R*%HF!=KS M**CO24.-L$^29$J*D=M-!!2BLKV,,H7VL;Z"?5=V$V MGT+ZA*CG!7C%O]Q=&LU=I7[7/25EZ454Z;CCLZB-40^REQ<@REZ!]RC-AVI& M;C;<&_PO\#Q(74$6DC^]:M4^)RCENYNVSJ!0RSPV]'ZVD\J2JXYN &3P"L%/:?,=AW?1*%] M/A/5A+Y@;0-$8+W,RU=\WC41F#?YU#D.DWU*QV>]_87^+(5M^'7__&WPTJD@ M[]$"'1;V?N<;@C3:X!D^R%,WO)2&..:W/QA6K2@-J[?U4/ M>LIP*W_,0$AA?<9%Y[O4->0/U)+O74-7+?'>.[-MJ\D#?F'EQV?-/K)#Q&=@ M*8]7M Y1A7MB<^>3)*_.UK&Z*7;$LO^3A?U[%OH? <7 2B]PODV"-QY6S699 M(ZMC/3+\Q3E.ZTA](U4EH+S*SU&I_D=YS:F1;I ZQIRN?)U%<'AW8?MF5/V@ M, 891Y9$P%5EZIV?S:;?-5V[;MW;^\H_.N76D\SQ4GKGJ%4B?%7'G8WA._': M1J[?B%Q9+:*0/O)H7X$&M8J2A3=597%D@7HV!7)\LD DK2W 48R[,'E_1P-Q MKARE3TU"##34 #1(+U MG%TJP,I**3L>HK>C%BBK*^B4UQ4/JT$H#A>U^NS<.\4RAOLM#*XX?^MUU>0UE06 M^GXN4IB:@R(VG,GB MGN8HN 'Y&N2\;=E?2%BZAU./\IY/Z]KO+_1R#A]1TY M.5]*K$DE&TX[N#X,[ JVL*$ ]F WU3B5;AY.#!R^;HLS;?*YG'S&K;U3^O!M.Y-N[OBT*"4_Q>IBKAZY[AFPB1][BMA5 M#!,)I;2,N=<+CX]<&(XV]$@7S467('>2+R)VJ6!_!O08VO"GOW[($!QGB=9N M?7L&=JDRD!FK=OU8_I/$H/+'+_J+[H45=.P:8>XSR5\APE$= 75+;Q'ZM6_+ M3F_1QB#+1\TMK.POB/XX2N$&X%_5'S5K0X@,^W9^)N*$8I#=5I7^^L219L=% MQCEZYG:&J#;P]30P69FDC!*%LQV2GEG-0,20WE+A 34U#+2HT3AI#R3)-E:F ML>K,W/ ?([1G!:R] ICDW80WA3,+!#^SRS-8?/BFZ$;]=ES'%'??\*=_4IH-_C6B*,0 M0S.I+&06>"+?6WBO^2;(3UJ'%> -;,)3Y.B4LO:RI1I]Q6AE 938T:9R'E-+ MC$:?SN]6GM MVKJZNX[M=#[A.OF$3)H\#I';G#;V-,/S\%X'&A![7>ID" N^I=QM%_HR2$S[ MEL8L49O=D^W-H:(L4.?+O]7E_ROQ15,24%((!:C-_0U":(Q #>3_L2FB]<^T M]]\I\-\E_\;4$L#!!0 ( (&:?E1H4FUI8@0 $T4 8 M :V)N="TR,#(Q,3(S,7AE>#(S9#$N:'1M[5AM;]LV$/XK-Q=96R!ZL947 M378-I+;3&DVDI-1V5ZS8LC4KX@^R=#S>/7?' MNR,Y^,EQ)EE*LH11>+^XO JDW+-,@V)8D0CM>(ZA87,.\YP@*)&S1R911!X@>_U_%X/_"#JA='1"5Q?PJO;Q>BUY1Y? MC1:_7D]JK=>W;R^F(^@XGO>#&N!XY#-=,$DI2H@NDWG=O% MN1,BA^9:L.' :_]KWEC2S7! ^1T4>B/8F\Z:J!7/'"WS*/!SW<>9'@[O\=P[ M%:'-07_"Z;X\F7?>-BB#>@V)(IAK4.ARS'G*UXH1N&&XVURY2^ N02/I0QQ_=# MF&:)BP4-SJ5:PXT3PJMS+AC,I M!$#B]XU,_#(%D%/;IIZ?A:R-*E@I5(Q - MU);'2Z*2% +_$$Q]/*Q+K&)%SA(+WDP@)>4U$@/46"8%KZ88%FQ.!?OTZ M9&)I8Y:P=)/+AJZ9>"$';* MD[2UC)MIB2@-KYV/A+,L*Q'EO.9H?=CUG0]?PEU*994:!%]3Z?XGJWJ+L8>C MW[C(;3/0),8ET,B)I<)T-ZDM2%ZPJ'W91G*""M*Z?)KBCF'6Z)(&7-TY2*EE M2ZC[AJ7L=!=CQ6YOL1ECT#B";&393-IJ'AVPN83]Q98PTPE5B[Q!U*U]H^E# MOC.E>4)$DX;8D[1<-T*/<1L0'&R[M0'4NGBKI6W)ERAS*635^K;]=BI%\BC& M_<0GIT)'_F6;K,'4BEM6$F/2E)KMV/UDRF*]?VB>FGZKHX]PTW7R[.A_XFA/ M*[/<'VUI_PMV>H5GVT2YAHN+Z]J,1UPC3R4R_Y-H_&W;GL/U/<+UG#A/)1(7 MTNP"5TRPXA!&9\_A^/Z)\?G@\>-'P[-;X+;W/Q5X6]N1]&'/'9/DTTK),J-[ MEP%;]S^[ \WFSIQ1S)V"TWS[.Z>'^HYIY_BP0WJXT,K)BCGU-I L\4 0D3O) M:1/Y,'1[1P?]YD13TWQ[!U9?E-F;M^$?4$L#!!0 ( (&:?E3'C$.<;@@ M -,K 8 :V)N="TR,#(Q,3(S,7AE>#,Q9#$N:'1M[5KQ4^.V$OY7]'+S M>C 3QTX"+34<,SV@4Z:]'G/-S9OWHVQOL!ZRY4IR0MY?_W8E.W$" 3J%>[D6 M9@A87JU6JV]W/RDZ^4<07)0Y+U/(V$^3#[^P3*5U :5EJ09NL74N;,XFJJIX MR3Z UD)*]EZ+[!H8^WXP' ZBP=%A$)R>H*JSIH\J8S8.QU$XBD8C%HWCT5%\ M\#V[^L#V/D_.]IWT^<>SR;^O+ORH5Y_?_W)YQGI!&/YK?!:&YY-S_^)@$ W9 M1//2""M4R6487OS:8[W1!*I0P,,IOU3D^H M!3^!9Z8BLWD\C*)_'E<\RT1Y'4B8VOAP<'2T:M+B M.E^V*3^U6(/D5LR ='>TIA*XCA-E\^/- >[K6;7]IJJTP9070B[BMQ-1@&&_ MPIQ]4@4OW_9]"_XUH,7T[;&3-N*_@*IQ>A9N;<"EN$;E9*MO$&6&R(C'WZ*$ M=TB,PHQ^AR/\&(\.O&N2-2/FX*:;*)GARXO;7"0"A8>#X4F8H!^K%[ Z14-! M=ZQ\S*PST%9,19?^KOD-7<,)ZIBA+8_\>M MJTAZ@K6_04I0_>;-\-OH>!R-"+,V!_8;UPDOP00?;R4LW K@FU$4C5YN)O^I M#0;/XLY4HN54+OOLBM<252<8:*;/4A=O"S29V]A997DB@25*9Z#?]:(>BDC9 M9,SELZEXVCQC#XV_63N9&6E,N6QLY\)"0!TA+M5<9!#3,!SW4B$.A]=EFF@^/5!$-:O= M^NO:]TY' M.[_V[[EQU(X5"W:#SI2 '+#O(="L?:;0D%(A><01N2@1&@M6EU;7@)8C-73, M$D'!68%/6B!LIIPRE&:J$)1NO=P=@1)2,(;K!8D4_ 9@)0@OAIA(1?YWA-@#:;"A$NC MD]X*35,93A.!ATY)%ETWO()\&X3&7R_(@4U%B3 B1*Y@TW=L!KDYXFKU7I13 MS(">22*)E'6&.A&:'8ST$=9"RP6K$%D4%!0LN+-:HKX!G-D8&@,K:FC0,-U\)838R&4Z.W&ZWL=^!L6F/N6/N*Z&UX M.=AY1$_6EO^;-T>CX7?'IL%LP\(HS2F_MW' N&1<@X,@0DK0&B-4&!A:;V%R M$B>Q E,\I7EZSH1)I3(U]J/DKY7T6*RT2B'#9L/V$'H9()8]OK9M$@[WH+-) MH*=]-_PFCE&"R$C\0MC<#KB-Q?[Z0 MA4I[ @C09B1/%E2M40'FQYDP+NNB%)1.#^U<5OFZF_/]>0P&1<,65JCM-_6 M7@K,W6B+45)D[M3,U(D1F>!:T 2$YS2N"I6DJ3;$,US<&D=*7(Y6!M @BS6! M.E6TX7\)D"!F?^P/V4ME^[]11"4['U$7,RYK M!SO"!TRG=)PP@Q)9]EW2L*P:3P@C_W@_CW#AA!TQ!(QG*XFJ[78+GA+H?"D- M1,6FC_-SEK0DSZ4&\)Y >XY)^2OX_RRTTIT'_[G'U5U\TGZU827NS;U!(.C8 MKO1DG##)"&4=CNYU^=2+)4*E::T)A9U\?(_60AF+[70HB+H,(H#]7F,Z1]5[ M6[I,,9QP;[HAW1B.FP!P6^UR_8!FWUN5<[,L7E@KN L_R%SA=/[@1I6(^05N MJ&] -OON#?G^GW;12X;J'Z)XMJ5F$R@?4[)'H8+%AM#Q0S_$@=L M8QQ^KP6:[^*Y+MUAO=E_W:W\#78K/TC):!?AOD_$Y:=-;RH 0=KPH^6N80[\ MA@@/F#9M^_V'.Q!M#W7^$/0;@N_W[_?D<)YA1P/+%+XU3!(AA75=$.N(R[YG M708IEZD+= -ZR4VF*9WW'G^],JJ' +7SNXDG QYITU1C(NTC_,#E?@2P.T=O MD-[WK$.4,R5G0-2CY-?-UP&Z*1=05%(M -_.<^5K!%^+(\3]L_"RP19$/J<+ MVV6AETL@"B-\6,6YR#(H48"LC\:XY29!__6LNU?BHZ/IZ(,D2)64O#(0M_]T MAR;,YOX;8KHG0CY [[;+YRZA\-JJML%?07$M:Q=5HA7T&QEJZ=PZZ3&W^N]Z M_NMK%Y:MG2)K#:C? M#4;WIZ/N5:7 2ZV%Y#FFI)CY>Q-/^?S -1;4<=1G=)OMODS\F%^:\&UIQ("N M1;AC/_8F+;O6IY-0Z61C8;/&0JXG1+>?7)94>*;#??Y 3 M/)]B=8WY3(FL"8FCH\'H8)E-?%ODPLI?5W7W7T__!U!+ P04 " "!FGY4 M!9AK%$0( E*P & &MB;G0M,C R,3$R,S%X97@S,60R+FAT;>U:;7/; M-A+^*SAEKK%G2%$O=L]'.9YI;&?.UZ;)I,IT[B-(KDR<08(%0,FZ7W^[ "E1 MLA4[4_M.:9V9R"*X6"P6S^X^@'#ZES"\+'->II"Q?TS?_\0RE=8%E):E&KC% MUH6P.9NJJN(E>P]:"RG96RVR:V#L[_WAL#_HGQR'X=DIJCIO^J@R9N-H/(A& M@]&(#<;QZ"0^'K*/[]G!Y^GYH9.^^' ^_=?'2S_JQ\]O?[HZ9[TPBGX=GT?1 MQ?3"OSCJ#X9LJGEIA!6JY#**+G_NL5YN;15'T6*QZ"_&?:6OH^FG*+>%/(JD M4@;ZF#RDZP9X2OMV1NPX7(;!X/!X._3BJ>9:*\#B7, M;'S5M+A)AV7C8'YU&"3JM>@834\0KZ(Z- M#YEU#MJ*F4@YN8^I&?NH19F*BDOV3I08#0*_?9BA!.@],KNJM:DYQJ95>V35 MY2T&58GIX(?4LD^UQ(&'8QX.CP[X(>-EQH;'F7\*]LAJ;AC/5$79ZO_CUJ^* MHU\@):A^]VKX_6 R'HP(LS8']@O7"2_!A!]N)2S="N";T6#PC-'V[]I@\"SO M3&6PFLI5P/ZI3%YS]BL(8P*6NGA;HLGEP] MFXJGS3/VT/@_:RY17]9^][9:._7 M_BTWCL>Q8LENT)D2D/ %'@+-VF<*#2D5,D4KD[ B6D8 S72Q(I^ VX7+?2:; M0V-P2$E)LDV& MJ=#(75$,V:Q!2Q!>##&1YLS4]+'NOP -C1*:0"$,DBSRO6>[&DR%"9=&)[T5 MFJ8RG"8"#YV2++MN> 'Y+@B-OUV0 YNM:. :-H%C,TC$$5?K]Z*<80;T3!)) MI*PSU(G0[& D0%@++9>L0F114%"PX#9JA?H&<&9K: RLS#'\@"1JB0((=85X M=,,99T_*3CX=\FIL%LP\(HS2F_MW' N&)<@X,@0DK0&B-4&!A:;V%R$B>Q E,\ MI7EZSH1)I3(U]J/DKY7T6*RT2B'#9L,.$'H9()8]OG9M$HX/H+-)H*=#-_PV MCE&"R$C\3-C<#;BMQ?[V0

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end

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end XML 77 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 78 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 79 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 193 414 1 true 96 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.kubient.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.kubient.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.kubient.com/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00200 - Statement - Consolidated Statements of Operations Sheet http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00300 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency) Sheet http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency Consolidated Statements of Changes in Stockholders' Equity (Deficiency) Statements 5 false false R6.htm 00305 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical) Sheet http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiencyParenthetical Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical) Statements 6 false false R7.htm 00400 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 7 false false R8.htm 00405 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical Condensed Consolidated Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES Sheet http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertainties BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES Notes 9 false false R10.htm 10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 10301 - Disclosure - BUSINESS COMBINATION Sheet http://www.kubient.com/role/DisclosureBusinessCombination BUSINESS COMBINATION Notes 11 false false R12.htm 10401 - Disclosure - INTANGIBLE ASSETS Sheet http://www.kubient.com/role/DisclosureIntangibleAssets INTANGIBLE ASSETS Notes 12 false false R13.htm 10501 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Notes 13 false false R14.htm 10601 - Disclosure - INCOME TAXES Sheet http://www.kubient.com/role/DisclosureIncomeTaxes INCOME TAXES Notes 14 false false R15.htm 10701 - Disclosure - NOTES PAYABLE Notes http://www.kubient.com/role/DisclosureNotesPayable NOTES PAYABLE Notes 15 false false R16.htm 10801 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.kubient.com/role/DisclosureStockholdersEquity STOCKHOLDERS' EQUITY Notes 16 false false R17.htm 10901 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.kubient.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 17 false false R18.htm 11001 - Disclosure - CONCENTRATIONS Sheet http://www.kubient.com/role/DisclosureConcentrations CONCENTRATIONS Notes 18 false false R19.htm 11101 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.kubient.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS Notes 19 false false R20.htm 20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 20 false false R21.htm 30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.kubient.com/role/DisclosureSignificantAccountingPolicies 21 false false R22.htm 30303 - Disclosure - BUSINESS COMBINATION (Tables) Sheet http://www.kubient.com/role/DisclosureBusinessCombinationTables BUSINESS COMBINATION (Tables) Tables http://www.kubient.com/role/DisclosureBusinessCombination 22 false false R23.htm 30403 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://www.kubient.com/role/DisclosureIntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://www.kubient.com/role/DisclosureIntangibleAssets 23 false false R24.htm 30503 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) Tables http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities 24 false false R25.htm 30603 - Disclosure - INCOME TAXES (Tables) Sheet http://www.kubient.com/role/DisclosureIncomeTaxesTables INCOME TAXES (Tables) Tables http://www.kubient.com/role/DisclosureIncomeTaxes 25 false false R26.htm 30803 - Disclosure - STOCKHOLDERS' EQUITY (Tables) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityTables STOCKHOLDERS' EQUITY (Tables) Tables http://www.kubient.com/role/DisclosureStockholdersEquity 26 false false R27.htm 31003 - Disclosure - CONCENTRATIONS (Tables) Sheet http://www.kubient.com/role/DisclosureConcentrationsTables CONCENTRATIONS (Tables) Tables http://www.kubient.com/role/DisclosureConcentrations 27 false false R28.htm 40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details) Details 28 false false R29.htm 40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details) Details 29 false false R30.htm 40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable and Accounts Payable (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesAccountsReceivableAndAccountsPayableDetails SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable and Accounts Payable (Details) Details 30 false false R31.htm 40204 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPropertyAndEquipmentDetails SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details) Details 31 false false R32.htm 40205 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets (Details) Details 32 false false R33.htm 40206 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Advertising Costs (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesAdvertisingCostsDetails SIGNIFICANT ACCOUNTING POLICIES - Advertising Costs (Details) Details 33 false false R34.htm 40207 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) Sheet http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details) Details 34 false false R35.htm 40301 - Disclosure - BUSINESS COMBINATION - Purchase consideration (Details) Sheet http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails BUSINESS COMBINATION - Purchase consideration (Details) Details 35 false false R36.htm 40302 - Disclosure - BUSINESS COMBINATION - Debt-free net working capital (Details) Sheet http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails BUSINESS COMBINATION - Debt-free net working capital (Details) Details 36 false false R37.htm 40303 - Disclosure - BUSINESS COMBINATION - Pro Forma Information (Details) Sheet http://www.kubient.com/role/DisclosureBusinessCombinationProFormaInformationDetails BUSINESS COMBINATION - Pro Forma Information (Details) Details 37 false false R38.htm 40304 - Disclosure - BUSINESS COMBINATION - Additional information (Details) Sheet http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails BUSINESS COMBINATION - Additional information (Details) Details 38 false false R39.htm 40401 - Disclosure - INTANGIBLE ASSETS (Details) Sheet http://www.kubient.com/role/DisclosureIntangibleAssetsDetails INTANGIBLE ASSETS (Details) Details http://www.kubient.com/role/DisclosureIntangibleAssetsTables 39 false false R40.htm 40402 - Disclosure - INTANGIBLE ASSETS - Intangible assets consist (Details) Sheet http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails INTANGIBLE ASSETS - Intangible assets consist (Details) Details 40 false false R41.htm 40403 - Disclosure - INTANGIBLE ASSETS - Amortization of intangible assets consists (Details) Sheet http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails INTANGIBLE ASSETS - Amortization of intangible assets consists (Details) Details 41 false false R42.htm 40404 - Disclosure - INTANGIBLE ASSETS - Future amortization expense (Details) Sheet http://www.kubient.com/role/DisclosureIntangibleAssetsFutureAmortizationExpenseDetails INTANGIBLE ASSETS - Future amortization expense (Details) Details 42 false false R43.htm 40501 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) Sheet http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) Details http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables 43 false false R44.htm 40601 - Disclosure - INCOME TAXES - Provision for income taxes (Details) Sheet http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails INCOME TAXES - Provision for income taxes (Details) Details 44 false false R45.htm 40602 - Disclosure - INCOME TAXES - Statutory federal income tax rates (Details) Sheet http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails INCOME TAXES - Statutory federal income tax rates (Details) Details 45 false false R46.htm 40603 - Disclosure - INCOME TAXES - Deferred tax assets relate to temporary differences and carryforwards (Details) Sheet http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails INCOME TAXES - Deferred tax assets relate to temporary differences and carryforwards (Details) Details 46 false false R47.htm 40604 - Disclosure - INCOME TAXES - (Details) Sheet http://www.kubient.com/role/DisclosureIncomeTaxesDetails INCOME TAXES - (Details) Details http://www.kubient.com/role/DisclosureIncomeTaxesTables 47 false false R48.htm 40701 - Disclosure - NOTES PAYABLE - (Details) Notes http://www.kubient.com/role/DisclosureNotesPayableDetails NOTES PAYABLE - (Details) Details http://www.kubient.com/role/DisclosureNotesPayable 48 false false R49.htm 40703 - Disclosure - NOTES PAYABLE - Note Payable to Related Parties (Details) Notes http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails NOTES PAYABLE - Note Payable to Related Parties (Details) Details 49 false false R50.htm 40704 - Disclosure - NOTES PAYABLE - Convertible Notes Payable (Details) Notes http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails NOTES PAYABLE - Convertible Notes Payable (Details) Details 50 false false R51.htm 40801 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details http://www.kubient.com/role/DisclosureStockholdersEquityTables 51 false false R52.htm 40802 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details) Details 52 false false R53.htm 40803 - Disclosure - STOCKHOLDERS' EQUITY - Black-Scholes Option Pricing Model to Stock Options Granted (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails STOCKHOLDERS' EQUITY - Black-Scholes Option Pricing Model to Stock Options Granted (Details) Details 53 false false R54.htm 40804 - Disclosure - STOCKHOLDERS' EQUITY - Company's stock option activity (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails STOCKHOLDERS' EQUITY - Company's stock option activity (Details) Details 54 false false R55.htm 40805 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Information Related to Stock Options (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails STOCKHOLDERS' EQUITY - Schedule of Information Related to Stock Options (Details) Details 55 false false R56.htm 40806 - Disclosure - STOCKHOLDERS' EQUITY - Estimation of fair value of warrants (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails STOCKHOLDERS' EQUITY - Estimation of fair value of warrants (Details) Details 56 false false R57.htm 40807 - Disclosure - STOCKHOLDERS' EQUITY - Warrant Activity (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails STOCKHOLDERS' EQUITY - Warrant Activity (Details) Details 57 false false R58.htm 40808 - Disclosure - STOCKHOLDERS' EQUITY - Stock Warrants (Details) Sheet http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails STOCKHOLDERS' EQUITY - Stock Warrants (Details) Details 58 false false R59.htm 40902 - Disclosure - COMMITMENTS AND CONTINGENCIES - Settlements (Details) Sheet http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails COMMITMENTS AND CONTINGENCIES - Settlements (Details) Details 59 false false R60.htm 40903 - Disclosure - COMMITMENTS AND CONTINGENCIES - Employment Agreements (Details) Sheet http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails COMMITMENTS AND CONTINGENCIES - Employment Agreements (Details) Details 60 false false R61.htm 41001 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details) Sheet http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails CONCENTRATIONS - Customer Concentrations (Details) Details 61 false false R62.htm 41002 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details) Sheet http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails CONCENTRATIONS - Supplier Concentrations (Details) Details 62 false false R63.htm 41101 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.kubient.com/role/DisclosureSubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://www.kubient.com/role/DisclosureSubsequentEvents 63 false false All Reports Book All Reports kbnt-20211231x10k.htm kbnt-20211231.xsd kbnt-20211231_cal.xml kbnt-20211231_def.xml kbnt-20211231_lab.xml kbnt-20211231_pre.xml kbnt-20211231xex23d1.htm kbnt-20211231xex31d1.htm kbnt-20211231xex31d2.htm kbnt-20211231xex32d1.htm kbnt-20211231x10k001.jpg http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true JSON 82 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kbnt-20211231x10k.htm": { "axisCustom": 0, "axisStandard": 30, "contextCount": 193, "dts": { "calculationLink": { "local": [ "kbnt-20211231_cal.xml" ] }, "definitionLink": { "local": [ "kbnt-20211231_def.xml" ] }, "inline": { "local": [ "kbnt-20211231x10k.htm" ] }, "labelLink": { "local": [ "kbnt-20211231_lab.xml" ] }, "presentationLink": { "local": [ "kbnt-20211231_pre.xml" ] }, "schema": { "local": [ "kbnt-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 640, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2021-01-31": 15, "http://xbrl.sec.gov/dei/2021q4": 7, "total": 22 }, "keyCustom": 120, "keyStandard": 294, "memberCustom": 51, "memberStandard": 40, "nsprefix": "kbnt", "nsuri": "http://www.kubient.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00090 - Document - Document and Entity Information", "role": "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10301 - Disclosure - BUSINESS COMBINATION", "role": "http://www.kubient.com/role/DisclosureBusinessCombination", "shortName": "BUSINESS COMBINATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10401 - Disclosure - INTANGIBLE ASSETS", "role": "http://www.kubient.com/role/DisclosureIntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10501 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10601 - Disclosure - INCOME TAXES", "role": "http://www.kubient.com/role/DisclosureIncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10701 - Disclosure - NOTES PAYABLE", "role": "http://www.kubient.com/role/DisclosureNotesPayable", "shortName": "NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10801 - Disclosure - STOCKHOLDERS' EQUITY", "role": "http://www.kubient.com/role/DisclosureStockholdersEquity", "shortName": "STOCKHOLDERS' EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10901 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.kubient.com/role/DisclosureCommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11001 - Disclosure - CONCENTRATIONS", "role": "http://www.kubient.com/role/DisclosureConcentrations", "shortName": "CONCENTRATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "11101 - Disclosure - SUBSEQUENT EVENTS", "role": "http://www.kubient.com/role/DisclosureSubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00100 - Statement - Consolidated Balance Sheets", "role": "http://www.kubient.com/role/StatementConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "20202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30303 - Disclosure - BUSINESS COMBINATION (Tables)", "role": "http://www.kubient.com/role/DisclosureBusinessCombinationTables", "shortName": "BUSINESS COMBINATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30403 - Disclosure - INTANGIBLE ASSETS (Tables)", "role": "http://www.kubient.com/role/DisclosureIntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30503 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30603 - Disclosure - INCOME TAXES (Tables)", "role": "http://www.kubient.com/role/DisclosureIncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "30803 - Disclosure - STOCKHOLDERS' EQUITY (Tables)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityTables", "shortName": "STOCKHOLDERS' EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "31003 - Disclosure - CONCENTRATIONS (Tables)", "role": "http://www.kubient.com/role/DisclosureConcentrationsTables", "shortName": "CONCENTRATIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EnergyMarketingContractLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Revenue Recognition (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EnergyMarketingContractLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueRemainingPerformanceObligation", "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Performance Obligation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueRemainingPerformanceObligation", "p", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueRemainingPerformanceObligation", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_nD30VyglaE-yxxE-iMnjYQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00105 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://www.kubient.com/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesIssued", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "kbnt:ReceivableAndPayablePolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable and Accounts Payable (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesAccountsReceivableAndAccountsPayableDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable and Accounts Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "kbnt:ReceivableAndPayablePolicyPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40204 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPropertyAndEquipmentDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ComputerSoftwareIntangibleAssetMember_I98Pob58CkCViq3X6_uDHw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40205 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_ComputerSoftwareIntangibleAssetMember_I98Pob58CkCViq3X6_uDHw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "us-gaap:AdvertisingCostsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AdvertisingExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40206 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Advertising Costs (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesAdvertisingCostsDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Advertising Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:AdvertisingCostsPolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AdvertisingExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40207 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)", "role": "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "shortName": "SIGNIFICANT ACCOUNTING POLICIES - Net Loss Per Common Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40301 - Disclosure - BUSINESS COMBINATION - Purchase consideration (Details)", "role": "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "shortName": "BUSINESS COMBINATION - Purchase consideration (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_11_30_2021_To_11_30_2021_us-gaap_BusinessAcquisitionAxis_kbnt_MediacrossingIncMember_2--qrr76zEmpbcuvVsv5iQ", "decimals": "0", "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_11_30_2021_us-gaap_BusinessAcquisitionAxis_kbnt_MediacrossingIncMember_EZQ0ZtqVI0uziowhxCSERA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40302 - Disclosure - BUSINESS COMBINATION - Debt-free net working capital (Details)", "role": "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails", "shortName": "BUSINESS COMBINATION - Debt-free net working capital (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_11_30_2021_us-gaap_BusinessAcquisitionAxis_kbnt_MediacrossingIncMember_EZQ0ZtqVI0uziowhxCSERA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_us-gaap_BusinessAcquisitionAxis_kbnt_MediacrossingIncMember_5-FHYIWQfESK5cE-ZVN01Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40303 - Disclosure - BUSINESS COMBINATION - Pro Forma Information (Details)", "role": "http://www.kubient.com/role/DisclosureBusinessCombinationProFormaInformationDetails", "shortName": "BUSINESS COMBINATION - Pro Forma Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_us-gaap_BusinessAcquisitionAxis_kbnt_MediacrossingIncMember_5-FHYIWQfESK5cE-ZVN01Q", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_nD30VyglaE-yxxE-iMnjYQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40304 - Disclosure - BUSINESS COMBINATION - Additional information (Details)", "role": "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "shortName": "BUSINESS COMBINATION - Additional information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_11_30_2021_To_11_30_2021_us-gaap_BusinessAcquisitionAxis_kbnt_MediacrossingIncMember_2--qrr76zEmpbcuvVsv5iQ", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40401 - Disclosure - INTANGIBLE ASSETS (Details)", "role": "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails", "shortName": "INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_6_4_2021_To_6_4_2021_us-gaap_AssetAcquisitionAxis_kbnt_AdvisioSolutionsLlcMember_gjKX3ZhaxkeMqMXvuploQQ", "decimals": "0", "lang": null, "name": "us-gaap:PaymentsToAcquireProductiveAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00200 - Statement - Consolidated Statements of Operations", "role": "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40402 - Disclosure - INTANGIBLE ASSETS - Intangible assets consist (Details)", "role": "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails", "shortName": "INTANGIBLE ASSETS - Intangible assets consist (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2020_vwD-IL4d80CcthDY9drsnw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40403 - Disclosure - INTANGIBLE ASSETS - Amortization of intangible assets consists (Details)", "role": "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "shortName": "INTANGIBLE ASSETS - Amortization of intangible assets consists (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "lang": null, "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40404 - Disclosure - INTANGIBLE ASSETS - Future amortization expense (Details)", "role": "http://www.kubient.com/role/DisclosureIntangibleAssetsFutureAmortizationExpenseDetails", "shortName": "INTANGIBLE ASSETS - Future amortization expense (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedBonusesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40501 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)", "role": "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails", "shortName": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedBonusesCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredFederalIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40601 - Disclosure - INCOME TAXES - Provision for income taxes (Details)", "role": "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails", "shortName": "INCOME TAXES - Provision for income taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredFederalIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_-kH4lM3Lx0qh6T9ToTyG0Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40602 - Disclosure - INCOME TAXES - Statutory federal income tax rates (Details)", "role": "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails", "shortName": "INCOME TAXES - Statutory federal income tax rates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_-kH4lM3Lx0qh6T9ToTyG0Q", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40603 - Disclosure - INCOME TAXES - Deferred tax assets relate to temporary differences and carryforwards (Details)", "role": "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails", "shortName": "INCOME TAXES - Deferred tax assets relate to temporary differences and carryforwards (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "kbnt:FederalNetOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40604 - Disclosure - INCOME TAXES - (Details)", "role": "http://www.kubient.com/role/DisclosureIncomeTaxesDetails", "shortName": "INCOME TAXES - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "kbnt:FederalNetOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "kbnt:NotesPayablePastDueAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40701 - Disclosure - NOTES PAYABLE - (Details)", "role": "http://www.kubient.com/role/DisclosureNotesPayableDetails", "shortName": "NOTES PAYABLE - (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "kbnt:NotesPayablePastDueAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_8_14_2020_NJcGo8S5bkWKv0TizFsqrg", "decimals": "0", "first": true, "lang": null, "name": "kbnt:DebtConversionAccruedInterestOnOriginalDebtAmount", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40703 - Disclosure - NOTES PAYABLE - Note Payable to Related Parties (Details)", "role": "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails", "shortName": "NOTES PAYABLE - Note Payable to Related Parties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_8_14_2020_To_8_14_2020_us-gaap_SubsidiarySaleOfStockAxis_us-gaap_IPOMember_fIjA1Hr6l0qGQXXf_42nIA", "decimals": "-5", "lang": null, "name": "kbnt:NetProceedsFromIssuanceOfUnits", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_4nQqAeC8d0Cf7r6nUXOLBA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00300 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency)", "role": "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency", "shortName": "Consolidated Statements of Changes in Stockholders' Equity (Deficiency)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2019_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember_4nQqAeC8d0Cf7r6nUXOLBA", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_8_14_2020_NJcGo8S5bkWKv0TizFsqrg", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_nD30VyglaE-yxxE-iMnjYQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40704 - Disclosure - NOTES PAYABLE - Convertible Notes Payable (Details)", "role": "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "shortName": "NOTES PAYABLE - Convertible Notes Payable (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_8_14_2020_NJcGo8S5bkWKv0TizFsqrg", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_nD30VyglaE-yxxE-iMnjYQ", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "span", "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40801 - Disclosure - STOCKHOLDERS' EQUITY (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "shortName": "STOCKHOLDERS' EQUITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "lang": "en-US", "name": "us-gaap:CommonStockVotingRights", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40802 - Disclosure - STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails", "shortName": "STOCKHOLDERS' EQUITY - Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingAndMarketingExpenseMember_vB3z1xEAeUK_-sUORyB5qw", "decimals": "0", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_eA7iF2sKdE6l2UAU-vOtuw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40803 - Disclosure - STOCKHOLDERS' EQUITY - Black-Scholes Option Pricing Model to Stock Options Granted (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails", "shortName": "STOCKHOLDERS' EQUITY - Black-Scholes Option Pricing Model to Stock Options Granted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2020_To_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_eA7iF2sKdE6l2UAU-vOtuw", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_oC0coLvjW0SvH34fcC1t7g", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40804 - Disclosure - STOCKHOLDERS' EQUITY - Company's stock option activity (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails", "shortName": "STOCKHOLDERS' EQUITY - Company's stock option activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2020_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember_oC0coLvjW0SvH34fcC1t7g", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember__YGVKRr1g0q0goAnNrFgqA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40805 - Disclosure - STOCKHOLDERS' EQUITY - Schedule of Information Related to Stock Options (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails", "shortName": "STOCKHOLDERS' EQUITY - Schedule of Information Related to Stock Options (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_us-gaap_AwardTypeAxis_us-gaap_EmployeeStockOptionMember__YGVKRr1g0q0goAnNrFgqA", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_us-gaap_StatementEquityComponentsAxis_us-gaap_WarrantMember_x8dUAmnyLUq_siVZC-j3UQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_-kH4lM3Lx0qh6T9ToTyG0Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40806 - Disclosure - STOCKHOLDERS' EQUITY - Estimation of fair value of warrants (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails", "shortName": "STOCKHOLDERS' EQUITY - Estimation of fair value of warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2020_srt_RangeAxis_srt_MinimumMember_us-gaap_MeasurementInputTypeAxis_us-gaap_MeasurementInputExpectedTermMember_us-gaap_StatementEquityComponentsAxis_us-gaap_WarrantMember_x8dUAmnyLUq_siVZC-j3UQ", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_-kH4lM3Lx0qh6T9ToTyG0Q", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleOfWarrantsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2020_vwD-IL4d80CcthDY9drsnw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40807 - Disclosure - STOCKHOLDERS' EQUITY - Warrant Activity (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails", "shortName": "STOCKHOLDERS' EQUITY - Warrant Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleOfWarrantsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "lang": null, "name": "kbnt:ClassOfWarrantOrRightWarrantsIssued", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_shares_0osiH-LOzkqPY5A9CCqxuA", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "kbnt:ScheduleOfWarrantsActivityTableTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "2", "first": true, "lang": null, "name": "kbnt:ClassOfWarrantOrRightWarrantsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unitRef": "Unit_Divide_USD_shares_nD30VyglaE-yxxE-iMnjYQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40808 - Disclosure - STOCKHOLDERS' EQUITY - Stock Warrants (Details)", "role": "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails", "shortName": "STOCKHOLDERS' EQUITY - Stock Warrants (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_kbnt_WarrantsExercisePriceOneMember_vqJaLrDD7UuO6NOWBh1bLg", "decimals": "2", "lang": null, "name": "kbnt:ClassOfWarrantOrRightWarrantsOutstandingWeightedAverageExercisePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_Divide_USD_shares_nD30VyglaE-yxxE-iMnjYQ", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2020_To_12_31_2020_8BCuF8q5EkmrroMEksu7kw", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RepaymentsOfNotesPayable", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40902 - Disclosure - COMMITMENTS AND CONTINGENCIES - Settlements (Details)", "role": "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Settlements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_11_14_2018_To_11_14_2018_srt_LitigationCaseAxis_kbnt_EngageBdrLlcMember_NgxFjnbs2kGf8Bx0XdAfxA", "decimals": "0", "lang": null, "name": "us-gaap:LossContingencyDamagesSoughtValue", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "link:footnote", "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "kbnt:GrossProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00305 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical)", "role": "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiencyParenthetical", "shortName": "Consolidated Statements of Changes in Stockholders' Equity (Deficiency) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2020_To_12_31_2020_8BCuF8q5EkmrroMEksu7kw", "decimals": "0", "lang": null, "name": "kbnt:GrossProceedsFromIssuanceOfCommonStockAndWarrantsInFollowOnPublicOffering", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_4_9_2021_To_4_9_2021_srt_TitleOfIndividualAxis_kbnt_ChiefProductOfficerMember_eOJChjUeR0CpLNc-hokGwg", "decimals": "0", "first": true, "lang": null, "name": "kbnt:AnnualBaseSalary", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "40903 - Disclosure - COMMITMENTS AND CONTINGENCIES - Employment Agreements (Details)", "role": "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - Employment Agreements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_4_9_2021_To_4_9_2021_srt_TitleOfIndividualAxis_kbnt_ChiefProductOfficerMember_eOJChjUeR0CpLNc-hokGwg", "decimals": "0", "first": true, "lang": null, "name": "kbnt:AnnualBaseSalary", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "As_Of_12_31_2021_UQEVNTK-C0uAZHogXcZ57A", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41001 - Disclosure - CONCENTRATIONS - Customer Concentrations (Details)", "role": "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "shortName": "CONCENTRATIONS - Customer Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_srt_MajorCustomersAxis_kbnt_CustomerMember_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_RevenueFromContractWithCustomerMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_CustomerConcentrationRiskMember_HqA3UMaSlEiHBkB5PGGWxA", "decimals": "4", "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_-kH4lM3Lx0qh6T9ToTyG0Q", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2020_To_12_31_2020_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_CostOfGoodsProductLineMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_kbnt_SupplierBMember_m4R53zalnESa9nDeZjRLZw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_-kH4lM3Lx0qh6T9ToTyG0Q", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41002 - Disclosure - CONCENTRATIONS - Supplier Concentrations (Details)", "role": "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails", "shortName": "CONCENTRATIONS - Supplier Concentrations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "ix:continuation", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2020_To_12_31_2020_us-gaap_ConcentrationRiskByBenchmarkAxis_us-gaap_CostOfGoodsProductLineMember_us-gaap_ConcentrationRiskByTypeAxis_us-gaap_SupplierConcentrationRiskMember_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_kbnt_SupplierBMember_m4R53zalnESa9nDeZjRLZw", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_pure_-kH4lM3Lx0qh6T9ToTyG0Q", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GainLossRelatedToLitigationSettlement", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "41101 - Disclosure - SUBSEQUENT EVENTS (Details)", "role": "http://www.kubient.com/role/DisclosureSubsequentEventsDetails", "shortName": "SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_srt_LitigationCaseAxis_kbnt_AureusHoldingsLlcDBLo70sMember_us-gaap_LitigationStatusAxis_us-gaap_SettledLitigationMember_kWLwHt_V5EayWahtket9RQ", "decimals": "0", "lang": null, "name": "us-gaap:GainLossRelatedToLitigationSettlement", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00400 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "link:footnote", "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "first": true, "lang": null, "name": "kbnt:GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants", "reportCount": 1, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00405 - Statement - Condensed Consolidated Statements of Cash Flows (Parenthetical)", "role": "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical", "shortName": "Condensed Consolidated Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "link:footnote", "p", "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": "0", "lang": null, "name": "kbnt:PaymentsOfOfferingCostsForIssuanceOfConvertibleNotesPayableAndInvestorWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_Standard_USD_0G2akeShvEuCPc7dCxlHxQ", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "10101 - Disclosure - BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES", "role": "http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertainties", "shortName": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "kbnt-20211231x10k.htm", "contextRef": "Duration_1_1_2021_To_12_31_2021_56yYP6ottkWN1g40I-dOtg", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 96, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r523", "r524", "r525" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r523", "r524", "r525" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r523", "r524", "r525" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Document and Entity Information [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r523", "r524", "r525" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r526" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Adress Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r523", "r524", "r525" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "kbnt_AccountsPayableSupplierCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable to supplier for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Supplier, Current", "terseLabel": "Accounts payable - suppliers" } } }, "localname": "AccountsPayableSupplierCurrent", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "kbnt_AccrualOfFollowOnOfferingDeferredOfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The accrual of follow-on offering deferred offering costs.", "label": "Accrual of Follow-on Offering Deferred Offering Costs", "verboseLabel": "Accrual of follow-on offering deferred offering costs" } } }, "localname": "AccrualOfFollowOnOfferingDeferredOfferingCosts", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_AccrualOfWarrantExerciseIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrual of warrant exercise issuance costs in a noncash financing activities.", "label": "Accrual of Warrant Exercise Issuance Costs", "terseLabel": "Accrual of warrant exercise issuance costs" } } }, "localname": "AccrualOfWarrantExerciseIssuanceCosts", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedAndOtherLiabilitiesCurrentOtherThanInterestPayable": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other other than interest payable. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued And Other Liabilities, Current, Other Than Interest Payable", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "AccruedAndOtherLiabilitiesCurrentOtherThanInterestPayable", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedCommissions": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 8.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued commissions.", "label": "Accrued Commissions", "terseLabel": "Accrued commissions" } } }, "localname": "AccruedCommissions", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of total accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities", "totalLabel": "Total accrued expenses and other current liabilities" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedExpensesAndOtherCurrentLiabilitiesOthers": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other accrued expenses and other current liabilities.", "label": "Accrued Expenses And Other Current Liabilities, Others", "terseLabel": "Other" } } }, "localname": "AccruedExpensesAndOtherCurrentLiabilitiesOthers", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedIssuableEquity": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 5.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued issuable equity.", "label": "Accrued Issuable Equity", "terseLabel": "Accrued issuable equity" } } }, "localname": "AccruedIssuableEquity", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedMediaCommissions": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 9.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued media commissions.", "label": "Accrued Media Commissions", "terseLabel": "Accrued media commissions" } } }, "localname": "AccruedMediaCommissions", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedPayroll": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 3.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll", "terseLabel": "Accrued payroll" } } }, "localname": "AccruedPayroll", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedProgrammingExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 4.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued programming expenses payable.", "label": "Accrued Programming Expenses", "terseLabel": "Accrued programming expenses" } } }, "localname": "AccruedProgrammingExpenses", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedSupplierExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 11.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accrued supplier expenses.", "label": "Accrued Supplier Expenses", "terseLabel": "Accrued supplier expenses" } } }, "localname": "AccruedSupplierExpenses", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccruedWarrantExerciseIssuanceCostsCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for warrant exercise issuance costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Warrant Exercise Issuance Costs, Current", "terseLabel": "Accrued warrant exercise costs" } } }, "localname": "AccruedWarrantExerciseIssuanceCostsCurrent", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AccumulatedAmortizationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Accumulated Amortization.", "label": "Accumulated Amortization" } } }, "localname": "AccumulatedAmortizationMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails" ], "xbrltype": "domainItemType" }, "kbnt_AcquiredDataMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to acquired data.", "label": "Acquired data" } } }, "localname": "AcquiredDataMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails" ], "xbrltype": "domainItemType" }, "kbnt_AcquiredSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to acquired software.", "label": "Acquired software" } } }, "localname": "AcquiredSoftwareMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails" ], "xbrltype": "domainItemType" }, "kbnt_AdditionalSharesOfCommonStockAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional Shares Of Common Stock Acquired", "label": "Additional Shares Of Common Stock Acquired" } } }, "localname": "AdditionalSharesOfCommonStockAcquired", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "kbnt_AdjustmentsToAdditionalPaidInCapitalAccruedExpensesByRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from forgiveness of accrued expenses by related party.", "label": "Adjustments to Additional Paid in Capital, Accrued Expenses by Related Party", "terseLabel": "Forgiveness of accrued expenses by related party" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalAccruedExpensesByRelatedParty", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "kbnt_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsReversalOfEarlierPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of adjustment in additional paid in capital (APIC) resulting from reversal of stock issuance costs associated with issuing stock as non cash or part non cash transaction.", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs, Reversal of Earlier Payments", "terseLabel": "Reduction of additional paid-in capital for initial public offering issuance costs that were previously paid" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsReversalOfEarlierPayments", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_AdjustmentsToAdditionalPaidInCapitalWarrantExercise": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the exercise of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Adjustments To Additional Paid In Capital Warrant Exercise", "verboseLabel": "Exercise of warrant" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantExercise", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "kbnt_AdvisioSolutionsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to Advisio Solutions, LLC.", "label": "Advisio Solutions, LLC" } } }, "localname": "AdvisioSolutionsLlcMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "kbnt_AmortizationOfBeneficialConversionFeatureOnConvertibleDebt": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to amortization of beneficial conversion feature on debt instrument.", "label": "Amortization of Beneficial Conversion Feature on Convertible Debt", "negatedLabel": "Amortization of beneficial conversion feature", "terseLabel": "Amortization of beneficial conversion feature" } } }, "localname": "AmortizationOfBeneficialConversionFeatureOnConvertibleDebt", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_AmortizationOfDebtIssuanceCostsAndDiscountsRelatedParties": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs in connection with related parties.", "label": "Amortization of Debt Issuance Costs and Discounts, Related Parties", "terseLabel": "Amortization of debt discount and debt issuance costs - related parties" } } }, "localname": "AmortizationOfDebtIssuanceCostsAndDiscountsRelatedParties", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_AmortizationOfDebtIssuanceCostsRelatedParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs on a debt or other obligation to related party.", "label": "Amortization Of Debt Issuance Costs, Related Party", "terseLabel": "Non-cash amortization of debt discount and debt issuance costs - related parties" } } }, "localname": "AmortizationOfDebtIssuanceCostsRelatedParty", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AmountAccruedForCashPayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount outstanding for cash settlement.", "label": "Amount Accrued For Cash Payment", "terseLabel": "Amount accrued for cash payment" } } }, "localname": "AmountAccruedForCashPayment", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AmountPayableOnTerminationForAgreedPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount payable on termination for agreed period.", "label": "Amount Payable on Termination for Agreed Period", "terseLabel": "Amount payable upon termination" } } }, "localname": "AmountPayableOnTerminationForAgreedPeriod", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AnnualBaseSalary": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the annual base salary to employee.", "label": "Annual Base Salary", "terseLabel": "Annual base salary" } } }, "localname": "AnnualBaseSalary", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.", "label": "Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable, Shares", "terseLabel": "Aggregate shares of common stock shares issued as a part of consideration" } } }, "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuableShares", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "sharesItemType" }, "kbnt_AureusHoldingsLlcDBLo70sMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Aureus Holdings, LLC d/b/a Lo70s.", "label": "Aureus Holdings, LLC d/b/a Lo70s" } } }, "localname": "AureusHoldingsLlcDBLo70sMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "kbnt_BusinessCombinationFairValueOfIdentifiedNetAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value of Identified Net Assets at the acquisition date.", "label": "Business Combination, Fair Value Of Identified Net Assets", "totalLabel": "Fair Value of Identified Net Assets" } } }, "localname": "BusinessCombinationFairValueOfIdentifiedNetAssets", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherCurrentLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Accrued Expenses And Other Current Liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accrued Expenses And Other Current Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpensesAndOtherCurrentLiabilities", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_CapitalizedSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to capitalized software.", "label": "Capitalized Software" } } }, "localname": "CapitalizedSoftwareMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CashPaymentForSettlementAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash payment for Settlement Agreement.", "label": "Cash Payment For Settlement Agreement", "terseLabel": "Cash payment" } } }, "localname": "CashPaymentForSettlementAgreement", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_ChiefProductOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Person with designation of chief product officer.", "label": "Mr. Leon Zemel" } } }, "localname": "ChiefProductOfficerMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ChiefTechnologyOfficerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Person with designation of Chief Technology Officer", "label": "Mitchell Berg" } } }, "localname": "ChiefTechnologyOfficerMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ClassOfWarrantOrRightNumberOfWarrantsExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants exercisable in to shares of common stock.", "label": "Class of Warrant or Right, Number of Warrants Exercisable", "terseLabel": "Number of warrants exercisable (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfWarrantsExercisable", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "kbnt_ClassOfWarrantOrRightPriceOfWarrantsOrRights": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single warrant.", "label": "Class Of Warrant Or Right Price Of Warrants Or Rights", "terseLabel": "Price per warrant" } } }, "localname": "ClassOfWarrantOrRightPriceOfWarrantsOrRights", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "kbnt_ClassOfWarrantOrRightWarrantsExercisableNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially exercised warrants outstanding as of the balance sheet date can be currently converted.", "label": "Class of Warrant or Right, Warrants, Exercisable Number", "terseLabel": "Exercisable (in shares)", "verboseLabel": "Exercisable number of warrants (in shares)" } } }, "localname": "ClassOfWarrantOrRightWarrantsExercisableNumber", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "kbnt_ClassOfWarrantOrRightWarrantsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on warrants outstanding and currently exercisable.", "label": "Class of Warrant or Right, Warrants, Exercisable, Weighted Average Exercise Price", "terseLabel": "Exercisable (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightWarrantsExercisableWeightedAverageExercisePrice", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "kbnt_ClassOfWarrantOrRightWarrantsExercisableWeightedAverageRemainingLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for exercised portions of warrants outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Class of Warrant or Right, Warrants, Exercisable, Weighted Average Remaining Life", "terseLabel": "Weighted Average Remaining Life, Exercisable (in years)" } } }, "localname": "ClassOfWarrantOrRightWarrantsExercisableWeightedAverageRemainingLife", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "kbnt_ClassOfWarrantOrRightWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants exercised during the period.", "label": "Class of Warrant or Right, Warrants, Exercised", "terseLabel": "Exercised (in shares)", "verboseLabel": "Warrants exercised" } } }, "localname": "ClassOfWarrantOrRightWarrantsExercised", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "kbnt_ClassOfWarrantOrRightWarrantsExercisedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which warrant holders acquired shares when converting their warrants into shares.", "label": "Class of Warrant or Right, Warrants, Exercised, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)", "verboseLabel": "Exercise price of warrants exercised" } } }, "localname": "ClassOfWarrantOrRightWarrantsExercisedWeightedAverageExercisePrice", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "kbnt_ClassOfWarrantOrRightWarrantsIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of warrants issued during the period.", "label": "Class of Warrant or Right, Warrants, Issued", "terseLabel": "Issued (in shares)" } } }, "localname": "ClassOfWarrantOrRightWarrantsIssued", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "kbnt_ClassOfWarrantOrRightWarrantsIssuedWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants.", "label": "Class of Warrant or Right, Warrants, Issued, Weighted Average Exercise Price", "terseLabel": "Issued (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightWarrantsIssuedWeightedAverageExercisePrice", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "kbnt_ClassOfWarrantOrRightWarrantsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the warrants.", "label": "Class of Warrant or Right, Warrants, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding, end of the period (in dollars per share)", "periodStartLabel": "Outstanding, beginning of the period (in dollars per share)", "terseLabel": "Exercise Price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightWarrantsOutstandingWeightedAverageExercisePrice", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "kbnt_ClassOfWarrantOrRightWarrantsOutstandingWeightedAverageRemainingLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for warrants outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Class of Warrant or Right, Warrants, Outstanding, Weighted Average Remaining Life", "terseLabel": "Weighted Average Remaining Life, Outstanding (in years)" } } }, "localname": "ClassOfWarrantOrRightWarrantsOutstandingWeightedAverageRemainingLife", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "kbnt_ClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class Of Warrants Or Rights Number Of Securities Called By Warrants Or Right", "terseLabel": "Warrants to purchase shares of common stock" } } }, "localname": "ClassOfWarrantsOrRightsNumberOfSecuritiesCalledByWarrantsOrRight", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "kbnt_ContingentConsideration": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "\"\t\nAmount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.\"", "label": "Contingent Consideration", "terseLabel": "Contingent consideration" } } }, "localname": "ContingentConsideration", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_CreditCardPayable": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 7.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of credit card payable.", "label": "Credit Card Payable", "terseLabel": "Credit card payable" } } }, "localname": "CreditCardPayable", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_CustomerBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer B.", "label": "Customer B" } } }, "localname": "CustomerBMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerContractsAndRelatedCustomerRelationshipsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer contracts and related customer relationships.", "label": "Customer contracts and related customer relationships" } } }, "localname": "CustomerContractsAndRelatedCustomerRelationshipsMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer D.", "label": "Customer D" } } }, "localname": "CustomerDMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer E.", "label": "Customer E" } } }, "localname": "CustomerEMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer F.", "label": "Customer F" } } }, "localname": "CustomerFMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Customer G.", "label": "Customer G" } } }, "localname": "CustomerGMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_CustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for customer A.", "label": "Customer A" } } }, "localname": "CustomerMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_DebtConversionAccruedInterestOnOriginalDebtAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the accrued interest on original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Accrued Interest On Original Debt, Amount", "terseLabel": "Accrued interest of notes payable converted to common stock", "verboseLabel": "Aggregate accrued interest" } } }, "localname": "DebtConversionAccruedInterestOnOriginalDebtAmount", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_DebtInstrumentConvertibleBeneficialConversionFeatureExpenseForRecognition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for recognition of favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion.", "label": "Debt Instrument, Convertible, Beneficial Conversion Feature, Expense For Recognition", "terseLabel": "Expense in associated with recognition of a beneficial conversion feature" } } }, "localname": "DebtInstrumentConvertibleBeneficialConversionFeatureExpenseForRecognition", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_DeferredTaxAssetsAccruedLegalSettlement": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Deferred tax assets accrued legal settlement.", "label": "Deferred Tax Assets Accrued Legal Settlement", "terseLabel": "Accrued Legal Settlement" } } }, "localname": "DeferredTaxAssetsAccruedLegalSettlement", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_DeferredTaxAssetsOtherReserve": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from Other reserve.", "label": "Deferred Tax Assets, Other Reserve", "terseLabel": "Other reserve" } } }, "localname": "DeferredTaxAssetsOtherReserve", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_DeferredTaxAssetsTaxCredits": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from tax credits.", "label": "Deferred Tax Assets, Tax Credits", "terseLabel": "Tax credits" } } }, "localname": "DeferredTaxAssetsTaxCredits", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_DeferredTaxLiabilitiesFixedAssets": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from fixed assets.", "label": "Deferred Tax Liabilities, Fixed Assets", "negatedLabel": "Fixed assets" } } }, "localname": "DeferredTaxLiabilitiesFixedAssets", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_EconomicInjuryDisasterLoanCaresActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Economic Injury Disaster Loan under CARES Act.", "label": "EIDL Loan" } } }, "localname": "EconomicInjuryDisasterLoanCaresActMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "kbnt_EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails": { "order": 3.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to Permanent differences.", "label": "Effective Income Tax Rate Reconciliation, Permanent Differences, Percent", "terseLabel": "Permanent differences" } } }, "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails" ], "xbrltype": "percentItemType" }, "kbnt_EffectiveIncomeTaxRateReconciliationTrueUpPercent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails": { "order": 5.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to True-up.", "label": "Effective Income Tax Rate Reconciliation, True-up, Percent", "terseLabel": "True-up" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTrueUpPercent", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails" ], "xbrltype": "percentItemType" }, "kbnt_EmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to employees.", "label": "Employees" } } }, "localname": "EmployeesMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_EmploymentAgreementTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employment Agreement Term", "label": "Employment Agreement Term", "terseLabel": "Employment Agreement Term" } } }, "localname": "EmploymentAgreementTerm", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "durationItemType" }, "kbnt_EmploymentAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employment Agreements [Member]", "label": "Employment Agreements" } } }, "localname": "EmploymentAgreementsMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "domainItemType" }, "kbnt_EngageBdrLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Engage BDR, LLC.", "label": "Engage BDR, LLC" } } }, "localname": "EngageBdrLlcMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ExercisePriceRangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Four [Member]", "label": "Exercise Price $33.75" } } }, "localname": "ExercisePriceRangeFourMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ExercisePriceRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range One [Member]", "label": "Exercise Price $2.81" } } }, "localname": "ExercisePriceRangeOneMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ExercisePriceRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Three [Member]", "label": "Exercise Price $4.95" } } }, "localname": "ExercisePriceRangeThreeMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ExercisePriceRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Two [Member]", "label": "Exercise Price $2.97" } } }, "localname": "ExercisePriceRangeTwoMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "domainItemType" }, "kbnt_FairValueOfStockOptionsAndWarrantsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value of stock options and warrants.", "label": "Fair Value of Stock Options and Warrants, Policy [Policy Text Block]", "terseLabel": "Fair Value of Stock Options and Warrants" } } }, "localname": "FairValueOfStockOptionsAndWarrantsPolicyPolicyTextBlock", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "kbnt_FederalNetOperatingLossCarryforwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of federal net operating loss (\"NOL\") carryforwards, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Federal Net Operating Loss Carryforwards", "terseLabel": "Federal net operating loss (\"NOL\") carryforwards" } } }, "localname": "FederalNetOperatingLossCarryforwards", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_FederalNetOperatingLossHaveExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of federal net operating losses, have expiration.", "label": "Federal Net Operating Loss, Have Expiration", "terseLabel": "Federal net operating losses, have expiration" } } }, "localname": "FederalNetOperatingLossHaveExpiration", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_FederalNetOperatingLossHaveNoExpiration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of federal net operating losses, have no expiration.", "label": "Federal Net Operating Loss, Have No Expiration", "terseLabel": "Federal net operating losses, have no expiration" } } }, "localname": "FederalNetOperatingLossHaveNoExpiration", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_FederalResearchTaxCreditCarryforwards": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of federal research tax credit carryforwards", "label": "Federal Research Tax Credit Carryforwards", "terseLabel": "Federal research and development credit carryforwards" } } }, "localname": "FederalResearchTaxCreditCarryforwards", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_FinancedDirectorAndOfficerInsurancePremiums": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 14.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying amount as of the balance sheet date of financed director and officer insurance premiums, current.", "label": "Financed Director And Officer Insurance Premiums", "terseLabel": "Financed director and officer insurance premiums" } } }, "localname": "FinancedDirectorAndOfficerInsurancePremiums", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_FinancingOfInsurancePremiums": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of financing of insurance premiums under non cash investing and financing activities.", "label": "Financing Of Insurance Premiums", "terseLabel": "Financing of insurance premiums" } } }, "localname": "FinancingOfInsurancePremiums", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_FirstYearBonusOn12MonthAnniversaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to first year bonus on 12- month anniversary.", "label": "First year bonus on 12- month anniversary" } } }, "localname": "FirstYearBonusOn12MonthAnniversaryMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ForgivenessOfRelatedPartyLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The forgiveness of related party liability in a noncash or partial noncash transaction.", "label": "Forgiveness Of Related Party Liability", "terseLabel": "Forgiveness of related party liability" } } }, "localname": "ForgivenessOfRelatedPartyLiability", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_GainLossOnSettlementOfNotesAndOtherPayables": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of notes and other payables.", "label": "Gain (Loss) on Settlement of Notes and Other Payables", "verboseLabel": "Gain on settlement of notes and other payables, net" } } }, "localname": "GainLossOnSettlementOfNotesAndOtherPayables", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_GainLossesOnSettlementOfNotesAndOtherPayables": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of gain losses on settlement of notes and other payables.", "label": "Gain Losses On Settlement Of Notes And Other Payables", "negatedTerseLabel": "Gain on settlement of notes and other payables" } } }, "localname": "GainLossesOnSettlementOfNotesAndOtherPayables", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_GainOnForgivenessOfAccountsPayableSupplier": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of gain on forgiveness of accounts payable, supplier.", "label": "Gain On Forgiveness Of Accounts Payable, Supplier", "negatedLabel": "Gain on forgiveness of accounts payable - supplier", "terseLabel": "Gain on forgiveness of accounts payable - supplier" } } }, "localname": "GainOnForgivenessOfAccountsPayableSupplier", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_GeneralAndAdministrativeExpenseOtherThanTechnology": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line other than technology.", "label": "General and Administrative Expense Other Than Technology", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseOtherThanTechnology", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_GrantUnderEconomicInjuryDisasterLoanCaresActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for grant received under the Economic Injury Disaster Loan under CARES Act.", "label": "Grant under EIDL Loan" } } }, "localname": "GrantUnderEconomicInjuryDisasterLoanCaresActMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "kbnt_GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross cash inflow from issuance of convertible notes payable and investor warrants.", "label": "Gross Proceeds From Convertible Notes Payable and Investor Warrants", "terseLabel": "Gross proceeds from initial public offering" } } }, "localname": "GrossProceedsFromConvertibleNotesPayableAndInvestorWarrants", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_GrossProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross cash inflow associated with the amount received from entity's first offering of stock to the public, before deduction of offering costs.", "label": "Gross Proceeds from Issuance Initial Public Offering", "terseLabel": "Gross proceeds from initial public offering" } } }, "localname": "GrossProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiencyParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_GrossProceedsFromIssuanceOfCommonStockAndWarrantsInFollowOnPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross cash inflow from issuance of common stock and warrants in follow-on public offering", "label": "Gross Proceeds From Issuance of Common Stock and Warrants in Follow-on Public Offering", "verboseLabel": "Gross proceeds from Issuance of common stock and warrants in follow-on public offering" } } }, "localname": "GrossProceedsFromIssuanceOfCommonStockAndWarrantsInFollowOnPublicOffering", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiencyParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_GrossProceedsFromIssuanceOfSharesOnExerciseOfWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross cash inflow associated with the exercise of warrwnts, before deduction of offering costs.", "label": "Gross Proceeds From Issuance Of Shares On Exercise Of Warrants", "terseLabel": "Gross proceeds upon exercise of warrants" } } }, "localname": "GrossProceedsFromIssuanceOfSharesOnExerciseOfWarrants", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiencyParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_GrossProceedsFromSaleOfCommonStockAndWarrantsInFollowOnPublicOfferingNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The gross cash inflow from sale of common stock and warrants in follow-on public offering, net.", "label": "Gross Proceeds From Sale of Common Stock and Warrants in Follow-on Public Offering, Net", "verboseLabel": "Gross proceeds from sale of common stock and warrants in follow-on public offering, net" } } }, "localname": "GrossProceedsFromSaleOfCommonStockAndWarrantsInFollowOnPublicOfferingNet", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_HoldersOfNotesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to holders of notes payable.", "label": "Holders of notes payable" } } }, "localname": "HoldersOfNotesPayableMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "kbnt_IncreaseDecreaseInAccountsPayableSuppliers": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of supplies used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Suppliers", "terseLabel": "Accounts payable - suppliers" } } }, "localname": "IncreaseDecreaseInAccountsPayableSuppliers", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_InterestExpenseRelatedParties": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of Interest expense - related parties.", "label": "Interest Expense, Related Parties", "negatedLabel": "Interest expense - related parties" } } }, "localname": "InterestExpenseRelatedParties", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "kbnt_InterestExpenseRelatedPartyDebt": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for related party debt.", "label": "Interest Expense, Related Party Debt", "terseLabel": "Interest expense - related parties" } } }, "localname": "InterestExpenseRelatedPartyDebt", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_InvoicePaymentTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Invoice payment terms.", "label": "Invoice Payment Terms", "terseLabel": "Invoice payment terms" } } }, "localname": "InvoicePaymentTerms", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "durationItemType" }, "kbnt_IssuanceOfCommonStockAndWarrantsInFollowOnPublicOfferingSharesNetOfIssuanceCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information about issuance of common stock and warrants in follow-on public offering, shares, net of issuance costs.", "label": "Issuance of Common Stock and Warrants in follow-on Public Offering, Shares, Net of Issuance Costs", "verboseLabel": "Issuance of common stock and warrants in follow-on public offering, net of issuance costs (in shares)" } } }, "localname": "IssuanceOfCommonStockAndWarrantsInFollowOnPublicOfferingSharesNetOfIssuanceCosts", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "kbnt_IssuanceOfCommonStockAndWarrantsInFollowOnPublicOfferingValueNetOfIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents information about issuance of common stock and warrants in follow-on public offering, value, net of issuance costs.", "label": "Issuance of Common Stock and Warrants in follow-on Public Offering, Value, Net of Issuance Costs", "verboseLabel": "Issuance of common stock and warrants in follow-on public offering, net of issuance costs" } } }, "localname": "IssuanceOfCommonStockAndWarrantsInFollowOnPublicOfferingValueNetOfIssuanceCosts", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "kbnt_LossOnSettlementOfOtherPayables": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount represents the loss on settlement of other payables.", "label": "Loss On Settlement Of Other Payables", "verboseLabel": "Loss on settlement of other payables" } } }, "localname": "LossOnSettlementOfOtherPayables", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_MediacrossingIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for MediaCrossing Inc.", "label": "MediaCrossing Inc [Member]", "terseLabel": "MediaCrossing Inc" } } }, "localname": "MediacrossingIncMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationProFormaInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationTables" ], "xbrltype": "domainItemType" }, "kbnt_NetProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net cash inflow associated with the amount received from entity's first offering of stock to the public, before deduction of offering costs.", "label": "Net Proceeds From Issuance Initial Public Offering" } } }, "localname": "NetProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_NetProceedsFromIssuanceOfUnits": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net proceeds from sale of units.", "label": "Net Proceeds From Issuance Of Units" } } }, "localname": "NetProceedsFromIssuanceOfUnits", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_NonEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to non employees.", "label": "Non-employees" } } }, "localname": "NonEmployeesMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_NotesPayablePastDueAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of notes payable past due and classified as current by the company.", "label": "Notes Payable, Past Due, Amount", "terseLabel": "Notes payable past due and classified as current" } } }, "localname": "NotesPayablePastDueAmount", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_NotesPayableRelatedPartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Notes Payable - Related Parties.", "label": "Notes Payable - Related Parties" } } }, "localname": "NotesPayableRelatedPartiesMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "kbnt_NotesPayableRelatedPartiesNumberOfExecutiveOfficers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of executive officers, to whom the notes payable were issued by the company.", "label": "Notes Payable, Related Parties, Number Of Executive Officers", "terseLabel": "Number of executives to whom notes payable were issued" } } }, "localname": "NotesPayableRelatedPartiesNumberOfExecutiveOfficers", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "integerItemType" }, "kbnt_NumberOfEmployeesInShareBasedCompensationPlan": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of employees in a share based compensation plan.", "label": "Number of Employees in a Share Based Compensation Plan", "terseLabel": "Number of employees in a share based compensation plan" } } }, "localname": "NumberOfEmployeesInShareBasedCompensationPlan", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "integerItemType" }, "kbnt_NumberOfMemberOfBoardOfDirectorToWhomSharesWereIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of member of board of directors to whom shares were issued.", "label": "Number Of Member Of Board Of Director To Whom Shares Were Issued", "terseLabel": "Number of member of board of directors to whom shares were issued" } } }, "localname": "NumberOfMemberOfBoardOfDirectorToWhomSharesWereIssued", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "integerItemType" }, "kbnt_NumberOfMonthsForWhichTerminationCompensationWillPayAfterTermination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of months for which termination compensation will pay after termination.", "label": "Number of Months for Which Termination Compensation Will Pay After Termination", "terseLabel": "Number of months for which termination compensation will pay after termination" } } }, "localname": "NumberOfMonthsForWhichTerminationCompensationWillPayAfterTermination", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "durationItemType" }, "kbnt_NumberOfVicePresidentsInEmploymentAgreement": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of vice presidents in a employment agreement.", "label": "Number of Vice Presidents in a Employment Agreement", "terseLabel": "Number of vice presidents in a employment agreement" } } }, "localname": "NumberOfVicePresidentsInEmploymentAgreement", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "integerItemType" }, "kbnt_NumberOfWarrantsActivityRollForwardAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Number of Warrants, Activity, Roll Forward [Abstract]", "verboseLabel": "Number of Warrants" } } }, "localname": "NumberOfWarrantsActivityRollForwardAbstract", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "stringItemType" }, "kbnt_NumberOfWarrantsIssuedPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of warrants in a unit.", "label": "Number Of Warrants Issued Per Unit", "terseLabel": "Number of warrant to purchase share of common stock per unit" } } }, "localname": "NumberOfWarrantsIssuedPerUnit", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "kbnt_OriginalIssueDiscountInConnectionWithConvertibleNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of original issue discount in connection with convertible notes payable incurred during a noncash or partial noncash transaction.", "label": "Original Issue Discount In Connection With Convertible Notes Payable", "terseLabel": "Original issue discount in connection with convertible notes payable" } } }, "localname": "OriginalIssueDiscountInConnectionWithConvertibleNotesPayable", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_OriginalIssueDiscountInConnectionWithConvertibleNotesPayableRelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of original issue discount in connection with convertible notes payable of related parties incurred during a noncash or partial noncash transaction.", "label": "Original Issue Discount In Connection With Convertible Notes Payable, Related Parties", "terseLabel": "Original issue discount in connection with convertible notes payable - related party" } } }, "localname": "OriginalIssueDiscountInConnectionWithConvertibleNotesPayableRelatedParties", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_OutstandingLoanAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of loan payable due within one year or the operating cycle if longer.", "label": "Outstanding Loan Amount", "terseLabel": "Outstanding PPP loan" } } }, "localname": "OutstandingLoanAmount", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_PaycheckProtectionProgramLoanCaresActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Paycheck Protection Program Loan under CARES Act.", "label": "Paycheck Protection Program Loan" } } }, "localname": "PaycheckProtectionProgramLoanCaresActMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "kbnt_PaymentOfFollowOnPublicOfferingIssuanceCosts": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "It represents information about payment of follow-on public offering issuance costs.", "label": "Payment of Follow-on Public Offering Issuance Costs", "negatedLabel": "Payment of follow-on public offering issuance costs" } } }, "localname": "PaymentOfFollowOnPublicOfferingIssuanceCosts", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_PaymentsOfIssuanceCostsUponExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of payments of issuance costs upon exercise of warrants.", "label": "Payments Of Issuance Costs Upon Exercise Of Warrants", "terseLabel": "Issuance costs upon exercise of warrants" } } }, "localname": "PaymentsOfIssuanceCostsUponExerciseOfWarrants", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiencyParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_PaymentsOfIssuanceOfFollowOnPublicOffering": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of Issuance Of Follow On Public Offering", "label": "Payments of Issuance Of Follow On Public Offering", "verboseLabel": "Issuance costs on follow-on public offering" } } }, "localname": "PaymentsOfIssuanceOfFollowOnPublicOffering", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiencyParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_PaymentsOfOfferingCostsForIssuanceOfConvertibleNotesPayableAndInvestorWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from payments of offering costs for issuance of convertible notes payable and investor warrants.", "label": "Payments Of Offering Costs for Issuance of Convertible Notes Payable and Investor Warrants", "verboseLabel": "Payments of offering costs for initial public offering" } } }, "localname": "PaymentsOfOfferingCostsForIssuanceOfConvertibleNotesPayableAndInvestorWarrants", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_PaymentsOfOfferingCostsFromSaleOfCommonStockAndWarrantsInFollowOnPublicOfferingNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from payments of offering costs for sale of common stock and warrants in follow-on public offering, net", "label": "Payments Of Offering Costs From Sale of Common Stock and Warrants in Follow-on Public Offering, Net", "verboseLabel": "Payments of offering costs for sale of common stock and warrants in follow-on public offering, net" } } }, "localname": "PaymentsOfOfferingCostsFromSaleOfCommonStockAndWarrantsInFollowOnPublicOfferingNet", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "kbnt_PercentageOfAnnualPerformanceBonusesWithTargetAchievementOfBaseSalary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the percentage of annual performance bonuses with a target achievement of base salary.", "label": "Percentage of Annual Performance Bonuses With Target Achievement of Base Salary", "terseLabel": "Annual performance bonuses with a target achievement of base salary (as a percent)" } } }, "localname": "PercentageOfAnnualPerformanceBonusesWithTargetAchievementOfBaseSalary", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "percentItemType" }, "kbnt_PercentageOfTargetAward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The percentage of target awards by the grantee.", "label": "Percentage Of Target Award", "terseLabel": "Percentage of target award" } } }, "localname": "PercentageOfTargetAward", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "kbnt_PerformanceMarketingAmountInExcessHigherThresholdLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Performance marketing condition maximum threshold limit.", "label": "Performance Marketing Amount in Excess, Higher Threshold Limit", "terseLabel": "Performance marketing condition maximum threshold limit" } } }, "localname": "PerformanceMarketingAmountInExcessHigherThresholdLimit", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_PerformanceMarketingAmountInExcessLowerThresholdLimit": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Performance marketing condition minimum threshold limit.", "label": "Performance Marketing Amount in Excess, Lower Threshold Limit", "terseLabel": "Performance marketing condition minimum threshold limit" } } }, "localname": "PerformanceMarketingAmountInExcessLowerThresholdLimit", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_PeriodForContinuedHealthcareCoverage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the period for continued healthcare coverage.", "label": "Period For Continued Healthcare Coverage", "terseLabel": "Period for continued healthcare coverage" } } }, "localname": "PeriodForContinuedHealthcareCoverage", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "durationItemType" }, "kbnt_PeriodForEquityAwardsVestedAndExercisableAfterTermination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the period for equity awards vested and exercisable after termination.", "label": "Period For Equity Awards Vested And Exercisable After Termination", "terseLabel": "Period for equity awards vested and exercisable after termination" } } }, "localname": "PeriodForEquityAwardsVestedAndExercisableAfterTermination", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "durationItemType" }, "kbnt_PeriodForWhichEmployeeIsEntitledToReceiveSalary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the period for which employee is entitled to receive salary.", "label": "Period For Which Employee Is Entitled To Receive Salary", "terseLabel": "Period for which employee is entitled to receive salary" } } }, "localname": "PeriodForWhichEmployeeIsEntitledToReceiveSalary", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "durationItemType" }, "kbnt_Plan2017Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2017 plan.", "label": "2017 Plan" } } }, "localname": "Plan2017Member", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_Plan2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the information pertaining to Plan 2021", "label": "2021 Plan" } } }, "localname": "Plan2021Member", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ProceedsFromNotesPayableRelatedParties": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation in connection with related parties.", "label": "Proceeds from Notes Payable, Related Parties", "terseLabel": "Proceeds from issuance of notes payable - related parties", "verboseLabel": "Proceeds in connection with note payable" } } }, "localname": "ProceedsFromNotesPayableRelatedParties", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_ProceedsFromSaleOfCommonStockAndWarrantsInFollowOnPublicOfferingNet": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represents information about Proceeds from sale of common stock and warrants in follow-on public offering, net.", "label": "Proceeds from Sale of Common Stock and Warrants in Follow-on Public Offering, Net", "verboseLabel": "Proceeds from sale of common stock and warrants in follow-on public offering, net [3]" } } }, "localname": "ProceedsFromSaleOfCommonStockAndWarrantsInFollowOnPublicOfferingNet", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_ReceivableAndPayablePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivables and payables. Includes, but is not limited to, accounts receivable and financing receivable, accounts payable and financing payable.", "label": "Receivable and Payable, Policy [Policy Text Block]", "terseLabel": "Accounts Receivable and Accounts Payable" } } }, "localname": "ReceivableAndPayablePolicyPolicyTextBlock", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "kbnt_RepaymentOfFinancedDirectorAndOfficerInsurancePremiums": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt.", "label": "Repayment Of Financed Director And Officer Insurance Premiums", "negatedLabel": "Repayment of financed director and officer insurance premiums" } } }, "localname": "RepaymentOfFinancedDirectorAndOfficerInsurancePremiums", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_RestrictiveCovenantAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Restrictive covenant agreements.", "label": "Restrictive covenant agreements" } } }, "localname": "RestrictiveCovenantAgreementsMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ReversalOfDeferredOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of reversal of deferred offering costs previously incurred as expenses, as a part of non cash or part non cash transaction.", "label": "Reversal of Deferred Offering Costs", "terseLabel": "Reversal of previously accrued deferred offering costs" } } }, "localname": "ReversalOfDeferredOfferingCosts", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the accrued expenses and other current liabilities .", "label": "Schedule Accrued Expenses And Other Current Liabilities [Table Text Block]", "terseLabel": "Schedule of accrued expenses and other current liabilities" } } }, "localname": "ScheduleAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "kbnt_ScheduleOfWarrantsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants activity during the period.", "label": "Schedule of Warrants Activity [Table Text Block]", "terseLabel": "Summary of the warrant activity" } } }, "localname": "ScheduleOfWarrantsActivityTableTextBlock", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "kbnt_SecondYearBonusOn24MonthAnniversaryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to second year bonus on 24- month anniversary.", "label": "Second year bonus on 24- month anniversary" } } }, "localname": "SecondYearBonusOn24MonthAnniversaryMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ServiceProvidersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents information pertaining to service providers for employees and non-employee.", "label": "Service Providers" } } }, "localname": "ServiceProvidersMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_SettlementAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for settlement agreements.", "label": "Settlement Agreements" } } }, "localname": "SettlementAgreementsMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "domainItemType" }, "kbnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining vesting period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Remaining Vesting Period", "terseLabel": "Remaining vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "kbnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodTotalGrantDateFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the total fair value of Non- option equity instruments granted during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Non-Option Equity Instruments Grants In Period Total Grant Date Fair Value", "terseLabel": "Aggregate grant date fair value of award" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodTotalGrantDateFairValue", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrantDateFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the total fair value of options granted during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Total Grant Date Fair Value", "terseLabel": "Aggregate grant date fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodTotalGrantDateFairValue", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingOnNumberOfAnniversariesOfGrantDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of anniversaries of grant date on which share-based compensation awards vest.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Vesting On Number Of Anniversaries Of Grant Date", "terseLabel": "Number of vesting equity installments" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestingOnNumberOfAnniversariesOfGrantDate", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "integerItemType" }, "kbnt_ShareBasedCompensationRemainingSharesVested": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Remaining Shares Vested", "label": "Share Based Compensation Remaining Shares Vested", "verboseLabel": "Remaining shares vested" } } }, "localname": "ShareBasedCompensationRemainingSharesVested", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "kbnt_ShareBasedPaymentArrangementTrancheFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fourth portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Vesting if termination is after one year anniversary date of the agreement" } } }, "localname": "ShareBasedPaymentArrangementTrancheFourMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SharesIssuedAsPartialConsiderationForIntangibleAsset": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Shares issued as partial consideration for intangible asset in a noncash financing activities.", "label": "Shares Issued as Partial Consideration for Intangible Asset", "terseLabel": "Shares issued as partial consideration for intangible asset" } } }, "localname": "SharesIssuedAsPartialConsiderationForIntangibleAsset", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_SharesIssuedSharesUponExerciseOfWarrantsNetOfIssuanceCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued upon exercise of warrants, net of issuance costs .", "label": "Shares Issued Shares Upon Exercise Of Warrants Net Of Issuance Costs", "terseLabel": "Shares issued upon exercise of warrants, net of issuance costs (in shares)" } } }, "localname": "SharesIssuedSharesUponExerciseOfWarrantsNetOfIssuanceCosts", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "kbnt_SharesIssuedValueUponExerciseOfWarrantsNetOfIssuanceCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of value of shares issued upon exercise of warrants, net of issuance costs.", "label": "Shares Issued Value Upon Exercise Of Warrants Net Of Issuance Costs", "terseLabel": "Shares issued upon exercise of warrants, net of issuance costs" } } }, "localname": "SharesIssuedValueUponExerciseOfWarrantsNetOfIssuanceCosts", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "kbnt_StateAndLocalNetOperatingLoss": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of state and local NOLs", "label": "State And Local Net Operating Loss", "terseLabel": "State and local NOLs" } } }, "localname": "StateAndLocalNetOperatingLoss", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "kbnt_StockIssuedDuringPeriodSharesExerciseOfWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period due to exercise of warrant.", "label": "Stock Issued During Period, Shares, Exercise of Warrant", "verboseLabel": "Exercise of warrant (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesExerciseOfWarrant", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "kbnt_StockIssuedDuringPeriodSharesStockAndWarrantsConversionOfConvertibleSecurities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities in to stocks and warrants..", "label": "Stock Issued During Period, Shares, Stock and Warrants, Conversion of Convertible Securities", "terseLabel": "Conversion of notes payable and accrued interest into common stock and warrants (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockAndWarrantsConversionOfConvertibleSecurities", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "kbnt_StockIssuedDuringPeriodValueStockAndWarrantsConversionOfConvertibleSecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities in to stocks and warrants.", "label": "Stock Issued During Period, Value, Stock and Warrants, Conversion of Convertible Securities", "terseLabel": "Conversion of notes payable and accrued interest into common stock and warrants" } } }, "localname": "StockIssuedDuringPeriodValueStockAndWarrantsConversionOfConvertibleSecurities", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "kbnt_StockOptionsPlanExpense": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of stock options plan expense.", "label": "Stock Options Plan Expense", "verboseLabel": "Stock-based compensation: Stock options" } } }, "localname": "StockOptionsPlanExpense", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "kbnt_SupplierBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier B.", "label": "Supplier B" } } }, "localname": "SupplierBMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier D.", "label": "Supplier D" } } }, "localname": "SupplierDMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_SupplierEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Supplier E.", "label": "Supplier E" } } }, "localname": "SupplierEMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopFiveCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member represents for Top Five Customers.", "label": "Top Five Customers" } } }, "localname": "TopFiveCustomersMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopFourSuppliersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Top Four Suppliers.", "label": "Top Four Suppliers" } } }, "localname": "TopFourSuppliersMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TopThreeCustomersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This member stands for Top Three Customers.", "label": "Top Three Customers" } } }, "localname": "TopThreeCustomersMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "kbnt_TwoThousandSeventeenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Seventeen Equity Incentive Plan [Member]", "label": "2017 Equity Incentive Plan" } } }, "localname": "TwoThousandSeventeenEquityIncentivePlanMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_TwoThousandSeventeenStockOptionPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand Seventeen Stock Option Plan [Member]", "label": "2017 Stock Option Plan" } } }, "localname": "TwoThousandSeventeenStockOptionPlanMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_UnderwritersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriters [Member]", "label": "Underwriters" } } }, "localname": "UnderwritersMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "kbnt_UnitPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single unit.", "label": "Unit Price", "terseLabel": "Price per unit" } } }, "localname": "UnitPrice", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "kbnt_UnitsIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of new units issued during the period.", "label": "Units Issued During Period Shares New Issues", "terseLabel": "Number of units issued" } } }, "localname": "UnitsIssuedDuringPeriodSharesNewIssues", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "kbnt_WarrantsExercisePriceFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the exercise price range five, on warrants issued.", "label": "Warrant Exercise Price $ 6.38" } } }, "localname": "WarrantsExercisePriceFiveMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails" ], "xbrltype": "domainItemType" }, "kbnt_WarrantsExercisePriceFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the exercise price range four, on warrants issued.", "label": "Warrant Exercise Price $ 6.25" } } }, "localname": "WarrantsExercisePriceFourMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails" ], "xbrltype": "domainItemType" }, "kbnt_WarrantsExercisePriceOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the exercise price range one, on warrants issued.", "label": "Warrant Exercise Price $ 4.20" } } }, "localname": "WarrantsExercisePriceOneMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails" ], "xbrltype": "domainItemType" }, "kbnt_WarrantsExercisePriceThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the exercise price range three, on warrants issued.", "label": "Warrant Exercise Price $ 5.50" } } }, "localname": "WarrantsExercisePriceThreeMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails" ], "xbrltype": "domainItemType" }, "kbnt_WarrantsExercisePriceTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the exercise price range two, on warrants issued.", "label": "Warrant Exercise Price $ 4.95" } } }, "localname": "WarrantsExercisePriceTwoMember", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails" ], "xbrltype": "domainItemType" }, "kbnt_WarrantsWeightedAverageExercisePriceRollForwardAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "n/a", "label": "Warrants, Weighted Average Exercise Price, Roll Forward [Abstract]", "verboseLabel": "Weighted Average Exercise Price" } } }, "localname": "WarrantsWeightedAverageExercisePriceRollForwardAbstract", "nsuri": "http://www.kubient.com/20211231", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "stringItemType" }, "srt_BoardOfDirectorsChairmanMember": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "label": "Board of Directors" } } }, "localname": "BoardOfDirectorsChairmanMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "label": "Chief financial officer" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ExecutiveOfficerMember": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "label": "Executive Officer" } } }, "localname": "ExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "srt_LitigationCaseAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Axis]" } } }, "localname": "LitigationCaseAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_LitigationCaseTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation Case [Domain]" } } }, "localname": "LitigationCaseTypeDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r164", "r296", "r299", "r505" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r228", "r268", "r307", "r310", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r504", "r506", "r518", "r519" ], "lang": { "en-us": { "role": { "label": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r228", "r268", "r307", "r310", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r504", "r506", "r518", "r519" ], "lang": { "en-us": { "role": { "label": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r164", "r296", "r299", "r505" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r228", "r268", "r304", "r307", "r310", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r504", "r506", "r518", "r519" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r228", "r268", "r304", "r307", "r310", "r452", "r453", "r454", "r455", "r456", "r457", "r458", "r504", "r506", "r518", "r519" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r110", "r115", "r308" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r110", "r115", "r203", "r308", "r450" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r165", "r443" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_VicePresidentMember": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "label": "Vice President" } } }, "localname": "VicePresidentMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsAndOtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.", "label": "Accounts and Other Receivables, Net, Current", "terseLabel": "Other receivables" } } }, "localname": "AccountsAndOtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "terseLabel": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r8", "r33" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "terseLabel": "Accounts payable - trade" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r21", "r166", "r167" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedBonusesCurrent": { "auth_ref": [ "r7", "r8", "r37" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 13.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Bonuses, Current", "terseLabel": "Accrued bonuses" } } }, "localname": "AccruedBonusesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r8", "r37" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 12.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Payroll Taxes, Current", "terseLabel": "Accrued payroll taxes" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r7", "r8", "r37" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 10.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees, Current", "terseLabel": "Accrued legal and professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r22", "r347", "r447" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r102", "r103", "r104", "r344", "r345", "r346", "r416" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition", "terseLabel": "Stock-based compensation: Options" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Cost [Policy Text Block]", "verboseLabel": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r351" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesAdvertisingCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r314", "r340", "r349" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense", "totalLabel": "Total" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r168", "r172", "r173", "r175" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss", "verboseLabel": "Allowance for uncollectible accounts receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesAccountsReceivableAndAccountsPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r60", "r77", "r248", "r438" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of Debt Issuance Costs", "terseLabel": "Non-cash amortization of debt discount and debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r77", "r248", "r258", "r259", "r438" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "terseLabel": "Amortization of debt discount and debt issuance costs" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r77", "r179", "r187" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Shares excluded from the calculation of weighted average dilutive common shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Net Loss Per Common Share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetAcquisitionAxis": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Information by asset acquisition.", "label": "Asset Acquisition [Axis]" } } }, "localname": "AssetAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable": { "auth_ref": [ "r396", "r397", "r398" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of acquirer's equity interest issued and issuable as part of consideration transferred in asset acquisition.", "label": "Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable", "terseLabel": "Fair value of common stock issued as a part of consideration" } } }, "localname": "AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetAcquisitionDomain": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Asset acquisition.", "label": "Asset Acquisition [Domain]" } } }, "localname": "AssetAcquisitionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r95", "r151", "r154", "r160", "r170", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r401", "r406", "r426", "r445", "r447", "r479", "r495" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets.", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r6", "r46", "r95", "r170", "r214", "r215", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r401", "r406", "r426", "r445", "r447" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r316", "r342" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "verboseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r306", "r309" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationProFormaInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationTables" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r306", "r309", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationProFormaInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationTables" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationProFormaInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationTables" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r381", "r382" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Business Acquisition, Pro Forma Information [Table Text Block]", "terseLabel": "Schedule of Business acquisition, Pro Forma information" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Share price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r381", "r382" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "terseLabel": "Net Loss" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r381", "r382" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "terseLabel": "Net Revenues" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationProFormaInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r390", "r391", "r393" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "totalLabel": "Total purchase consideration" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": { "auth_ref": [ "r389", "r392" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.", "label": "Business Combination, Contingent Consideration, Liability, Noncurrent", "terseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "BUSINESS COMBINATION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombination" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "auth_ref": [ "r385" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "terseLabel": "Total Current Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r385" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r385" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Other receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r385" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "terseLabel": "Total Current Liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r385" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r385" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]", "terseLabel": "Current Assets:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BUSINESS COMBINATION" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r30", "r79" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r10", "r80" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "verboseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r73", "r79", "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and Cash Equivalents - End of the Year", "periodStartLabel": "Cash and Cash Equivalents - Beginning of the Year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r73", "r427" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net Increase In Cash and Cash Equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price of warrants issued", "verboseLabel": "Exercise price of warrants (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Number of shares per warrant" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Warrants to purchase shares of common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Outstanding, end of the period (in shares)", "periodStartLabel": "Outstanding, beginning of the period (in shares)", "terseLabel": "Outstanding number of warrants (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r291", "r313" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r41", "r202", "r484", "r500" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 9)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r199", "r200", "r201", "r211", "r515" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "terseLabel": "Common stock reserved" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r102", "r103", "r416" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r20" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r20", "r282" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r20", "r447" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.00001 par value; 95,000,000 shares authorized; 14,253,948 and 11,756,109 shares issued and outstanding as of December 31, 2021 and 2020 respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommonStockVotingRights": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Common Stock, Voting Rights" } } }, "localname": "CommonStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommunicationsAndInformationTechnology": { "auth_ref": [ "r61" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense in the period for communications and data processing expense.", "label": "Communications and Information Technology", "terseLabel": "Technology" } } }, "localname": "CommunicationsAndInformationTechnology", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r180", "r185", "r388" ], "lang": { "en-us": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer software" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r139", "r140", "r164", "r423", "r424", "r514" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r139", "r140", "r164", "r423", "r424", "r512", "r514" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r139", "r140", "r164", "r423", "r424", "r512", "r514" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "CONCENTRATIONS.", "terseLabel": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r139", "r140", "r164", "r423", "r424" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk (as a percent)" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r137", "r139", "r140", "r141", "r423", "r425", "r514" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r139", "r140", "r164", "r423", "r424", "r514" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails", "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r87", "r403" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "verboseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r14", "r480", "r493", "r513" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible notes" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsProductLineMember": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Cost of product sold and service rendered from specified product or service, when it serves as benchmark in concentration of risk calculation.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsProductLineMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r138", "r164" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentrations" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r387" ], "lang": { "en-us": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer list" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsTables", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r82", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount", "terseLabel": "Conversion of notes payable and accrued interest into common stock" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r82", "r84" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion, Converted Instrument, Shares Issued", "terseLabel": "Number of shares of common stock issued upon conversion" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": { "auth_ref": [ "r82", "r84" ], "lang": { "en-us": { "role": { "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Warrants or Options Issued", "terseLabel": "Warrants to purchase shares of common stock" } } }, "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r82", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Original Debt, Amount", "terseLabel": "Principal amount of notes payable converted to common stock", "verboseLabel": "Aggregate principal balance" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NOTES PAYABLE" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r91", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r242", "r249", "r250", "r252", "r262" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "NOTES PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r14", "r15", "r16", "r94", "r100", "r225", "r226", "r227", "r228", "r229", "r230", "r232", "r238", "r239", "r240", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r256", "r257", "r258", "r259", "r439", "r480", "r482", "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "auth_ref": [ "r289" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.", "label": "Debt Instrument, Convertible, Beneficial Conversion Feature", "terseLabel": "Beneficial conversion feature" } } }, "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r227", "r253" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r225", "r256", "r257", "r437", "r439", "r440" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Principal amount of debt" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r39", "r254", "r437", "r439" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Interest on related party notes payable", "verboseLabel": "Effective Percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r39", "r226" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest rate (as a percent)" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r40", "r94", "r100", "r225", "r226", "r227", "r228", "r229", "r230", "r232", "r238", "r239", "r240", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r256", "r257", "r258", "r259", "r439" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPayment": { "auth_ref": [ "r40", "r490" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments including both interest and principal payments.", "label": "Debt Instrument, Periodic Payment", "terseLabel": "Periodic installment amount" } } }, "localname": "DebtInstrumentPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r40", "r94", "r100", "r225", "r226", "r227", "r228", "r229", "r230", "r232", "r238", "r239", "r240", "r241", "r243", "r244", "r245", "r246", "r247", "r248", "r251", "r256", "r257", "r258", "r259", "r283", "r287", "r288", "r289", "r436", "r437", "r439", "r440", "r491" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Term of the debt" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r238", "r436", "r440" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.", "label": "Deferred Charges, Policy [Policy Text Block]", "verboseLabel": "Deferred Offering Costs" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredCosts": { "auth_ref": [ "r13", "r478", "r494" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.", "label": "Deferred Costs, Noncurrent", "terseLabel": "Deferred offering costs" } } }, "localname": "DeferredCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r96", "r368", "r374" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "totalLabel": "Total" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]", "verboseLabel": "Deferred tax benefit:" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r17", "r18", "r360", "r481", "r492" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Deferred Revenue, Current", "terseLabel": "Deferred revenue" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r96", "r368", "r374" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "State and local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "auth_ref": [ "r366", "r367" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.", "label": "Deferred Tax Assets, Deferred Income", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredTaxAssetsDeferredIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.", "label": "Deferred Tax Assets, Goodwill and Intangible Assets", "verboseLabel": "Intangibles" } } }, "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r361" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r363" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets, Net [Abstract]" } } }, "localname": "DeferredTaxAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r366", "r367" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "verboseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r366", "r367" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost", "verboseLabel": "Stock-based compensation expense" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r362" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDeferredTaxAssetsRelateToTemporaryDifferencesAndCarryforwardsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r77", "r149" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r99", "r411", "r412", "r413", "r414", "r415" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives, Policy [Policy Text Block]", "verboseLabel": "Convertible Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "auth_ref": [ "r316", "r342" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of share-based payment arrangement.", "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]", "verboseLabel": "Summary of Black-Scholes Pricing Model Stock Options" } } }, "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r56", "r107", "r108", "r109", "r110", "r111", "r116", "r120", "r123", "r124", "r125", "r128", "r129", "r417", "r418", "r486", "r502" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net Loss Per Share - Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r56", "r107", "r108", "r109", "r110", "r111", "r120", "r123", "r124", "r125", "r128", "r129", "r417", "r418", "r486", "r502" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net Loss Per Share - Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r126", "r127" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r355" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "totalLabel": "Effective income tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r97", "r355", "r375" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails": { "order": 1.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "verboseLabel": "Tax expense at the federal statutory rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r355", "r375" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails": { "order": 2.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "verboseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r355", "r375" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails": { "order": 4.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "verboseLabel": "State taxes, net of federal benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesStatutoryFederalIncomeTaxRatesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Unrecognized stock-based compensation expense", "verboseLabel": "Unrecognized stock-based compensation expense" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Unrecognized stock-based compensation expense, period of recognition", "verboseLabel": "Unrecognized stock-based compensation expense, period of recognition" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Stock options" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Stock Options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EnergyMarketingContractLiabilitiesCurrent": { "auth_ref": [ "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current liabilities attributable to energy marketing activities (trading activities). Current energy marketing (trading activities) are when entities engage in both financial and physical trading to increase profits, manage their commodity price risk and enhance system reliability. They may trade electricity, coal, natural gas and oil. These entities typically use a variety of financial instruments, including forward contracts, options and swaps.", "label": "Energy Marketing Contract Liabilities, Current", "terseLabel": "Contract liabilities" } } }, "localname": "EnergyMarketingContractLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesRevenueRecognitionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r50", "r51", "r52", "r102", "r103", "r104", "r106", "r112", "r114", "r130", "r171", "r282", "r290", "r344", "r345", "r346", "r370", "r371", "r416", "r428", "r429", "r430", "r431", "r432", "r433", "r507", "r508", "r509", "r530" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails", "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "verboseLabel": "Summary of assumptions fair value of warrants" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r421", "r422" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "verboseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life", "terseLabel": "Estimated useful lives, Intangible assets", "verboseLabel": "Estimated useful lives, Intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r186" ], "calculation": { "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedLabel": "Less: accumulated amortization", "periodEndLabel": "Finite-Lived Intangible Assets, Accumulated Amortization, Ending Balance", "periodStartLabel": "Finite-Lived Intangible Assets, Accumulated Amortization, Beginning Balance" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r188" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Amortization of intangible assets consists" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r188" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "terseLabel": "2026 and beyond" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r188" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r188" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r188" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r180", "r183", "r186", "r190", "r463", "r464" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsTables", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsFutureAmortizationExpenseDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r186", "r464" ], "calculation": { "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "periodEndLabel": "Finite-Lived Intangible Assets, Gross, Ending Balance", "periodStartLabel": "Finite-Lived Intangible Assets, Gross, Beginning Balance", "verboseLabel": "Intangible assets, gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsTables", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r180", "r185" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsTables", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r186", "r463" ], "calculation": { "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "periodEndLabel": "Finite-Lived Intangible Assets, Net, Ending Balance", "periodStartLabel": "Finite-Lived Intangible Assets, Net, Beginning Balance", "totalLabel": "Intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "terseLabel": "Weighted average remaining amortization period" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Finite-lived Intangible Assets [Roll Forward]" } } }, "localname": "FiniteLivedIntangibleAssetsRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "auth_ref": [ "r181" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition.", "label": "Finite-lived Intangible Assets Acquired", "terseLabel": "Additions" } } }, "localname": "FinitelivedIntangibleAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r202" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain (Loss) Related to Litigation Settlement", "negatedLabel": "Loss on legal settlement", "verboseLabel": "Loss on legal settlement" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails", "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r77", "r260", "r261" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedLabel": "Loss on extinguishment of convertible note payable", "terseLabel": "Extinguishment loss on convertible note payable", "verboseLabel": "Loss on extinguishment of convertible note payable" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows", "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing general and administrative expense.", "label": "General and Administrative Expense [Member]", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r176", "r177", "r447", "r477" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill", "verboseLabel": "Remaining Unidentified Goodwill Value" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INTANGIBLE ASSETS" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusAxis": { "auth_ref": [ "r311", "r312", "r338" ], "lang": { "en-us": { "role": { "documentation": "Information by status of recipient to whom award is granted.", "label": "Grantee Status [Axis]" } } }, "localname": "GranteeStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GranteeStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Status of recipient to whom award is granted.", "label": "Grantee Status [Domain]" } } }, "localname": "GranteeStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r194", "r197" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]", "verboseLabel": "Impairment of Long-lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Operations" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r196", "r198" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r198" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r97", "r356", "r358", "r365", "r372", "r376", "r378", "r379", "r380" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r98", "r113", "r114", "r150", "r354", "r373", "r377", "r503" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "totalLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r49", "r352", "r353", "r358", "r359", "r364", "r369" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": { "auth_ref": [ "r76" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.", "label": "Increase (Decrease) in Accounts and Other Receivables", "negatedLabel": "Other receivable" } } }, "localname": "IncreaseDecreaseInAccountsAndOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r76" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "terseLabel": "Accounts payable - trade" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r76" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r76" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Accrued expenses and other current liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "auth_ref": [ "r76" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Deferred Revenue", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r76" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r182", "r189" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r182", "r189" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r193" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r88", "r185", "r459", "r460", "r461", "r463" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r178", "r184" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net", "verboseLabel": "Intangible asset" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r53", "r148", "r435", "r438", "r487" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r63", "r246", "r255", "r258", "r259" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense, Debt", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "verboseLabel": "Interest income" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r71", "r74", "r81" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "verboseLabel": "Interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r8", "r9", "r37" ], "calculation": { "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails": { "order": 6.0, "parentTag": "kbnt_AccruedExpensesAndOtherCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable, Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InternalUseSoftwarePolicy": { "auth_ref": [ "r191", "r192" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.", "label": "Internal Use Software, Policy [Policy Text Block]", "terseLabel": "Software Development Costs" } } }, "localname": "InternalUseSoftwarePolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r36", "r95", "r155", "r170", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r402", "r406", "r407", "r426", "r445", "r446" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r95", "r170", "r426", "r447", "r483", "r498" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Deficiency", "terseLabel": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r38", "r95", "r170", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r402", "r406", "r407", "r426", "r445", "r446", "r447" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount awarded from other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded from Other Party", "terseLabel": "Settlement amount agreed" } } }, "localname": "LitigationSettlementAmountAwardedFromOtherParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationStatusAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by status of pending, threatened, or settled litigation.", "label": "Litigation Status [Axis]" } } }, "localname": "LitigationStatusAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LitigationStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Status of pending, threatened, or settled litigation.", "label": "Litigation Status [Domain]" } } }, "localname": "LitigationStatusDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r40" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes Payable, Noncurrent", "terseLabel": "Notes payable, non-current portion" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r202", "r203", "r204", "r206", "r207", "r208", "r210", "r212", "r213" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingency Nature [Axis]" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r202", "r203", "r204", "r206", "r207", "r208", "r210", "r212", "r213" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyDamagesSoughtValue": { "auth_ref": [ "r202", "r205", "r209" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.", "label": "Loss Contingency, Damages Sought, Value", "terseLabel": "Loss contingency, damage sought" } } }, "localname": "LossContingencyDamagesSoughtValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesOutstandingLitigationDetails", "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r202", "r203", "r204", "r206", "r207", "r208", "r210", "r212", "r213" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency, Nature [Domain]" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Expected dividends" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Expected term (years)" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputOptionVolatilityMember": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns.", "label": "Expected volatility" } } }, "localname": "MeasurementInputOptionVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Risk free interest rate" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r73" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided By Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows From Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r73" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Cash Used In Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows From Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r73", "r75", "r78" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Used In Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows From Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r47", "r48", "r52", "r55", "r78", "r95", "r105", "r107", "r108", "r109", "r110", "r113", "r114", "r121", "r151", "r153", "r156", "r159", "r161", "r170", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r418", "r426", "r485", "r501" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency", "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r107", "r108", "r109", "r110", "r116", "r117", "r122", "r125", "r151", "r153", "r156", "r159", "r161" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net Loss Attributable to Common Shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Issued Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r62" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total Other Income (Expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other (Expense) Income:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r35" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Costs and Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "verboseLabel": "Costs and Expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r151", "r153", "r156", "r159", "r161" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss From Operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r2", "r410" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "BUSINESS ORGANIZATION, NATURE OF OPERATIONS, RISKS AND UNCERTAINTIES" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessOrganizationNatureOfOperationsRisksAndUncertainties" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r59" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income", "terseLabel": "Other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-allotment option" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsOfFinancingCosts": { "auth_ref": [ "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for loan and debt issuance costs.", "label": "Payments of Financing Costs", "terseLabel": "Issuance costs from exercise of warrants", "verboseLabel": "Issuance costs on initial public offering" } } }, "localname": "PaymentsOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlowsParenthetical", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiencyParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r70" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payment of initial public offering issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r68" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "terseLabel": "Stock-Based Compensation tax withholding obligation" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r64", "r394" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Cash consideration" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r64" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Purchase consideration of MediaCrossing" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r65" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Purchase of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireProductiveAssets": { "auth_ref": [ "r65", "r396", "r397", "r398" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Payments to Acquire Productive Assets", "terseLabel": "Cash consideration" } } }, "localname": "PaymentsToAcquireProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r65" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "PSUs" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r316", "r342" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r19", "r266" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r19", "r266" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r19", "r447" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.00001 par value; 5,000,000 shares authorized; No shares issued and outstanding as of December 31, 2021 and 2020" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r5", "r28", "r29" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r66" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "verboseLabel": "Proceeds from sale of common stock and warrants in initial public offering, net [2]" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r66" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Aggregate proceeds from issuance of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r67" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from Notes Payable", "terseLabel": "Proceeds from issuance of notes payable", "verboseLabel": "Proceeds from notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r67" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Aggregate proceeds from related party notes payable" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.", "label": "Proceeds from (Repayments of) Notes Payable", "terseLabel": "Proceeds from repayment of notes payable" } } }, "localname": "ProceedsFromRepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Proceeds from (Repayments of) Related Party Debt", "verboseLabel": "Repayment of note payable - related party" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r66", "r343" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of options", "verboseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r66" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from Warrant Exercises", "verboseLabel": "Proceeds from exercise of warrants [1]" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r1", "r47", "r48", "r52", "r72", "r95", "r105", "r113", "r114", "r151", "r153", "r156", "r159", "r161", "r170", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r400", "r404", "r405", "r408", "r409", "r418", "r426", "r488" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r11", "r12", "r195", "r447", "r489", "r499" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r31", "r195", "r516", "r517" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property, Plant and Equipment, Useful Life", "verboseLabel": "Property and equipment estimated useful lives" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPropertyAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r58", "r174" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "terseLabel": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r305", "r441", "r442" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r305", "r441", "r444", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r69" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of Debt", "negatedLabel": "Repayment of PPP loan" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r69" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of Notes Payable", "negatedLabel": "Repayment of notes payable", "terseLabel": "Repayments of notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesSettlementsDetails", "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r69" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayment of advance from related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockExpense": { "auth_ref": [ "r77" ], "calculation": { "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.", "label": "Restricted Stock or Unit Expense", "terseLabel": "Stock-based compensation: Common stock" } } }, "localname": "RestrictedStockExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted stock awards" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted stock units (RSUs)" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringPlanAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by individual restructuring plan.", "label": "Restructuring Plan [Axis]" } } }, "localname": "RestructuringPlanAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringPlanDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Identification of the individual restructuring plans.", "label": "Restructuring Plan [Domain]" } } }, "localname": "RestructuringPlanDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r23", "r290", "r347", "r447", "r497", "r510", "r511" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r102", "r103", "r104", "r106", "r112", "r114", "r171", "r344", "r345", "r346", "r370", "r371", "r416", "r507", "r509" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r146", "r147", "r152", "r157", "r158", "r162", "r163", "r164", "r295", "r296", "r462" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net Revenues" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r139", "r164" ], "lang": { "en-us": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsCustomerConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r89", "r90" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligation": { "auth_ref": [ "r293" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.", "label": "Revenue, Remaining Performance Obligation, Amount", "terseLabel": "Revenue recognized from performance obligations satisfied" } } }, "localname": "RevenueRemainingPerformanceObligation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "terseLabel": "Revenue recognized from performance obligations satisfaction period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPerformanceObligationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r54", "r95", "r146", "r147", "r152", "r157", "r158", "r162", "r163", "r164", "r170", "r214", "r215", "r216", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r426", "r488" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONCENTRATIONS" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r126" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of calculation of weighted average dilutive common shares" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationDebtFreeNetWorkingCapitalDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationProFormaInformationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationPurchaseConsiderationDetails", "http://www.kubient.com/role/DisclosureBusinessCombinationTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Schedule of Components of debt free net working capital deficit" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r369" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "verboseLabel": "Schedule of provision for income taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "verboseLabel": "Schedule of components of deferred tax assets relate to temporary differences and carryforwards" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "verboseLabel": "Schedule of provision for income taxes differs from the statutory federal income tax rates" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r314", "r339", "r349" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r314", "r339", "r349" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "terseLabel": "Schedule of stock based compensation expense related to stock options and common stock" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r180", "r185", "r463" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsAmortizationOfIntangibleAssetsConsistsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsIntangibleAssetsConsistDetails", "http://www.kubient.com/role/DisclosureIntangibleAssetsTables", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r180", "r185" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of Intangible assets" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Recognized identified assets acquired and liabilities asumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]", "verboseLabel": "Summary of stock option exercise price" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r320", "r329", "r332" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]", "verboseLabel": "Summary of stock option activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r42", "r92", "r131", "r132", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r271", "r275", "r280", "r283", "r285", "r286", "r287", "r288", "r289", "r290" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r291", "r313" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Summary of stock warrants" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of estimated future amortization expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "auth_ref": [ "r137", "r139", "r140", "r141", "r423", "r425" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "terseLabel": "Summary of customer and supplier concentrations" } } }, "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuredDebt": { "auth_ref": [ "r16", "r482", "r496" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.", "label": "Secured Debt", "verboseLabel": "Principal amount of secured debt" } } }, "localname": "SecuredDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingAndMarketingExpenseMember": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling and marketing expense.", "label": "Selling and Marketing Expense [Member]", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpenseMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SettledLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.", "label": "Settled Litigation [Member]" } } }, "localname": "SettledLitigationMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period", "verboseLabel": "Vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Number of units issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "terseLabel": "Aggregate issuance date fair value of awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "verboseLabel": "Expected dividends" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "verboseLabel": "Expected volatility, Maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "verboseLabel": "Expected volatility, Minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "verboseLabel": "Risk free interest rate, Maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "verboseLabel": "Risk free interest rate, Minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted", "terseLabel": "Number of shares granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "verboseLabel": "Weighted Average Remaining Term (Years) and Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number", "verboseLabel": "Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Shares of common stock granted", "verboseLabel": "Options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r342" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value", "verboseLabel": "Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r322", "r342" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Outstanding", "periodStartLabel": "Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]", "verboseLabel": "Number of Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Outstanding", "periodStartLabel": "Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "verboseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r313", "r318" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercise price", "verboseLabel": "Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price", "verboseLabel": "Forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Tranche one" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Vesting if termination is before the one year anniversary date of the agreement" } } }, "localname": "ShareBasedCompensationAwardTrancheThreeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Trance two" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r316", "r319" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share-based Payment Arrangement [Policy Text Block]", "verboseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Exercise Price Range [Domain]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityStockWarrantsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "verboseLabel": "Options Exercisable, Exercisable Number of Options" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding", "verboseLabel": "Options Outstanding, Weighted Outstanding Number of Options" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by supplier.", "label": "Supplier [Axis]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.", "label": "Supplier [Domain]" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": { "auth_ref": [ "r311", "r338" ], "lang": { "en-us": { "role": { "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.", "label": "Non-employee directors" } } }, "localname": "ShareBasedPaymentArrangementNonemployeeMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage", "verboseLabel": "Vesting percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r336", "r348" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "verboseLabel": "Expected term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r342" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value", "verboseLabel": "Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "verboseLabel": "Exercisable (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "verboseLabel": "Outstanding (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares", "verboseLabel": "Vesting (Shares)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term", "verboseLabel": "Options Exercisable, Average Remaining Life In Years" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "verboseLabel": "Options Outstanding, Exercise price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityScheduleOfInformationRelatedToStockOptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance at the end (in shares)", "periodStartLabel": "Balance at the beginning (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "terseLabel": "Shares withheld for tax withholding obligation" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r86", "r101" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r45", "r50", "r51", "r52", "r102", "r103", "r104", "r106", "r112", "r114", "r130", "r171", "r282", "r290", "r344", "r345", "r346", "r370", "r371", "r416", "r428", "r429", "r430", "r431", "r432", "r433", "r507", "r508", "r509", "r530" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails", "http://www.kubient.com/role/DocumentDocumentAndEntityInformation", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Condensed Consolidated Statements of Cash Flows" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Balance Sheets" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Consolidated Statements of Changes in Stockholders' Equity (Deficiency)" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r102", "r103", "r104", "r130", "r462" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityBlackScholesOptionPricingModelToStockOptionsGrantedDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r82", "r83", "r84" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Shares of common stock issued in satisfaction of accrued issuable equity" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r19", "r20", "r290" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Business acquisition, Number of shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureBusinessCombinationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r44", "r243", "r282", "r283", "r290" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Conversion of notes payable and accrued interest into common stock (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r19", "r20", "r282", "r290" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock and warrants in initial public offering, net of issuance costs (in shares)", "verboseLabel": "Common stock issued during the period" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Stock Issued During Period, Shares, Purchase of Assets", "terseLabel": "Shares issued as partial consideration for intangible asset (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesReverseStockSplits": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Reduction in the number of shares during the period as a result of a reverse stock split.", "label": "Stock Issued During Period, Shares, Reverse Stock Splits", "terseLabel": "Effect of reverse stock-split (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesReverseStockSplits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r19", "r20", "r282", "r290" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation: Common stock (in shares)", "verboseLabel": "Number of shares issued under share based compensation plan" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r19", "r20", "r282", "r290", "r325" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised", "terseLabel": "Common stock issued upon exercise of options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityCompanySStockOptionActivityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r45", "r282", "r290" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Conversion of notes payable and accrued interest into common stock" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r19", "r20", "r282", "r290" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock and warrants in initial public offering, net of issuance costs" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValuePurchaseOfAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Stock Issued During Period, Value, Purchase of Assets", "terseLabel": "Shares issued as partial consideration for intangible asset" } } }, "localname": "StockIssuedDuringPeriodValuePurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r19", "r20", "r290", "r315", "r330" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation: Common stock", "verboseLabel": "Common stock aggregate issuance date fair value" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r45", "r282", "r290" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Common stock issued upon exercise of options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r20", "r24", "r25", "r95", "r169", "r170", "r426", "r447" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance at the end", "periodStartLabel": "Balance at the beginning", "totalLabel": "Total Stockholders' Equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets", "http://www.kubient.com/role/StatementConsolidatedStatementsOfChangesInStockholdersEquityDeficiency" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Deficiency:", "terseLabel": "Stockholders' Equity :" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r93", "r267", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r281", "r290", "r292" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "STOCKHOLDERS' EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r434", "r449" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r434", "r449" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r434", "r449" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r434", "r449" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r448", "r451" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental Disclosures of Cash Flow Information:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Cash paid during the year for:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentrations" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureConcentrationsSupplierConcentrationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TechnologyServiceMember": { "auth_ref": [ "r297" ], "lang": { "en-us": { "role": { "documentation": "Technology assistance, including but not limited to, training, installation, engineering, and software design.", "label": "Technology Service [Member]", "terseLabel": "Technology" } } }, "localname": "TechnologyServiceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityStockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "verboseLabel": "Tax related interest or penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r133", "r134", "r135", "r136", "r142", "r143", "r144" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "verboseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r363" ], "calculation": { "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "terseLabel": "Increased the valuation allowance", "verboseLabel": "Change in valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureIncomeTaxesDetails", "http://www.kubient.com/role/DisclosureIncomeTaxesProvisionForIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureCommitmentsAndContingenciesEmploymentAgreementsDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount": { "auth_ref": [ "r118", "r125", "r284" ], "calculation": { "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of (increase) decrease in equity for down round feature triggered for warrant classified as equity.", "label": "Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount", "negatedLabel": "Deemed dividend related to warrant down round adjustment", "verboseLabel": "Deemed dividend related to warrant down round adjustment" } } }, "localname": "WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails", "http://www.kubient.com/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and Rights Outstanding, Measurement Input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureStockholdersEquityEstimationOfFairValueOfWarrantsDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Term of warrants", "verboseLabel": "Warrants term (in years)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/DisclosureNotesPayableConvertibleNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableDetails", "http://www.kubient.com/role/DisclosureNotesPayableNotePayableToRelatedPartiesDetails", "http://www.kubient.com/role/DisclosureSignificantAccountingPoliciesNetLossPerCommonShareDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityDetails", "http://www.kubient.com/role/DisclosureStockholdersEquityWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r119", "r125" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted Average Common Shares Outstanding - Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r116", "r125" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Common Shares Outstanding - Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.kubient.com/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r101": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "12B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL109261756-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "40", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286" }, "r193": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r201": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r211": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629" }, "r262": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL109261905-112644" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=SL116886442-113899" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "15", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123385561&loc=d3e9135-128495" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9212-128498" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "50", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=123362884&loc=d3e9215-128498" }, "r399": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r451": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r520": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r521": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r522": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r523": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r524": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r525": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r526": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r527": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r528": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r529": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" } }, "version": "2.1" } ZIP 83 0001410578-22-000664-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001410578-22-000664-xbrl.zip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